data_1ahl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ahl _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.931 0.872 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.5 m -92.36 169.07 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.3 p -162.71 157.79 22.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.11 127.62 32.1 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 125.14 1.525 . . . . 0.0 112.594 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 60.7 m -93.39 173.05 7.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 125.338 1.649 . . . . 0.0 106.596 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.87 0.843 . . . . 0.0 109.817 179.838 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -84.37 -159.5 29.92 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.779 -1.677 . . . . 0.0 109.846 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 8.1 m -150.06 134.19 17.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -93.49 142.55 27.21 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.649 -2.523 . . . . 0.0 108.875 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -119.41 134.03 55.42 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 111.938 -2.392 . . . . 0.0 105.712 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.61 -11.89 44.19 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.943 1.354 . . . . 0.0 108.372 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -55.46 144.16 54.25 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 111.25 -2.704 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -64.95 -7.94 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.098 1.865 . . . . 0.0 113.55 -165.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 34.5 p -132.52 17.46 4.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 64.83 -112.02 4.66 Favored Glycine 0 N--CA 1.477 1.384 0 CA-C-N 113.601 -1.636 . . . . 0.0 116.633 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.615 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -47.06 116.87 4.32 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 111.003 -2.599 . . . . 0.0 115.238 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.9 Cg_endo -81.44 152.56 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.774 2.316 . . . . 0.0 109.794 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.1 t -64.57 109.11 1.87 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.956 -1.929 . . . . 0.0 106.18 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.79 -2.1 4.4 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 105.876 -2.89 . . . . 0.0 105.876 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.615 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -109.51 -154.04 0.53 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.441 ' CD2' ' ND2' ' A' ' 35' ' ' ASN . 20.3 t-160 -137.55 -65.57 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.734 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.5 p30 137.42 147.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 128.299 2.64 . . . . 0.0 108.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.74 -1.33 0.38 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.167 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 11.5 mmmm -140.5 106.36 5.16 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.818 0.699 . . . . 0.0 109.177 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.25 -13.76 62.58 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.748 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -140.12 -112.79 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -31.86 129.98 0.22 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.526 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 41.7 Cg_endo -71.46 -173.26 9.55 Favored 'Cis proline' 0 N--CA 1.508 2.367 0 N-CA-C 118.379 2.415 . . . . 0.0 118.379 6.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 t -122.23 18.53 10.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.2 mt -132.25 -75.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.58 -155.18 31.07 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.427 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 6.5 m95 -141.17 167.5 22.03 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.57 1.685 . . . . 0.0 109.55 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 5.5 m -124.38 128.4 49.0 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.442 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.734 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.8 t -144.82 -169.25 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 35' ' ' ASN . 6.4 ptpp? -150.36 156.64 41.9 Favored 'General case' 0 C--N 1.298 -1.67 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.478 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.528 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 t . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -79.54 165.94 22.45 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 119.339 0.972 . . . . 0.0 111.808 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.8 t -162.79 144.48 10.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 115.19 27.5 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 m -88.04 156.62 19.21 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.019 -2.586 . . . . 0.0 104.019 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 40.9 m-20 . . . . . 0 N--CA 1.496 1.854 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.074 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.88 160.5 52.84 Favored Glycine 0 CA--C 1.496 -1.144 0 CA-C-O 124.226 2.015 . . . . 0.0 109.287 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 m -142.66 138.02 30.36 Favored 'General case' 0 C--N 1.28 -2.443 1 N-CA-C 100.108 -4.034 . . . . 0.0 100.108 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.82 140.86 33.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.444 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -114.61 131.91 56.54 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 111.688 -2.506 . . . . 0.0 108.481 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.79 -12.63 41.5 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.339 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -58.38 139.5 84.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 111.89 -2.414 . . . . 0.0 105.393 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -64.98 -7.07 14.15 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.432 1.422 . . . . 0.0 113.86 -163.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.4 p -122.68 13.11 9.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.591 1.182 . . . . 0.0 110.789 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.507 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 67.42 -118.62 10.24 Favored Glycine 0 C--N 1.298 -1.569 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.78 106.54 0.57 Allowed Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 110.87 -2.665 . . . . 0.0 113.503 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -76.52 130.32 11.68 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.877 2.385 . . . . 0.0 108.774 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -42.58 111.2 0.23 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.362 -1.745 . . . . 0.0 106.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.53 -8.55 4.97 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 104.33 -3.508 . . . . 0.0 104.33 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.725 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.2 m95 -105.69 -167.97 1.39 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.448 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.9 m-70 -135.5 -114.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.586 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -174.92 134.99 0.36 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 31.8 p -141.47 -52.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.168 -1.413 . . . . 0.0 109.86 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 39' ' ' HIS . 27.8 mmmt -88.13 65.56 8.19 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.591 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.9 -3.24 1.5 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.389 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 37' ' ' LYS . 12.9 m170 -98.58 -15.21 19.58 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.32 -166.29 24.76 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.168 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 23.8 Cg_endo -74.39 -179.17 25.16 Favored 'Cis proline' 0 N--CA 1.494 1.501 0 N-CA-C 115.513 1.313 . . . . 0.0 115.513 25.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 p -89.42 11.91 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.969 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.0 101.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.89 -171.38 46.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 103.572 -3.811 . . . . 0.0 103.572 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.507 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -127.04 149.41 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 118.95 1.375 . . . . 0.0 108.241 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.587 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 1.2 m -110.48 129.21 55.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.9 t -150.65 -168.05 2.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.799 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -150.38 162.22 40.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 115.789 -2.053 . . . . 0.0 106.982 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 122.223 1.011 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.66 160.02 23.83 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.935 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.12 144.09 9.49 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 123.547 0.53 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.452 ' HA ' ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -74.2 176.8 6.29 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.34 138.7 54.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.748 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 20.0 m-20 . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.452 ' H ' ' HA ' ' A' ' 5' ' ' LEU . 49.4 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.85 -164.76 10.24 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -150.41 159.21 44.63 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.39 146.18 40.89 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -119.64 133.64 55.56 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 111.786 -2.461 . . . . 0.0 109.608 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -88.87 -14.9 35.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.83 144.2 81.61 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 111.43 -2.623 . . . . 0.0 105.913 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -66.9 -19.73 52.12 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.182 1.255 . . . . 0.0 112.486 -162.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.2 p -107.02 5.47 28.11 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.288 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.452 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 69.37 -113.82 5.35 Favored Glycine 0 C--N 1.298 -1.53 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.999 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -43.82 108.97 0.75 Allowed Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 110.451 -2.874 . . . . 0.0 111.316 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 38.1 Cg_endo -74.91 130.81 13.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 N-CA-C 106.06 -2.323 . . . . 0.0 106.06 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -45.92 101.87 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.018 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.6 -4.83 1.99 Allowed Glycine 0 C--N 1.296 -1.673 0 N-CA-C 104.375 -3.49 . . . . 0.0 104.375 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.589 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.2 m95 -105.53 -168.54 1.47 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -140.16 -70.61 0.39 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.743 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 7.8 p30 155.91 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 126.131 1.773 . . . . 0.0 114.258 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -140.82 -7.65 1.08 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.541 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.499 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 18.9 mmmt -134.22 108.31 8.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.359 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.79 31.31 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.492 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m-70 -132.58 -145.99 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.5 -98.3 1.87 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -79.13 -165.59 4.73 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 N-CA-C 114.195 0.806 . . . . 0.0 114.195 1.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -84.76 14.65 4.53 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.996 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 pt -147.24 81.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.7 171.55 44.95 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 107.561 -2.215 . . . . 0.0 107.561 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.4 m95 -116.68 142.44 46.9 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.058 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 13.1 m -103.9 120.74 41.65 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.743 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 1.7 t -142.64 -167.38 2.5 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 27.9 pttt -151.17 164.06 37.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 125.026 1.454 . . . . 0.0 112.714 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -79.71 163.19 24.71 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.6 t -157.06 155.85 31.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.924 0.765 . . . . 0.0 109.917 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.401 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -89.67 121.01 31.44 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.0 m -94.41 152.78 18.35 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.823 0.82 . . . . 0.0 111.039 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.507 ' CG ' ' NZ ' ' A' ' 37' ' ' LYS . 2.7 m-20 . . . . . 0 N--CA 1.507 2.402 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.711 0.291 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.84 -172.51 48.86 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -150.15 144.63 25.8 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.94 138.17 37.38 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 111.585 -2.552 . . . . 0.0 108.256 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -112.2 129.42 56.26 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 110.712 -2.949 . . . . 0.0 107.577 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.23 -14.11 36.68 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -57.33 148.77 51.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 CA-C-N 112.44 -2.164 . . . . 0.0 106.085 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -19.78 68.3 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 120.991 1.128 . . . . 0.0 113.283 -162.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -113.02 7.28 18.05 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.742 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 72.77 -115.59 5.32 Favored Glycine 0 CA--C 1.49 -1.526 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.576 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.0 OUTLIER -48.46 115.03 3.94 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 111.591 -2.304 . . . . 0.0 112.766 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.518 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 63.4 Cg_endo -77.89 165.94 25.79 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.556 2.171 . . . . 0.0 112.469 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 91.66 3.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 111.761 -2.472 . . . . 0.0 108.562 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.42 -1.04 0.34 Allowed Glycine 0 C--N 1.29 -1.992 0 CA-C-N 109.806 -3.361 . . . . 0.0 105.656 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.633 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.9 m95 -116.65 -167.35 1.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -127.34 -73.38 0.61 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 117.795 2.517 . . . . 0.0 117.795 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.736 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.4 p30 143.06 150.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.025 2.53 . . . . 0.0 109.314 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 20.8 p -151.46 -53.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 123.341 1.543 . . . . 0.0 109.407 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.507 ' NZ ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -88.39 78.33 7.96 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.129 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.62 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.775 -1.557 . . . . 0.0 108.62 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 37' ' ' LYS . 88.5 m-70 -109.33 -55.36 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.86 -162.75 9.24 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.439 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.703 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 25.6 Cg_endo -78.71 -173.59 13.16 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 CA-C-N 117.718 0.759 . . . . 0.0 111.384 4.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 p -90.07 5.96 44.46 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.167 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 pt -145.39 102.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 123.91 0.756 . . . . 0.0 109.071 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 169.93 46.12 Favored Glycine 0 N--CA 1.506 3.31 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.504 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 12.3 m95 -109.06 149.78 28.78 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 118.176 0.988 . . . . 0.0 110.522 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.703 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.7 m -111.06 130.75 55.51 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.736 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 11.7 t -150.19 -167.9 2.95 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.514 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.39 160.57 43.65 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.7 tt0 . . . . . 0 C--N 1.298 -1.657 0 O-C-N 125.182 1.551 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -80.79 163.43 23.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 35.4 t -144.38 168.44 20.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.576 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 5.3 tp -119.09 129.85 55.29 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD ' ' A' ' 48' ' ' LYS . 80.7 m -97.56 151.08 20.41 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.304 0.573 . . . . 0.0 110.653 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 62.5 m-20 . . . . . 0 N--CA 1.508 2.432 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 121.163 0.506 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -166.29 37.64 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.3 m -150.01 157.3 43.0 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.97 141.62 45.4 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 111.946 -2.388 . . . . 0.0 107.274 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.404 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 80.0 m95 -112.85 130.86 55.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.8 -2.909 . . . . 0.0 106.138 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.22 -13.1 41.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.523 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 8.5 m-30 -56.67 142.71 70.63 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 111.576 -2.556 . . . . 0.0 107.067 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -63.33 -17.01 58.1 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.015 1.143 . . . . 0.0 113.652 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.7 p -113.62 6.41 16.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.791 -1.549 . . . . 0.0 112.82 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 73.98 -116.71 5.4 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.478 -1.344 . . . . 0.0 115.043 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -45.75 116.36 3.25 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 111.785 -2.207 . . . . 0.0 112.668 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 93.0 Cg_endo -81.48 160.88 19.66 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.117 1.878 . . . . 0.0 108.206 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -69.56 110.2 4.67 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.071 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.28 -4.63 4.52 Favored Glycine 0 C--N 1.289 -2.042 0 N-CA-C 105.208 -3.157 . . . . 0.0 105.208 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.565 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 19.0 m95 -116.49 -164.85 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -126.39 -87.93 0.58 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.669 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.1 p30 149.9 149.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 127.047 2.139 . . . . 0.0 108.627 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.406 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 23.1 p -150.78 -46.78 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.555 1.169 . . . . 0.0 108.3 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 39' ' ' HIS . 25.3 mmmt -88.61 80.19 7.37 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.118 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.6 49.82 1.23 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.338 1.066 . . . . 0.0 108.266 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' H ' ' C ' ' A' ' 37' ' ' LYS . 69.7 m-70 -146.81 -52.26 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.177 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -143.27 4.93 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.505 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 59.2 Cg_endo -70.55 161.24 88.9 Favored 'Cis proline' 0 C--N 1.311 -1.424 0 CA-C-O 123.135 1.223 . . . . 0.0 115.214 8.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 p -72.53 33.38 0.06 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.368 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' ' 41' ' ' PRO . 22.4 pt -140.98 -41.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 121.506 0.67 . . . . 0.0 111.248 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.12 165.27 28.59 Favored Glycine 0 N--CA 1.493 2.466 1 N-CA-C 101.367 -4.693 . . . . 0.0 101.367 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.466 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 11.5 m95 -100.95 154.6 18.54 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.443 2.121 . . . . 0.0 111.741 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.3 m -107.19 123.86 48.89 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.669 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.8 t -150.5 -179.83 7.55 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.844 0.831 . . . . 0.0 110.087 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CD ' ' SG ' ' A' ' 6' ' ' CYS . 34.5 mtmt -142.2 156.15 45.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 3.7 tt0 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 125.555 1.784 . . . . 0.0 114.607 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 m -75.59 165.05 25.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.0 t -159.79 165.8 31.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -100.79 150.03 23.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 48' ' ' LYS . 32.6 m -99.94 161.78 13.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.743 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 7.3 m-20 . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 122.313 1.054 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.58 -169.62 27.76 Favored Glycine 0 C--N 1.3 -1.469 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -150.56 146.79 26.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.28 141.83 34.48 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 111.522 -2.581 . . . . 0.0 107.94 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.3 m95 -114.23 132.64 56.05 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.461 -3.063 . . . . 0.0 107.215 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.66 -12.26 42.98 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.364 -1.743 . . . . 0.0 108.282 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -59.43 139.05 89.01 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.254 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.13 -13.13 33.57 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 120.66 0.907 . . . . 0.0 114.26 -160.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 p -114.57 4.6 15.21 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.167 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.95 -122.09 5.74 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 113.771 -1.558 . . . . 0.0 116.178 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -44.64 116.24 2.63 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 111.04 -2.58 . . . . 0.0 114.341 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 87.7 Cg_endo -77.5 167.1 24.89 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.779 2.319 . . . . 0.0 112.853 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -70.7 103.16 2.48 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.182 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.31 1.44 4.36 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 105.056 -3.218 . . . . 0.0 105.056 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.713 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -117.26 -162.56 0.87 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.5 m-70 -133.5 -114.82 0.21 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.758 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER 177.93 136.5 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 23.9 p -145.62 -46.63 0.21 Allowed 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.579 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 39' ' ' HIS . 27.3 mmmt -88.54 69.66 8.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.704 1.24 . . . . 0.0 109.785 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 5.76 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.163 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.495 ' H ' ' C ' ' A' ' 37' ' ' LYS . 95.1 m-70 -107.57 -16.12 14.43 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.09 -148.79 17.13 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.654 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 92.3 Cg_endo -68.15 -171.3 5.44 Favored 'Cis proline' 0 N--CA 1.493 1.474 0 CA-C-N 118.67 1.235 . . . . 0.0 114.681 4.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 t -93.36 20.81 6.7 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.837 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 mm -123.84 -57.52 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 CA-C-O 121.552 0.691 . . . . 0.0 110.114 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.71 13.61 Favored Glycine 0 N--CA 1.501 3.015 1 N-CA-C 102.913 -4.075 . . . . 0.0 102.913 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -108.49 146.22 33.51 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 120.293 2.046 . . . . 0.0 109.684 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.654 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 6.7 m -104.2 130.46 51.96 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.758 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.9 t -150.48 -163.98 1.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.625 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -150.19 164.25 36.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 116.484 -1.722 . . . . 0.0 109.692 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 51.2 m -134.73 177.36 7.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.588 1.18 . . . . 0.0 109.305 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -160.49 160.79 32.44 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 125.924 2.015 . . . . 0.0 110.993 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.92 117.12 5.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 126.143 2.152 . . . . 0.0 110.394 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.492 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 76.5 m -93.61 159.58 15.16 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.705 -0.798 . . . . 0.0 113.099 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.492 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -86.51 -156.88 29.27 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.5 m -150.36 148.71 29.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 102.327 -3.212 . . . . 0.0 102.327 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.635 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.3 tt -109.56 138.86 45.3 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.864 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -108.55 130.8 55.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.934 -2.394 . . . . 0.0 109.368 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.78 -16.18 32.79 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.075 -2.329 . . . . 0.0 108.847 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -57.37 147.24 59.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 112.138 -2.301 . . . . 0.0 108.12 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -65.49 -12.13 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.047 1.831 . . . . 0.0 113.41 -162.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 p -120.81 6.08 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.499 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.32 -119.6 6.28 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-O 122.984 1.325 . . . . 0.0 113.775 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.57 109.37 0.93 Allowed Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 110.63 -2.785 . . . . 0.0 114.047 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 75.1 Cg_endo -79.25 136.1 12.51 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.966 3.111 . . . . 0.0 110.128 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 m -47.32 104.27 0.05 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.748 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.5 -3.62 2.68 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.725 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.8 m95 -117.6 -171.43 2.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 55.9 m80 -140.45 -99.64 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.16 0.912 . . . . 0.0 112.977 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.711 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -163.47 153.25 15.14 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.67 -30.78 0.23 Allowed 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.51 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 39' ' ' HIS . 14.6 mmmt -117.68 93.53 4.19 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.87 42.9 0.4 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' A' ' 37' ' ' LYS . 71.2 m-70 -140.21 -29.43 0.7 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.355 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.65 -114.8 0.93 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.639 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 14.5 Cg_endo -86.49 -152.95 0.7 Allowed 'Cis proline' 0 C--N 1.314 -1.265 0 CA-C-N 118.537 1.169 . . . . 0.0 110.59 8.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -82.57 9.3 9.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.97 113.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.23 -174.02 27.52 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 106.041 -2.824 . . . . 0.0 106.041 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.495 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 m95 -127.17 135.07 50.18 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.441 1.121 . . . . 0.0 108.187 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.639 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 51.9 m -96.12 122.24 38.74 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.31 1.053 . . . . 0.0 108.987 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.711 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 5.5 t -144.26 -168.92 3.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.464 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.61 168.75 23.35 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 3.4 tt0 . . . . . 0 C--N 1.297 -1.681 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 24.4 m -90.41 -178.33 5.32 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 49.2 t -162.63 169.01 20.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 125.611 1.819 . . . . 0.0 108.356 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.2 mt -104.77 137.76 42.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.585 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -89.93 161.73 15.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.692 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.94 -166.22 10.98 Favored Glycine 0 CA--C 1.555 2.547 0 O-C-N 125.27 1.607 . . . . 0.0 111.872 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 90.0 m -150.76 160.27 43.97 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 103.066 -2.938 . . . . 0.0 103.066 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -113.13 136.88 52.24 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -110.01 134.12 52.47 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.956 1.36 . . . . 0.0 110.574 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.96 -17.01 30.37 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.409 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -57.9 147.46 63.48 Favored Pre-proline 0 N--CA 1.492 1.641 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.424 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -63.69 -11.11 24.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.034 1.823 . . . . 0.0 114.58 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -126.17 10.07 7.44 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.61 1.194 . . . . 0.0 110.744 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.547 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.18 -114.17 4.85 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 119.381 -1.39 . . . . 0.0 113.823 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.22 112.09 1.48 Allowed Pre-proline 0 C--N 1.295 -1.772 0 CA-C-N 111.639 -2.281 . . . . 0.0 111.892 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 85.1 Cg_endo -83.57 151.91 13.34 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 123.191 2.594 . . . . 0.0 109.207 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -52.96 116.35 2.31 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.287 -2.233 . . . . 0.0 108.138 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 2.23 11.7 Favored Glycine 0 C--N 1.29 -2.024 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.333 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.558 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 28.3 m95 -114.33 -177.91 3.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 4.7 m-70 -130.4 -101.52 0.3 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.569 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -169.45 133.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 m -133.46 -20.09 2.1 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.952 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 5' ' ' LEU . 31.4 mmmt -140.77 95.89 2.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.454 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.961 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -120.13 -64.73 1.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.56 -160.9 15.85 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 39.2 Cg_endo -76.45 162.68 91.42 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 CA-C-N 118.707 1.253 . . . . 0.0 113.473 25.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 33.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 41' ' ' PRO . 16.1 tt -150.48 117.9 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.59 45.76 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 103.759 -3.736 . . . . 0.0 103.759 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 42.7 m95 -136.49 156.9 47.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 119.781 1.791 . . . . 0.0 107.564 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.57 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.9 m -120.16 117.28 27.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.5 t -150.66 -173.8 4.58 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 2.6 tmmm? -150.44 155.44 39.55 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.307 -1.259 0 O-C-N 125.878 1.986 . . . . 0.0 108.561 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.9 m -98.75 177.25 5.35 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.265 0.353 . . . . 0.0 110.479 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 t -175.92 172.69 2.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 124.954 1.409 . . . . 0.0 110.557 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -113.33 166.47 11.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.1 m -99.88 171.5 7.82 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.342 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.509 2.48 0 CA-C-O 123.408 1.575 . . . . 0.0 111.9 179.852 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.505 2.302 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.17 -162.07 10.8 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.437 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 62.4 m -150.84 160.96 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 101.358 -3.571 . . . . 0.0 101.358 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 tt -116.97 141.66 47.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.271 -1.786 . . . . 0.0 108.5 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -119.5 129.62 54.8 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 110.634 -2.984 . . . . 0.0 106.715 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.62 -18.98 26.86 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -45.54 146.09 1.88 Allowed Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 110.843 -2.89 . . . . 0.0 109.187 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -65.72 -12.11 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.792 1.661 . . . . 0.0 112.61 -162.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 63.4 p -129.12 21.43 5.76 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.543 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 59.43 -115.66 7.76 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.487 -1.233 . . . . 0.0 116.042 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.23 108.16 0.78 Allowed Pre-proline 0 C--N 1.298 -1.649 0 CA-C-N 110.928 -2.636 . . . . 0.0 113.423 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -76.65 139.17 19.91 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.607 2.205 . . . . 0.0 108.12 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 p -52.24 101.45 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 112.253 -2.248 . . . . 0.0 108.296 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.5 -3.81 1.66 Allowed Glycine 0 CA--C 1.543 1.804 0 N-CA-C 104.942 -3.263 . . . . 0.0 104.942 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.73 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.4 m95 -112.92 -174.68 2.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.3 m-70 -131.68 -101.84 0.28 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.637 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -167.37 146.58 5.07 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.31 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -145.44 -51.98 0.26 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.503 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.5 mmmt -98.65 106.69 18.99 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.478 -1.289 . . . . 0.0 107.84 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.15 2.94 55.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -129.69 -83.58 0.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.42 -169.05 45.53 Favored Glycine 0 N--CA 1.504 3.213 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 5.1 Cg_endo -85.02 28.95 7.87 Favored 'Cis proline' 0 N--CA 1.499 1.798 0 CA-C-N 119.424 1.612 . . . . 0.0 115.522 -6.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.4 m 67.05 -23.09 0.11 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 41' ' ' PRO . 60.4 mt -108.13 137.33 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.23 -151.98 9.01 Favored Glycine 0 N--CA 1.508 3.471 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.543 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 5.7 m95 -135.96 127.92 29.51 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.372 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.503 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 3.4 m -99.44 113.89 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.585 1.184 . . . . 0.0 108.094 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.4 t -134.09 -163.75 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HZ3' ' C ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.73 154.17 36.88 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.671 ' C ' ' HZ3' ' A' ' 48' ' ' LYS . 36.8 tt0 . . . . . 0 C--N 1.303 -1.453 1 N-CA-C 98.803 -4.517 . . . . 0.0 98.803 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 15.5 m -85.29 -178.53 6.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 109.333 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 t -162.67 149.33 12.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.945 1.403 . . . . 0.0 112.384 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 mt -94.72 139.09 31.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 61.2 m -88.36 146.96 24.98 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.752 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.474 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 19.0 t . . . . . 0 N--CA 1.512 2.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.49 -175.31 14.17 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-O 123.213 1.452 . . . . 0.0 111.921 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 89.5 m -150.58 153.59 36.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 135.57 44.7 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 110.856 -2.884 . . . . 0.0 109.09 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.428 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 85.3 m95 -109.91 129.34 55.67 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 109.816 -3.356 . . . . 0.0 107.263 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -88.66 -12.74 41.58 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.117 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -57.17 148.46 51.76 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 111.852 -2.431 . . . . 0.0 108.918 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -63.53 -16.54 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.355 1.37 . . . . 0.0 113.247 -163.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.6 p -121.3 10.16 10.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.218 1.574 . . . . 0.0 111.637 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.46 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.0 -116.78 6.1 Favored Glycine 0 C--N 1.298 -1.574 0 CA-C-N 114.559 -1.2 . . . . 0.0 115.012 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -42.9 109.49 0.76 Allowed Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 111.807 -2.196 . . . . 0.0 113.104 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -77.42 126.03 8.09 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.973 2.448 . . . . 0.0 108.688 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -43.26 100.35 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 112.578 -2.101 . . . . 0.0 109.837 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.54 -8.11 1.81 Allowed Glycine 0 C--N 1.296 -1.688 0 N-CA-C 104.087 -3.605 . . . . 0.0 104.087 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.654 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.8 m95 -97.97 -151.5 0.37 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.556 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.6 t-160 -150.07 -105.73 0.07 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.007 0.192 . . . . 0.0 111.064 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.658 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -168.4 141.12 2.96 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 119.587 -0.245 . . . . 0.0 111.655 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -147.66 -15.83 0.37 Allowed 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 46' ' ' CYS . 1.6 mmpt? -129.3 105.6 8.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 1.88 53.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.97 1.419 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -132.25 -60.02 0.91 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.24 -160.61 17.97 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.753 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 50.1 Cg_endo -73.45 -175.58 15.12 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 O-C-N 122.829 0.91 . . . . 0.0 111.093 -7.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -86.92 5.24 38.06 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.3 pt -143.88 123.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.66 -169.47 54.31 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.46 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 20.9 m95 -130.16 155.2 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.618 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -122.21 129.67 52.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.55 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.1 t -150.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.58 165.67 33.56 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.238 -1.839 . . . . 0.0 108.497 179.619 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -69.57 166.78 18.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.475 ' SG ' ' HG3' ' A' ' 37' ' ' LYS . 7.2 t -156.08 135.48 12.32 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.09 118.06 30.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 8.8 m -88.23 153.96 20.81 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.512 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.297 -1.682 0 CA-C-N 113.375 -1.738 . . . . 0.0 113.454 -179.711 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.506 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -90.8 164.96 30.44 Favored Glycine 0 C--N 1.309 -0.954 0 CA-C-O 125.207 2.559 . . . . 0.0 114.991 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 m -151.1 136.58 17.81 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.17 -2.515 . . . . 0.0 106.184 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 19.5 tp -93.11 138.03 31.91 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 109.703 -3.408 . . . . 0.0 107.649 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.545 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 86.5 m95 -118.51 130.41 55.91 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.429 -3.078 . . . . 0.0 106.263 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.92 -7.05 56.79 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.086 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -58.6 154.64 33.79 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.181 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.18 -24.75 72.63 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.295 1.33 . . . . 0.0 112.358 -166.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 29' ' ' CYS . 25.3 p -116.74 9.16 13.91 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.541 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 45' ' ' TRP . . . 49.77 -84.75 0.01 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 125.919 2.012 . . . . 0.0 110.435 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -38.53 93.63 0.07 OUTLIER Pre-proline 0 C--N 1.283 -2.308 1 CA-C-N 107.764 -4.218 . . . . 0.0 109.942 -179.93 . . . . . . . . 4 4 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 42.7 Cg_endo -86.61 126.18 2.55 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.037 1.824 . . . . 0.0 110.376 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -44.62 112.78 0.46 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.068 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.57 -5.16 6.23 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 104.457 -3.457 . . . . 0.0 104.457 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 15.0 m95 -108.17 -171.06 1.79 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 3.7 m-70 -128.56 -124.43 0.22 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.867 -3.012 . . . . 0.0 102.867 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 6.3 p30 -162.39 159.0 24.72 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.61 -49.71 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.423 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 39' ' ' HIS . 9.7 mmtt -89.01 75.14 8.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -4.81 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.024 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 37' ' ' LYS . 83.7 m-70 -103.73 -21.84 13.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.55 -165.61 27.11 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.812 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -171.15 7.61 Favored 'Cis proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.348 1.574 . . . . 0.0 114.347 16.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 t -95.71 -6.6 39.47 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.671 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.8 pt -106.68 99.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.08 -159.25 28.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 105.129 -3.188 . . . . 0.0 105.129 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 28' ' ' GLY . 4.6 m95 -141.58 142.45 33.48 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.3 m -106.37 116.84 32.63 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 90.7 m -133.31 -171.83 2.79 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -137.75 161.63 36.03 Favored 'General case' 0 C--N 1.295 -1.767 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.451 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 2.5 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 115.357 -2.259 . . . . 0.0 111.087 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m -79.49 160.08 26.69 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t -158.68 151.17 21.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.5 164.55 18.72 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 m -103.7 163.12 12.53 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 3.1 p30 . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.754 0.311 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -171.25 23.7 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 106.742 -2.543 . . . . 0.0 106.742 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.9 m -150.41 149.76 30.47 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.15 143.14 40.69 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.065 -1.88 . . . . 0.0 107.538 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.42 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 87.1 m95 -114.09 131.75 56.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 111.499 -2.591 . . . . 0.0 108.453 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.38 -10.75 48.26 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.882 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.42 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 7.3 m-30 -56.87 145.78 61.76 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 112.172 -2.285 . . . . 0.0 106.99 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -66.18 -16.59 52.46 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.488 1.459 . . . . 0.0 113.265 -164.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 p -111.81 6.11 19.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.112 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.567 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 74.66 -117.78 5.56 Favored Glycine 0 C--N 1.297 -1.589 0 CA-C-N 114.5 -1.227 . . . . 0.0 114.363 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -53.8 119.97 21.26 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 111.616 -2.292 . . . . 0.0 113.115 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.5 Cg_endo -74.85 165.04 32.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-O 125.528 2.22 . . . . 0.0 112.897 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -78.39 79.31 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.363 -2.653 . . . . 0.0 113.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.79 9.64 0.04 OUTLIER Glycine 0 C--N 1.29 -2.017 1 CA-C-N 107.738 -4.301 . . . . 0.0 106.168 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.662 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.7 m95 -125.09 -169.84 2.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.442 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.6 m-70 -133.52 -106.31 0.24 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.65 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.0 OUTLIER 179.93 131.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 122.703 0.401 . . . . 0.0 111.879 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.9 p -150.57 11.61 0.69 Allowed 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 39' ' ' HIS . 0.9 OUTLIER -150.5 67.46 0.95 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.08 29.94 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.463 ' H ' ' C ' ' A' ' 37' ' ' LYS . 37.4 m170 -110.74 -10.12 14.47 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.56 0.344 . . . . 0.0 111.073 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -123.98 4.35 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 43' ' ' ILE . 52.2 Cg_endo -71.6 148.9 91.4 Favored 'Cis proline' 0 N--CA 1.494 1.54 0 N-CA-C 116.42 1.661 . . . . 0.0 116.42 -8.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.16 -9.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 41' ' ' PRO . 47.6 pt -122.7 0.01 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.66 144.34 7.37 Favored Glycine 0 N--CA 1.503 3.139 1 N-CA-C 102.733 -4.147 . . . . 0.0 102.733 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.567 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 1.3 m95 -95.15 138.65 32.58 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 119.719 1.759 . . . . 0.0 111.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.67 127.12 43.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.7 t -148.2 -164.8 2.1 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.001 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HD3' ' SG ' ' A' ' 6' ' ' CYS . 65.3 pttt -151.12 165.16 34.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.511 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.154 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m -114.0 176.42 5.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.33 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 p -174.34 161.95 3.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.21 153.36 23.67 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 4.4 m -99.37 162.15 13.2 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 . . . . . 0 N--CA 1.497 1.905 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.498 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.23 -166.33 38.16 Favored Glycine 0 N--CA 1.483 1.779 0 CA-C-O 122.825 1.236 . . . . 0.0 113.031 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.411 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 2.8 m -141.1 137.49 32.85 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -101.68 133.05 46.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.438 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 72.5 m95 -107.63 127.42 53.64 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.467 -2.151 . . . . 0.0 109.881 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.28 -9.8 51.7 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.283 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -63.37 149.34 91.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 CA-C-N 112.413 -2.176 . . . . 0.0 105.465 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -62.22 -14.77 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.495 1.463 . . . . 0.0 114.052 -161.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 p -123.17 5.49 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.385 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -120.46 5.23 Favored Glycine 0 C--N 1.299 -1.513 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.874 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -40.78 107.48 0.48 Allowed Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 110.583 -2.808 . . . . 0.0 113.172 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 59.4 Cg_endo -79.49 129.96 8.71 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.381 2.721 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -42.06 106.04 0.06 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.629 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.92 -4.64 3.27 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 104.181 -3.567 . . . . 0.0 104.181 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.722 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.0 m95 -110.04 -162.93 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HD1' ' C ' ' A' ' 49' ' ' GLN . 43.3 m80 -137.55 -117.28 0.15 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.686 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p-10 -176.34 132.78 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.611 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 32.0 p -140.01 -53.37 0.52 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.836 -1.146 . . . . 0.0 109.74 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 39' ' ' HIS . 28.9 mmmt -87.19 66.96 9.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.335 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 2.94 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.495 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m170 -113.48 -9.46 13.3 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 133.78 -171.52 22.0 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.621 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.51 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 22.6 Cg_endo -76.74 174.89 12.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 N-CA-C 116.728 1.78 . . . . 0.0 116.728 33.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -79.92 26.12 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.577 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.5 mt -148.57 99.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.99 -173.31 52.21 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 104.935 -3.266 . . . . 0.0 104.935 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -125.31 147.77 48.99 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 120.154 1.977 . . . . 0.0 108.966 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.51 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 4.4 m -110.51 129.7 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.5 t -150.64 -166.94 2.68 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.406 -1.724 . . . . 0.0 109.172 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -150.96 159.88 44.28 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.577 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 2.8 tt0 . . . . . 0 C--N 1.305 -1.361 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.531 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 74.4 m -135.27 179.78 6.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.164 0.915 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -162.91 166.24 24.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 125.736 1.898 . . . . 0.0 109.496 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.13 130.25 42.17 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 124.456 1.098 . . . . 0.0 110.307 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.05 156.27 16.73 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.762 0.792 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.406 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.19 -153.26 7.39 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 118.748 -1.692 . . . . 0.0 112.608 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 33.1 m -150.2 147.21 27.43 Favored 'General case' 0 C--N 1.298 -1.658 1 N-CA-C 100.0 -4.074 . . . . 0.0 100.0 179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.6 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -103.51 137.66 41.29 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 69.7 m95 -111.59 129.73 55.98 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.021 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mt -88.25 -13.55 40.67 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 111.973 -2.376 . . . . 0.0 108.706 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -59.19 147.61 74.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 112.355 -2.202 . . . . 0.0 106.84 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.95 -12.0 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.936 1.757 . . . . 0.0 114.342 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 p -124.17 12.56 8.92 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.45 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 71.75 -120.64 8.22 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-O 122.448 1.027 . . . . 0.0 113.521 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.75 120.7 6.34 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 111.431 -2.385 . . . . 0.0 113.816 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 23' ' ' TRP . 96.6 Cg_endo -79.4 -177.48 3.91 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.545 2.163 . . . . 0.0 108.663 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -87.26 137.59 32.22 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.82 13.04 41.62 Favored Glycine 0 C--N 1.285 -2.251 0 CA-C-N 111.578 -2.556 . . . . 0.0 107.692 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.578 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 9.4 m95 -119.5 -160.24 0.81 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.521 ' CG ' ' H ' ' A' ' 35' ' ' ASN . 16.0 t-160 -132.86 -127.23 0.18 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.646 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -172.36 132.77 0.63 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 18.9 p -142.07 -59.57 0.46 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.401 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.627 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 30.4 mmmt -87.55 60.7 6.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 123.49 1.614 . . . . 0.0 110.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.78 24.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.597 ' H ' ' C ' ' A' ' 37' ' ' LYS . 92.5 m-70 -126.47 -66.31 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.56 -177.77 40.85 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.66 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 36.5 Cg_endo -74.53 176.99 40.48 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 O-C-N 123.738 1.388 . . . . 0.0 112.256 29.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -97.43 -8.7 28.8 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -96.33 78.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.81 -178.01 33.31 Favored Glycine 0 N--CA 1.497 2.718 1 N-CA-C 102.659 -4.177 . . . . 0.0 102.659 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.45 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.5 m95 -121.03 160.49 23.48 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.66 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 20.2 m -119.99 131.84 55.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.646 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.3 t -151.15 -168.55 3.13 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -151.45 166.43 31.12 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 101.489 -3.522 . . . . 0.0 101.489 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 3.9 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.492 1.67 1 N-CA-C 100.126 -4.027 . . . . 0.0 100.126 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -79.42 155.84 28.17 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -159.57 133.86 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.94 178.47 0.81 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.375 1.083 . . . . 0.0 113.291 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 37' ' ' LYS . 32.9 m -101.19 -177.96 3.6 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.548 -1.66 . . . . 0.0 113.224 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.501 2.082 0 O-C-N 120.608 -1.307 . . . . 0.0 111.297 -179.769 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 117.327 2.344 . . . . 0.0 117.327 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.435 ' C ' ' HG1' ' A' ' 21' ' ' THR . . . -92.89 -164.34 37.76 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 20' ' ' GLY . 20.4 m -151.2 147.39 26.95 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 137.19 38.77 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -112.65 128.6 56.43 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 110.985 -2.825 . . . . 0.0 105.984 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.46 -10.19 49.95 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.278 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -57.21 145.47 66.21 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 111.999 -2.364 . . . . 0.0 107.846 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -64.94 -9.72 22.53 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.71 1.607 . . . . 0.0 113.67 -164.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 p -125.75 15.78 8.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.173 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.51 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 63.56 -117.86 12.12 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.451 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.73 110.91 1.36 Allowed Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.759 -2.721 . . . . 0.0 114.989 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -77.09 136.45 16.33 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 124.3 3.334 . . . . 0.0 109.718 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -48.15 108.38 0.17 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.029 1.395 . . . . 0.0 108.182 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.55 2.18 3.66 Favored Glycine 0 N--CA 1.481 1.689 0 CA-C-N 110.532 -3.031 . . . . 0.0 106.45 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.756 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.0 m95 -116.44 -157.4 0.65 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.453 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.5 t-160 -150.25 -110.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.107 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.606 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 2.3 p30 -169.45 147.9 3.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.31 -63.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 124.233 0.958 . . . . 0.0 109.247 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 39' ' ' HIS . 32.1 mmmt -88.71 59.31 5.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.37 17.15 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.9 p80 -129.32 -36.6 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.02 171.72 32.66 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.667 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 65.1 Cg_endo -73.04 175.34 45.61 Favored 'Cis proline' 0 N--CA 1.5 1.881 0 O-C-N 122.903 0.949 . . . . 0.0 114.559 4.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -93.43 19.56 8.22 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.152 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.04 -39.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.711 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.01 165.97 20.81 Favored Glycine 0 N--CA 1.505 3.276 1 N-CA-C 102.276 -4.33 . . . . 0.0 102.276 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 3.7 m95 -101.58 132.01 47.47 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 119.651 1.725 . . . . 0.0 110.532 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.513 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.6 m -99.62 111.9 24.19 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.7 t -127.53 -168.09 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.728 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.66 164.81 36.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 33' ' ' TRP . 3.5 tt0 . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.9 m -84.02 172.08 12.34 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 t -155.93 165.11 37.45 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.6 tp -105.33 129.23 53.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.578 ' SG ' ' HE3' ' A' ' 48' ' ' LYS . 79.8 m -87.49 158.39 18.96 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.211 -2.195 . . . . 0.0 107.118 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.528 ' N ' ' HZ3' ' A' ' 37' ' ' LYS . 71.4 m-20 . . . . . 0 N--CA 1.507 2.386 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.47 -177.13 49.62 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 41.7 m -149.1 145.01 27.02 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.85 133.97 43.42 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.514 -3.039 . . . . 0.0 109.271 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . 0.485 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 81.3 m95 -109.61 129.45 55.59 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 111.548 -2.569 . . . . 0.0 107.546 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.89 -7.55 57.02 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . 0.423 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 11.3 m-30 -57.99 149.7 54.13 Favored Pre-proline 0 C--N 1.301 -1.518 0 CA-C-N 111.913 -2.403 . . . . 0.0 106.569 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.32 -15.06 45.89 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.287 1.324 . . . . 0.0 113.946 -163.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 p -122.1 7.84 9.77 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.157 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.503 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 78.36 -119.42 5.15 Favored Glycine 0 CA--C 1.489 -1.548 0 CA-C-N 114.175 -1.375 . . . . 0.0 114.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.82 115.79 3.53 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 111.851 -2.175 . . . . 0.0 113.318 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 79.1 Cg_endo -76.4 174.94 12.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 CA-C-O 125.604 2.252 . . . . 0.0 114.169 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m -81.69 107.22 14.26 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 110.311 -3.132 . . . . 0.0 105.271 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.67 3.87 5.41 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.616 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 11.9 m95 -119.7 -159.63 0.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 8.1 t-80 -134.49 -118.0 0.18 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.748 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.742 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p30 -175.62 129.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.524 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.82 10.37 0.63 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HZ3' ' N ' ' A' ' 7' ' ' ASP . 2.2 mmpt? -135.87 92.02 2.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.58 38.0 0.09 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -140.89 -26.09 0.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 45' ' ' TRP . . . 141.43 -107.65 0.52 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.66 -173.86 10.59 Favored 'Cis proline' 0 N--CA 1.494 1.527 0 N-CA-C 117.782 2.186 . . . . 0.0 117.782 -4.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -85.51 19.25 2.43 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.325 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.38 23.85 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 122.21 1.005 . . . . 0.0 109.689 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.64 167.09 11.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 103.178 -3.969 . . . . 0.0 103.178 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.503 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -106.69 158.95 16.57 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.66 1.73 . . . . 0.0 110.97 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.438 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 1.8 m -116.28 126.98 54.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.013 0.821 . . . . 0.0 109.205 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.742 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 16.0 t -151.6 -163.74 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.749 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' SG ' ' A' ' 6' ' ' CYS . 32.5 ttmt -150.93 163.31 39.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.8 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.895 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.6 m -90.07 172.13 9.05 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 30.8 t -146.18 160.77 41.5 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.497 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 6.8 mp -83.59 126.13 32.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.32 -178.77 5.98 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 123.63 1.681 . . . . 0.0 108.346 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 48' ' ' LYS . . . -77.24 -169.59 32.21 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.398 0.999 . . . . 0.0 111.43 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 30.2 m -150.55 147.35 27.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 101.676 -3.453 . . . . 0.0 101.676 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 45' ' ' TRP . 5.0 tt -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.225 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -119.1 137.42 53.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.893 -1.958 . . . . 0.0 107.133 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.84 -15.23 35.05 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.486 1.612 . . . . 0.0 108.873 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -56.98 138.49 79.3 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 110.541 -3.027 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.09 -6.54 14.78 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.627 1.552 . . . . 0.0 112.662 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 p -126.74 22.25 6.89 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.944 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 57.8 -111.75 3.26 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 114.126 -1.397 . . . . 0.0 116.274 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.699 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.16 115.48 5.42 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 112.038 -2.081 . . . . 0.0 113.308 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.504 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 71.2 Cg_endo -80.28 150.84 20.14 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.678 2.252 . . . . 0.0 108.72 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.7 t -60.91 108.62 0.89 Allowed 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.43 -4.17 3.36 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 110.706 -2.952 . . . . 0.0 106.637 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.699 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 24.4 m95 -115.48 -160.55 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 78.8 m-70 -135.89 -89.56 0.31 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.703 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER 177.19 156.42 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.6 -43.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 124.357 1.035 . . . . 0.0 109.997 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 39' ' ' HIS . 4.3 mmtt -99.52 104.2 16.0 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.97 21.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' A' ' 37' ' ' LYS . 35.9 m80 -135.96 -15.48 1.76 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.15 -86.44 0.23 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.699 -1.239 . . . . 0.0 112.111 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.47 -164.02 2.32 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 CA-C-N 118.394 1.097 . . . . 0.0 111.091 -6.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 p -74.31 23.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.4 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 41' ' ' PRO . 5.2 mp -148.38 100.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.13 -149.8 21.24 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 104.794 -3.322 . . . . 0.0 104.794 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 14.2 m95 -142.89 152.88 42.57 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.986 1.393 . . . . 0.0 107.724 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.445 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 6.2 m -114.07 116.11 28.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.066 0.936 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 12.0 t -139.34 -168.62 2.49 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.879 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 28.8 tptp -151.25 151.82 32.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 103.0 -2.963 . . . . 0.0 103.0 179.68 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 75.3 m -119.3 174.67 6.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 168.51 22.34 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.527 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.43 ' O ' ' NZ ' ' A' ' 37' ' ' LYS . 2.1 tt -80.49 106.46 12.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.525 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 58.3 m -89.68 162.02 15.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 123.5 1.619 . . . . 0.0 112.165 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.555 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -91.37 -163.99 38.9 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.282 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 15.5 m -150.84 142.3 23.44 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 98.971 -4.455 . . . . 0.0 98.971 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tt -105.02 143.97 32.47 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -117.21 135.46 53.77 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 111.822 -2.445 . . . . 0.0 107.954 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.72 -17.4 30.0 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.874 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -52.07 138.65 35.52 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 110.907 -2.861 . . . . 0.0 109.097 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -66.18 -10.81 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.551 1.501 . . . . 0.0 113.254 -166.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -118.72 16.76 13.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.827 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.5 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 60.75 -118.64 15.64 Favored Glycine 0 C--N 1.297 -1.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 117.089 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.08 114.45 4.35 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 110.713 -2.744 . . . . 0.0 114.295 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 76.1 Cg_endo -80.66 127.63 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.57 2.18 . . . . 0.0 109.762 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 p -44.45 106.58 0.07 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.554 -2.112 . . . . 0.0 105.952 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.4 -7.33 3.1 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.73 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.4 m95 -111.3 -164.24 0.9 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.623 ' HD1' ' C ' ' A' ' 49' ' ' GLN . 48.2 m80 -139.44 -109.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 123.94 0.775 . . . . 0.0 110.254 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.709 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.7 p-10 -164.36 153.02 13.02 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.33 -33.82 0.17 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.457 1.599 . . . . 0.0 111.118 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.481 ' HA ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -115.48 105.01 12.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.64 4.11 17.04 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.996 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -117.22 -112.98 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.282 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.82 -154.87 20.29 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 116.739 1.456 . . . . 0.0 116.739 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 91.7 Cg_endo -67.02 167.68 56.85 Favored 'Cis proline' 0 N--CA 1.501 1.953 0 O-C-N 122.77 0.879 . . . . 0.0 111.373 11.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -25.12 61.66 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.883 0.849 . . . . 0.0 109.585 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 tp -103.37 106.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.33 -177.16 39.21 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.5 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 3.4 m95 -135.88 135.57 39.83 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.72 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 21.5 m -97.47 130.81 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 17.6 t -148.58 -166.54 2.57 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.496 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' NZ ' ' OXT' ' A' ' 49' ' ' GLN . 12.3 ptmm? -152.18 164.0 38.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.623 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 3.2 tt0 . . . . . 0 C--N 1.305 -1.342 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 123.002 1.382 . . . . 0.0 112.16 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.4 m -72.71 170.51 14.4 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.184 -2.28 . . . . 0.0 110.985 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' GLY . 45.7 t -159.39 143.02 14.71 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -73.12 167.72 20.56 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.8 176.05 5.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.421 0 O-C-N 120.56 -1.338 . . . . 0.0 112.163 -179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -80.51 -159.65 21.02 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 63.1 m -151.42 153.86 35.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.52 149.82 23.7 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.016 -1.902 . . . . 0.0 106.683 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -127.51 128.39 45.59 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.082 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -88.99 -10.71 46.63 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.006 -2.815 . . . . 0.0 108.721 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -63.25 150.43 89.17 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 112.524 -2.125 . . . . 0.0 106.21 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.18 -14.39 43.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.663 1.576 . . . . 0.0 113.817 -163.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 p -125.51 13.75 8.16 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 45' ' ' TRP . . . 69.03 -115.73 6.71 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.156 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.3 t -42.67 107.69 0.57 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 110.557 -2.822 . . . . 0.0 113.315 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 37.1 Cg_endo -75.47 124.76 8.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 174.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 p -41.34 108.43 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.21 -4.11 3.76 Favored Glycine 0 C--N 1.293 -1.829 0 N-CA-C 105.08 -3.208 . . . . 0.0 105.08 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.707 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.5 m95 -116.97 167.48 11.09 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 100.906 -3.738 . . . . 0.0 100.906 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.594 ' CG ' ' HZ3' ' A' ' 48' ' ' LYS . 77.8 m80 -93.91 -83.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 119.69 3.219 . . . . 0.0 119.69 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.775 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 7.6 p30 154.07 153.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 128.93 2.892 . . . . 0.0 105.057 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -150.66 -31.72 0.18 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 123.468 0.48 . . . . 0.0 111.642 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.499 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.1 mmmt -125.96 88.35 2.84 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.45 34.5 0.05 Allowed 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.78 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 37' ' ' LYS . 89.6 m-70 -137.49 -21.39 1.16 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.64 -130.23 2.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -61.89 -179.79 5.86 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 CA-C-N 119.167 1.483 . . . . 0.0 113.738 -5.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 p -78.12 -10.04 59.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.177 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tt -97.1 -26.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 121.917 0.865 . . . . 0.0 109.86 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 155.61 27.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 105.577 -3.009 . . . . 0.0 105.577 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' GLY . 6.2 m95 -92.59 140.11 29.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 1.6 m -101.3 117.23 34.56 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 119.269 0.94 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 14.5 t -129.5 -165.05 1.47 Allowed 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.536 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HZ3' ' CG ' ' A' ' 34' ' ' HIS . 14.9 pttp -151.4 152.23 32.81 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.587 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 5.6 tt0 . . . . . 0 C--N 1.299 -1.603 0 O-C-N 124.545 1.153 . . . . 0.0 108.367 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.4 t . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.6 m -70.61 167.73 17.92 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -160.1 121.22 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.645 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.5 mt -59.57 164.66 3.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.504 0.668 . . . . 0.0 110.775 179.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.8 m -101.0 158.51 15.95 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.998 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 6.6 m-20 . . . . . 0 N--CA 1.506 2.335 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.501 2.121 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.42 -174.24 14.23 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-O 122.372 0.985 . . . . 0.0 112.608 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 99.6 m -151.17 155.41 38.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -104.81 141.12 37.07 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 112.304 -2.225 . . . . 0.0 108.325 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -111.85 133.43 54.07 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.292 -2.231 . . . . 0.0 110.83 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.25 -16.51 31.03 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.293 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -60.65 143.38 90.64 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.381 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -66.93 -9.95 26.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.882 1.721 . . . . 0.0 113.62 -165.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 p -117.47 12.14 14.08 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.328 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 67.59 -117.21 8.59 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-N 113.984 -1.462 . . . . 0.0 116.231 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 2.7 t -51.3 113.05 3.51 Favored Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 110.839 -2.68 . . . . 0.0 112.562 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 83.2 Cg_endo -80.92 138.21 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.161 2.574 . . . . 0.0 110.851 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -46.33 99.45 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -1.52 2.46 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 105.424 -3.07 . . . . 0.0 105.424 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TRP . . . . . 0.696 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 21.7 m95 -109.65 -153.85 0.52 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.619 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 17.7 t-160 -150.52 -101.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.489 0.661 . . . . 0.0 110.215 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.613 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -169.78 157.76 7.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.54 -39.03 0.13 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.186 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 22.2 mmmt -101.31 114.48 28.5 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' ND1' ' A' ' 39' ' ' HIS . . . -76.89 10.33 2.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.893 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 38' ' ' ALA . 17.0 m-70 -133.26 -127.35 0.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.38 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.53 -145.65 10.21 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.1 -177.27 17.38 Favored 'Cis proline' 0 N--CA 1.499 1.842 0 CA-C-N 117.968 0.884 . . . . 0.0 111.764 7.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -91.14 -6.53 53.45 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.362 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -116.89 96.75 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.01 157.41 27.71 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TRP . . . . . 0.517 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -109.68 157.59 18.95 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 7.5 m -117.06 119.3 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.079 1.418 . . . . 0.0 109.137 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' C ' ' A' ' 34' ' ' HIS . 9.0 t -134.63 -163.76 1.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.408 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.635 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.04 149.71 29.87 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' C ' ' CE ' ' A' ' 48' ' ' LYS . 46.3 tt0 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.361 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 105.731 -2.948 . . . . 0.0 105.731 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.99 115.12 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.931 0.872 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.5 m -92.36 169.07 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.491 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.3 p -162.71 157.79 22.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.11 127.62 32.1 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 125.14 1.525 . . . . 0.0 112.594 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.514 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 60.7 m -93.39 173.05 7.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 125.338 1.649 . . . . 0.0 106.596 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.59 -14.05 17.9 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.87 0.843 . . . . 0.0 109.817 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -97.5 1.15 48.72 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.434 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -106.3 160.02 15.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.82 -72.55 0.43 Allowed Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.19 166.77 28.72 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.93 1.753 . . . . 0.0 111.582 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 p -89.2 91.14 8.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.35 1.071 . . . . 0.0 109.13 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -132.34 158.54 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 109.823 -3.353 . . . . 0.0 109.461 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.14 134.37 56.42 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.398 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.58 1.78 58.87 Favored Glycine 0 N--CA 1.499 2.854 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.22 161.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 126.006 1.651 . . . . 0.0 113.246 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m 105.16 175.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.488 ' CD2' ' H ' ' A' ' 18' ' ' LEU . 1.2 pt? -87.61 89.19 7.9 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 125.188 2.423 . . . . 0.0 107.294 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -87.72 -3.61 58.95 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 111.729 -2.487 . . . . 0.0 117.158 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.514 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -84.37 -159.5 29.92 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.779 -1.677 . . . . 0.0 109.846 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 8.1 m -150.06 134.19 17.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -93.49 142.55 27.21 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.649 -2.523 . . . . 0.0 108.875 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -119.41 134.03 55.42 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 111.938 -2.392 . . . . 0.0 105.712 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.61 -11.89 44.19 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.943 1.354 . . . . 0.0 108.372 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -55.46 144.16 54.25 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 111.25 -2.704 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -64.95 -7.94 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.098 1.865 . . . . 0.0 113.55 -165.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.426 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 34.5 p -132.52 17.46 4.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 64.83 -112.02 4.66 Favored Glycine 0 N--CA 1.477 1.384 0 CA-C-N 113.601 -1.636 . . . . 0.0 116.633 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.615 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -47.06 116.87 4.32 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 111.003 -2.599 . . . . 0.0 115.238 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.507 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.9 Cg_endo -81.44 152.56 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.774 2.316 . . . . 0.0 109.794 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.1 t -64.57 109.11 1.87 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.956 -1.929 . . . . 0.0 106.18 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.79 -2.1 4.4 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 105.876 -2.89 . . . . 0.0 105.876 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.615 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -109.51 -154.04 0.53 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' CD2' ' ND2' ' A' ' 35' ' ' ASN . 20.3 t-160 -137.55 -65.57 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.734 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.5 p30 137.42 147.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 128.299 2.64 . . . . 0.0 108.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.74 -1.33 0.38 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.167 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.432 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 11.5 mmmm -140.5 106.36 5.16 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.818 0.699 . . . . 0.0 109.177 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.25 -13.76 62.58 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.748 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -140.12 -112.79 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -31.86 129.98 0.22 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.526 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 41.7 Cg_endo -71.46 -173.26 9.55 Favored 'Cis proline' 0 N--CA 1.508 2.367 0 N-CA-C 118.379 2.415 . . . . 0.0 118.379 6.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 t -122.23 18.53 10.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.2 mt -132.25 -75.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -90.58 -155.18 31.07 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.427 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 6.5 m95 -141.17 167.5 22.03 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.57 1.685 . . . . 0.0 109.55 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.526 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 5.5 m -124.38 128.4 49.0 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.442 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.734 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.8 t -144.82 -169.25 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 35' ' ' ASN . 6.4 ptpp? -150.36 156.64 41.9 Favored 'General case' 0 C--N 1.298 -1.67 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.478 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.528 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.588 0 N-CA-C 105.694 -2.962 . . . . 0.0 105.694 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 28.4 t -90.09 152.39 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 5.4 m -79.54 165.94 22.45 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 119.339 0.972 . . . . 0.0 111.808 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.8 t -162.79 144.48 10.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 115.19 27.5 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 m -88.04 156.62 19.21 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.019 -2.586 . . . . 0.0 104.019 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.433 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 40.9 m-20 -61.73 -16.44 49.34 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.074 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -89.9 -1.74 58.04 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.349 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -89.44 91.72 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.24 124.01 26.96 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.467 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.65 166.75 21.1 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.58 2.187 . . . . 0.0 114.742 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -150.3 -176.58 5.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.69 -156.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -61.82 131.17 48.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.585 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 29.75 4.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -68.6 173.98 4.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.012 0.911 . . . . 0.0 111.831 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.7 p -123.75 -177.96 3.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.574 -2.103 . . . . 0.0 107.362 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 3.2 mp -147.39 115.29 6.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 m -84.8 -33.43 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.88 160.5 52.84 Favored Glycine 0 CA--C 1.496 -1.144 0 CA-C-O 124.226 2.015 . . . . 0.0 109.287 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 17.9 m -142.66 138.02 30.36 Favored 'General case' 0 C--N 1.28 -2.443 1 N-CA-C 100.108 -4.034 . . . . 0.0 100.108 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -99.82 140.86 33.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.444 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.1 m95 -114.61 131.91 56.54 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 111.688 -2.506 . . . . 0.0 108.481 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.79 -12.63 41.5 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.339 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -58.38 139.5 84.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 111.89 -2.414 . . . . 0.0 105.393 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -64.98 -7.07 14.15 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.432 1.422 . . . . 0.0 113.86 -163.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.4 p -122.68 13.11 9.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.591 1.182 . . . . 0.0 110.789 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.507 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 67.42 -118.62 10.24 Favored Glycine 0 C--N 1.298 -1.569 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.78 106.54 0.57 Allowed Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 110.87 -2.665 . . . . 0.0 113.503 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -76.52 130.32 11.68 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.877 2.385 . . . . 0.0 108.774 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -42.58 111.2 0.23 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.362 -1.745 . . . . 0.0 106.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.53 -8.55 4.97 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 104.33 -3.508 . . . . 0.0 104.33 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.725 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.2 m95 -105.69 -167.97 1.39 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.448 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.9 m-70 -135.5 -114.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.586 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -174.92 134.99 0.36 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.481 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 31.8 p -141.47 -52.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.168 -1.413 . . . . 0.0 109.86 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.503 ' C ' ' H ' ' A' ' 39' ' ' HIS . 27.8 mmmt -88.13 65.56 8.19 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.591 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.9 -3.24 1.5 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.389 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.503 ' H ' ' C ' ' A' ' 37' ' ' LYS . 12.9 m170 -98.58 -15.21 19.58 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 136.32 -166.29 24.76 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.168 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.587 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 23.8 Cg_endo -74.39 -179.17 25.16 Favored 'Cis proline' 0 N--CA 1.494 1.501 0 N-CA-C 115.513 1.313 . . . . 0.0 115.513 25.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 p -89.42 11.91 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.969 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.0 101.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.89 -171.38 46.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 103.572 -3.811 . . . . 0.0 103.572 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.507 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -127.04 149.41 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 118.95 1.375 . . . . 0.0 108.241 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.587 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 1.2 m -110.48 129.21 55.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.586 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.9 t -150.65 -168.05 2.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.799 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -150.38 162.22 40.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 115.789 -2.053 . . . . 0.0 106.982 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.865 0 N-CA-C 105.916 -2.873 . . . . 0.0 105.916 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 t -140.12 144.68 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 125.016 1.068 . . . . 0.0 108.841 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.53 ' HB3' ' CD1' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -81.66 160.02 23.83 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.935 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.12 144.09 9.49 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 123.547 0.53 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.452 ' HA ' ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -74.2 176.8 6.29 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.34 138.7 54.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.748 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 20.0 m-20 -54.05 -2.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -110.32 -6.13 15.08 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.86 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.48 115.18 29.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 60.64 0.54 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.226 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -67.7 150.45 79.32 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.983 1.789 . . . . 0.0 109.805 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 p -89.02 102.34 14.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.567 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.4 p 179.06 171.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 111.952 -2.386 . . . . 0.0 106.994 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.446 ' C ' ' H ' ' A' ' 16' ' ' ASN . 0.6 OUTLIER -156.82 167.55 30.13 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.41 -32.18 1.38 Allowed Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.666 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.446 ' H ' ' C ' ' A' ' 14' ' ' ARG . 51.8 t30 -140.94 167.15 22.87 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 m 90.91 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.746 1.904 . . . . 0.0 112.239 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 3' ' ' SER . 1.4 pp -150.89 159.11 44.77 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.452 ' H ' ' HA ' ' A' ' 5' ' ' LEU . 49.4 m -141.56 2.45 1.62 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.232 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.85 -164.76 10.24 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -150.41 159.21 44.63 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.39 146.18 40.89 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -119.64 133.64 55.56 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 111.786 -2.461 . . . . 0.0 109.608 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -88.87 -14.9 35.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.83 144.2 81.61 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 111.43 -2.623 . . . . 0.0 105.913 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -66.9 -19.73 52.12 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.182 1.255 . . . . 0.0 112.486 -162.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.2 p -107.02 5.47 28.11 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.288 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.452 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 69.37 -113.82 5.35 Favored Glycine 0 C--N 1.298 -1.53 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.999 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.589 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -43.82 108.97 0.75 Allowed Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 110.451 -2.874 . . . . 0.0 111.316 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.551 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 38.1 Cg_endo -74.91 130.81 13.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 N-CA-C 106.06 -2.323 . . . . 0.0 106.06 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -45.92 101.87 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.018 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.6 -4.83 1.99 Allowed Glycine 0 C--N 1.296 -1.673 0 N-CA-C 104.375 -3.49 . . . . 0.0 104.375 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 20.2 m95 -105.53 -168.54 1.47 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -140.16 -70.61 0.39 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.743 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 7.8 p30 155.91 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 126.131 1.773 . . . . 0.0 114.258 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -140.82 -7.65 1.08 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.541 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.499 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 18.9 mmmt -134.22 108.31 8.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.359 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.79 31.31 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.492 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m-70 -132.58 -145.99 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.5 -98.3 1.87 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -79.13 -165.59 4.73 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 N-CA-C 114.195 0.806 . . . . 0.0 114.195 1.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -84.76 14.65 4.53 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.996 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 pt -147.24 81.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.7 171.55 44.95 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 107.561 -2.215 . . . . 0.0 107.561 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.452 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.4 m95 -116.68 142.44 46.9 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.058 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 13.1 m -103.9 120.74 41.65 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.743 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 1.7 t -142.64 -167.38 2.5 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.409 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 27.9 pttt -151.17 164.06 37.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 125.026 1.454 . . . . 0.0 112.714 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.736 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.55 142.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -79.71 163.19 24.71 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.6 t -157.06 155.85 31.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.924 0.765 . . . . 0.0 109.917 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HG ' ' HB3' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -89.67 121.01 31.44 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' C ' ' H ' ' A' ' 8' ' ' SER . 20.0 m -94.41 152.78 18.35 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.823 0.82 . . . . 0.0 111.039 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.507 ' CG ' ' NZ ' ' A' ' 37' ' ' LYS . 2.7 m-20 -65.79 15.32 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.506 ' H ' ' C ' ' A' ' 6' ' ' CYS . 22.7 t -131.72 1.16 4.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.408 ' HB2' ' CD2' ' A' ' 5' ' ' LEU . 39.9 m-20 -88.73 61.2 5.9 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.04 -121.39 11.66 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.051 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.33 173.63 9.36 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 121.566 1.511 . . . . 0.0 112.268 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -88.95 -176.75 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.718 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 p 45.46 -132.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 123.651 0.595 . . . . 0.0 109.582 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 39.3 mtt85 -118.97 160.81 21.29 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.12 -33.5 1.6 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 17' ' ' THR . 20.8 t30 -109.91 164.03 12.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.158 -1.521 . . . . 0.0 110.444 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.437 ' N ' ' CG ' ' A' ' 16' ' ' ASN . 69.0 m -66.49 150.3 49.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.44 ' H ' HD21 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -102.36 136.62 41.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.848 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 p -126.2 0.61 7.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.922 1.389 . . . . 0.0 110.243 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.84 -172.51 48.86 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -150.15 144.63 25.8 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.94 138.17 37.38 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 111.585 -2.552 . . . . 0.0 108.256 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -112.2 129.42 56.26 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 110.712 -2.949 . . . . 0.0 107.577 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.23 -14.11 36.68 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -57.33 148.77 51.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 CA-C-N 112.44 -2.164 . . . . 0.0 106.085 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -19.78 68.3 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 120.991 1.128 . . . . 0.0 113.283 -162.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -113.02 7.28 18.05 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.742 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 72.77 -115.59 5.32 Favored Glycine 0 CA--C 1.49 -1.526 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.576 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.0 OUTLIER -48.46 115.03 3.94 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 111.591 -2.304 . . . . 0.0 112.766 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.518 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 63.4 Cg_endo -77.89 165.94 25.79 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.556 2.171 . . . . 0.0 112.469 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 91.66 3.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 111.761 -2.472 . . . . 0.0 108.562 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 151.42 -1.04 0.34 Allowed Glycine 0 C--N 1.29 -1.992 0 CA-C-N 109.806 -3.361 . . . . 0.0 105.656 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.633 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.9 m95 -116.65 -167.35 1.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -127.34 -73.38 0.61 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 117.795 2.517 . . . . 0.0 117.795 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.736 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.4 p30 143.06 150.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.025 2.53 . . . . 0.0 109.314 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 20.8 p -151.46 -53.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 123.341 1.543 . . . . 0.0 109.407 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.507 ' NZ ' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -88.39 78.33 7.96 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.129 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.62 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.775 -1.557 . . . . 0.0 108.62 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 37' ' ' LYS . 88.5 m-70 -109.33 -55.36 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.86 -162.75 9.24 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.439 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.703 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 25.6 Cg_endo -78.71 -173.59 13.16 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 CA-C-N 117.718 0.759 . . . . 0.0 111.384 4.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 p -90.07 5.96 44.46 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.167 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 pt -145.39 102.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 123.91 0.756 . . . . 0.0 109.071 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 169.93 46.12 Favored Glycine 0 N--CA 1.506 3.31 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.504 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 12.3 m95 -109.06 149.78 28.78 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 118.176 0.988 . . . . 0.0 110.522 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.703 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.7 m -111.06 130.75 55.51 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.736 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 11.7 t -150.19 -167.9 2.95 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.514 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.39 160.57 43.65 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.428 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.7 tt0 . . . . . 0 C--N 1.298 -1.657 0 O-C-N 125.182 1.551 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.618 0 N-CA-C 105.794 -2.922 . . . . 0.0 105.794 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -99.18 143.82 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -80.79 163.43 23.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 35.4 t -144.38 168.44 20.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.576 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 5.3 tp -119.09 129.85 55.29 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD ' ' A' ' 48' ' ' LYS . 80.7 m -97.56 151.08 20.41 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.304 0.573 . . . . 0.0 110.653 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 62.5 m-20 -60.68 -16.27 37.49 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -88.48 1.4 54.89 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.199 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.428 ' OD1' ' NZ ' ' A' ' 48' ' ' LYS . 20.1 m-20 -105.55 133.94 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.016 0.822 . . . . 0.0 110.363 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.28 59.3 0.3 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -80.45 136.12 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 123.133 2.555 . . . . 0.0 111.229 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 p -89.29 93.56 9.59 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.574 1.178 . . . . 0.0 109.732 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.9 p -154.21 174.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 110.743 -2.935 . . . . 0.0 107.798 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -134.75 149.61 50.45 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.96 -29.65 10.0 Favored Glycine 0 N--CA 1.507 3.388 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -160.51 153.2 21.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.472 ' H ' HD22 ' A' ' 18' ' ' LEU . 25.1 m -156.53 36.48 0.32 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 125.425 1.703 . . . . 0.0 109.027 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.472 HD22 ' H ' ' A' ' 17' ' ' THR . 2.0 pt? -151.13 125.62 9.51 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 t -131.42 5.47 4.39 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 124.777 1.298 . . . . 0.0 110.201 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -166.29 37.64 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.3 m -150.01 157.3 43.0 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -111.97 141.62 45.4 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 111.946 -2.388 . . . . 0.0 107.274 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.404 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 80.0 m95 -112.85 130.86 55.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.8 -2.909 . . . . 0.0 106.138 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.22 -13.1 41.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.523 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.404 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 8.5 m-30 -56.67 142.71 70.63 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 111.576 -2.556 . . . . 0.0 107.067 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -63.33 -17.01 58.1 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.015 1.143 . . . . 0.0 113.652 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.7 p -113.62 6.41 16.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.791 -1.549 . . . . 0.0 112.82 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 73.98 -116.71 5.4 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.478 -1.344 . . . . 0.0 115.043 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -45.75 116.36 3.25 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 111.785 -2.207 . . . . 0.0 112.668 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 93.0 Cg_endo -81.48 160.88 19.66 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.117 1.878 . . . . 0.0 108.206 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -69.56 110.2 4.67 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.071 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.28 -4.63 4.52 Favored Glycine 0 C--N 1.289 -2.042 0 N-CA-C 105.208 -3.157 . . . . 0.0 105.208 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.565 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 19.0 m95 -116.49 -164.85 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -126.39 -87.93 0.58 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.669 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.1 p30 149.9 149.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 127.047 2.139 . . . . 0.0 108.627 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.406 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 23.1 p -150.78 -46.78 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.555 1.169 . . . . 0.0 108.3 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.423 ' C ' ' H ' ' A' ' 39' ' ' HIS . 25.3 mmmt -88.61 80.19 7.37 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.118 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.6 49.82 1.23 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.338 1.066 . . . . 0.0 108.266 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' H ' ' C ' ' A' ' 37' ' ' LYS . 69.7 m-70 -146.81 -52.26 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.177 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -143.27 4.93 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.505 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 59.2 Cg_endo -70.55 161.24 88.9 Favored 'Cis proline' 0 C--N 1.311 -1.424 0 CA-C-O 123.135 1.223 . . . . 0.0 115.214 8.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 p -72.53 33.38 0.06 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.368 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.405 ' H ' ' C ' ' A' ' 41' ' ' PRO . 22.4 pt -140.98 -41.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 121.506 0.67 . . . . 0.0 111.248 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.12 165.27 28.59 Favored Glycine 0 N--CA 1.493 2.466 1 N-CA-C 101.367 -4.693 . . . . 0.0 101.367 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.466 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 11.5 m95 -100.95 154.6 18.54 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.443 2.121 . . . . 0.0 111.741 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.3 m -107.19 123.86 48.89 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.669 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.8 t -150.5 -179.83 7.55 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.844 0.831 . . . . 0.0 110.087 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CD ' ' SG ' ' A' ' 6' ' ' CYS . 34.5 mtmt -142.2 156.15 45.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 3.7 tt0 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 125.555 1.784 . . . . 0.0 114.607 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.45 133.08 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 m -75.59 165.05 25.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.0 t -159.79 165.8 31.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -100.79 150.03 23.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 48' ' ' LYS . 32.6 m -99.94 161.78 13.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.743 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.436 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 7.3 m-20 -61.86 -23.82 66.52 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.313 1.054 . . . . 0.0 111.054 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -67.3 -29.01 68.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.95 68.35 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -38.77 118.12 0.73 Allowed Glycine 0 N--CA 1.502 3.071 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.432 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -69.51 176.74 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.965 1.777 . . . . 0.0 113.55 -162.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.0 p -144.93 156.22 43.86 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.8 m -81.34 79.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.8 ttt85 85.47 165.06 0.09 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 111.452 -2.613 . . . . 0.0 106.564 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.68 7.52 74.65 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -68.28 149.65 49.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.496 -1.352 . . . . 0.0 109.681 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 107.343 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 18' ' ' LEU . 1.1 pt? -149.47 78.73 1.38 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.273 1.511 . . . . 0.0 112.063 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -82.47 2.92 30.44 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.8 -2.0 . . . . 0.0 114.005 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.58 -169.62 27.76 Favored Glycine 0 C--N 1.3 -1.469 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -150.56 146.79 26.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -102.28 141.83 34.48 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 111.522 -2.581 . . . . 0.0 107.94 179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.445 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.3 m95 -114.23 132.64 56.05 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.461 -3.063 . . . . 0.0 107.215 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.66 -12.26 42.98 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.364 -1.743 . . . . 0.0 108.282 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -59.43 139.05 89.01 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.254 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.13 -13.13 33.57 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 120.66 0.907 . . . . 0.0 114.26 -160.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 p -114.57 4.6 15.21 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.167 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.95 -122.09 5.74 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 113.771 -1.558 . . . . 0.0 116.178 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.713 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -44.64 116.24 2.63 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 111.04 -2.58 . . . . 0.0 114.341 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 87.7 Cg_endo -77.5 167.1 24.89 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.779 2.319 . . . . 0.0 112.853 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -70.7 103.16 2.48 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.182 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.31 1.44 4.36 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 105.056 -3.218 . . . . 0.0 105.056 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.713 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -117.26 -162.56 0.87 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.5 m-70 -133.5 -114.82 0.21 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.758 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER 177.93 136.5 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 23.9 p -145.62 -46.63 0.21 Allowed 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.579 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 39' ' ' HIS . 27.3 mmmt -88.54 69.66 8.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.704 1.24 . . . . 0.0 109.785 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 5.76 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.163 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.495 ' H ' ' C ' ' A' ' 37' ' ' LYS . 95.1 m-70 -107.57 -16.12 14.43 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.09 -148.79 17.13 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.654 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 92.3 Cg_endo -68.15 -171.3 5.44 Favored 'Cis proline' 0 N--CA 1.493 1.474 0 CA-C-N 118.67 1.235 . . . . 0.0 114.681 4.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 t -93.36 20.81 6.7 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.837 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 mm -123.84 -57.52 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 CA-C-O 121.552 0.691 . . . . 0.0 110.114 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.71 13.61 Favored Glycine 0 N--CA 1.501 3.015 1 N-CA-C 102.913 -4.075 . . . . 0.0 102.913 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -108.49 146.22 33.51 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 120.293 2.046 . . . . 0.0 109.684 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.654 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 6.7 m -104.2 130.46 51.96 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.758 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.9 t -150.48 -163.98 1.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.625 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -150.19 164.25 36.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.544 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 116.484 -1.722 . . . . 0.0 109.692 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.847 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.15 139.88 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 51.2 m -134.73 177.36 7.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.588 1.18 . . . . 0.0 109.305 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.635 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -160.49 160.79 32.44 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 125.924 2.015 . . . . 0.0 110.993 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 9' ' ' ASP . 4.2 tt -61.92 117.12 5.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 126.143 2.152 . . . . 0.0 110.394 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.492 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 76.5 m -93.61 159.58 15.16 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.705 -0.798 . . . . 0.0 113.099 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.29 -14.19 0.09 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -97.26 -20.23 18.03 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.938 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 5' ' ' LEU . 2.1 m-20 -89.66 112.36 23.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.96 64.58 0.35 Allowed Glycine 0 N--CA 1.497 2.712 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.372 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.99 -174.97 1.92 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.59 2.193 . . . . 0.0 113.859 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 p -90.04 -179.87 5.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.427 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -73.9 124.66 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 1 N-CA-C 96.364 -5.421 . . . . 0.0 96.364 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 83.14 135.81 0.06 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 103.414 -2.81 . . . . 0.0 103.414 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.92 18.86 Favored Glycine 0 N--CA 1.505 3.262 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.615 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -54.46 129.18 34.99 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.922 0.868 . . . . 0.0 109.48 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -103.1 128.13 50.12 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.8 mp -89.32 61.85 5.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 124.109 1.909 . . . . 0.0 106.675 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 -50.52 64.92 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 108.939 -3.755 . . . . 0.0 110.156 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.492 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -86.51 -156.88 29.27 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.5 m -150.36 148.71 29.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 102.327 -3.212 . . . . 0.0 102.327 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.635 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.3 tt -109.56 138.86 45.3 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.864 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 82.4 m95 -108.55 130.8 55.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.934 -2.394 . . . . 0.0 109.368 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.78 -16.18 32.79 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.075 -2.329 . . . . 0.0 108.847 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -57.37 147.24 59.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 112.138 -2.301 . . . . 0.0 108.12 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -65.49 -12.13 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.047 1.831 . . . . 0.0 113.41 -162.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 p -120.81 6.08 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.499 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.495 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.32 -119.6 6.28 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-O 122.984 1.325 . . . . 0.0 113.775 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.57 109.37 0.93 Allowed Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 110.63 -2.785 . . . . 0.0 114.047 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 75.1 Cg_endo -79.25 136.1 12.51 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.966 3.111 . . . . 0.0 110.128 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 m -47.32 104.27 0.05 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.748 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.5 -3.62 2.68 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.725 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.8 m95 -117.6 -171.43 2.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 55.9 m80 -140.45 -99.64 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.16 0.912 . . . . 0.0 112.977 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.711 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -163.47 153.25 15.14 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.67 -30.78 0.23 Allowed 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.51 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.483 ' C ' ' H ' ' A' ' 39' ' ' HIS . 14.6 mmmt -117.68 93.53 4.19 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.87 42.9 0.4 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.483 ' H ' ' C ' ' A' ' 37' ' ' LYS . 71.2 m-70 -140.21 -29.43 0.7 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.355 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.65 -114.8 0.93 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.639 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 14.5 Cg_endo -86.49 -152.95 0.7 Allowed 'Cis proline' 0 C--N 1.314 -1.265 0 CA-C-N 118.537 1.169 . . . . 0.0 110.59 8.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -82.57 9.3 9.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.419 HD11 ' N ' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.97 113.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.23 -174.02 27.52 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 106.041 -2.824 . . . . 0.0 106.041 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.495 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 m95 -127.17 135.07 50.18 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.441 1.121 . . . . 0.0 108.187 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.639 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 51.9 m -96.12 122.24 38.74 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.31 1.053 . . . . 0.0 108.987 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.711 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 5.5 t -144.26 -168.92 3.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.464 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.61 168.75 23.35 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 3.4 tt0 . . . . . 0 C--N 1.297 -1.681 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.687 0 N-CA-C 105.974 -2.85 . . . . 0.0 105.974 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.45 132.68 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 24.4 m -90.41 -178.33 5.32 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 49.2 t -162.63 169.01 20.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 125.611 1.819 . . . . 0.0 108.356 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.2 mt -104.77 137.76 42.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.585 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -89.93 161.73 15.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.692 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -62.41 -34.66 77.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.7 m -77.1 -2.09 32.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 125.123 1.514 . . . . 0.0 113.452 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -89.97 176.69 6.71 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.95 173.05 48.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 109.239 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.61 -170.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.936 1.091 . . . . 0.0 110.097 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.45 103.58 15.99 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 123.285 1.517 . . . . 0.0 110.176 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -163.97 163.65 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 112.333 -2.212 . . . . 0.0 107.965 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.424 ' C ' ' H ' ' A' ' 16' ' ' ASN . 58.0 mtp180 -67.59 167.65 12.6 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.35 -43.49 3.24 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 106.128 -2.789 . . . . 0.0 106.128 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.424 ' H ' ' C ' ' A' ' 14' ' ' ARG . 56.5 t30 -74.55 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.6 m -144.08 164.15 31.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.586 0.707 . . . . 0.0 112.16 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.9 mp -88.68 86.69 7.04 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 m -81.92 25.94 0.54 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.481 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.94 -166.22 10.98 Favored Glycine 0 CA--C 1.555 2.547 0 O-C-N 125.27 1.607 . . . . 0.0 111.872 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 90.0 m -150.76 160.27 43.97 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 103.066 -2.938 . . . . 0.0 103.066 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -113.13 136.88 52.24 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -110.01 134.12 52.47 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.956 1.36 . . . . 0.0 110.574 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.96 -17.01 30.37 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.409 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -57.9 147.46 63.48 Favored Pre-proline 0 N--CA 1.492 1.641 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.424 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -63.69 -11.11 24.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.034 1.823 . . . . 0.0 114.58 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 67.9 p -126.17 10.07 7.44 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.61 1.194 . . . . 0.0 110.744 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.547 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.18 -114.17 4.85 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 119.381 -1.39 . . . . 0.0 113.823 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.22 112.09 1.48 Allowed Pre-proline 0 C--N 1.295 -1.772 0 CA-C-N 111.639 -2.281 . . . . 0.0 111.892 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 85.1 Cg_endo -83.57 151.91 13.34 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 123.191 2.594 . . . . 0.0 109.207 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -52.96 116.35 2.31 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.287 -2.233 . . . . 0.0 108.138 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 2.23 11.7 Favored Glycine 0 C--N 1.29 -2.024 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.333 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.558 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 28.3 m95 -114.33 -177.91 3.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 4.7 m-70 -130.4 -101.52 0.3 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.569 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -169.45 133.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.485 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 m -133.46 -20.09 2.1 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.952 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 5' ' ' LEU . 31.4 mmmt -140.77 95.89 2.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.454 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.961 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -120.13 -64.73 1.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -167.56 -160.9 15.85 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.57 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 39.2 Cg_endo -76.45 162.68 91.42 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 CA-C-N 118.707 1.253 . . . . 0.0 113.473 25.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 33.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.415 ' H ' ' C ' ' A' ' 41' ' ' PRO . 16.1 tt -150.48 117.9 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.59 45.76 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 103.759 -3.736 . . . . 0.0 103.759 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 42.7 m95 -136.49 156.9 47.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 119.781 1.791 . . . . 0.0 107.564 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.57 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.9 m -120.16 117.28 27.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.569 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.5 t -150.66 -173.8 4.58 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.485 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 2.6 tmmm? -150.44 155.44 39.55 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.307 -1.259 0 O-C-N 125.878 1.986 . . . . 0.0 108.561 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.731 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.57 148.08 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.446 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 71.9 m -98.75 177.25 5.35 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.265 0.353 . . . . 0.0 110.479 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 t -175.92 172.69 2.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 124.954 1.409 . . . . 0.0 110.557 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -113.33 166.47 11.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' C ' ' H ' ' A' ' 8' ' ' SER . 60.1 m -99.88 171.5 7.82 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.56 16.5 1.7 Allowed 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 123.408 1.575 . . . . 0.0 111.9 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.463 ' H ' ' C ' ' A' ' 6' ' ' CYS . 23.8 p -108.53 -49.78 3.12 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.956 -2.383 . . . . 0.0 107.657 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.19 175.76 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.77 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.72 59.22 0.01 OUTLIER Glycine 0 N--CA 1.481 1.669 0 CA-C-N 113.01 -1.904 . . . . 0.0 109.381 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.57 131.97 15.47 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 C-N-CA 121.6 1.533 . . . . 0.0 111.413 -168.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -90.02 169.52 11.13 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 38.9 t 69.35 167.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.858 1.313 . . . . 0.0 112.882 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -60.29 143.47 52.75 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.928 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.12 24.22 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -47.75 154.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 125.112 1.125 . . . . 0.0 111.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -147.33 175.44 10.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.545 -1.207 . . . . 0.0 113.181 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.446 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 1.1 mt -114.44 103.04 10.65 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.4 p -81.27 -7.1 59.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.17 -162.07 10.8 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.437 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 62.4 m -150.84 160.96 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 101.358 -3.571 . . . . 0.0 101.358 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.1 tt -116.97 141.66 47.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.271 -1.786 . . . . 0.0 108.5 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -119.5 129.62 54.8 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 110.634 -2.984 . . . . 0.0 106.715 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.62 -18.98 26.86 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -45.54 146.09 1.88 Allowed Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 110.843 -2.89 . . . . 0.0 109.187 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -65.72 -12.11 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.792 1.661 . . . . 0.0 112.61 -162.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.452 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 63.4 p -129.12 21.43 5.76 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.543 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 59.43 -115.66 7.76 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.487 -1.233 . . . . 0.0 116.042 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.23 108.16 0.78 Allowed Pre-proline 0 C--N 1.298 -1.649 0 CA-C-N 110.928 -2.636 . . . . 0.0 113.423 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.486 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -76.65 139.17 19.91 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.607 2.205 . . . . 0.0 108.12 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 p -52.24 101.45 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 112.253 -2.248 . . . . 0.0 108.296 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.5 -3.81 1.66 Allowed Glycine 0 CA--C 1.543 1.804 0 N-CA-C 104.942 -3.263 . . . . 0.0 104.942 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.73 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.4 m95 -112.92 -174.68 2.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.3 m-70 -131.68 -101.84 0.28 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.637 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -167.37 146.58 5.07 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.31 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -145.44 -51.98 0.26 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.503 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.5 mmmt -98.65 106.69 18.99 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.478 -1.289 . . . . 0.0 107.84 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.15 2.94 55.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -129.69 -83.58 0.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.42 -169.05 45.53 Favored Glycine 0 N--CA 1.504 3.213 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.45 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 5.1 Cg_endo -85.02 28.95 7.87 Favored 'Cis proline' 0 N--CA 1.499 1.798 0 CA-C-N 119.424 1.612 . . . . 0.0 115.522 -6.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.4 m 67.05 -23.09 0.11 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.447 ' H ' ' C ' ' A' ' 41' ' ' PRO . 60.4 mt -108.13 137.33 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.23 -151.98 9.01 Favored Glycine 0 N--CA 1.508 3.471 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.543 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 5.7 m95 -135.96 127.92 29.51 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.372 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.503 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 3.4 m -99.44 113.89 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.585 1.184 . . . . 0.0 108.094 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.637 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.4 t -134.09 -163.75 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.671 ' HZ3' ' C ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -150.73 154.17 36.88 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.671 ' C ' ' HZ3' ' A' ' 48' ' ' LYS . 36.8 tt0 . . . . . 0 C--N 1.303 -1.453 1 N-CA-C 98.803 -4.517 . . . . 0.0 98.803 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.701 0 N-CA-C 105.945 -2.862 . . . . 0.0 105.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 t -147.17 142.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.485 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 15.5 m -85.29 -178.53 6.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 109.333 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 9.0 t -162.67 149.33 12.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.945 1.403 . . . . 0.0 112.384 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.8 mt -94.72 139.09 31.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 61.2 m -88.36 146.96 24.98 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.06 -32.33 61.82 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.752 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -78.03 -0.2 27.0 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.612 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -89.76 35.39 0.83 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 119.491 1.042 . . . . 0.0 110.373 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.52 -155.67 51.43 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.433 -1.365 . . . . 0.0 111.477 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.89 164.15 32.19 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.913 2.408 . . . . 0.0 113.656 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -91.6 -175.43 4.19 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t 57.31 24.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.152 0.977 . . . . 0.0 112.194 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -173.82 -159.05 0.1 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 -48.28 3.46 Favored Glycine 0 N--CA 1.488 2.12 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.6 t30 74.02 160.04 0.23 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.1 m 71.04 168.96 0.32 Allowed 'General case' 0 N--CA 1.51 2.53 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.485 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 4.5 mp -140.35 130.18 24.54 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.827 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.474 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 19.0 t -89.44 -4.64 57.9 Favored 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 119.918 1.236 . . . . 0.0 108.165 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.49 -175.31 14.17 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-O 123.213 1.452 . . . . 0.0 111.921 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 89.5 m -150.58 153.59 36.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 135.57 44.7 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 110.856 -2.884 . . . . 0.0 109.09 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.428 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 85.3 m95 -109.91 129.34 55.67 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 109.816 -3.356 . . . . 0.0 107.263 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -88.66 -12.74 41.58 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.117 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -57.17 148.46 51.76 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 111.852 -2.431 . . . . 0.0 108.918 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -63.53 -16.54 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.355 1.37 . . . . 0.0 113.247 -163.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.6 p -121.3 10.16 10.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.218 1.574 . . . . 0.0 111.637 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.46 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.0 -116.78 6.1 Favored Glycine 0 C--N 1.298 -1.574 0 CA-C-N 114.559 -1.2 . . . . 0.0 115.012 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -42.9 109.49 0.76 Allowed Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 111.807 -2.196 . . . . 0.0 113.104 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -77.42 126.03 8.09 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.973 2.448 . . . . 0.0 108.688 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -43.26 100.35 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 112.578 -2.101 . . . . 0.0 109.837 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.54 -8.11 1.81 Allowed Glycine 0 C--N 1.296 -1.688 0 N-CA-C 104.087 -3.605 . . . . 0.0 104.087 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.654 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.8 m95 -97.97 -151.5 0.37 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.556 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.6 t-160 -150.07 -105.73 0.07 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.007 0.192 . . . . 0.0 111.064 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.658 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -168.4 141.12 2.96 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 119.587 -0.245 . . . . 0.0 111.655 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.583 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -147.66 -15.83 0.37 Allowed 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.525 ' HG3' ' CB ' ' A' ' 46' ' ' CYS . 1.6 mmpt? -129.3 105.6 8.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 1.88 53.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.97 1.419 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -132.25 -60.02 0.91 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.24 -160.61 17.97 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.753 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.618 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 50.1 Cg_endo -73.45 -175.58 15.12 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 O-C-N 122.829 0.91 . . . . 0.0 111.093 -7.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -86.92 5.24 38.06 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.3 pt -143.88 123.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.66 -169.47 54.31 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.46 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 20.9 m95 -130.16 155.2 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.618 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -122.21 129.67 52.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.55 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.658 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.1 t -150.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.583 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.58 165.67 33.56 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.238 -1.839 . . . . 0.0 108.497 179.619 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.029 0 N-CA-C 105.419 -3.072 . . . . 0.0 105.419 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.48 140.66 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.496 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 6.3 m -69.57 166.78 18.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.475 ' SG ' ' HG3' ' A' ' 37' ' ' LYS . 7.2 t -156.08 135.48 12.32 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 mt -92.09 118.06 30.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 8.8 m -88.23 153.96 20.81 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.512 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.44 -8.76 2.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.375 -1.738 . . . . 0.0 113.454 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -97.52 -6.76 32.92 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.145 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.497 ' CG ' ' HG ' ' A' ' 19' ' ' SER . 8.1 m-20 -89.52 156.08 18.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 125.152 1.533 . . . . 0.0 110.623 -179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.63 115.86 3.32 Favored Glycine 0 N--CA 1.492 2.422 0 CA-C-O 118.727 -1.041 . . . . 0.0 111.311 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.44 163.35 39.14 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.039 1.826 . . . . 0.0 112.903 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 p -133.03 170.93 14.67 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.006 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 m -78.27 84.03 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 76.21 -167.83 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 112.005 -2.361 . . . . 0.0 109.081 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.34 -41.98 3.07 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.429 HD22 ' CD1' ' A' ' 18' ' ' LEU . 15.0 t30 65.72 148.84 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.593 0.819 . . . . 0.0 112.518 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.1 p -169.91 138.63 1.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.975 -2.972 . . . . 0.0 102.975 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.496 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 3.7 mp -140.9 121.88 14.58 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.497 ' HG ' ' CG ' ' A' ' 9' ' ' ASP . 5.5 m -83.43 -27.08 29.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.506 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -90.8 164.96 30.44 Favored Glycine 0 C--N 1.309 -0.954 0 CA-C-O 125.207 2.559 . . . . 0.0 114.991 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 m -151.1 136.58 17.81 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.17 -2.515 . . . . 0.0 106.184 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 19.5 tp -93.11 138.03 31.91 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 109.703 -3.408 . . . . 0.0 107.649 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.545 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 86.5 m95 -118.51 130.41 55.91 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.429 -3.078 . . . . 0.0 106.263 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.92 -7.05 56.79 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.086 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -58.6 154.64 33.79 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.181 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.18 -24.75 72.63 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.295 1.33 . . . . 0.0 112.358 -166.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 29' ' ' CYS . 25.3 p -116.74 9.16 13.91 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.541 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.421 ' N ' ' CD1' ' A' ' 45' ' ' TRP . . . 49.77 -84.75 0.01 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 125.919 2.012 . . . . 0.0 110.435 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -38.53 93.63 0.07 OUTLIER Pre-proline 0 C--N 1.283 -2.308 1 CA-C-N 107.764 -4.218 . . . . 0.0 109.942 -179.93 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.589 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 42.7 Cg_endo -86.61 126.18 2.55 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.037 1.824 . . . . 0.0 110.376 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -44.62 112.78 0.46 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.068 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.57 -5.16 6.23 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 104.457 -3.457 . . . . 0.0 104.457 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.589 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 15.0 m95 -108.17 -171.06 1.79 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 3.7 m-70 -128.56 -124.43 0.22 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.867 -3.012 . . . . 0.0 102.867 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.421 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 6.3 p30 -162.39 159.0 24.72 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.61 -49.71 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.423 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.501 ' C ' ' H ' ' A' ' 39' ' ' HIS . 9.7 mmtt -89.01 75.14 8.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -4.81 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.024 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.501 ' H ' ' C ' ' A' ' 37' ' ' LYS . 83.7 m-70 -103.73 -21.84 13.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 143.55 -165.61 27.11 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.812 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.86 -171.15 7.61 Favored 'Cis proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.348 1.574 . . . . 0.0 114.347 16.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 t -95.71 -6.6 39.47 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.671 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.8 pt -106.68 99.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.08 -159.25 28.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 105.129 -3.188 . . . . 0.0 105.129 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.421 ' CD1' ' N ' ' A' ' 28' ' ' GLY . 4.6 m95 -141.58 142.45 33.48 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.492 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.3 m -106.37 116.84 32.63 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 90.7 m -133.31 -171.83 2.79 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -137.75 161.63 36.03 Favored 'General case' 0 C--N 1.295 -1.767 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.451 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 2.5 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 115.357 -2.259 . . . . 0.0 111.087 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.776 0 N-CA-C 105.094 -3.202 . . . . 0.0 105.094 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.82 143.45 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.8 m -79.49 160.08 26.69 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t -158.68 151.17 21.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.5 164.55 18.72 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.42 ' SG ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 m -103.7 163.12 12.53 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.411 ' N ' ' HD2' ' A' ' 37' ' ' LYS . 3.1 p30 -50.97 -28.48 9.96 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 m -66.64 -13.86 61.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.201 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -88.15 58.58 4.85 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 123.943 1.83 . . . . 0.0 108.753 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.28 -52.47 6.71 Favored Glycine 0 N--CA 1.496 2.67 0 CA-C-N 111.707 -2.497 . . . . 0.0 112.232 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.14 175.67 10.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.369 2.046 . . . . 0.0 111.764 167.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.428 ' HA ' ' OG1' ' A' ' 17' ' ' THR . 89.1 p -150.35 142.54 24.13 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.836 -1.078 . . . . 0.0 109.811 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.01 168.34 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 124.554 1.159 . . . . 0.0 108.971 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -42.7 125.85 3.49 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 123.738 0.649 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.71 -33.03 6.3 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 104.955 -3.258 . . . . 0.0 104.955 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.2 t30 88.95 158.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 128.285 2.634 . . . . 0.0 110.904 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -92.46 92.57 8.15 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.046 0.927 . . . . 0.0 113.43 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.88 119.31 6.42 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -143.0 14.09 1.88 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.425 -0.797 . . . . 0.0 110.799 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -171.25 23.7 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 106.742 -2.543 . . . . 0.0 106.742 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 32.9 m -150.41 149.76 30.47 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -110.15 143.14 40.69 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.065 -1.88 . . . . 0.0 107.538 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.42 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 87.1 m95 -114.09 131.75 56.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 111.499 -2.591 . . . . 0.0 108.453 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.38 -10.75 48.26 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.882 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.42 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 7.3 m-30 -56.87 145.78 61.76 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 112.172 -2.285 . . . . 0.0 106.99 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -66.18 -16.59 52.46 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.488 1.459 . . . . 0.0 113.265 -164.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 p -111.81 6.11 19.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.112 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.567 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 74.66 -117.78 5.56 Favored Glycine 0 C--N 1.297 -1.589 0 CA-C-N 114.5 -1.227 . . . . 0.0 114.363 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -53.8 119.97 21.26 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 111.616 -2.292 . . . . 0.0 113.115 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.5 Cg_endo -74.85 165.04 32.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-O 125.528 2.22 . . . . 0.0 112.897 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -78.39 79.31 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.363 -2.653 . . . . 0.0 113.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.79 9.64 0.04 OUTLIER Glycine 0 C--N 1.29 -2.017 1 CA-C-N 107.738 -4.301 . . . . 0.0 106.168 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.662 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.7 m95 -125.09 -169.84 2.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.442 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.6 m-70 -133.52 -106.31 0.24 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.65 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.0 OUTLIER 179.93 131.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 122.703 0.401 . . . . 0.0 111.879 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.9 p -150.57 11.61 0.69 Allowed 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 39' ' ' HIS . 0.9 OUTLIER -150.5 67.46 0.95 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.08 29.94 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.463 ' H ' ' C ' ' A' ' 37' ' ' LYS . 37.4 m170 -110.74 -10.12 14.47 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.56 0.344 . . . . 0.0 111.073 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -123.98 4.35 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 43' ' ' ILE . 52.2 Cg_endo -71.6 148.9 91.4 Favored 'Cis proline' 0 N--CA 1.494 1.54 0 N-CA-C 116.42 1.661 . . . . 0.0 116.42 -8.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.16 -9.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 41' ' ' PRO . 47.6 pt -122.7 0.01 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.66 144.34 7.37 Favored Glycine 0 N--CA 1.503 3.139 1 N-CA-C 102.733 -4.147 . . . . 0.0 102.733 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.567 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 1.3 m95 -95.15 138.65 32.58 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 119.719 1.759 . . . . 0.0 111.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.67 127.12 43.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.7 t -148.2 -164.8 2.1 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.001 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.42 ' HD3' ' SG ' ' A' ' 6' ' ' CYS . 65.3 pttt -151.12 165.16 34.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.511 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.154 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.76 0 N-CA-C 105.803 -2.919 . . . . 0.0 105.803 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 t -131.3 135.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.764 1.282 . . . . 0.0 108.048 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m -114.0 176.42 5.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.33 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 p -174.34 161.95 3.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.21 153.36 23.67 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.416 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 4.4 m -99.37 162.15 13.2 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -57.11 -23.4 46.74 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -59.79 -20.51 57.23 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.24 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.54 2.8 54.14 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.828 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.69 -135.08 20.45 Favored Glycine 0 N--CA 1.501 3.029 0 CA-C-N 113.704 -1.589 . . . . 0.0 116.675 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.39 142.72 21.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.114 2.543 . . . . 0.0 115.431 -160.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -89.17 78.48 7.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.027 1.87 . . . . 0.0 111.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 t -97.68 28.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 110.066 -3.243 . . . . 0.0 107.732 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? 66.51 157.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.77 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.1 30.78 76.25 Favored Glycine 0 N--CA 1.503 3.134 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.21 169.23 16.58 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.557 1.17 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 p -94.28 122.19 36.57 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 112.308 -2.224 . . . . 0.0 116.348 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.25 62.65 6.21 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -78.2 -24.66 47.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.23 -166.33 38.16 Favored Glycine 0 N--CA 1.483 1.779 0 CA-C-O 122.825 1.236 . . . . 0.0 113.031 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.411 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 2.8 m -141.1 137.49 32.85 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -101.68 133.05 46.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.438 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 72.5 m95 -107.63 127.42 53.64 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.467 -2.151 . . . . 0.0 109.881 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.28 -9.8 51.7 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.283 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -63.37 149.34 91.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 CA-C-N 112.413 -2.176 . . . . 0.0 105.465 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -62.22 -14.77 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.495 1.463 . . . . 0.0 114.052 -161.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 5.7 p -123.17 5.49 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.385 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.87 -120.46 5.23 Favored Glycine 0 C--N 1.299 -1.513 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.874 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.722 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -40.78 107.48 0.48 Allowed Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 110.583 -2.808 . . . . 0.0 113.172 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 59.4 Cg_endo -79.49 129.96 8.71 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.381 2.721 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -42.06 106.04 0.06 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.629 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.92 -4.64 3.27 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 104.181 -3.567 . . . . 0.0 104.181 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.722 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.0 m95 -110.04 -162.93 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.577 ' HD1' ' C ' ' A' ' 49' ' ' GLN . 43.3 m80 -137.55 -117.28 0.15 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.686 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p-10 -176.34 132.78 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.611 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 32.0 p -140.01 -53.37 0.52 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.836 -1.146 . . . . 0.0 109.74 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.495 ' C ' ' H ' ' A' ' 39' ' ' HIS . 28.9 mmmt -87.19 66.96 9.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.335 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 2.94 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.495 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m170 -113.48 -9.46 13.3 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 133.78 -171.52 22.0 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.621 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.51 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 22.6 Cg_endo -76.74 174.89 12.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 N-CA-C 116.728 1.78 . . . . 0.0 116.728 33.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -79.92 26.12 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.577 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.5 mt -148.57 99.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.99 -173.31 52.21 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 104.935 -3.266 . . . . 0.0 104.935 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . . . . . . . . . 25.1 m95 -125.31 147.77 48.99 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 120.154 1.977 . . . . 0.0 108.966 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.51 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 4.4 m -110.51 129.7 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.686 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.5 t -150.64 -166.94 2.68 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.406 -1.724 . . . . 0.0 109.172 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -150.96 159.88 44.28 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.577 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 2.8 tt0 . . . . . 0 C--N 1.305 -1.361 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.531 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.703 0 N-CA-C 106.021 -2.832 . . . . 0.0 106.021 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t -143.9 141.75 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.452 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 74.4 m -135.27 179.78 6.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.164 0.915 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.6 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -162.91 166.24 24.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 125.736 1.898 . . . . 0.0 109.496 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.13 130.25 42.17 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 124.456 1.098 . . . . 0.0 110.307 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.05 156.27 16.73 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.762 0.792 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.505 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 0.2 OUTLIER -63.42 -5.65 3.91 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -107.82 12.34 27.35 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.75 4.66 27.9 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.09 -141.82 14.57 Favored Glycine 0 N--CA 1.49 2.273 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.037 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -80.38 171.95 14.21 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.809 2.339 . . . . 0.0 112.148 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 115.92 27.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.229 -0.988 . . . . 0.0 108.697 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.401 ' CG2' ' H ' ' A' ' 14' ' ' ARG . 4.3 p -170.57 -179.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.401 ' H ' ' CG2' ' A' ' 13' ' ' VAL . 9.1 ptt180 -131.52 135.73 47.3 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.23 -27.23 4.28 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.76 -75.28 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 t 179.98 -173.33 0.22 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.493 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.5 OUTLIER -145.96 58.41 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.167 1.46 . . . . 0.0 111.026 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -33.61 1.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 112.193 -2.276 . . . . 0.0 114.912 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.19 -153.26 7.39 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 118.748 -1.692 . . . . 0.0 112.608 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.452 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 33.1 m -150.2 147.21 27.43 Favored 'General case' 0 C--N 1.298 -1.658 1 N-CA-C 100.0 -4.074 . . . . 0.0 100.0 179.322 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.6 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -103.51 137.66 41.29 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.418 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 69.7 m95 -111.59 129.73 55.98 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.021 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mt -88.25 -13.55 40.67 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 111.973 -2.376 . . . . 0.0 108.706 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -59.19 147.61 74.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 112.355 -2.202 . . . . 0.0 106.84 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.95 -12.0 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.936 1.757 . . . . 0.0 114.342 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 p -124.17 12.56 8.92 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.45 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 71.75 -120.64 8.22 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-O 122.448 1.027 . . . . 0.0 113.521 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.75 120.7 6.34 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 111.431 -2.385 . . . . 0.0 113.816 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.418 ' HG3' ' CZ2' ' A' ' 23' ' ' TRP . 96.6 Cg_endo -79.4 -177.48 3.91 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.545 2.163 . . . . 0.0 108.663 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -87.26 137.59 32.22 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.82 13.04 41.62 Favored Glycine 0 C--N 1.285 -2.251 0 CA-C-N 111.578 -2.556 . . . . 0.0 107.692 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.578 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 9.4 m95 -119.5 -160.24 0.81 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.521 ' CG ' ' H ' ' A' ' 35' ' ' ASN . 16.0 t-160 -132.86 -127.23 0.18 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.646 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -172.36 132.77 0.63 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.627 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 18.9 p -142.07 -59.57 0.46 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.401 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.627 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 30.4 mmmt -87.55 60.7 6.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 123.49 1.614 . . . . 0.0 110.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.78 24.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.597 ' H ' ' C ' ' A' ' 37' ' ' LYS . 92.5 m-70 -126.47 -66.31 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.56 -177.77 40.85 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.66 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 36.5 Cg_endo -74.53 176.99 40.48 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 O-C-N 123.738 1.388 . . . . 0.0 112.256 29.606 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -97.43 -8.7 28.8 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -96.33 78.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.81 -178.01 33.31 Favored Glycine 0 N--CA 1.497 2.718 1 N-CA-C 102.659 -4.177 . . . . 0.0 102.659 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.45 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.5 m95 -121.03 160.49 23.48 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.66 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 20.2 m -119.99 131.84 55.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.646 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.3 t -151.15 -168.55 3.13 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -151.45 166.43 31.12 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 101.489 -3.522 . . . . 0.0 101.489 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.412 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 3.9 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.873 0 N-CA-C 104.837 -3.305 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.26 135.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 N-CA-C 100.126 -4.027 . . . . 0.0 100.126 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.413 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 1.1 m -79.42 155.84 28.17 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -159.57 133.86 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.94 178.47 0.81 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.375 1.083 . . . . 0.0 113.291 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.423 ' C ' ' HD3' ' A' ' 37' ' ' LYS . 32.9 m -101.19 -177.96 3.6 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.548 -1.66 . . . . 0.0 113.224 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' CG ' ' N ' ' A' ' 8' ' ' SER . 9.4 p-10 -66.1 -47.19 75.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.608 -1.307 . . . . 0.0 111.297 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 20.2 m -69.24 0.53 4.75 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 111.652 -2.522 . . . . 0.0 112.606 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -89.57 -167.73 1.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.16 0.913 . . . . 0.0 110.719 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.02 -175.6 49.93 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.561 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.41 153.98 67.12 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.951 1.767 . . . . 0.0 111.238 -171.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -88.51 94.26 9.81 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.693 1.711 . . . . 0.0 114.388 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -156.33 159.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.419 ' C ' ' H ' ' A' ' 16' ' ' ASN . 14.7 ttt-85 -72.15 -174.24 1.23 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 116.899 -1.921 . . . . 0.0 107.503 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 80.85 -40.04 2.45 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.525 ' ND2' ' H ' ' A' ' 17' ' ' THR . 0.7 OUTLIER -80.81 -152.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.525 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 24.7 p -82.11 156.79 24.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.455 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.3 pt? -152.32 44.54 0.71 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.6 m -63.29 -27.87 69.63 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.327 2.344 . . . . 0.0 117.327 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.435 ' C ' ' HG1' ' A' ' 21' ' ' THR . . . -92.89 -164.34 37.76 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 20' ' ' GLY . 20.4 m -151.2 147.39 26.95 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.98 137.19 38.77 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -112.65 128.6 56.43 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 110.985 -2.825 . . . . 0.0 105.984 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.46 -10.19 49.95 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.278 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -57.21 145.47 66.21 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 111.999 -2.364 . . . . 0.0 107.846 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -64.94 -9.72 22.53 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.71 1.607 . . . . 0.0 113.67 -164.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 35.6 p -125.75 15.78 8.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.173 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.51 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 63.56 -117.86 12.12 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.451 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.73 110.91 1.36 Allowed Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.759 -2.721 . . . . 0.0 114.989 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -77.09 136.45 16.33 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 124.3 3.334 . . . . 0.0 109.718 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -48.15 108.38 0.17 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.029 1.395 . . . . 0.0 108.182 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.55 2.18 3.66 Favored Glycine 0 N--CA 1.481 1.689 0 CA-C-N 110.532 -3.031 . . . . 0.0 106.45 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.756 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.0 m95 -116.44 -157.4 0.65 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.453 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.5 t-160 -150.25 -110.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.107 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.606 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 2.3 p30 -169.45 147.9 3.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.593 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.31 -63.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 124.233 0.958 . . . . 0.0 109.247 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.507 ' C ' ' H ' ' A' ' 39' ' ' HIS . 32.1 mmmt -88.71 59.31 5.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.37 17.15 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.507 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.9 p80 -129.32 -36.6 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.02 171.72 32.66 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.667 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 65.1 Cg_endo -73.04 175.34 45.61 Favored 'Cis proline' 0 N--CA 1.5 1.881 0 O-C-N 122.903 0.949 . . . . 0.0 114.559 4.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -93.43 19.56 8.22 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.152 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.04 -39.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.711 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.01 165.97 20.81 Favored Glycine 0 N--CA 1.505 3.276 1 N-CA-C 102.276 -4.33 . . . . 0.0 102.276 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.51 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 3.7 m95 -101.58 132.01 47.47 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 119.651 1.725 . . . . 0.0 110.532 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.513 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.6 m -99.62 111.9 24.19 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.606 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.7 t -127.53 -168.09 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.728 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.66 164.81 36.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 33' ' ' TRP . 3.5 tt0 . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.798 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t -149.26 143.78 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.9 m -84.02 172.08 12.34 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 t -155.93 165.11 37.45 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.407 HD21 ' ND2' ' A' ' 16' ' ' ASN . 4.6 tp -105.33 129.23 53.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.578 ' SG ' ' HE3' ' A' ' 48' ' ' LYS . 79.8 m -87.49 158.39 18.96 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.211 -2.195 . . . . 0.0 107.118 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.528 ' N ' ' HZ3' ' A' ' 37' ' ' LYS . 71.4 m-20 -64.88 -7.03 9.68 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 t -113.71 5.56 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.173 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -99.95 27.13 5.72 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.8 0.81 . . . . 0.0 110.566 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.48 171.3 14.98 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.48 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.39 -174.89 2.29 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 123.069 2.513 . . . . 0.0 110.315 162.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -89.49 158.23 17.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.042 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.1 t 94.08 146.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 C-N-CA 127.232 2.213 . . . . 0.0 107.127 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 155.24 2.37 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.194 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.5 -28.53 3.26 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 105.333 -3.107 . . . . 0.0 105.333 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.407 ' ND2' HD21 ' A' ' 5' ' ' LEU . 7.2 p-10 -73.08 178.95 4.04 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 112.064 -2.068 . . . . 0.0 108.628 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -118.36 -175.08 2.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.421 ' N ' HD21 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -148.91 83.75 1.46 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.729 1.252 . . . . 0.0 109.149 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 p -86.66 2.18 49.33 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.506 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.47 -177.13 49.62 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 41.7 m -149.1 145.01 27.02 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.85 133.97 43.42 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.514 -3.039 . . . . 0.0 109.271 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.485 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 81.3 m95 -109.61 129.45 55.59 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 111.548 -2.569 . . . . 0.0 107.546 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.89 -7.55 57.02 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . 0.423 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 11.3 m-30 -57.99 149.7 54.13 Favored Pre-proline 0 C--N 1.301 -1.518 0 CA-C-N 111.913 -2.403 . . . . 0.0 106.569 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.32 -15.06 45.89 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.287 1.324 . . . . 0.0 113.946 -163.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 p -122.1 7.84 9.77 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.157 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.503 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 78.36 -119.42 5.15 Favored Glycine 0 CA--C 1.489 -1.548 0 CA-C-N 114.175 -1.375 . . . . 0.0 114.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.82 115.79 3.53 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 111.851 -2.175 . . . . 0.0 113.318 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 79.1 Cg_endo -76.4 174.94 12.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 CA-C-O 125.604 2.252 . . . . 0.0 114.169 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m -81.69 107.22 14.26 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 110.311 -3.132 . . . . 0.0 105.271 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.67 3.87 5.41 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.616 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 11.9 m95 -119.7 -159.63 0.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 8.1 t-80 -134.49 -118.0 0.18 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.748 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.742 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p30 -175.62 129.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.524 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 18.0 p -150.82 10.37 0.63 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.528 ' HZ3' ' N ' ' A' ' 7' ' ' ASP . 2.2 mmpt? -135.87 92.02 2.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.58 38.0 0.09 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -140.89 -26.09 0.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 45' ' ' TRP . . . 141.43 -107.65 0.52 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.66 -173.86 10.59 Favored 'Cis proline' 0 N--CA 1.494 1.527 0 N-CA-C 117.782 2.186 . . . . 0.0 117.782 -4.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -85.51 19.25 2.43 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.325 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.38 23.85 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 122.21 1.005 . . . . 0.0 109.689 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.64 167.09 11.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 103.178 -3.969 . . . . 0.0 103.178 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.503 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -106.69 158.95 16.57 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.66 1.73 . . . . 0.0 110.97 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.438 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 1.8 m -116.28 126.98 54.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.013 0.821 . . . . 0.0 109.205 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.742 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 16.0 t -151.6 -163.74 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.749 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' SG ' ' A' ' 6' ' ' CYS . 32.5 ttmt -150.93 163.31 39.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.8 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.895 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.609 0 N-CA-C 105.748 -2.941 . . . . 0.0 105.748 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.67 133.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.6 m -90.07 172.13 9.05 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 30.8 t -146.18 160.77 41.5 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.497 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 6.8 mp -83.59 126.13 32.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.32 -178.77 5.98 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -33.72 67.6 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.63 1.681 . . . . 0.0 108.346 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -64.64 -32.89 74.75 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 112.468 -2.151 . . . . 0.0 108.253 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -89.46 73.4 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.95 -70.24 0.67 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 111.671 -2.513 . . . . 0.0 109.013 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -76.2 150.75 33.51 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.035 1.823 . . . . 0.0 113.446 177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 p -89.59 110.27 21.15 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.65 141.91 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 125.968 2.043 . . . . 0.0 108.824 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -63.31 121.88 14.82 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.41 -23.4 12.38 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.569 ' ND2' ' H ' ' A' ' 17' ' ' THR . 9.2 t-20 -68.18 167.2 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.569 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 6.8 t -172.45 -154.92 0.08 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' N ' HD22 ' A' ' 18' ' ' LEU . 0.3 OUTLIER -121.36 93.06 3.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -16.95 59.19 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.784 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.469 ' HA2' ' HD3' ' A' ' 48' ' ' LYS . . . -77.24 -169.59 32.21 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.398 0.999 . . . . 0.0 111.43 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.457 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 30.2 m -150.55 147.35 27.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 101.676 -3.453 . . . . 0.0 101.676 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 45' ' ' TRP . 5.0 tt -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.225 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -119.1 137.42 53.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.893 -1.958 . . . . 0.0 107.133 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.84 -15.23 35.05 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.486 1.612 . . . . 0.0 108.873 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -56.98 138.49 79.3 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 110.541 -3.027 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.09 -6.54 14.78 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.627 1.552 . . . . 0.0 112.662 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 p -126.74 22.25 6.89 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.944 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 57.8 -111.75 3.26 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 114.126 -1.397 . . . . 0.0 116.274 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.699 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.16 115.48 5.42 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 112.038 -2.081 . . . . 0.0 113.308 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.504 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 71.2 Cg_endo -80.28 150.84 20.14 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.678 2.252 . . . . 0.0 108.72 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.7 t -60.91 108.62 0.89 Allowed 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.43 -4.17 3.36 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 110.706 -2.952 . . . . 0.0 106.637 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.699 ' CB ' ' SG ' ' A' ' 29' ' ' CYS . 24.4 m95 -115.48 -160.55 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 78.8 m-70 -135.89 -89.56 0.31 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.703 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER 177.19 156.42 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.556 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.6 -43.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 124.357 1.035 . . . . 0.0 109.997 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 39' ' ' HIS . 4.3 mmtt -99.52 104.2 16.0 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.97 21.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.468 ' H ' ' C ' ' A' ' 37' ' ' LYS . 35.9 m80 -135.96 -15.48 1.76 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.15 -86.44 0.23 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.699 -1.239 . . . . 0.0 112.111 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' C ' ' H ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.47 -164.02 2.32 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 CA-C-N 118.394 1.097 . . . . 0.0 111.091 -6.091 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 p -74.31 23.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.4 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' H ' ' C ' ' A' ' 41' ' ' PRO . 5.2 mp -148.38 100.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.13 -149.8 21.24 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 104.794 -3.322 . . . . 0.0 104.794 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 14.2 m95 -142.89 152.88 42.57 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.986 1.393 . . . . 0.0 107.724 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.445 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 6.2 m -114.07 116.11 28.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.066 0.936 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.703 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 12.0 t -139.34 -168.62 2.49 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.879 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 28.8 tptp -151.25 151.82 32.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 103.0 -2.963 . . . . 0.0 103.0 179.68 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.695 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t -124.41 164.95 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 75.3 m -119.3 174.67 6.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.25 168.51 22.34 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.527 -179.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.43 ' O ' ' NZ ' ' A' ' 37' ' ' LYS . 2.1 tt -80.49 106.46 12.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.525 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 58.3 m -89.68 162.02 15.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 123.5 1.619 . . . . 0.0 112.165 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 0.9 OUTLIER -66.17 21.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.431 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.502 ' H ' ' C ' ' A' ' 6' ' ' CYS . 69.3 m -147.91 19.51 1.13 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.168 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.53 -145.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 153.65 22.95 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 104.484 -3.446 . . . . 0.0 104.484 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -78.74 140.77 16.72 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.28 2.653 . . . . 0.0 115.078 -176.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.3 p -149.46 -166.35 2.53 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.8 175.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -74.59 168.38 19.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.97 18.42 64.49 Favored Glycine 0 N--CA 1.504 3.218 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -163.39 -178.59 5.99 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.4 m 81.61 42.96 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.895 1.331 . . . . 0.0 113.104 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -150.38 109.85 4.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.852 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -104.6 -6.32 20.62 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.555 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -91.37 -163.99 38.9 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.282 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 15.5 m -150.84 142.3 23.44 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 98.971 -4.455 . . . . 0.0 98.971 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.2 tt -105.02 143.97 32.47 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -117.21 135.46 53.77 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 111.822 -2.445 . . . . 0.0 107.954 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.7 mt -88.72 -17.4 30.0 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.874 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -52.07 138.65 35.52 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 110.907 -2.861 . . . . 0.0 109.097 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -66.18 -10.81 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.551 1.501 . . . . 0.0 113.254 -166.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -118.72 16.76 13.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.827 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.5 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 60.75 -118.64 15.64 Favored Glycine 0 C--N 1.297 -1.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 117.089 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.08 114.45 4.35 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 110.713 -2.744 . . . . 0.0 114.295 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.513 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 76.1 Cg_endo -80.66 127.63 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.57 2.18 . . . . 0.0 109.762 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 p -44.45 106.58 0.07 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.554 -2.112 . . . . 0.0 105.952 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.4 -7.33 3.1 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.73 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.4 m95 -111.3 -164.24 0.9 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.623 ' HD1' ' C ' ' A' ' 49' ' ' GLN . 48.2 m80 -139.44 -109.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 123.94 0.775 . . . . 0.0 110.254 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.709 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.7 p-10 -164.36 153.02 13.02 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.33 -33.82 0.17 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.457 1.599 . . . . 0.0 111.118 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.481 ' HA ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -115.48 105.01 12.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.64 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.64 4.11 17.04 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.996 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -117.22 -112.98 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.282 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.82 -154.87 20.29 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 116.739 1.456 . . . . 0.0 116.739 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 91.7 Cg_endo -67.02 167.68 56.85 Favored 'Cis proline' 0 N--CA 1.501 1.953 0 O-C-N 122.77 0.879 . . . . 0.0 111.373 11.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -25.12 61.66 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.883 0.849 . . . . 0.0 109.585 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 tp -103.37 106.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.33 -177.16 39.21 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.5 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 3.4 m95 -135.88 135.57 39.83 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.72 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 21.5 m -97.47 130.81 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.709 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 17.6 t -148.58 -166.54 2.57 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.496 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' NZ ' ' OXT' ' A' ' 49' ' ' GLN . 12.3 ptmm? -152.18 164.0 38.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.623 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 3.2 tt0 . . . . . 0 C--N 1.305 -1.342 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.615 0 N-CA-C 104.837 -3.305 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.44 131.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 123.002 1.382 . . . . 0.0 112.16 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.4 m -72.71 170.51 14.4 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.184 -2.28 . . . . 0.0 110.985 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' GLY . 45.7 t -159.39 143.02 14.71 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.4 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . 1.4 pt? -73.12 167.72 20.56 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.8 176.05 5.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 -11.36 60.19 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.56 -1.338 . . . . 0.0 112.163 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 t -92.53 -5.62 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -89.74 96.62 10.77 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 124.342 1.026 . . . . 0.0 108.992 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.81 74.33 0.21 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 106.55 -2.62 . . . . 0.0 106.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.12 176.42 7.07 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.939 1.759 . . . . 0.0 113.683 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -89.67 171.3 9.76 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 18.8 m -73.27 82.87 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 21.8 ttt180 109.9 145.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.64 6.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -59.29 140.23 56.23 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.267 -0.466 . . . . 0.0 110.949 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -111.65 147.75 34.85 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.422 ' N ' HD22 ' A' ' 18' ' ' LEU . 1.2 pt? -150.39 70.87 1.03 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.476 1.131 . . . . 0.0 111.215 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.6 m -70.31 -26.9 64.0 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -80.51 -159.65 21.02 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 63.1 m -151.42 153.86 35.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 3.1 tp -101.52 149.82 23.7 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.016 -1.902 . . . . 0.0 106.683 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -127.51 128.39 45.59 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.082 -179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.7 mt -88.99 -10.71 46.63 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.006 -2.815 . . . . 0.0 108.721 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -63.25 150.43 89.17 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 112.524 -2.125 . . . . 0.0 106.21 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.18 -14.39 43.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.663 1.576 . . . . 0.0 113.817 -163.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 p -125.51 13.75 8.16 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.434 ' N ' ' CD1' ' A' ' 45' ' ' TRP . . . 69.03 -115.73 6.71 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.156 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.707 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.3 t -42.67 107.69 0.57 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 110.557 -2.822 . . . . 0.0 113.315 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 37.1 Cg_endo -75.47 124.76 8.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 174.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 p -41.34 108.43 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.21 -4.11 3.76 Favored Glycine 0 C--N 1.293 -1.829 0 N-CA-C 105.08 -3.208 . . . . 0.0 105.08 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.707 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.5 m95 -116.97 167.48 11.09 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 100.906 -3.738 . . . . 0.0 100.906 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.594 ' CG ' ' HZ3' ' A' ' 48' ' ' LYS . 77.8 m80 -93.91 -83.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 119.69 3.219 . . . . 0.0 119.69 -179.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.775 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 7.6 p30 154.07 153.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 128.93 2.892 . . . . 0.0 105.057 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -150.66 -31.72 0.18 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 123.468 0.48 . . . . 0.0 111.642 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.499 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.1 mmmt -125.96 88.35 2.84 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.45 34.5 0.05 Allowed 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.78 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.435 ' H ' ' C ' ' A' ' 37' ' ' LYS . 89.6 m-70 -137.49 -21.39 1.16 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.64 -130.23 2.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -61.89 -179.79 5.86 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 CA-C-N 119.167 1.483 . . . . 0.0 113.738 -5.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 p -78.12 -10.04 59.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.177 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tt -97.1 -26.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 121.917 0.865 . . . . 0.0 109.86 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 155.61 27.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 105.577 -3.009 . . . . 0.0 105.577 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.434 ' CD1' ' N ' ' A' ' 28' ' ' GLY . 6.2 m95 -92.59 140.11 29.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.499 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 1.6 m -101.3 117.23 34.56 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 119.269 0.94 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 14.5 t -129.5 -165.05 1.47 Allowed 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.536 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HZ3' ' CG ' ' A' ' 34' ' ' HIS . 14.9 pttp -151.4 152.23 32.81 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.587 ' C ' ' HD1' ' A' ' 34' ' ' HIS . 5.6 tt0 . . . . . 0 C--N 1.299 -1.603 0 O-C-N 124.545 1.153 . . . . 0.0 108.367 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.672 0 N-CA-C 105.435 -3.066 . . . . 0.0 105.435 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.4 t -89.68 157.09 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.6 m -70.61 167.73 17.92 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -160.1 121.22 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.645 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.509 HD21 ' CB ' ' A' ' 9' ' ' ASP . 9.5 mt -59.57 164.66 3.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.504 0.668 . . . . 0.0 110.775 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.528 ' C ' ' H ' ' A' ' 8' ' ' SER . 26.8 m -101.0 158.51 15.95 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.998 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 6.6 m-20 -73.77 30.13 0.07 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.528 ' H ' ' C ' ' A' ' 6' ' ' CYS . 2.4 t -129.74 -12.4 4.3 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 111.855 -2.43 . . . . 0.0 107.562 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.509 ' CB ' HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -98.51 -178.54 4.04 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 -175.96 34.33 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.62 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.82 166.97 24.56 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 123.4 2.733 . . . . 0.0 112.106 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.61 93.79 9.42 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 123.48 1.61 . . . . 0.0 110.703 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.29 21.74 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 111.903 -2.408 . . . . 0.0 107.259 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.48 ' C ' ' H ' ' A' ' 16' ' ' ASN . 30.1 ttm180 76.28 163.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.744 -2.025 . . . . 0.0 107.24 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.16 -47.78 3.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 103.517 -3.833 . . . . 0.0 103.517 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' H ' ' C ' ' A' ' 14' ' ' ARG . 3.2 p-10 -61.0 167.28 3.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.234 1.196 . . . . 0.0 107.866 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.405 ' C ' HD13 ' A' ' 18' ' ' LEU . 11.7 t -134.96 -166.4 1.82 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.435 HD21 ' CB ' ' A' ' 3' ' ' SER . 6.2 mp -110.87 99.91 8.74 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 126.5 1.92 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -95.69 -6.32 40.21 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.642 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.42 -174.24 14.23 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-O 122.372 0.985 . . . . 0.0 112.608 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 99.6 m -151.17 155.41 38.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -104.81 141.12 37.07 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 112.304 -2.225 . . . . 0.0 108.325 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 78.2 m95 -111.85 133.43 54.07 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.292 -2.231 . . . . 0.0 110.83 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.25 -16.51 31.03 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.293 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -60.65 143.38 90.64 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.381 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -66.93 -9.95 26.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.882 1.721 . . . . 0.0 113.62 -165.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 p -117.47 12.14 14.08 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.328 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 67.59 -117.21 8.59 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-N 113.984 -1.462 . . . . 0.0 116.231 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.696 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 2.7 t -51.3 113.05 3.51 Favored Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 110.839 -2.68 . . . . 0.0 112.562 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.549 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 83.2 Cg_endo -80.92 138.21 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.161 2.574 . . . . 0.0 110.851 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -46.33 99.45 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -1.52 2.46 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 105.424 -3.07 . . . . 0.0 105.424 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TRP . . . . . 0.696 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 21.7 m95 -109.65 -153.85 0.52 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.619 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 17.7 t-160 -150.52 -101.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.489 0.661 . . . . 0.0 110.215 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.613 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -169.78 157.76 7.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.54 -39.03 0.13 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.186 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 22.2 mmmt -101.31 114.48 28.5 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' ND1' ' A' ' 39' ' ' HIS . . . -76.89 10.33 2.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.893 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 38' ' ' ALA . 17.0 m-70 -133.26 -127.35 0.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.38 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.53 -145.65 10.21 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.1 -177.27 17.38 Favored 'Cis proline' 0 N--CA 1.499 1.842 0 CA-C-N 117.968 0.884 . . . . 0.0 111.764 7.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -91.14 -6.53 53.45 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.362 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -116.89 96.75 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.01 157.41 27.71 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TRP . . . . . 0.517 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -109.68 157.59 18.95 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.404 ' HB3' ' CG ' ' A' ' 37' ' ' LYS . 7.5 m -117.06 119.3 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.079 1.418 . . . . 0.0 109.137 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' C ' ' A' ' 34' ' ' HIS . 9.0 t -134.63 -163.76 1.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.408 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.635 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.04 149.71 29.87 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' C ' ' CE ' ' A' ' 48' ' ' LYS . 46.3 tt0 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.361 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.931 0.872 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.5 m -92.36 169.07 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.3 p -162.71 157.79 22.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.11 127.62 32.1 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 125.14 1.525 . . . . 0.0 112.594 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 60.7 m -93.39 173.05 7.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 125.338 1.649 . . . . 0.0 106.596 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.87 0.843 . . . . 0.0 109.817 179.838 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.532 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -84.37 -159.5 29.92 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.779 -1.677 . . . . 0.0 109.846 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 8.1 m -150.06 134.19 17.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -93.49 142.55 27.21 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.649 -2.523 . . . . 0.0 108.875 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 80.1 m95 -119.41 134.03 55.42 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 111.938 -2.392 . . . . 0.0 105.712 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.61 -11.89 44.19 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.943 1.354 . . . . 0.0 108.372 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -55.46 144.16 54.25 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 111.25 -2.704 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -64.95 -7.94 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.098 1.865 . . . . 0.0 113.55 -165.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 34.5 p -132.52 17.46 4.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 64.83 -112.02 4.66 Favored Glycine 0 N--CA 1.477 1.384 0 CA-C-N 113.601 -1.636 . . . . 0.0 116.633 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.615 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -47.06 116.87 4.32 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 111.003 -2.599 . . . . 0.0 115.238 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.9 Cg_endo -81.44 152.56 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.774 2.316 . . . . 0.0 109.794 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.1 t -64.57 109.11 1.87 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.956 -1.929 . . . . 0.0 106.18 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.79 -2.1 4.4 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 105.876 -2.89 . . . . 0.0 105.876 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 15.3 m95 -109.51 -154.04 0.53 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 1.0 OUTLIER -137.55 -65.57 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.795 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.5 p30 137.42 147.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 128.299 2.64 . . . . 0.0 108.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.74 -1.33 0.38 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.167 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 11.5 mmmm -140.5 106.36 5.16 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.818 0.699 . . . . 0.0 109.177 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.25 -13.76 62.58 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.748 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -140.12 -112.79 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -31.86 129.98 0.22 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.562 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 41.7 Cg_endo -71.46 -173.26 9.55 Favored 'Cis proline' 0 N--CA 1.508 2.367 0 N-CA-C 118.379 2.415 . . . . 0.0 118.379 6.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 t -122.23 18.53 10.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.2 mt -132.25 -75.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' PRO . . . -90.58 -155.18 31.07 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 27' ' ' SER . 6.5 m95 -141.17 167.5 22.03 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.57 1.685 . . . . 0.0 109.55 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.562 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 5.5 m -124.38 128.4 49.0 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.442 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.795 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.8 t -144.82 -169.25 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 35' ' ' ASN . 6.4 ptpp? -150.36 156.64 41.9 Favored 'General case' 0 C--N 1.298 -1.67 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.528 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' THR . 28.4 t . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -79.54 165.94 22.45 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 119.339 0.972 . . . . 0.0 111.808 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.8 t -162.79 144.48 10.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 115.19 27.5 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 m -88.04 156.62 19.21 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.019 -2.586 . . . . 0.0 104.019 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.542 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 40.9 m-20 . . . . . 0 N--CA 1.496 1.854 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.074 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.88 160.5 52.84 Favored Glycine 0 CA--C 1.496 -1.144 0 CA-C-O 124.226 2.015 . . . . 0.0 109.287 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 17.9 m -142.66 138.02 30.36 Favored 'General case' 0 C--N 1.28 -2.443 1 N-CA-C 100.108 -4.034 . . . . 0.0 100.108 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -99.82 140.86 33.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.444 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.437 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.1 m95 -114.61 131.91 56.54 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 111.688 -2.506 . . . . 0.0 108.481 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.79 -12.63 41.5 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.339 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -58.38 139.5 84.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 111.89 -2.414 . . . . 0.0 105.393 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -64.98 -7.07 14.15 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.432 1.422 . . . . 0.0 113.86 -163.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.4 p -122.68 13.11 9.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.591 1.182 . . . . 0.0 110.789 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.507 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 67.42 -118.62 10.24 Favored Glycine 0 C--N 1.298 -1.569 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.78 106.54 0.57 Allowed Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 110.87 -2.665 . . . . 0.0 113.503 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -76.52 130.32 11.68 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.877 2.385 . . . . 0.0 108.774 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -42.58 111.2 0.23 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.362 -1.745 . . . . 0.0 106.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.53 -8.55 4.97 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 104.33 -3.508 . . . . 0.0 104.33 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.2 m95 -105.69 -167.97 1.39 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.448 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.9 m-70 -135.5 -114.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.588 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -174.92 134.99 0.36 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 31.8 p -141.47 -52.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.168 -1.413 . . . . 0.0 109.86 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.542 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.8 mmmt -88.13 65.56 8.19 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.591 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.9 -3.24 1.5 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.389 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.437 ' H ' ' C ' ' A' ' 37' ' ' LYS . 12.9 m170 -98.58 -15.21 19.58 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 136.32 -166.29 24.76 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.168 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 23.8 Cg_endo -74.39 -179.17 25.16 Favored 'Cis proline' 0 N--CA 1.494 1.501 0 N-CA-C 115.513 1.313 . . . . 0.0 115.513 25.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 p -89.42 11.91 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.969 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.0 101.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.89 -171.38 46.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 103.572 -3.811 . . . . 0.0 103.572 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.507 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -127.04 149.41 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 118.95 1.375 . . . . 0.0 108.241 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -110.48 129.21 55.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.9 t -150.65 -168.05 2.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.799 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -150.38 162.22 40.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 115.789 -2.053 . . . . 0.0 106.982 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 122.223 1.011 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.66 160.02 23.83 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.935 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.12 144.09 9.49 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 123.547 0.53 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.2 176.8 6.29 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.34 138.7 54.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.748 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 20.0 m-20 . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.85 -164.76 10.24 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -150.41 159.21 44.63 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.39 146.18 40.89 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.41 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 86.7 m95 -119.64 133.64 55.56 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 111.786 -2.461 . . . . 0.0 109.608 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -88.87 -14.9 35.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.83 144.2 81.61 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 111.43 -2.623 . . . . 0.0 105.913 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -66.9 -19.73 52.12 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.182 1.255 . . . . 0.0 112.486 -162.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.2 p -107.02 5.47 28.11 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.288 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 69.37 -113.82 5.35 Favored Glycine 0 C--N 1.298 -1.53 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.999 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -43.82 108.97 0.75 Allowed Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 110.451 -2.874 . . . . 0.0 111.316 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 38.1 Cg_endo -74.91 130.81 13.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 N-CA-C 106.06 -2.323 . . . . 0.0 106.06 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -45.92 101.87 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.018 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.6 -4.83 1.99 Allowed Glycine 0 C--N 1.296 -1.673 0 N-CA-C 104.375 -3.49 . . . . 0.0 104.375 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.692 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 20.2 m95 -105.53 -168.54 1.47 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -140.16 -70.61 0.39 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.832 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 7.8 p30 155.91 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 126.131 1.773 . . . . 0.0 114.258 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -140.82 -7.65 1.08 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.541 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.499 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 18.9 mmmt -134.22 108.31 8.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.359 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.79 31.31 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 37' ' ' LYS . 5.9 m80 -132.58 -145.99 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.5 -98.3 1.87 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -79.13 -165.59 4.73 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 N-CA-C 114.195 0.806 . . . . 0.0 114.195 1.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -84.76 14.65 4.53 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.996 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 pt -147.24 81.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.7 171.55 44.95 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 107.561 -2.215 . . . . 0.0 107.561 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.48 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.4 m95 -116.68 142.44 46.9 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.058 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 13.1 m -103.9 120.74 41.65 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.832 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 1.7 t -142.64 -167.38 2.5 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 27.9 pttt -151.17 164.06 37.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 125.026 1.454 . . . . 0.0 112.714 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -79.71 163.19 24.71 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.6 t -157.06 155.85 31.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.924 0.765 . . . . 0.0 109.917 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -89.67 121.01 31.44 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.0 m -94.41 152.78 18.35 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.823 0.82 . . . . 0.0 111.039 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.715 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 2.7 m-20 . . . . . 0 N--CA 1.507 2.402 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.711 0.291 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.84 -172.51 48.86 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -150.15 144.63 25.8 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.94 138.17 37.38 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 111.585 -2.552 . . . . 0.0 108.256 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -112.2 129.42 56.26 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 110.712 -2.949 . . . . 0.0 107.577 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.23 -14.11 36.68 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -57.33 148.77 51.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 CA-C-N 112.44 -2.164 . . . . 0.0 106.085 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -19.78 68.3 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 120.991 1.128 . . . . 0.0 113.283 -162.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -113.02 7.28 18.05 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.742 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 72.77 -115.59 5.32 Favored Glycine 0 CA--C 1.49 -1.526 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.576 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.0 OUTLIER -48.46 115.03 3.94 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 111.591 -2.304 . . . . 0.0 112.766 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 63.4 Cg_endo -77.89 165.94 25.79 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.556 2.171 . . . . 0.0 112.469 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 91.66 3.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 111.761 -2.472 . . . . 0.0 108.562 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 151.42 -1.04 0.34 Allowed Glycine 0 C--N 1.29 -1.992 0 CA-C-N 109.806 -3.361 . . . . 0.0 105.656 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.672 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.9 m95 -116.65 -167.35 1.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 4.6 m-70 -127.34 -73.38 0.61 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 117.795 2.517 . . . . 0.0 117.795 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.781 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.4 p30 143.06 150.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.025 2.53 . . . . 0.0 109.314 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 20.8 p -151.46 -53.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 123.341 1.543 . . . . 0.0 109.407 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HZ1' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -88.39 78.33 7.96 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.129 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.62 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.775 -1.557 . . . . 0.0 108.62 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.33 -55.36 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.86 -162.75 9.24 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.439 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.762 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 25.6 Cg_endo -78.71 -173.59 13.16 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 CA-C-N 117.718 0.759 . . . . 0.0 111.384 4.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 p -90.07 5.96 44.46 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.167 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 pt -145.39 102.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 123.91 0.756 . . . . 0.0 109.071 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 169.93 46.12 Favored Glycine 0 N--CA 1.506 3.31 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.542 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 12.3 m95 -109.06 149.78 28.78 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 118.176 0.988 . . . . 0.0 110.522 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.762 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.7 m -111.06 130.75 55.51 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 11.7 t -150.19 -167.9 2.95 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.514 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.39 160.57 43.65 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.7 tt0 . . . . . 0 C--N 1.298 -1.657 0 O-C-N 125.182 1.551 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -80.79 163.43 23.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 35.4 t -144.38 168.44 20.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.576 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 5.3 tp -119.09 129.85 55.29 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD ' ' A' ' 48' ' ' LYS . 80.7 m -97.56 151.08 20.41 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.304 0.573 . . . . 0.0 110.653 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 62.5 m-20 . . . . . 0 N--CA 1.508 2.432 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 121.163 0.506 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -166.29 37.64 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.3 m -150.01 157.3 43.0 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -111.97 141.62 45.4 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 111.946 -2.388 . . . . 0.0 107.274 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.419 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 80.0 m95 -112.85 130.86 55.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.8 -2.909 . . . . 0.0 106.138 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.22 -13.1 41.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.523 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 8.5 m-30 -56.67 142.71 70.63 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 111.576 -2.556 . . . . 0.0 107.067 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -63.33 -17.01 58.1 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.015 1.143 . . . . 0.0 113.652 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.7 p -113.62 6.41 16.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.791 -1.549 . . . . 0.0 112.82 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.515 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 73.98 -116.71 5.4 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.478 -1.344 . . . . 0.0 115.043 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -45.75 116.36 3.25 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 111.785 -2.207 . . . . 0.0 112.668 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 93.0 Cg_endo -81.48 160.88 19.66 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.117 1.878 . . . . 0.0 108.206 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -69.56 110.2 4.67 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.071 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.28 -4.63 4.52 Favored Glycine 0 C--N 1.289 -2.042 0 N-CA-C 105.208 -3.157 . . . . 0.0 105.208 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 19.0 m95 -116.49 -164.85 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -126.39 -87.93 0.58 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.694 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.1 p30 149.9 149.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 127.047 2.139 . . . . 0.0 108.627 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 23.1 p -150.78 -46.78 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.555 1.169 . . . . 0.0 108.3 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 25.3 mmmt -88.61 80.19 7.37 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.118 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.6 49.82 1.23 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.338 1.066 . . . . 0.0 108.266 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -146.81 -52.26 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.177 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -143.27 4.93 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 59.2 Cg_endo -70.55 161.24 88.9 Favored 'Cis proline' 0 C--N 1.311 -1.424 0 CA-C-O 123.135 1.223 . . . . 0.0 115.214 8.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 p -72.53 33.38 0.06 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.368 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.4 pt -140.98 -41.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 121.506 0.67 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.12 165.27 28.59 Favored Glycine 0 N--CA 1.493 2.466 1 N-CA-C 101.367 -4.693 . . . . 0.0 101.367 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.515 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 11.5 m95 -100.95 154.6 18.54 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.443 2.121 . . . . 0.0 111.741 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.3 m -107.19 123.86 48.89 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.694 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.8 t -150.5 -179.83 7.55 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.844 0.831 . . . . 0.0 110.087 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CD ' ' SG ' ' A' ' 6' ' ' CYS . 34.5 mtmt -142.2 156.15 45.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.7 tt0 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 125.555 1.784 . . . . 0.0 114.607 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 m -75.59 165.05 25.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.0 t -159.79 165.8 31.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -100.79 150.03 23.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 48' ' ' LYS . 32.6 m -99.94 161.78 13.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.743 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 7.3 m-20 . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 122.313 1.054 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.58 -169.62 27.76 Favored Glycine 0 C--N 1.3 -1.469 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -150.56 146.79 26.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -102.28 141.83 34.48 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 111.522 -2.581 . . . . 0.0 107.94 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.3 m95 -114.23 132.64 56.05 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.461 -3.063 . . . . 0.0 107.215 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.66 -12.26 42.98 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.364 -1.743 . . . . 0.0 108.282 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -59.43 139.05 89.01 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.254 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.13 -13.13 33.57 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 120.66 0.907 . . . . 0.0 114.26 -160.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 p -114.57 4.6 15.21 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.167 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 78.95 -122.09 5.74 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 113.771 -1.558 . . . . 0.0 116.178 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -44.64 116.24 2.63 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 111.04 -2.58 . . . . 0.0 114.341 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 87.7 Cg_endo -77.5 167.1 24.89 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.779 2.319 . . . . 0.0 112.853 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -70.7 103.16 2.48 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.182 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.31 1.44 4.36 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 105.056 -3.218 . . . . 0.0 105.056 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.781 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -117.26 -162.56 0.87 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.5 m-70 -133.5 -114.82 0.21 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.732 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER 177.93 136.5 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 23.9 p -145.62 -46.63 0.21 Allowed 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.579 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.3 mmmt -88.54 69.66 8.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.704 1.24 . . . . 0.0 109.785 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 5.76 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.163 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 95.1 m-70 -107.57 -16.12 14.43 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.09 -148.79 17.13 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.706 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 92.3 Cg_endo -68.15 -171.3 5.44 Favored 'Cis proline' 0 N--CA 1.493 1.474 0 CA-C-N 118.67 1.235 . . . . 0.0 114.681 4.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 t -93.36 20.81 6.7 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.837 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 mm -123.84 -57.52 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 CA-C-O 121.552 0.691 . . . . 0.0 110.114 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.71 13.61 Favored Glycine 0 N--CA 1.501 3.015 1 N-CA-C 102.913 -4.075 . . . . 0.0 102.913 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 11.3 m95 -108.49 146.22 33.51 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 120.293 2.046 . . . . 0.0 109.684 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.706 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 6.7 m -104.2 130.46 51.96 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.9 t -150.48 -163.98 1.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.625 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -150.19 164.25 36.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 116.484 -1.722 . . . . 0.0 109.692 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 51.2 m -134.73 177.36 7.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.588 1.18 . . . . 0.0 109.305 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -160.49 160.79 32.44 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 125.924 2.015 . . . . 0.0 110.993 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.92 117.12 5.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 126.143 2.152 . . . . 0.0 110.394 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.5 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 76.5 m -93.61 159.58 15.16 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.705 -0.798 . . . . 0.0 113.099 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -86.51 -156.88 29.27 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.5 m -150.36 148.71 29.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 102.327 -3.212 . . . . 0.0 102.327 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.3 tt -109.56 138.86 45.3 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.864 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 82.4 m95 -108.55 130.8 55.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.934 -2.394 . . . . 0.0 109.368 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.78 -16.18 32.79 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.075 -2.329 . . . . 0.0 108.847 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -57.37 147.24 59.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 112.138 -2.301 . . . . 0.0 108.12 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -65.49 -12.13 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.047 1.831 . . . . 0.0 113.41 -162.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 p -120.81 6.08 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.499 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.32 -119.6 6.28 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-O 122.984 1.325 . . . . 0.0 113.775 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.57 109.37 0.93 Allowed Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 110.63 -2.785 . . . . 0.0 114.047 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 75.1 Cg_endo -79.25 136.1 12.51 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.966 3.111 . . . . 0.0 110.128 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 m -47.32 104.27 0.05 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.748 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.5 -3.62 2.68 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.79 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.8 m95 -117.6 -171.43 2.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 55.9 m80 -140.45 -99.64 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.16 0.912 . . . . 0.0 112.977 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.665 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 20.3 p30 -163.47 153.25 15.14 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.67 -30.78 0.23 Allowed 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.51 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 14.6 mmmt -117.68 93.53 4.19 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.87 42.9 0.4 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 71.2 m-70 -140.21 -29.43 0.7 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.355 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.65 -114.8 0.93 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.669 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 14.5 Cg_endo -86.49 -152.95 0.7 Allowed 'Cis proline' 0 C--N 1.314 -1.265 0 CA-C-N 118.537 1.169 . . . . 0.0 110.59 8.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -82.57 9.3 9.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.97 113.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.23 -174.02 27.52 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 106.041 -2.824 . . . . 0.0 106.041 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.521 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 m95 -127.17 135.07 50.18 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.441 1.121 . . . . 0.0 108.187 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.669 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 51.9 m -96.12 122.24 38.74 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.31 1.053 . . . . 0.0 108.987 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 5.5 t -144.26 -168.92 3.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.61 168.75 23.35 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 3.4 tt0 . . . . . 0 C--N 1.297 -1.681 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 24.4 m -90.41 -178.33 5.32 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 49.2 t -162.63 169.01 20.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 125.611 1.819 . . . . 0.0 108.356 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.2 mt -104.77 137.76 42.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.585 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -89.93 161.73 15.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.692 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.94 -166.22 10.98 Favored Glycine 0 CA--C 1.555 2.547 0 O-C-N 125.27 1.607 . . . . 0.0 111.872 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 90.0 m -150.76 160.27 43.97 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 103.066 -2.938 . . . . 0.0 103.066 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -113.13 136.88 52.24 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -110.01 134.12 52.47 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.956 1.36 . . . . 0.0 110.574 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.96 -17.01 30.37 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.409 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -57.9 147.46 63.48 Favored Pre-proline 0 N--CA 1.492 1.641 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.424 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -63.69 -11.11 24.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.034 1.823 . . . . 0.0 114.58 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 67.9 p -126.17 10.07 7.44 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.61 1.194 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.547 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.18 -114.17 4.85 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 119.381 -1.39 . . . . 0.0 113.823 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.22 112.09 1.48 Allowed Pre-proline 0 C--N 1.295 -1.772 0 CA-C-N 111.639 -2.281 . . . . 0.0 111.892 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 85.1 Cg_endo -83.57 151.91 13.34 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 123.191 2.594 . . . . 0.0 109.207 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -52.96 116.35 2.31 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.287 -2.233 . . . . 0.0 108.138 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 2.23 11.7 Favored Glycine 0 C--N 1.29 -2.024 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.333 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.572 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.3 m95 -114.33 -177.91 3.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 4.7 m-70 -130.4 -101.52 0.3 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.594 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -169.45 133.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 m -133.46 -20.09 2.1 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.952 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 31.4 mmmt -140.77 95.89 2.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.454 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.961 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -120.13 -64.73 1.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -167.56 -160.9 15.85 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 39.2 Cg_endo -76.45 162.68 91.42 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 CA-C-N 118.707 1.253 . . . . 0.0 113.473 25.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 33.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 tt -150.48 117.9 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.59 45.76 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 103.759 -3.736 . . . . 0.0 103.759 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 42.7 m95 -136.49 156.9 47.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 119.781 1.791 . . . . 0.0 107.564 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.9 m -120.16 117.28 27.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.5 t -150.66 -173.8 4.58 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 2.6 tmmm? -150.44 155.44 39.55 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.307 -1.259 0 O-C-N 125.878 1.986 . . . . 0.0 108.561 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.9 m -98.75 177.25 5.35 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.265 0.353 . . . . 0.0 110.479 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 t -175.92 172.69 2.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 124.954 1.409 . . . . 0.0 110.557 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -113.33 166.47 11.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.1 m -99.88 171.5 7.82 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.342 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.509 2.48 0 CA-C-O 123.408 1.575 . . . . 0.0 111.9 179.852 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.505 2.302 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.17 -162.07 10.8 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.4 m -150.84 160.96 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 101.358 -3.571 . . . . 0.0 101.358 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.1 tt -116.97 141.66 47.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.271 -1.786 . . . . 0.0 108.5 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -119.5 129.62 54.8 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 110.634 -2.984 . . . . 0.0 106.715 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.62 -18.98 26.86 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -45.54 146.09 1.88 Allowed Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 110.843 -2.89 . . . . 0.0 109.187 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -65.72 -12.11 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.792 1.661 . . . . 0.0 112.61 -162.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 63.4 p -129.12 21.43 5.76 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.573 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 59.43 -115.66 7.76 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.487 -1.233 . . . . 0.0 116.042 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.23 108.16 0.78 Allowed Pre-proline 0 C--N 1.298 -1.649 0 CA-C-N 110.928 -2.636 . . . . 0.0 113.423 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -76.65 139.17 19.91 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.607 2.205 . . . . 0.0 108.12 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 p -52.24 101.45 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 112.253 -2.248 . . . . 0.0 108.296 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.5 -3.81 1.66 Allowed Glycine 0 CA--C 1.543 1.804 0 N-CA-C 104.942 -3.263 . . . . 0.0 104.942 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.4 m95 -112.92 -174.68 2.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.3 m-70 -131.68 -101.84 0.28 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.67 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -167.37 146.58 5.07 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.31 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -145.44 -51.98 0.26 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.5 mmmt -98.65 106.69 18.99 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.478 -1.289 . . . . 0.0 107.84 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.15 2.94 55.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -129.69 -83.58 0.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.42 -169.05 45.53 Favored Glycine 0 N--CA 1.504 3.213 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 5.1 Cg_endo -85.02 28.95 7.87 Favored 'Cis proline' 0 N--CA 1.499 1.798 0 CA-C-N 119.424 1.612 . . . . 0.0 115.522 -6.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.4 m 67.05 -23.09 0.11 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -108.13 137.33 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.23 -151.98 9.01 Favored Glycine 0 N--CA 1.508 3.471 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.573 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 5.7 m95 -135.96 127.92 29.51 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.372 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 m -99.44 113.89 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.585 1.184 . . . . 0.0 108.094 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.4 t -134.09 -163.75 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.73 154.17 36.88 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.303 -1.453 1 N-CA-C 98.803 -4.517 . . . . 0.0 98.803 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 15.5 m -85.29 -178.53 6.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 109.333 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 t -162.67 149.33 12.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.945 1.403 . . . . 0.0 112.384 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 4.8 mt -94.72 139.09 31.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 61.2 m -88.36 146.96 24.98 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.752 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 19.0 t . . . . . 0 N--CA 1.512 2.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.49 -175.31 14.17 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-O 123.213 1.452 . . . . 0.0 111.921 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 89.5 m -150.58 153.59 36.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 135.57 44.7 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 110.856 -2.884 . . . . 0.0 109.09 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.48 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 85.3 m95 -109.91 129.34 55.67 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 109.816 -3.356 . . . . 0.0 107.263 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -88.66 -12.74 41.58 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.117 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -57.17 148.46 51.76 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 111.852 -2.431 . . . . 0.0 108.918 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -63.53 -16.54 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.355 1.37 . . . . 0.0 113.247 -163.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.414 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 57.6 p -121.3 10.16 10.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.218 1.574 . . . . 0.0 111.637 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.46 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.0 -116.78 6.1 Favored Glycine 0 C--N 1.298 -1.574 0 CA-C-N 114.559 -1.2 . . . . 0.0 115.012 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -42.9 109.49 0.76 Allowed Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 111.807 -2.196 . . . . 0.0 113.104 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -77.42 126.03 8.09 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.973 2.448 . . . . 0.0 108.688 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -43.26 100.35 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 112.578 -2.101 . . . . 0.0 109.837 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.54 -8.11 1.81 Allowed Glycine 0 C--N 1.296 -1.688 0 N-CA-C 104.087 -3.605 . . . . 0.0 104.087 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.691 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.8 m95 -97.97 -151.5 0.37 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.556 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -150.07 -105.73 0.07 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.007 0.192 . . . . 0.0 111.064 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.679 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -168.4 141.12 2.96 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 119.587 -0.245 . . . . 0.0 111.655 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.591 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -147.66 -15.83 0.37 Allowed 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HG3' ' CB ' ' A' ' 46' ' ' CYS . 1.6 mmpt? -129.3 105.6 8.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 1.88 53.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.97 1.419 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -132.25 -60.02 0.91 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.24 -160.61 17.97 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.753 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.67 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 50.1 Cg_endo -73.45 -175.58 15.12 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 O-C-N 122.829 0.91 . . . . 0.0 111.093 -7.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -86.92 5.24 38.06 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.3 pt -143.88 123.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.66 -169.47 54.31 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.46 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 20.9 m95 -130.16 155.2 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.67 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -122.21 129.67 52.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.55 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.1 t -150.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.591 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.58 165.67 33.56 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.238 -1.839 . . . . 0.0 108.497 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -69.57 166.78 18.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 37' ' ' LYS . 7.2 t -156.08 135.48 12.32 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.407 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 4.5 mt -92.09 118.06 30.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 8.8 m -88.23 153.96 20.81 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.512 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.297 -1.682 0 CA-C-N 113.375 -1.738 . . . . 0.0 113.454 -179.711 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -90.8 164.96 30.44 Favored Glycine 0 C--N 1.309 -0.954 0 CA-C-O 125.207 2.559 . . . . 0.0 114.991 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 m -151.1 136.58 17.81 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.17 -2.515 . . . . 0.0 106.184 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 19.5 tp -93.11 138.03 31.91 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 109.703 -3.408 . . . . 0.0 107.649 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 86.5 m95 -118.51 130.41 55.91 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.429 -3.078 . . . . 0.0 106.263 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.92 -7.05 56.79 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.086 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -58.6 154.64 33.79 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.181 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.18 -24.75 72.63 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.295 1.33 . . . . 0.0 112.358 -166.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 29' ' ' CYS . 25.3 p -116.74 9.16 13.91 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.541 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 49.77 -84.75 0.01 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 125.919 2.012 . . . . 0.0 110.435 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -38.53 93.63 0.07 OUTLIER Pre-proline 0 C--N 1.283 -2.308 1 CA-C-N 107.764 -4.218 . . . . 0.0 109.942 -179.93 . . . . . . . . 4 4 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 42.7 Cg_endo -86.61 126.18 2.55 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.037 1.824 . . . . 0.0 110.376 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -44.62 112.78 0.46 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.068 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.57 -5.16 6.23 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 104.457 -3.457 . . . . 0.0 104.457 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.613 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 15.0 m95 -108.17 -171.06 1.79 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 3.7 m-70 -128.56 -124.43 0.22 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.867 -3.012 . . . . 0.0 102.867 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 6.3 p30 -162.39 159.0 24.72 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.61 -49.71 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.423 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 9.7 mmtt -89.01 75.14 8.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -4.81 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.024 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 37' ' ' LYS . 83.7 m-70 -103.73 -21.84 13.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 143.55 -165.61 27.11 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.812 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 43.8 Cg_endo -71.86 -171.15 7.61 Favored 'Cis proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.348 1.574 . . . . 0.0 114.347 16.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 t -95.71 -6.6 39.47 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.671 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.8 pt -106.68 99.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.08 -159.25 28.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 105.129 -3.188 . . . . 0.0 105.129 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 4.6 m95 -141.58 142.45 33.48 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.3 m -106.37 116.84 32.63 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 90.7 m -133.31 -171.83 2.79 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -137.75 161.63 36.03 Favored 'General case' 0 C--N 1.295 -1.767 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.5 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 115.357 -2.259 . . . . 0.0 111.087 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 4.8 m -79.49 160.08 26.69 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t -158.68 151.17 21.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.5 164.55 18.72 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 m -103.7 163.12 12.53 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.414 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.754 0.311 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -171.25 23.7 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 106.742 -2.543 . . . . 0.0 106.742 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.9 m -150.41 149.76 30.47 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 1.4 tt -110.15 143.14 40.69 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.065 -1.88 . . . . 0.0 107.538 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 87.1 m95 -114.09 131.75 56.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 111.499 -2.591 . . . . 0.0 108.453 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.38 -10.75 48.26 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.882 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 7.3 m-30 -56.87 145.78 61.76 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 112.172 -2.285 . . . . 0.0 106.99 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -66.18 -16.59 52.46 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.488 1.459 . . . . 0.0 113.265 -164.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 p -111.81 6.11 19.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.112 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.575 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.66 -117.78 5.56 Favored Glycine 0 C--N 1.297 -1.589 0 CA-C-N 114.5 -1.227 . . . . 0.0 114.363 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -53.8 119.97 21.26 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 111.616 -2.292 . . . . 0.0 113.115 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.5 Cg_endo -74.85 165.04 32.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-O 125.528 2.22 . . . . 0.0 112.897 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -78.39 79.31 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.363 -2.653 . . . . 0.0 113.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 159.79 9.64 0.04 OUTLIER Glycine 0 C--N 1.29 -2.017 1 CA-C-N 107.738 -4.301 . . . . 0.0 106.168 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.7 m95 -125.09 -169.84 2.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.442 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.6 m-70 -133.52 -106.31 0.24 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.65 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p-10 179.93 131.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 122.703 0.401 . . . . 0.0 111.879 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.9 p -150.57 11.61 0.69 Allowed 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 39' ' ' HIS . 0.9 OUTLIER -150.5 67.46 0.95 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.08 29.94 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 37' ' ' LYS . 37.4 m170 -110.74 -10.12 14.47 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.56 0.344 . . . . 0.0 111.073 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -123.98 4.35 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 43' ' ' ILE . 52.2 Cg_endo -71.6 148.9 91.4 Favored 'Cis proline' 0 N--CA 1.494 1.54 0 N-CA-C 116.42 1.661 . . . . 0.0 116.42 -8.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.16 -9.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 41' ' ' PRO . 47.6 pt -122.7 0.01 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.66 144.34 7.37 Favored Glycine 0 N--CA 1.503 3.139 1 N-CA-C 102.733 -4.147 . . . . 0.0 102.733 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.575 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -95.15 138.65 32.58 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 119.719 1.759 . . . . 0.0 111.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.67 127.12 43.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.7 t -148.2 -164.8 2.1 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.001 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 6' ' ' CYS . 65.3 pttt -151.12 165.16 34.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.154 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m -114.0 176.42 5.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.33 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 p -174.34 161.95 3.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.21 153.36 23.67 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 4.4 m -99.37 162.15 13.2 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 . . . . . 0 N--CA 1.497 1.905 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.498 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.23 -166.33 38.16 Favored Glycine 0 N--CA 1.483 1.779 0 CA-C-O 122.825 1.236 . . . . 0.0 113.031 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -141.1 137.49 32.85 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -101.68 133.05 46.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.484 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 72.5 m95 -107.63 127.42 53.64 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.467 -2.151 . . . . 0.0 109.881 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.28 -9.8 51.7 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.283 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -63.37 149.34 91.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 CA-C-N 112.413 -2.176 . . . . 0.0 105.465 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -62.22 -14.77 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.495 1.463 . . . . 0.0 114.052 -161.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 5.7 p -123.17 5.49 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.385 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 79.87 -120.46 5.23 Favored Glycine 0 C--N 1.299 -1.513 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.874 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -40.78 107.48 0.48 Allowed Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 110.583 -2.808 . . . . 0.0 113.172 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 59.4 Cg_endo -79.49 129.96 8.71 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.381 2.721 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -42.06 106.04 0.06 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.629 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.92 -4.64 3.27 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 104.181 -3.567 . . . . 0.0 104.181 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.782 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.0 m95 -110.04 -162.93 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.46 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.3 m80 -137.55 -117.28 0.15 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.696 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 13.3 p30 -176.34 132.78 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.611 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 32.0 p -140.01 -53.37 0.52 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.836 -1.146 . . . . 0.0 109.74 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 28.9 mmmt -87.19 66.96 9.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.335 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 2.94 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m170 -113.48 -9.46 13.3 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 133.78 -171.52 22.0 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.621 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 22.6 Cg_endo -76.74 174.89 12.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 N-CA-C 116.728 1.78 . . . . 0.0 116.728 33.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -79.92 26.12 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.577 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.5 mt -148.57 99.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.99 -173.31 52.21 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 104.935 -3.266 . . . . 0.0 104.935 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 25.1 m95 -125.31 147.77 48.99 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 120.154 1.977 . . . . 0.0 108.966 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 m -110.51 129.7 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.5 t -150.64 -166.94 2.68 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.406 -1.724 . . . . 0.0 109.172 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -150.96 159.88 44.28 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.8 tt0 . . . . . 0 C--N 1.305 -1.361 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.531 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 74.4 m -135.27 179.78 6.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.164 0.915 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -162.91 166.24 24.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 125.736 1.898 . . . . 0.0 109.496 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.13 130.25 42.17 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 124.456 1.098 . . . . 0.0 110.307 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.05 156.27 16.73 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.762 0.792 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.406 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.19 -153.26 7.39 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 118.748 -1.692 . . . . 0.0 112.608 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 33.1 m -150.2 147.21 27.43 Favored 'General case' 0 C--N 1.298 -1.658 1 N-CA-C 100.0 -4.074 . . . . 0.0 100.0 179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -103.51 137.66 41.29 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.449 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 69.7 m95 -111.59 129.73 55.98 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.021 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mt -88.25 -13.55 40.67 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 111.973 -2.376 . . . . 0.0 108.706 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -59.19 147.61 74.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 112.355 -2.202 . . . . 0.0 106.84 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.95 -12.0 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.936 1.757 . . . . 0.0 114.342 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 p -124.17 12.56 8.92 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 71.75 -120.64 8.22 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-O 122.448 1.027 . . . . 0.0 113.521 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.75 120.7 6.34 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 111.431 -2.385 . . . . 0.0 113.816 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 23' ' ' TRP . 96.6 Cg_endo -79.4 -177.48 3.91 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.545 2.163 . . . . 0.0 108.663 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -87.26 137.59 32.22 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.82 13.04 41.62 Favored Glycine 0 C--N 1.285 -2.251 0 CA-C-N 111.578 -2.556 . . . . 0.0 107.692 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 9.4 m95 -119.5 -160.24 0.81 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -132.86 -127.23 0.18 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.0 p30 -172.36 132.77 0.63 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 18.9 p -142.07 -59.57 0.46 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.401 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.636 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 30.4 mmmt -87.55 60.7 6.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 123.49 1.614 . . . . 0.0 110.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.78 24.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 37' ' ' LYS . 92.5 m-70 -126.47 -66.31 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 41' ' ' PRO . . . -170.56 -177.77 40.85 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.749 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 36.5 Cg_endo -74.53 176.99 40.48 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 O-C-N 123.738 1.388 . . . . 0.0 112.256 29.606 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -97.43 -8.7 28.8 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -96.33 78.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.81 -178.01 33.31 Favored Glycine 0 N--CA 1.497 2.718 1 N-CA-C 102.659 -4.177 . . . . 0.0 102.659 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.466 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.5 m95 -121.03 160.49 23.48 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.749 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 20.2 m -119.99 131.84 55.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.3 t -151.15 -168.55 3.13 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -151.45 166.43 31.12 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 101.489 -3.522 . . . . 0.0 101.489 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.9 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.492 1.67 1 N-CA-C 100.126 -4.027 . . . . 0.0 100.126 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -79.42 155.84 28.17 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -159.57 133.86 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.94 178.47 0.81 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.375 1.083 . . . . 0.0 113.291 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' C ' ' HD3' ' A' ' 37' ' ' LYS . 32.9 m -101.19 -177.96 3.6 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.548 -1.66 . . . . 0.0 113.224 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.501 2.082 0 O-C-N 120.608 -1.307 . . . . 0.0 111.297 -179.769 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 117.327 2.344 . . . . 0.0 117.327 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.89 -164.34 37.76 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.4 m -151.2 147.39 26.95 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -99.98 137.19 38.77 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.415 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.8 m95 -112.65 128.6 56.43 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 110.985 -2.825 . . . . 0.0 105.984 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.46 -10.19 49.95 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.278 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -57.21 145.47 66.21 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 111.999 -2.364 . . . . 0.0 107.846 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -64.94 -9.72 22.53 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.71 1.607 . . . . 0.0 113.67 -164.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 35.6 p -125.75 15.78 8.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.173 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 63.56 -117.86 12.12 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.451 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.73 110.91 1.36 Allowed Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.759 -2.721 . . . . 0.0 114.989 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -77.09 136.45 16.33 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 124.3 3.334 . . . . 0.0 109.718 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -48.15 108.38 0.17 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.029 1.395 . . . . 0.0 108.182 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.55 2.18 3.66 Favored Glycine 0 N--CA 1.481 1.689 0 CA-C-N 110.532 -3.031 . . . . 0.0 106.45 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.0 m95 -116.44 -157.4 0.65 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.453 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 18.9 t60 -150.25 -110.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.107 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.592 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.4 p-10 -169.45 147.9 3.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.609 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.31 -63.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 124.233 0.958 . . . . 0.0 109.247 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.532 ' HD3' ' C ' ' A' ' 6' ' ' CYS . 32.1 mmmt -88.71 59.31 5.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.37 17.15 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.9 p80 -129.32 -36.6 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.02 171.72 32.66 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.667 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 65.1 Cg_endo -73.04 175.34 45.61 Favored 'Cis proline' 0 N--CA 1.5 1.881 0 O-C-N 122.903 0.949 . . . . 0.0 114.559 4.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -93.43 19.56 8.22 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.152 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.04 -39.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.711 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.01 165.97 20.81 Favored Glycine 0 N--CA 1.505 3.276 1 N-CA-C 102.276 -4.33 . . . . 0.0 102.276 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.7 m95 -101.58 132.01 47.47 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 119.651 1.725 . . . . 0.0 110.532 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.6 m -99.62 111.9 24.19 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.7 t -127.53 -168.09 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.728 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.66 164.81 36.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 33' ' ' TRP . 3.5 tt0 . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.9 m -84.02 172.08 12.34 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 t -155.93 165.11 37.45 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 4.6 tp -105.33 129.23 53.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' SG ' ' HE3' ' A' ' 48' ' ' LYS . 79.8 m -87.49 158.39 18.96 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.211 -2.195 . . . . 0.0 107.118 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 71.4 m-20 . . . . . 0 N--CA 1.507 2.386 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.47 -177.13 49.62 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 41.7 m -149.1 145.01 27.02 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -99.85 133.97 43.42 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.514 -3.039 . . . . 0.0 109.271 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 81.3 m95 -109.61 129.45 55.59 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 111.548 -2.569 . . . . 0.0 107.546 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.89 -7.55 57.02 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 11.3 m-30 -57.99 149.7 54.13 Favored Pre-proline 0 C--N 1.301 -1.518 0 CA-C-N 111.913 -2.403 . . . . 0.0 106.569 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.32 -15.06 45.89 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.287 1.324 . . . . 0.0 113.946 -163.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 p -122.1 7.84 9.77 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.157 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 78.36 -119.42 5.15 Favored Glycine 0 CA--C 1.489 -1.548 0 CA-C-N 114.175 -1.375 . . . . 0.0 114.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.82 115.79 3.53 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 111.851 -2.175 . . . . 0.0 113.318 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 79.1 Cg_endo -76.4 174.94 12.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 CA-C-O 125.604 2.252 . . . . 0.0 114.169 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m -81.69 107.22 14.26 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 110.311 -3.132 . . . . 0.0 105.271 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.67 3.87 5.41 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 11.9 m95 -119.7 -159.63 0.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 8.1 t-80 -134.49 -118.0 0.18 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.748 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.707 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 12.0 p-10 -175.62 129.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.524 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.436 ' C ' ' HG2' ' A' ' 37' ' ' LYS . 18.0 p -150.82 10.37 0.63 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 2.2 mmpt? -135.87 92.02 2.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.58 38.0 0.09 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -140.89 -26.09 0.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.43 -107.65 0.52 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.66 -173.86 10.59 Favored 'Cis proline' 0 N--CA 1.494 1.527 0 N-CA-C 117.782 2.186 . . . . 0.0 117.782 -4.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -85.51 19.25 2.43 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.325 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.38 23.85 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 122.21 1.005 . . . . 0.0 109.689 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.64 167.09 11.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 103.178 -3.969 . . . . 0.0 103.178 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.519 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.7 m95 -106.69 158.95 16.57 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.66 1.73 . . . . 0.0 110.97 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 1.8 m -116.28 126.98 54.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.013 0.821 . . . . 0.0 109.205 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 16.0 t -151.6 -163.74 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.749 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' SG ' ' A' ' 6' ' ' CYS . 32.5 ttmt -150.93 163.31 39.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.8 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.895 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.6 m -90.07 172.13 9.05 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 30.8 t -146.18 160.77 41.5 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.497 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 6.8 mp -83.59 126.13 32.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.32 -178.77 5.98 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 123.63 1.681 . . . . 0.0 108.346 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 48' ' ' LYS . . . -77.24 -169.59 32.21 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.398 0.999 . . . . 0.0 111.43 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 30.2 m -150.55 147.35 27.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 101.676 -3.453 . . . . 0.0 101.676 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 45' ' ' TRP . 5.0 tt -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.225 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -119.1 137.42 53.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.893 -1.958 . . . . 0.0 107.133 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.84 -15.23 35.05 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.486 1.612 . . . . 0.0 108.873 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -56.98 138.49 79.3 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 110.541 -3.027 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.09 -6.54 14.78 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.627 1.552 . . . . 0.0 112.662 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 p -126.74 22.25 6.89 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.944 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 57.8 -111.75 3.26 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 114.126 -1.397 . . . . 0.0 116.274 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.16 115.48 5.42 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 112.038 -2.081 . . . . 0.0 113.308 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 71.2 Cg_endo -80.28 150.84 20.14 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.678 2.252 . . . . 0.0 108.72 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.7 t -60.91 108.62 0.89 Allowed 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.43 -4.17 3.36 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 110.706 -2.952 . . . . 0.0 106.637 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.72 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 24.4 m95 -115.48 -160.55 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 78.8 m-70 -135.89 -89.56 0.31 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.658 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER 177.19 156.42 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.6 -43.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 124.357 1.035 . . . . 0.0 109.997 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 39' ' ' HIS . 4.3 mmtt -99.52 104.2 16.0 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.97 21.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 37' ' ' LYS . 35.9 m80 -135.96 -15.48 1.76 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.15 -86.44 0.23 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.699 -1.239 . . . . 0.0 112.111 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.47 -164.02 2.32 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 CA-C-N 118.394 1.097 . . . . 0.0 111.091 -6.091 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 p -74.31 23.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.4 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 5.2 mp -148.38 100.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.13 -149.8 21.24 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 104.794 -3.322 . . . . 0.0 104.794 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 14.2 m95 -142.89 152.88 42.57 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.986 1.393 . . . . 0.0 107.724 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 6.2 m -114.07 116.11 28.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.066 0.936 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.658 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 12.0 t -139.34 -168.62 2.49 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.879 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 28.8 tptp -151.25 151.82 32.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 103.0 -2.963 . . . . 0.0 103.0 179.68 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -119.3 174.67 6.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.25 168.51 22.34 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.527 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 2.1 tt -80.49 106.46 12.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.525 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 58.3 m -89.68 162.02 15.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 123.5 1.619 . . . . 0.0 112.165 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -91.37 -163.99 38.9 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.282 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.422 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 15.5 m -150.84 142.3 23.44 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 98.971 -4.455 . . . . 0.0 98.971 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 24' ' ' LEU . 4.2 tt -105.02 143.97 32.47 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.425 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.6 m95 -117.21 135.46 53.77 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 111.822 -2.445 . . . . 0.0 107.954 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 22' ' ' LEU . 11.7 mt -88.72 -17.4 30.0 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.874 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -52.07 138.65 35.52 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 110.907 -2.861 . . . . 0.0 109.097 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -66.18 -10.81 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.551 1.501 . . . . 0.0 113.254 -166.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -118.72 16.76 13.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.827 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 60.75 -118.64 15.64 Favored Glycine 0 C--N 1.297 -1.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 117.089 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.08 114.45 4.35 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 110.713 -2.744 . . . . 0.0 114.295 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 76.1 Cg_endo -80.66 127.63 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.57 2.18 . . . . 0.0 109.762 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 p -44.45 106.58 0.07 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.554 -2.112 . . . . 0.0 105.952 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.4 -7.33 3.1 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.785 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.4 m95 -111.3 -164.24 0.9 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 48.2 m80 -139.44 -109.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 123.94 0.775 . . . . 0.0 110.254 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.622 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.7 p-10 -164.36 153.02 13.02 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -150.33 -33.82 0.17 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.457 1.599 . . . . 0.0 111.118 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HA ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -115.48 105.01 12.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.64 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.64 4.11 17.04 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.996 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -117.22 -112.98 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.282 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.82 -154.87 20.29 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 116.739 1.456 . . . . 0.0 116.739 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 91.7 Cg_endo -67.02 167.68 56.85 Favored 'Cis proline' 0 N--CA 1.501 1.953 0 O-C-N 122.77 0.879 . . . . 0.0 111.373 11.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -25.12 61.66 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.883 0.849 . . . . 0.0 109.585 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 tp -103.37 106.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.33 -177.16 39.21 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.513 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.4 m95 -135.88 135.57 39.83 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.72 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 21.5 m -97.47 130.81 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 17.6 t -148.58 -166.54 2.57 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.496 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 36' ' ' CYS . 12.3 ptmm? -152.18 164.0 38.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.2 tt0 . . . . . 0 C--N 1.305 -1.342 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 123.002 1.382 . . . . 0.0 112.16 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.4 m -72.71 170.51 14.4 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.184 -2.28 . . . . 0.0 110.985 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' GLY . 45.7 t -159.39 143.02 14.71 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -73.12 167.72 20.56 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.8 176.05 5.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.421 0 O-C-N 120.56 -1.338 . . . . 0.0 112.163 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -80.51 -159.65 21.02 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 63.1 m -151.42 153.86 35.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 23' ' ' TRP . 3.1 tp -101.52 149.82 23.7 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.016 -1.902 . . . . 0.0 106.683 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.407 ' N ' ' HG ' ' A' ' 22' ' ' LEU . 68.8 m95 -127.51 128.39 45.59 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.082 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 3.7 mt -88.99 -10.71 46.63 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.006 -2.815 . . . . 0.0 108.721 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -63.25 150.43 89.17 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 112.524 -2.125 . . . . 0.0 106.21 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.18 -14.39 43.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.663 1.576 . . . . 0.0 113.817 -163.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 p -125.51 13.75 8.16 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 69.03 -115.73 6.71 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.156 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.3 t -42.67 107.69 0.57 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 110.557 -2.822 . . . . 0.0 113.315 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 37.1 Cg_endo -75.47 124.76 8.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 174.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 p -41.34 108.43 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.21 -4.11 3.76 Favored Glycine 0 C--N 1.293 -1.829 0 N-CA-C 105.08 -3.208 . . . . 0.0 105.08 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.733 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.5 m95 -116.97 167.48 11.09 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 100.906 -3.738 . . . . 0.0 100.906 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -93.91 -83.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 119.69 3.219 . . . . 0.0 119.69 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.775 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 7.6 p30 154.07 153.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 128.93 2.892 . . . . 0.0 105.057 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -150.66 -31.72 0.18 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 123.468 0.48 . . . . 0.0 111.642 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 29.1 mmmt -125.96 88.35 2.84 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.45 34.5 0.05 Allowed 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.78 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -137.49 -21.39 1.16 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.64 -130.23 2.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -61.89 -179.79 5.86 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 CA-C-N 119.167 1.483 . . . . 0.0 113.738 -5.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 p -78.12 -10.04 59.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.177 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tt -97.1 -26.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 121.917 0.865 . . . . 0.0 109.86 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 155.61 27.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 105.577 -3.009 . . . . 0.0 105.577 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 6.2 m95 -92.59 140.11 29.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 1.6 m -101.3 117.23 34.56 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 119.269 0.94 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 14.5 t -129.5 -165.05 1.47 Allowed 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.536 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 14.9 pttp -151.4 152.23 32.81 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.299 -1.603 0 O-C-N 124.545 1.153 . . . . 0.0 108.367 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.4 t . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.6 m -70.61 167.73 17.92 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -160.1 121.22 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.645 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 5' ' ' LEU . 9.5 mt -59.57 164.66 3.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.504 0.668 . . . . 0.0 110.775 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.8 m -101.0 158.51 15.95 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.998 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 6.6 m-20 . . . . . 0 N--CA 1.506 2.335 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.501 2.121 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.42 -174.24 14.23 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-O 122.372 0.985 . . . . 0.0 112.608 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 99.6 m -151.17 155.41 38.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -104.81 141.12 37.07 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 112.304 -2.225 . . . . 0.0 108.325 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 78.2 m95 -111.85 133.43 54.07 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.292 -2.231 . . . . 0.0 110.83 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.25 -16.51 31.03 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.293 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -60.65 143.38 90.64 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.381 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -66.93 -9.95 26.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.882 1.721 . . . . 0.0 113.62 -165.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 p -117.47 12.14 14.08 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.328 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.55 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 67.59 -117.21 8.59 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-N 113.984 -1.462 . . . . 0.0 116.231 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 2.7 t -51.3 113.05 3.51 Favored Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 110.839 -2.68 . . . . 0.0 112.562 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 83.2 Cg_endo -80.92 138.21 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.161 2.574 . . . . 0.0 110.851 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -46.33 99.45 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -1.52 2.46 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 105.424 -3.07 . . . . 0.0 105.424 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TRP . . . . . 0.741 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 21.7 m95 -109.65 -153.85 0.52 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.619 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -150.52 -101.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.489 0.661 . . . . 0.0 110.215 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.582 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 25.1 p30 -169.78 157.76 7.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.54 -39.03 0.13 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.186 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 22.2 mmmt -101.31 114.48 28.5 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' ND1' ' A' ' 39' ' ' HIS . . . -76.89 10.33 2.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.893 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 38' ' ' ALA . 17.0 m-70 -133.26 -127.35 0.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.38 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.53 -145.65 10.21 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.1 -177.27 17.38 Favored 'Cis proline' 0 N--CA 1.499 1.842 0 CA-C-N 117.968 0.884 . . . . 0.0 111.764 7.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -91.14 -6.53 53.45 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.362 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -116.89 96.75 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.01 157.41 27.71 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TRP . . . . . 0.55 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -109.68 157.59 18.95 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 7.5 m -117.06 119.3 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.079 1.418 . . . . 0.0 109.137 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' C ' ' A' ' 34' ' ' HIS . 9.0 t -134.63 -163.76 1.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.408 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.04 149.71 29.87 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' C ' ' CE ' ' A' ' 48' ' ' LYS . 46.3 tt0 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.361 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 105.731 -2.948 . . . . 0.0 105.731 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.99 115.12 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.931 0.872 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.5 m -92.36 169.07 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.3 p -162.71 157.79 22.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.11 127.62 32.1 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 125.14 1.525 . . . . 0.0 112.594 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 60.7 m -93.39 173.05 7.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 125.338 1.649 . . . . 0.0 106.596 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.59 -14.05 17.9 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.87 0.843 . . . . 0.0 109.817 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -97.5 1.15 48.72 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.434 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -106.3 160.02 15.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.82 -72.55 0.43 Allowed Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.19 166.77 28.72 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.93 1.753 . . . . 0.0 111.582 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 p -89.2 91.14 8.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.35 1.071 . . . . 0.0 109.13 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -132.34 158.54 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 109.823 -3.353 . . . . 0.0 109.461 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.14 134.37 56.42 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.398 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.58 1.78 58.87 Favored Glycine 0 N--CA 1.499 2.854 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -51.22 161.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 126.006 1.651 . . . . 0.0 113.246 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m 105.16 175.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.2 pt? -87.61 89.19 7.9 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 125.188 2.423 . . . . 0.0 107.294 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -87.72 -3.61 58.95 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 111.729 -2.487 . . . . 0.0 117.158 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.532 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -84.37 -159.5 29.92 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.779 -1.677 . . . . 0.0 109.846 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 8.1 m -150.06 134.19 17.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -93.49 142.55 27.21 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.649 -2.523 . . . . 0.0 108.875 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 80.1 m95 -119.41 134.03 55.42 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 111.938 -2.392 . . . . 0.0 105.712 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.61 -11.89 44.19 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.943 1.354 . . . . 0.0 108.372 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -55.46 144.16 54.25 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 111.25 -2.704 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -64.95 -7.94 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.098 1.865 . . . . 0.0 113.55 -165.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 34.5 p -132.52 17.46 4.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 64.83 -112.02 4.66 Favored Glycine 0 N--CA 1.477 1.384 0 CA-C-N 113.601 -1.636 . . . . 0.0 116.633 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.615 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -47.06 116.87 4.32 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 111.003 -2.599 . . . . 0.0 115.238 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.9 Cg_endo -81.44 152.56 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.774 2.316 . . . . 0.0 109.794 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.1 t -64.57 109.11 1.87 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.956 -1.929 . . . . 0.0 106.18 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.79 -2.1 4.4 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 105.876 -2.89 . . . . 0.0 105.876 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 15.3 m95 -109.51 -154.04 0.53 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 1.0 OUTLIER -137.55 -65.57 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.512 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.795 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.5 p30 137.42 147.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 128.299 2.64 . . . . 0.0 108.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.74 -1.33 0.38 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.167 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 11.5 mmmm -140.5 106.36 5.16 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.818 0.699 . . . . 0.0 109.177 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.25 -13.76 62.58 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.748 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -140.12 -112.79 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -31.86 129.98 0.22 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.562 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 41.7 Cg_endo -71.46 -173.26 9.55 Favored 'Cis proline' 0 N--CA 1.508 2.367 0 N-CA-C 118.379 2.415 . . . . 0.0 118.379 6.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 t -122.23 18.53 10.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.2 mt -132.25 -75.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' PRO . . . -90.58 -155.18 31.07 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 27' ' ' SER . 6.5 m95 -141.17 167.5 22.03 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.57 1.685 . . . . 0.0 109.55 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.562 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 5.5 m -124.38 128.4 49.0 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.442 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.795 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.8 t -144.82 -169.25 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 35' ' ' ASN . 6.4 ptpp? -150.36 156.64 41.9 Favored 'General case' 0 C--N 1.298 -1.67 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.528 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.588 0 N-CA-C 105.694 -2.962 . . . . 0.0 105.694 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' THR . 28.4 t -90.09 152.39 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 5.4 m -79.54 165.94 22.45 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 119.339 0.972 . . . . 0.0 111.808 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.8 t -162.79 144.48 10.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -90.56 115.19 27.5 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 m -88.04 156.62 19.21 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.019 -2.586 . . . . 0.0 104.019 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 40.9 m-20 -61.73 -16.44 49.34 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.074 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -89.9 -1.74 58.04 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.349 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB2' HD23 ' A' ' 5' ' ' LEU . 38.5 m-20 -89.44 91.72 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.24 124.01 26.96 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.467 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.65 166.75 21.1 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.58 2.187 . . . . 0.0 114.742 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -150.3 -176.58 5.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.69 -156.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -61.82 131.17 48.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.585 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 29.75 4.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -68.6 173.98 4.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.012 0.911 . . . . 0.0 111.831 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.7 p -123.75 -177.96 3.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.574 -2.103 . . . . 0.0 107.362 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.536 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 3.2 mp -147.39 115.29 6.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 m -84.8 -33.43 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.88 160.5 52.84 Favored Glycine 0 CA--C 1.496 -1.144 0 CA-C-O 124.226 2.015 . . . . 0.0 109.287 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 17.9 m -142.66 138.02 30.36 Favored 'General case' 0 C--N 1.28 -2.443 1 N-CA-C 100.108 -4.034 . . . . 0.0 100.108 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -99.82 140.86 33.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.444 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.437 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.1 m95 -114.61 131.91 56.54 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 111.688 -2.506 . . . . 0.0 108.481 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.79 -12.63 41.5 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.339 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -58.38 139.5 84.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 111.89 -2.414 . . . . 0.0 105.393 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -64.98 -7.07 14.15 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.432 1.422 . . . . 0.0 113.86 -163.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.4 p -122.68 13.11 9.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.591 1.182 . . . . 0.0 110.789 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.507 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 67.42 -118.62 10.24 Favored Glycine 0 C--N 1.298 -1.569 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.78 106.54 0.57 Allowed Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 110.87 -2.665 . . . . 0.0 113.503 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -76.52 130.32 11.68 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.877 2.385 . . . . 0.0 108.774 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -42.58 111.2 0.23 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.362 -1.745 . . . . 0.0 106.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.53 -8.55 4.97 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 104.33 -3.508 . . . . 0.0 104.33 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.2 m95 -105.69 -167.97 1.39 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.448 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.9 m-70 -135.5 -114.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.588 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -174.92 134.99 0.36 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 31.8 p -141.47 -52.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.168 -1.413 . . . . 0.0 109.86 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.542 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.8 mmmt -88.13 65.56 8.19 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.591 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.9 -3.24 1.5 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.389 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.437 ' H ' ' C ' ' A' ' 37' ' ' LYS . 12.9 m170 -98.58 -15.21 19.58 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 136.32 -166.29 24.76 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.168 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 23.8 Cg_endo -74.39 -179.17 25.16 Favored 'Cis proline' 0 N--CA 1.494 1.501 0 N-CA-C 115.513 1.313 . . . . 0.0 115.513 25.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 p -89.42 11.91 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.969 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.0 101.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.89 -171.38 46.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 103.572 -3.811 . . . . 0.0 103.572 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.507 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -127.04 149.41 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 118.95 1.375 . . . . 0.0 108.241 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -110.48 129.21 55.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.9 t -150.65 -168.05 2.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.799 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -150.38 162.22 40.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 115.789 -2.053 . . . . 0.0 106.982 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.865 0 N-CA-C 105.916 -2.873 . . . . 0.0 105.916 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 t -140.12 144.68 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 125.016 1.068 . . . . 0.0 108.841 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.608 ' CB ' HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -81.66 160.02 23.83 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.935 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.12 144.09 9.49 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 123.547 0.53 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.43 ' HA ' ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -74.2 176.8 6.29 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.34 138.7 54.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.748 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.499 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 20.0 m-20 -54.05 -2.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -110.32 -6.13 15.08 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.86 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.48 115.18 29.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 60.64 0.54 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.226 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -67.7 150.45 79.32 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.983 1.789 . . . . 0.0 109.805 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 p -89.02 102.34 14.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.567 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 14' ' ' ARG . 5.4 p 179.06 171.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 111.952 -2.386 . . . . 0.0 106.994 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -156.82 167.55 30.13 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.41 -32.18 1.38 Allowed Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.666 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 14' ' ' ARG . 51.8 t30 -140.94 167.15 22.87 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 m 90.91 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.746 1.904 . . . . 0.0 112.239 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' CB ' ' A' ' 3' ' ' SER . 1.4 pp -150.89 159.11 44.77 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 5' ' ' LEU . 49.4 m -141.56 2.45 1.62 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.232 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.85 -164.76 10.24 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -150.41 159.21 44.63 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.39 146.18 40.89 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.41 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 86.7 m95 -119.64 133.64 55.56 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 111.786 -2.461 . . . . 0.0 109.608 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -88.87 -14.9 35.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.83 144.2 81.61 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 111.43 -2.623 . . . . 0.0 105.913 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -66.9 -19.73 52.12 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.182 1.255 . . . . 0.0 112.486 -162.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.2 p -107.02 5.47 28.11 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.288 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 69.37 -113.82 5.35 Favored Glycine 0 C--N 1.298 -1.53 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.999 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -43.82 108.97 0.75 Allowed Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 110.451 -2.874 . . . . 0.0 111.316 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 38.1 Cg_endo -74.91 130.81 13.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 N-CA-C 106.06 -2.323 . . . . 0.0 106.06 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -45.92 101.87 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.018 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.6 -4.83 1.99 Allowed Glycine 0 C--N 1.296 -1.673 0 N-CA-C 104.375 -3.49 . . . . 0.0 104.375 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.692 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 20.2 m95 -105.53 -168.54 1.47 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -140.16 -70.61 0.39 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.832 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 7.8 p30 155.91 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 126.131 1.773 . . . . 0.0 114.258 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -140.82 -7.65 1.08 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.541 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.499 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 18.9 mmmt -134.22 108.31 8.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.359 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.79 31.31 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 37' ' ' LYS . 5.9 m80 -132.58 -145.99 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.5 -98.3 1.87 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -79.13 -165.59 4.73 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 N-CA-C 114.195 0.806 . . . . 0.0 114.195 1.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -84.76 14.65 4.53 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.996 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 pt -147.24 81.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.7 171.55 44.95 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 107.561 -2.215 . . . . 0.0 107.561 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.48 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.4 m95 -116.68 142.44 46.9 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.058 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 13.1 m -103.9 120.74 41.65 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.832 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 1.7 t -142.64 -167.38 2.5 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 27.9 pttt -151.17 164.06 37.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 125.026 1.454 . . . . 0.0 112.714 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.736 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.55 142.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -79.71 163.19 24.71 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 52.6 t -157.06 155.85 31.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.924 0.765 . . . . 0.0 109.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -89.67 121.01 31.44 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 8' ' ' SER . 20.0 m -94.41 152.78 18.35 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.823 0.82 . . . . 0.0 111.039 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.715 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 2.7 m-20 -65.79 15.32 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 6' ' ' CYS . 22.7 t -131.72 1.16 4.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB2' ' CD2' ' A' ' 5' ' ' LEU . 39.9 m-20 -88.73 61.2 5.9 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.04 -121.39 11.66 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.051 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.33 173.63 9.36 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 121.566 1.511 . . . . 0.0 112.268 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -88.95 -176.75 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.718 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 14' ' ' ARG . 11.9 p 45.46 -132.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 123.651 0.595 . . . . 0.0 109.582 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' VAL . 39.3 mtt85 -118.97 160.81 21.29 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.12 -33.5 1.6 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 17' ' ' THR . 20.8 t30 -109.91 164.03 12.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.158 -1.521 . . . . 0.0 110.444 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.437 ' N ' ' CG ' ' A' ' 16' ' ' ASN . 69.0 m -66.49 150.3 49.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -102.36 136.62 41.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.848 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 p -126.2 0.61 7.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.922 1.389 . . . . 0.0 110.243 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.84 -172.51 48.86 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -150.15 144.63 25.8 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.94 138.17 37.38 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 111.585 -2.552 . . . . 0.0 108.256 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -112.2 129.42 56.26 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 110.712 -2.949 . . . . 0.0 107.577 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.23 -14.11 36.68 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -57.33 148.77 51.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 CA-C-N 112.44 -2.164 . . . . 0.0 106.085 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -19.78 68.3 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 120.991 1.128 . . . . 0.0 113.283 -162.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -113.02 7.28 18.05 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.742 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 72.77 -115.59 5.32 Favored Glycine 0 CA--C 1.49 -1.526 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.576 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.0 OUTLIER -48.46 115.03 3.94 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 111.591 -2.304 . . . . 0.0 112.766 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 63.4 Cg_endo -77.89 165.94 25.79 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.556 2.171 . . . . 0.0 112.469 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 91.66 3.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 111.761 -2.472 . . . . 0.0 108.562 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 151.42 -1.04 0.34 Allowed Glycine 0 C--N 1.29 -1.992 0 CA-C-N 109.806 -3.361 . . . . 0.0 105.656 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.672 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.9 m95 -116.65 -167.35 1.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 4.6 m-70 -127.34 -73.38 0.61 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 117.795 2.517 . . . . 0.0 117.795 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.781 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.4 p30 143.06 150.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.025 2.53 . . . . 0.0 109.314 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 20.8 p -151.46 -53.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 123.341 1.543 . . . . 0.0 109.407 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HZ1' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -88.39 78.33 7.96 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.129 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.62 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.775 -1.557 . . . . 0.0 108.62 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.33 -55.36 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.86 -162.75 9.24 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.439 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.762 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 25.6 Cg_endo -78.71 -173.59 13.16 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 CA-C-N 117.718 0.759 . . . . 0.0 111.384 4.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 p -90.07 5.96 44.46 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.167 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 pt -145.39 102.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 123.91 0.756 . . . . 0.0 109.071 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 169.93 46.12 Favored Glycine 0 N--CA 1.506 3.31 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.542 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 12.3 m95 -109.06 149.78 28.78 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 118.176 0.988 . . . . 0.0 110.522 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.762 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.7 m -111.06 130.75 55.51 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 11.7 t -150.19 -167.9 2.95 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.514 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.39 160.57 43.65 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.7 tt0 . . . . . 0 C--N 1.298 -1.657 0 O-C-N 125.182 1.551 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.618 0 N-CA-C 105.794 -2.922 . . . . 0.0 105.794 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -99.18 143.82 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -80.79 163.43 23.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 35.4 t -144.38 168.44 20.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.576 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 5.3 tp -119.09 129.85 55.29 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD ' ' A' ' 48' ' ' LYS . 80.7 m -97.56 151.08 20.41 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.304 0.573 . . . . 0.0 110.653 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 62.5 m-20 -60.68 -16.27 37.49 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -88.48 1.4 54.89 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.199 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 5' ' ' LEU . 20.1 m-20 -105.55 133.94 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.016 0.822 . . . . 0.0 110.363 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.28 59.3 0.3 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -80.45 136.12 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 123.133 2.555 . . . . 0.0 111.229 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 p -89.29 93.56 9.59 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.574 1.178 . . . . 0.0 109.732 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 14' ' ' ARG . 8.9 p -154.21 174.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 110.743 -2.935 . . . . 0.0 107.798 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.404 ' N ' HG22 ' A' ' 13' ' ' VAL . 20.9 mtp180 -134.75 149.61 50.45 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.96 -29.65 10.0 Favored Glycine 0 N--CA 1.507 3.388 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -160.51 153.2 21.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.563 ' H ' HD23 ' A' ' 18' ' ' LEU . 25.1 m -156.53 36.48 0.32 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 125.425 1.703 . . . . 0.0 109.027 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 17' ' ' THR . 2.0 pt? -151.13 125.62 9.51 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 t -131.42 5.47 4.39 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 124.777 1.298 . . . . 0.0 110.201 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -166.29 37.64 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.3 m -150.01 157.3 43.0 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -111.97 141.62 45.4 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 111.946 -2.388 . . . . 0.0 107.274 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.419 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 80.0 m95 -112.85 130.86 55.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.8 -2.909 . . . . 0.0 106.138 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.22 -13.1 41.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.523 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 8.5 m-30 -56.67 142.71 70.63 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 111.576 -2.556 . . . . 0.0 107.067 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -63.33 -17.01 58.1 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.015 1.143 . . . . 0.0 113.652 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.7 p -113.62 6.41 16.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.791 -1.549 . . . . 0.0 112.82 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.515 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 73.98 -116.71 5.4 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.478 -1.344 . . . . 0.0 115.043 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -45.75 116.36 3.25 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 111.785 -2.207 . . . . 0.0 112.668 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 93.0 Cg_endo -81.48 160.88 19.66 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.117 1.878 . . . . 0.0 108.206 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -69.56 110.2 4.67 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.071 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.28 -4.63 4.52 Favored Glycine 0 C--N 1.289 -2.042 0 N-CA-C 105.208 -3.157 . . . . 0.0 105.208 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 19.0 m95 -116.49 -164.85 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -126.39 -87.93 0.58 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.694 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.1 p30 149.9 149.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 127.047 2.139 . . . . 0.0 108.627 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 23.1 p -150.78 -46.78 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.555 1.169 . . . . 0.0 108.3 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 25.3 mmmt -88.61 80.19 7.37 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.118 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.6 49.82 1.23 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.338 1.066 . . . . 0.0 108.266 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -146.81 -52.26 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.177 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -143.27 4.93 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 59.2 Cg_endo -70.55 161.24 88.9 Favored 'Cis proline' 0 C--N 1.311 -1.424 0 CA-C-O 123.135 1.223 . . . . 0.0 115.214 8.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 p -72.53 33.38 0.06 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.368 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.4 pt -140.98 -41.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 121.506 0.67 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.12 165.27 28.59 Favored Glycine 0 N--CA 1.493 2.466 1 N-CA-C 101.367 -4.693 . . . . 0.0 101.367 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.515 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 11.5 m95 -100.95 154.6 18.54 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.443 2.121 . . . . 0.0 111.741 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.3 m -107.19 123.86 48.89 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.694 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.8 t -150.5 -179.83 7.55 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.844 0.831 . . . . 0.0 110.087 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CD ' ' SG ' ' A' ' 6' ' ' CYS . 34.5 mtmt -142.2 156.15 45.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.7 tt0 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 125.555 1.784 . . . . 0.0 114.607 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.45 133.08 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 m -75.59 165.05 25.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.4 ' C ' ' HB2' ' A' ' 18' ' ' LEU . 52.0 t -159.79 165.8 31.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -100.79 150.03 23.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 48' ' ' LYS . 32.6 m -99.94 161.78 13.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.743 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 7.3 m-20 -61.86 -23.82 66.52 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.313 1.054 . . . . 0.0 111.054 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -67.3 -29.01 68.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.95 68.35 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -38.77 118.12 0.73 Allowed Glycine 0 N--CA 1.502 3.071 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.432 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -69.51 176.74 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.965 1.777 . . . . 0.0 113.55 -162.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.0 p -144.93 156.22 43.86 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.8 m -81.34 79.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 58.8 ttt85 85.47 165.06 0.09 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 111.452 -2.613 . . . . 0.0 106.564 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.68 7.52 74.65 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -68.28 149.65 49.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.496 -1.352 . . . . 0.0 109.681 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 107.343 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 18' ' ' LEU . 1.1 pt? -149.47 78.73 1.38 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.273 1.511 . . . . 0.0 112.063 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -82.47 2.92 30.44 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.8 -2.0 . . . . 0.0 114.005 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.58 -169.62 27.76 Favored Glycine 0 C--N 1.3 -1.469 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -150.56 146.79 26.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -102.28 141.83 34.48 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 111.522 -2.581 . . . . 0.0 107.94 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.3 m95 -114.23 132.64 56.05 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.461 -3.063 . . . . 0.0 107.215 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.66 -12.26 42.98 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.364 -1.743 . . . . 0.0 108.282 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -59.43 139.05 89.01 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.254 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.13 -13.13 33.57 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 120.66 0.907 . . . . 0.0 114.26 -160.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 p -114.57 4.6 15.21 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.167 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 78.95 -122.09 5.74 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 113.771 -1.558 . . . . 0.0 116.178 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -44.64 116.24 2.63 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 111.04 -2.58 . . . . 0.0 114.341 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 87.7 Cg_endo -77.5 167.1 24.89 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.779 2.319 . . . . 0.0 112.853 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -70.7 103.16 2.48 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.182 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.31 1.44 4.36 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 105.056 -3.218 . . . . 0.0 105.056 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.781 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -117.26 -162.56 0.87 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.5 m-70 -133.5 -114.82 0.21 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.732 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER 177.93 136.5 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 23.9 p -145.62 -46.63 0.21 Allowed 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.579 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.3 mmmt -88.54 69.66 8.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.704 1.24 . . . . 0.0 109.785 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 5.76 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.163 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 95.1 m-70 -107.57 -16.12 14.43 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.09 -148.79 17.13 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.706 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 92.3 Cg_endo -68.15 -171.3 5.44 Favored 'Cis proline' 0 N--CA 1.493 1.474 0 CA-C-N 118.67 1.235 . . . . 0.0 114.681 4.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 t -93.36 20.81 6.7 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.837 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 mm -123.84 -57.52 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 CA-C-O 121.552 0.691 . . . . 0.0 110.114 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.71 13.61 Favored Glycine 0 N--CA 1.501 3.015 1 N-CA-C 102.913 -4.075 . . . . 0.0 102.913 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 11.3 m95 -108.49 146.22 33.51 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 120.293 2.046 . . . . 0.0 109.684 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.706 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 6.7 m -104.2 130.46 51.96 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.9 t -150.48 -163.98 1.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.625 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -150.19 164.25 36.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 116.484 -1.722 . . . . 0.0 109.692 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.847 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.15 139.88 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 51.2 m -134.73 177.36 7.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.588 1.18 . . . . 0.0 109.305 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -160.49 160.79 32.44 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 125.924 2.015 . . . . 0.0 110.993 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 9' ' ' ASP . 4.2 tt -61.92 117.12 5.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 126.143 2.152 . . . . 0.0 110.394 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.5 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 76.5 m -93.61 159.58 15.16 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.705 -0.798 . . . . 0.0 113.099 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.29 -14.19 0.09 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -97.26 -20.23 18.03 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.938 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.536 ' O ' HD21 ' A' ' 5' ' ' LEU . 2.1 m-20 -89.66 112.36 23.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.96 64.58 0.35 Allowed Glycine 0 N--CA 1.497 2.712 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.372 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.99 -174.97 1.92 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.59 2.193 . . . . 0.0 113.859 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 p -90.04 -179.87 5.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.427 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -73.9 124.66 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 1 N-CA-C 96.364 -5.421 . . . . 0.0 96.364 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 83.14 135.81 0.06 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 103.414 -2.81 . . . . 0.0 103.414 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.92 18.86 Favored Glycine 0 N--CA 1.505 3.262 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.615 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -54.46 129.18 34.99 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.922 0.868 . . . . 0.0 109.48 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -103.1 128.13 50.12 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 18' ' ' LEU . 10.8 mp -89.32 61.85 5.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 124.109 1.909 . . . . 0.0 106.675 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 -50.52 64.92 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 108.939 -3.755 . . . . 0.0 110.156 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -86.51 -156.88 29.27 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.5 m -150.36 148.71 29.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 102.327 -3.212 . . . . 0.0 102.327 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.3 tt -109.56 138.86 45.3 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.864 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 82.4 m95 -108.55 130.8 55.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.934 -2.394 . . . . 0.0 109.368 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.78 -16.18 32.79 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.075 -2.329 . . . . 0.0 108.847 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -57.37 147.24 59.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 112.138 -2.301 . . . . 0.0 108.12 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -65.49 -12.13 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.047 1.831 . . . . 0.0 113.41 -162.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 p -120.81 6.08 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.499 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.32 -119.6 6.28 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-O 122.984 1.325 . . . . 0.0 113.775 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.57 109.37 0.93 Allowed Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 110.63 -2.785 . . . . 0.0 114.047 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 75.1 Cg_endo -79.25 136.1 12.51 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.966 3.111 . . . . 0.0 110.128 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 m -47.32 104.27 0.05 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.748 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.5 -3.62 2.68 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.79 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.8 m95 -117.6 -171.43 2.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 55.9 m80 -140.45 -99.64 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.16 0.912 . . . . 0.0 112.977 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.665 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 20.3 p30 -163.47 153.25 15.14 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.67 -30.78 0.23 Allowed 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.51 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 14.6 mmmt -117.68 93.53 4.19 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.87 42.9 0.4 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 71.2 m-70 -140.21 -29.43 0.7 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.355 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.65 -114.8 0.93 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.669 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 14.5 Cg_endo -86.49 -152.95 0.7 Allowed 'Cis proline' 0 C--N 1.314 -1.265 0 CA-C-N 118.537 1.169 . . . . 0.0 110.59 8.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -82.57 9.3 9.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.97 113.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.23 -174.02 27.52 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 106.041 -2.824 . . . . 0.0 106.041 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.521 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 m95 -127.17 135.07 50.18 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.441 1.121 . . . . 0.0 108.187 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.669 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 51.9 m -96.12 122.24 38.74 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.31 1.053 . . . . 0.0 108.987 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 5.5 t -144.26 -168.92 3.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.61 168.75 23.35 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 3.4 tt0 . . . . . 0 C--N 1.297 -1.681 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.687 0 N-CA-C 105.974 -2.85 . . . . 0.0 105.974 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.45 132.68 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 24.4 m -90.41 -178.33 5.32 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 49.2 t -162.63 169.01 20.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 125.611 1.819 . . . . 0.0 108.356 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.2 mt -104.77 137.76 42.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.585 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -89.93 161.73 15.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.692 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -62.41 -34.66 77.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.7 m -77.1 -2.09 32.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 125.123 1.514 . . . . 0.0 113.452 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -89.97 176.69 6.71 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.95 173.05 48.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 109.239 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.61 -170.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.936 1.091 . . . . 0.0 110.097 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.45 103.58 15.99 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 123.285 1.517 . . . . 0.0 110.176 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -163.97 163.65 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 112.333 -2.212 . . . . 0.0 107.965 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -67.59 167.65 12.6 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.35 -43.49 3.24 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 106.128 -2.789 . . . . 0.0 106.128 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -74.55 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 18' ' ' LEU . 63.6 m -144.08 164.15 31.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.586 0.707 . . . . 0.0 112.16 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 3' ' ' SER . 9.9 mp -88.68 86.69 7.04 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 m -81.92 25.94 0.54 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.481 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.94 -166.22 10.98 Favored Glycine 0 CA--C 1.555 2.547 0 O-C-N 125.27 1.607 . . . . 0.0 111.872 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 90.0 m -150.76 160.27 43.97 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 103.066 -2.938 . . . . 0.0 103.066 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -113.13 136.88 52.24 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -110.01 134.12 52.47 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.956 1.36 . . . . 0.0 110.574 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.96 -17.01 30.37 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.409 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -57.9 147.46 63.48 Favored Pre-proline 0 N--CA 1.492 1.641 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.424 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -63.69 -11.11 24.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.034 1.823 . . . . 0.0 114.58 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 67.9 p -126.17 10.07 7.44 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.61 1.194 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.547 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.18 -114.17 4.85 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 119.381 -1.39 . . . . 0.0 113.823 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.22 112.09 1.48 Allowed Pre-proline 0 C--N 1.295 -1.772 0 CA-C-N 111.639 -2.281 . . . . 0.0 111.892 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 85.1 Cg_endo -83.57 151.91 13.34 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 123.191 2.594 . . . . 0.0 109.207 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -52.96 116.35 2.31 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.287 -2.233 . . . . 0.0 108.138 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 2.23 11.7 Favored Glycine 0 C--N 1.29 -2.024 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.333 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.572 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.3 m95 -114.33 -177.91 3.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 4.7 m-70 -130.4 -101.52 0.3 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.594 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -169.45 133.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 m -133.46 -20.09 2.1 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.952 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 31.4 mmmt -140.77 95.89 2.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.454 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.961 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -120.13 -64.73 1.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -167.56 -160.9 15.85 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 39.2 Cg_endo -76.45 162.68 91.42 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 CA-C-N 118.707 1.253 . . . . 0.0 113.473 25.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 33.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 tt -150.48 117.9 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.59 45.76 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 103.759 -3.736 . . . . 0.0 103.759 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 42.7 m95 -136.49 156.9 47.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 119.781 1.791 . . . . 0.0 107.564 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.9 m -120.16 117.28 27.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.5 t -150.66 -173.8 4.58 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 2.6 tmmm? -150.44 155.44 39.55 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.307 -1.259 0 O-C-N 125.878 1.986 . . . . 0.0 108.561 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.731 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.57 148.08 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.476 ' CB ' HD22 ' A' ' 18' ' ' LEU . 71.9 m -98.75 177.25 5.35 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.265 0.353 . . . . 0.0 110.479 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 t -175.92 172.69 2.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 124.954 1.409 . . . . 0.0 110.557 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -113.33 166.47 11.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' C ' ' H ' ' A' ' 8' ' ' SER . 60.1 m -99.88 171.5 7.82 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.56 16.5 1.7 Allowed 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 123.408 1.575 . . . . 0.0 111.9 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 6' ' ' CYS . 23.8 p -108.53 -49.78 3.12 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.956 -2.383 . . . . 0.0 107.657 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.19 175.76 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.77 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.72 59.22 0.01 OUTLIER Glycine 0 N--CA 1.481 1.669 0 CA-C-N 113.01 -1.904 . . . . 0.0 109.381 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.57 131.97 15.47 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 C-N-CA 121.6 1.533 . . . . 0.0 111.413 -168.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -90.02 169.52 11.13 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 14' ' ' ARG . 38.9 t 69.35 167.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.858 1.313 . . . . 0.0 112.882 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' N ' HG12 ' A' ' 13' ' ' VAL . 9.8 ptm85 -60.29 143.47 52.75 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.928 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.12 24.22 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -47.75 154.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 125.112 1.125 . . . . 0.0 111.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -147.33 175.44 10.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.545 -1.207 . . . . 0.0 113.181 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD22 ' CB ' ' A' ' 3' ' ' SER . 1.1 mt -114.44 103.04 10.65 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.4 p -81.27 -7.1 59.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.17 -162.07 10.8 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.4 m -150.84 160.96 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 101.358 -3.571 . . . . 0.0 101.358 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.1 tt -116.97 141.66 47.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.271 -1.786 . . . . 0.0 108.5 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -119.5 129.62 54.8 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 110.634 -2.984 . . . . 0.0 106.715 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.62 -18.98 26.86 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -45.54 146.09 1.88 Allowed Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 110.843 -2.89 . . . . 0.0 109.187 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -65.72 -12.11 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.792 1.661 . . . . 0.0 112.61 -162.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 63.4 p -129.12 21.43 5.76 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.573 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 59.43 -115.66 7.76 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.487 -1.233 . . . . 0.0 116.042 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.23 108.16 0.78 Allowed Pre-proline 0 C--N 1.298 -1.649 0 CA-C-N 110.928 -2.636 . . . . 0.0 113.423 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -76.65 139.17 19.91 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.607 2.205 . . . . 0.0 108.12 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 p -52.24 101.45 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 112.253 -2.248 . . . . 0.0 108.296 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.5 -3.81 1.66 Allowed Glycine 0 CA--C 1.543 1.804 0 N-CA-C 104.942 -3.263 . . . . 0.0 104.942 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.4 m95 -112.92 -174.68 2.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.3 m-70 -131.68 -101.84 0.28 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.67 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -167.37 146.58 5.07 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.31 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -145.44 -51.98 0.26 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.5 mmmt -98.65 106.69 18.99 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.478 -1.289 . . . . 0.0 107.84 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.15 2.94 55.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -129.69 -83.58 0.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.42 -169.05 45.53 Favored Glycine 0 N--CA 1.504 3.213 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 5.1 Cg_endo -85.02 28.95 7.87 Favored 'Cis proline' 0 N--CA 1.499 1.798 0 CA-C-N 119.424 1.612 . . . . 0.0 115.522 -6.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.4 m 67.05 -23.09 0.11 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -108.13 137.33 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.23 -151.98 9.01 Favored Glycine 0 N--CA 1.508 3.471 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.573 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 5.7 m95 -135.96 127.92 29.51 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.372 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 m -99.44 113.89 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.585 1.184 . . . . 0.0 108.094 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.4 t -134.09 -163.75 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.73 154.17 36.88 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.303 -1.453 1 N-CA-C 98.803 -4.517 . . . . 0.0 98.803 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.701 0 N-CA-C 105.945 -2.862 . . . . 0.0 105.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 t -147.17 142.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 15.5 m -85.29 -178.53 6.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 109.333 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 9.0 t -162.67 149.33 12.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.945 1.403 . . . . 0.0 112.384 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 4.8 mt -94.72 139.09 31.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 61.2 m -88.36 146.96 24.98 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.06 -32.33 61.82 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.752 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -78.03 -0.2 27.0 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.612 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -89.76 35.39 0.83 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 119.491 1.042 . . . . 0.0 110.373 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.52 -155.67 51.43 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.433 -1.365 . . . . 0.0 111.477 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.89 164.15 32.19 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.913 2.408 . . . . 0.0 113.656 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -91.6 -175.43 4.19 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t 57.31 24.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.152 0.977 . . . . 0.0 112.194 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -173.82 -159.05 0.1 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 -48.28 3.46 Favored Glycine 0 N--CA 1.488 2.12 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.6 t30 74.02 160.04 0.23 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.1 m 71.04 168.96 0.32 Allowed 'General case' 0 N--CA 1.51 2.53 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 4.5 mp -140.35 130.18 24.54 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.827 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 19.0 t -89.44 -4.64 57.9 Favored 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 119.918 1.236 . . . . 0.0 108.165 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.49 -175.31 14.17 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-O 123.213 1.452 . . . . 0.0 111.921 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 89.5 m -150.58 153.59 36.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 135.57 44.7 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 110.856 -2.884 . . . . 0.0 109.09 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 85.3 m95 -109.91 129.34 55.67 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 109.816 -3.356 . . . . 0.0 107.263 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -88.66 -12.74 41.58 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.117 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -57.17 148.46 51.76 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 111.852 -2.431 . . . . 0.0 108.918 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -63.53 -16.54 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.355 1.37 . . . . 0.0 113.247 -163.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.414 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 57.6 p -121.3 10.16 10.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.218 1.574 . . . . 0.0 111.637 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.46 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.0 -116.78 6.1 Favored Glycine 0 C--N 1.298 -1.574 0 CA-C-N 114.559 -1.2 . . . . 0.0 115.012 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -42.9 109.49 0.76 Allowed Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 111.807 -2.196 . . . . 0.0 113.104 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -77.42 126.03 8.09 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.973 2.448 . . . . 0.0 108.688 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -43.26 100.35 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 112.578 -2.101 . . . . 0.0 109.837 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.54 -8.11 1.81 Allowed Glycine 0 C--N 1.296 -1.688 0 N-CA-C 104.087 -3.605 . . . . 0.0 104.087 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.691 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.8 m95 -97.97 -151.5 0.37 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.556 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -150.07 -105.73 0.07 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.007 0.192 . . . . 0.0 111.064 -179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.679 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -168.4 141.12 2.96 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 119.587 -0.245 . . . . 0.0 111.655 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.591 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -147.66 -15.83 0.37 Allowed 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HG3' ' CB ' ' A' ' 46' ' ' CYS . 1.6 mmpt? -129.3 105.6 8.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 1.88 53.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.97 1.419 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -132.25 -60.02 0.91 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.24 -160.61 17.97 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.753 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.67 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 50.1 Cg_endo -73.45 -175.58 15.12 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 O-C-N 122.829 0.91 . . . . 0.0 111.093 -7.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -86.92 5.24 38.06 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.3 pt -143.88 123.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.66 -169.47 54.31 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.46 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 20.9 m95 -130.16 155.2 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.67 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -122.21 129.67 52.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.55 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.1 t -150.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.591 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.58 165.67 33.56 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.238 -1.839 . . . . 0.0 108.497 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.029 0 N-CA-C 105.419 -3.072 . . . . 0.0 105.419 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.48 140.66 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.548 ' CB ' HD13 ' A' ' 18' ' ' LEU . 6.3 m -69.57 166.78 18.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 37' ' ' LYS . 7.2 t -156.08 135.48 12.32 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 5' ' ' LEU . 4.5 mt -92.09 118.06 30.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 8.8 m -88.23 153.96 20.81 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.512 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.44 -8.76 2.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.375 -1.738 . . . . 0.0 113.454 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -97.52 -6.76 32.92 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.145 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.52 156.08 18.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 125.152 1.533 . . . . 0.0 110.623 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.63 115.86 3.32 Favored Glycine 0 N--CA 1.492 2.422 0 CA-C-O 118.727 -1.041 . . . . 0.0 111.311 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.44 163.35 39.14 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.039 1.826 . . . . 0.0 112.903 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 p -133.03 170.93 14.67 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.006 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 m -78.27 84.03 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 76.21 -167.83 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 112.005 -2.361 . . . . 0.0 109.081 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.34 -41.98 3.07 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.458 HD21 ' CD1' ' A' ' 18' ' ' LEU . 15.0 t30 65.72 148.84 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.593 0.819 . . . . 0.0 112.518 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 16' ' ' ASN . 10.1 p -169.91 138.63 1.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.975 -2.972 . . . . 0.0 102.975 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' A' ' 3' ' ' SER . 3.7 mp -140.9 121.88 14.58 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.43 -27.08 29.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -90.8 164.96 30.44 Favored Glycine 0 C--N 1.309 -0.954 0 CA-C-O 125.207 2.559 . . . . 0.0 114.991 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 m -151.1 136.58 17.81 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.17 -2.515 . . . . 0.0 106.184 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 19.5 tp -93.11 138.03 31.91 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 109.703 -3.408 . . . . 0.0 107.649 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 86.5 m95 -118.51 130.41 55.91 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.429 -3.078 . . . . 0.0 106.263 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.92 -7.05 56.79 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.086 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -58.6 154.64 33.79 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.181 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.18 -24.75 72.63 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.295 1.33 . . . . 0.0 112.358 -166.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 29' ' ' CYS . 25.3 p -116.74 9.16 13.91 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.541 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 49.77 -84.75 0.01 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 125.919 2.012 . . . . 0.0 110.435 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -38.53 93.63 0.07 OUTLIER Pre-proline 0 C--N 1.283 -2.308 1 CA-C-N 107.764 -4.218 . . . . 0.0 109.942 -179.93 . . . . . . . . 4 4 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 42.7 Cg_endo -86.61 126.18 2.55 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.037 1.824 . . . . 0.0 110.376 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -44.62 112.78 0.46 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.068 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.57 -5.16 6.23 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 104.457 -3.457 . . . . 0.0 104.457 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.613 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 15.0 m95 -108.17 -171.06 1.79 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 3.7 m-70 -128.56 -124.43 0.22 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.867 -3.012 . . . . 0.0 102.867 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 6.3 p30 -162.39 159.0 24.72 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.61 -49.71 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.423 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 9.7 mmtt -89.01 75.14 8.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -4.81 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.024 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 37' ' ' LYS . 83.7 m-70 -103.73 -21.84 13.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 143.55 -165.61 27.11 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.812 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 43.8 Cg_endo -71.86 -171.15 7.61 Favored 'Cis proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.348 1.574 . . . . 0.0 114.347 16.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 t -95.71 -6.6 39.47 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.671 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.8 pt -106.68 99.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.08 -159.25 28.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 105.129 -3.188 . . . . 0.0 105.129 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 4.6 m95 -141.58 142.45 33.48 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.3 m -106.37 116.84 32.63 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 90.7 m -133.31 -171.83 2.79 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -137.75 161.63 36.03 Favored 'General case' 0 C--N 1.295 -1.767 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.5 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 115.357 -2.259 . . . . 0.0 111.087 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.776 0 N-CA-C 105.094 -3.202 . . . . 0.0 105.094 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.82 143.45 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 4.8 m -79.49 160.08 26.69 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t -158.68 151.17 21.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.5 164.55 18.72 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 m -103.7 163.12 12.53 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -50.97 -28.48 9.96 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 m -66.64 -13.86 61.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.201 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -88.15 58.58 4.85 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 123.943 1.83 . . . . 0.0 108.753 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.28 -52.47 6.71 Favored Glycine 0 N--CA 1.496 2.67 0 CA-C-N 111.707 -2.497 . . . . 0.0 112.232 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.14 175.67 10.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.369 2.046 . . . . 0.0 111.764 167.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 17' ' ' THR . 89.1 p -150.35 142.54 24.13 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.836 -1.078 . . . . 0.0 109.811 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.01 168.34 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 124.554 1.159 . . . . 0.0 108.971 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -42.7 125.85 3.49 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 123.738 0.649 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.71 -33.03 6.3 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 104.955 -3.258 . . . . 0.0 104.955 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.2 t30 88.95 158.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 128.285 2.634 . . . . 0.0 110.904 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -92.46 92.57 8.15 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.046 0.927 . . . . 0.0 113.43 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.88 119.31 6.42 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -143.0 14.09 1.88 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.425 -0.797 . . . . 0.0 110.799 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -171.25 23.7 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 106.742 -2.543 . . . . 0.0 106.742 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.9 m -150.41 149.76 30.47 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 1.4 tt -110.15 143.14 40.69 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.065 -1.88 . . . . 0.0 107.538 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 87.1 m95 -114.09 131.75 56.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 111.499 -2.591 . . . . 0.0 108.453 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.38 -10.75 48.26 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.882 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 7.3 m-30 -56.87 145.78 61.76 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 112.172 -2.285 . . . . 0.0 106.99 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -66.18 -16.59 52.46 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.488 1.459 . . . . 0.0 113.265 -164.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 p -111.81 6.11 19.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.112 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.575 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.66 -117.78 5.56 Favored Glycine 0 C--N 1.297 -1.589 0 CA-C-N 114.5 -1.227 . . . . 0.0 114.363 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -53.8 119.97 21.26 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 111.616 -2.292 . . . . 0.0 113.115 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.5 Cg_endo -74.85 165.04 32.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-O 125.528 2.22 . . . . 0.0 112.897 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -78.39 79.31 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.363 -2.653 . . . . 0.0 113.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 159.79 9.64 0.04 OUTLIER Glycine 0 C--N 1.29 -2.017 1 CA-C-N 107.738 -4.301 . . . . 0.0 106.168 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.7 m95 -125.09 -169.84 2.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.442 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.6 m-70 -133.52 -106.31 0.24 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.65 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.5 p-10 179.93 131.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 122.703 0.401 . . . . 0.0 111.879 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.9 p -150.57 11.61 0.69 Allowed 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 39' ' ' HIS . 0.9 OUTLIER -150.5 67.46 0.95 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.08 29.94 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 37' ' ' LYS . 37.4 m170 -110.74 -10.12 14.47 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.56 0.344 . . . . 0.0 111.073 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -123.98 4.35 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 43' ' ' ILE . 52.2 Cg_endo -71.6 148.9 91.4 Favored 'Cis proline' 0 N--CA 1.494 1.54 0 N-CA-C 116.42 1.661 . . . . 0.0 116.42 -8.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.16 -9.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 41' ' ' PRO . 47.6 pt -122.7 0.01 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.66 144.34 7.37 Favored Glycine 0 N--CA 1.503 3.139 1 N-CA-C 102.733 -4.147 . . . . 0.0 102.733 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.575 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -95.15 138.65 32.58 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 119.719 1.759 . . . . 0.0 111.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.67 127.12 43.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.7 t -148.2 -164.8 2.1 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.001 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 6' ' ' CYS . 65.3 pttt -151.12 165.16 34.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.154 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.76 0 N-CA-C 105.803 -2.919 . . . . 0.0 105.803 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 t -131.3 135.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.764 1.282 . . . . 0.0 108.048 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m -114.0 176.42 5.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.33 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 p -174.34 161.95 3.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.21 153.36 23.67 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 4.4 m -99.37 162.15 13.2 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -57.11 -23.4 46.74 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -59.79 -20.51 57.23 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.24 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.54 2.8 54.14 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.828 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.69 -135.08 20.45 Favored Glycine 0 N--CA 1.501 3.029 0 CA-C-N 113.704 -1.589 . . . . 0.0 116.675 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.39 142.72 21.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.114 2.543 . . . . 0.0 115.431 -160.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -89.17 78.48 7.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.027 1.87 . . . . 0.0 111.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 t -97.68 28.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 110.066 -3.243 . . . . 0.0 107.732 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? 66.51 157.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.77 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.1 30.78 76.25 Favored Glycine 0 N--CA 1.503 3.134 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.21 169.23 16.58 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.557 1.17 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 p -94.28 122.19 36.57 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 112.308 -2.224 . . . . 0.0 116.348 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.25 62.65 6.21 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -78.2 -24.66 47.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.23 -166.33 38.16 Favored Glycine 0 N--CA 1.483 1.779 0 CA-C-O 122.825 1.236 . . . . 0.0 113.031 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -141.1 137.49 32.85 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -101.68 133.05 46.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.484 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 72.5 m95 -107.63 127.42 53.64 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.467 -2.151 . . . . 0.0 109.881 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.28 -9.8 51.7 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.283 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -63.37 149.34 91.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 CA-C-N 112.413 -2.176 . . . . 0.0 105.465 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -62.22 -14.77 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.495 1.463 . . . . 0.0 114.052 -161.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 5.7 p -123.17 5.49 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.385 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 79.87 -120.46 5.23 Favored Glycine 0 C--N 1.299 -1.513 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.874 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -40.78 107.48 0.48 Allowed Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 110.583 -2.808 . . . . 0.0 113.172 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 59.4 Cg_endo -79.49 129.96 8.71 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.381 2.721 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -42.06 106.04 0.06 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.629 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.92 -4.64 3.27 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 104.181 -3.567 . . . . 0.0 104.181 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.782 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.0 m95 -110.04 -162.93 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.46 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.3 m80 -137.55 -117.28 0.15 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.696 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 13.3 p30 -176.34 132.78 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.611 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 32.0 p -140.01 -53.37 0.52 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.836 -1.146 . . . . 0.0 109.74 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 28.9 mmmt -87.19 66.96 9.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.335 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 2.94 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m170 -113.48 -9.46 13.3 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 133.78 -171.52 22.0 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.621 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 22.6 Cg_endo -76.74 174.89 12.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 N-CA-C 116.728 1.78 . . . . 0.0 116.728 33.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -79.92 26.12 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.577 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.5 mt -148.57 99.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.99 -173.31 52.21 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 104.935 -3.266 . . . . 0.0 104.935 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 25.1 m95 -125.31 147.77 48.99 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 120.154 1.977 . . . . 0.0 108.966 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 m -110.51 129.7 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.5 t -150.64 -166.94 2.68 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.406 -1.724 . . . . 0.0 109.172 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -150.96 159.88 44.28 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.8 tt0 . . . . . 0 C--N 1.305 -1.361 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.531 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.703 0 N-CA-C 106.021 -2.832 . . . . 0.0 106.021 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t -143.9 141.75 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 74.4 m -135.27 179.78 6.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.164 0.915 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -162.91 166.24 24.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 125.736 1.898 . . . . 0.0 109.496 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.13 130.25 42.17 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 124.456 1.098 . . . . 0.0 110.307 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.05 156.27 16.73 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.762 0.792 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -5.65 3.91 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -107.82 12.34 27.35 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.75 4.66 27.9 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.09 -141.82 14.57 Favored Glycine 0 N--CA 1.49 2.273 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.037 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -80.38 171.95 14.21 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.809 2.339 . . . . 0.0 112.148 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 115.92 27.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.229 -0.988 . . . . 0.0 108.697 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 14' ' ' ARG . 4.3 p -170.57 -179.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' N ' HG22 ' A' ' 13' ' ' VAL . 9.1 ptt180 -131.52 135.73 47.3 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.23 -27.23 4.28 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -61.76 -75.28 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 t 179.98 -173.33 0.22 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -145.96 58.41 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.167 1.46 . . . . 0.0 111.026 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -33.61 1.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 112.193 -2.276 . . . . 0.0 114.912 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.19 -153.26 7.39 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 118.748 -1.692 . . . . 0.0 112.608 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 33.1 m -150.2 147.21 27.43 Favored 'General case' 0 C--N 1.298 -1.658 1 N-CA-C 100.0 -4.074 . . . . 0.0 100.0 179.322 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -103.51 137.66 41.29 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.449 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 69.7 m95 -111.59 129.73 55.98 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.021 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mt -88.25 -13.55 40.67 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 111.973 -2.376 . . . . 0.0 108.706 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -59.19 147.61 74.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 112.355 -2.202 . . . . 0.0 106.84 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.95 -12.0 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.936 1.757 . . . . 0.0 114.342 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 p -124.17 12.56 8.92 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 71.75 -120.64 8.22 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-O 122.448 1.027 . . . . 0.0 113.521 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.75 120.7 6.34 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 111.431 -2.385 . . . . 0.0 113.816 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 23' ' ' TRP . 96.6 Cg_endo -79.4 -177.48 3.91 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.545 2.163 . . . . 0.0 108.663 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -87.26 137.59 32.22 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.82 13.04 41.62 Favored Glycine 0 C--N 1.285 -2.251 0 CA-C-N 111.578 -2.556 . . . . 0.0 107.692 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 9.4 m95 -119.5 -160.24 0.81 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 35' ' ' ASN . 0.6 OUTLIER -132.86 -127.23 0.18 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 15.0 p30 -172.36 132.77 0.63 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 18.9 p -142.07 -59.57 0.46 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.401 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.636 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 30.4 mmmt -87.55 60.7 6.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 123.49 1.614 . . . . 0.0 110.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.78 24.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 37' ' ' LYS . 92.5 m-70 -126.47 -66.31 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 41' ' ' PRO . . . -170.56 -177.77 40.85 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.749 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 36.5 Cg_endo -74.53 176.99 40.48 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 O-C-N 123.738 1.388 . . . . 0.0 112.256 29.606 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -97.43 -8.7 28.8 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -96.33 78.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.81 -178.01 33.31 Favored Glycine 0 N--CA 1.497 2.718 1 N-CA-C 102.659 -4.177 . . . . 0.0 102.659 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.466 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.5 m95 -121.03 160.49 23.48 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.749 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 20.2 m -119.99 131.84 55.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.3 t -151.15 -168.55 3.13 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -151.45 166.43 31.12 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 101.489 -3.522 . . . . 0.0 101.489 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.9 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.873 0 N-CA-C 104.837 -3.305 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.26 135.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 N-CA-C 100.126 -4.027 . . . . 0.0 100.126 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 1.1 m -79.42 155.84 28.17 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -159.57 133.86 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 17' ' ' THR . 3.9 pp -64.94 178.47 0.81 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.375 1.083 . . . . 0.0 113.291 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' C ' ' HD3' ' A' ' 37' ' ' LYS . 32.9 m -101.19 -177.96 3.6 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.548 -1.66 . . . . 0.0 113.224 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' CG ' ' N ' ' A' ' 8' ' ' SER . 9.4 p-10 -66.1 -47.19 75.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.608 -1.307 . . . . 0.0 111.297 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 20.2 m -69.24 0.53 4.75 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 111.652 -2.522 . . . . 0.0 112.606 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 5' ' ' LEU . 14.7 m-20 -89.57 -167.73 1.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.16 0.913 . . . . 0.0 110.719 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.02 -175.6 49.93 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.561 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.41 153.98 67.12 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.951 1.767 . . . . 0.0 111.238 -171.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -88.51 94.26 9.81 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.693 1.711 . . . . 0.0 114.388 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -156.33 159.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 14.7 ttt-85 -72.15 -174.24 1.23 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 116.899 -1.921 . . . . 0.0 107.503 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 14' ' ' ARG . . . 80.85 -40.04 2.45 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' ND2' ' H ' ' A' ' 17' ' ' THR . 0.7 OUTLIER -80.81 -152.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.544 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 24.7 p -82.11 156.79 24.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 18' ' ' LEU . 1.3 pt? -152.32 44.54 0.71 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.6 m -63.29 -27.87 69.63 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.327 2.344 . . . . 0.0 117.327 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.89 -164.34 37.76 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.4 m -151.2 147.39 26.95 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -99.98 137.19 38.77 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.415 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.8 m95 -112.65 128.6 56.43 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 110.985 -2.825 . . . . 0.0 105.984 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.46 -10.19 49.95 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.278 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -57.21 145.47 66.21 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 111.999 -2.364 . . . . 0.0 107.846 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -64.94 -9.72 22.53 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.71 1.607 . . . . 0.0 113.67 -164.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 35.6 p -125.75 15.78 8.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.173 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 63.56 -117.86 12.12 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.451 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.73 110.91 1.36 Allowed Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.759 -2.721 . . . . 0.0 114.989 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -77.09 136.45 16.33 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 124.3 3.334 . . . . 0.0 109.718 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -48.15 108.38 0.17 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.029 1.395 . . . . 0.0 108.182 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.55 2.18 3.66 Favored Glycine 0 N--CA 1.481 1.689 0 CA-C-N 110.532 -3.031 . . . . 0.0 106.45 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.0 m95 -116.44 -157.4 0.65 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.453 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 18.9 t60 -150.25 -110.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.107 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.592 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.4 p-10 -169.45 147.9 3.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.609 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.31 -63.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 124.233 0.958 . . . . 0.0 109.247 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.532 ' HD3' ' C ' ' A' ' 6' ' ' CYS . 32.1 mmmt -88.71 59.31 5.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.37 17.15 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.9 p80 -129.32 -36.6 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.02 171.72 32.66 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.667 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 65.1 Cg_endo -73.04 175.34 45.61 Favored 'Cis proline' 0 N--CA 1.5 1.881 0 O-C-N 122.903 0.949 . . . . 0.0 114.559 4.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -93.43 19.56 8.22 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.152 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.04 -39.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.711 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.01 165.97 20.81 Favored Glycine 0 N--CA 1.505 3.276 1 N-CA-C 102.276 -4.33 . . . . 0.0 102.276 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.7 m95 -101.58 132.01 47.47 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 119.651 1.725 . . . . 0.0 110.532 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.6 m -99.62 111.9 24.19 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.7 t -127.53 -168.09 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.728 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.66 164.81 36.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 33' ' ' TRP . 3.5 tt0 . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.798 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t -149.26 143.78 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.9 m -84.02 172.08 12.34 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 t -155.93 165.11 37.45 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 9' ' ' ASP . 4.6 tp -105.33 129.23 53.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' SG ' ' HE3' ' A' ' 48' ' ' LYS . 79.8 m -87.49 158.39 18.96 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.211 -2.195 . . . . 0.0 107.118 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 71.4 m-20 -64.88 -7.03 9.68 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 t -113.71 5.56 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.173 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 5' ' ' LEU . 34.0 m-20 -99.95 27.13 5.72 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.8 0.81 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.48 171.3 14.98 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.48 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.39 -174.89 2.29 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 123.069 2.513 . . . . 0.0 110.315 162.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -89.49 158.23 17.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.042 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.1 t 94.08 146.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 C-N-CA 127.232 2.213 . . . . 0.0 107.127 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 155.24 2.37 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.194 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.5 -28.53 3.26 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 105.333 -3.107 . . . . 0.0 105.333 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' ND2' HD22 ' A' ' 5' ' ' LEU . 7.2 p-10 -73.08 178.95 4.04 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 112.064 -2.068 . . . . 0.0 108.628 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -118.36 -175.08 2.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -148.91 83.75 1.46 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.729 1.252 . . . . 0.0 109.149 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 p -86.66 2.18 49.33 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.506 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.47 -177.13 49.62 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 41.7 m -149.1 145.01 27.02 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -99.85 133.97 43.42 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.514 -3.039 . . . . 0.0 109.271 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 81.3 m95 -109.61 129.45 55.59 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 111.548 -2.569 . . . . 0.0 107.546 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.89 -7.55 57.02 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 11.3 m-30 -57.99 149.7 54.13 Favored Pre-proline 0 C--N 1.301 -1.518 0 CA-C-N 111.913 -2.403 . . . . 0.0 106.569 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.32 -15.06 45.89 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.287 1.324 . . . . 0.0 113.946 -163.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 p -122.1 7.84 9.77 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.157 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 78.36 -119.42 5.15 Favored Glycine 0 CA--C 1.489 -1.548 0 CA-C-N 114.175 -1.375 . . . . 0.0 114.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.82 115.79 3.53 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 111.851 -2.175 . . . . 0.0 113.318 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 79.1 Cg_endo -76.4 174.94 12.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 CA-C-O 125.604 2.252 . . . . 0.0 114.169 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m -81.69 107.22 14.26 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 110.311 -3.132 . . . . 0.0 105.271 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.67 3.87 5.41 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 11.9 m95 -119.7 -159.63 0.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 8.1 t-80 -134.49 -118.0 0.18 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.748 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.707 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 12.0 p-10 -175.62 129.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.524 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.436 ' C ' ' HG2' ' A' ' 37' ' ' LYS . 18.0 p -150.82 10.37 0.63 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 2.2 mmpt? -135.87 92.02 2.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.58 38.0 0.09 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -140.89 -26.09 0.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.43 -107.65 0.52 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.66 -173.86 10.59 Favored 'Cis proline' 0 N--CA 1.494 1.527 0 N-CA-C 117.782 2.186 . . . . 0.0 117.782 -4.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -85.51 19.25 2.43 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.325 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.38 23.85 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 122.21 1.005 . . . . 0.0 109.689 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.64 167.09 11.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 103.178 -3.969 . . . . 0.0 103.178 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.519 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.7 m95 -106.69 158.95 16.57 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.66 1.73 . . . . 0.0 110.97 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 1.8 m -116.28 126.98 54.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.013 0.821 . . . . 0.0 109.205 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 16.0 t -151.6 -163.74 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.749 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' SG ' ' A' ' 6' ' ' CYS . 32.5 ttmt -150.93 163.31 39.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.8 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.895 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.609 0 N-CA-C 105.748 -2.941 . . . . 0.0 105.748 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.67 133.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.6 m -90.07 172.13 9.05 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 30.8 t -146.18 160.77 41.5 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.497 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 6.8 mp -83.59 126.13 32.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.32 -178.77 5.98 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -33.72 67.6 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.63 1.681 . . . . 0.0 108.346 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -64.64 -32.89 74.75 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 112.468 -2.151 . . . . 0.0 108.253 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -89.46 73.4 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' H ' ' HD2' ' A' ' 11' ' ' PRO . . . -108.95 -70.24 0.67 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 111.671 -2.513 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 38.2 Cg_endo -76.2 150.75 33.51 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.035 1.823 . . . . 0.0 113.446 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 p -89.59 110.27 21.15 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.65 141.91 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 125.968 2.043 . . . . 0.0 108.824 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -63.31 121.88 14.82 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.41 -23.4 12.38 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -68.18 167.2 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.8 t -172.45 -154.92 0.08 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -121.36 93.06 3.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -16.95 59.19 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.784 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 48' ' ' LYS . . . -77.24 -169.59 32.21 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.398 0.999 . . . . 0.0 111.43 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 30.2 m -150.55 147.35 27.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 101.676 -3.453 . . . . 0.0 101.676 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 45' ' ' TRP . 5.0 tt -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.225 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -119.1 137.42 53.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.893 -1.958 . . . . 0.0 107.133 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.84 -15.23 35.05 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.486 1.612 . . . . 0.0 108.873 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -56.98 138.49 79.3 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 110.541 -3.027 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.09 -6.54 14.78 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.627 1.552 . . . . 0.0 112.662 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 p -126.74 22.25 6.89 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.944 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 57.8 -111.75 3.26 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 114.126 -1.397 . . . . 0.0 116.274 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.16 115.48 5.42 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 112.038 -2.081 . . . . 0.0 113.308 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 71.2 Cg_endo -80.28 150.84 20.14 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.678 2.252 . . . . 0.0 108.72 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.7 t -60.91 108.62 0.89 Allowed 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.43 -4.17 3.36 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 110.706 -2.952 . . . . 0.0 106.637 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.72 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 24.4 m95 -115.48 -160.55 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 78.8 m-70 -135.89 -89.56 0.31 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.658 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER 177.19 156.42 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.6 -43.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 124.357 1.035 . . . . 0.0 109.997 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 39' ' ' HIS . 4.3 mmtt -99.52 104.2 16.0 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.97 21.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 37' ' ' LYS . 35.9 m80 -135.96 -15.48 1.76 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.15 -86.44 0.23 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.699 -1.239 . . . . 0.0 112.111 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.47 -164.02 2.32 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 CA-C-N 118.394 1.097 . . . . 0.0 111.091 -6.091 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 p -74.31 23.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.4 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 5.2 mp -148.38 100.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.13 -149.8 21.24 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 104.794 -3.322 . . . . 0.0 104.794 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 14.2 m95 -142.89 152.88 42.57 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.986 1.393 . . . . 0.0 107.724 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 6.2 m -114.07 116.11 28.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.066 0.936 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.658 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 12.0 t -139.34 -168.62 2.49 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.879 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 28.8 tptp -151.25 151.82 32.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 103.0 -2.963 . . . . 0.0 103.0 179.68 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.695 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t -124.41 164.95 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -119.3 174.67 6.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.25 168.51 22.34 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.527 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 2.1 tt -80.49 106.46 12.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.525 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 58.3 m -89.68 162.02 15.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 123.5 1.619 . . . . 0.0 112.165 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.17 21.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 6' ' ' CYS . 69.3 m -147.91 19.51 1.13 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.168 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.2 m-20 -89.53 -145.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 153.65 22.95 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 104.484 -3.446 . . . . 0.0 104.484 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.45 ' HA ' HG23 ' A' ' 17' ' ' THR . 21.7 Cg_endo -78.74 140.77 16.72 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.28 2.653 . . . . 0.0 115.078 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.3 p -149.46 -166.35 2.53 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.8 175.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.472 ' HA ' ' HE ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -74.59 168.38 19.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.97 18.42 64.49 Favored Glycine 0 N--CA 1.504 3.218 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -163.39 -178.59 5.99 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 11' ' ' PRO . 10.4 m 81.61 42.96 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.895 1.331 . . . . 0.0 113.104 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -150.38 109.85 4.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.852 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -104.6 -6.32 20.62 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -91.37 -163.99 38.9 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.282 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.422 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 15.5 m -150.84 142.3 23.44 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 98.971 -4.455 . . . . 0.0 98.971 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 24' ' ' LEU . 4.2 tt -105.02 143.97 32.47 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.425 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.6 m95 -117.21 135.46 53.77 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 111.822 -2.445 . . . . 0.0 107.954 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 22' ' ' LEU . 11.7 mt -88.72 -17.4 30.0 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.874 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -52.07 138.65 35.52 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 110.907 -2.861 . . . . 0.0 109.097 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -66.18 -10.81 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.551 1.501 . . . . 0.0 113.254 -166.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -118.72 16.76 13.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.827 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 60.75 -118.64 15.64 Favored Glycine 0 C--N 1.297 -1.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 117.089 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.08 114.45 4.35 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 110.713 -2.744 . . . . 0.0 114.295 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 76.1 Cg_endo -80.66 127.63 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.57 2.18 . . . . 0.0 109.762 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 p -44.45 106.58 0.07 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.554 -2.112 . . . . 0.0 105.952 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.4 -7.33 3.1 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.785 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.4 m95 -111.3 -164.24 0.9 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 48.2 m80 -139.44 -109.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 123.94 0.775 . . . . 0.0 110.254 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.622 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.7 p-10 -164.36 153.02 13.02 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -150.33 -33.82 0.17 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.457 1.599 . . . . 0.0 111.118 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HA ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -115.48 105.01 12.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.64 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.64 4.11 17.04 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.996 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -117.22 -112.98 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.282 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.82 -154.87 20.29 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 116.739 1.456 . . . . 0.0 116.739 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 91.7 Cg_endo -67.02 167.68 56.85 Favored 'Cis proline' 0 N--CA 1.501 1.953 0 O-C-N 122.77 0.879 . . . . 0.0 111.373 11.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -25.12 61.66 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.883 0.849 . . . . 0.0 109.585 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 tp -103.37 106.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.33 -177.16 39.21 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.513 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.4 m95 -135.88 135.57 39.83 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.72 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 21.5 m -97.47 130.81 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 17.6 t -148.58 -166.54 2.57 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.496 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 36' ' ' CYS . 12.3 ptmm? -152.18 164.0 38.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.2 tt0 . . . . . 0 C--N 1.305 -1.342 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.615 0 N-CA-C 104.837 -3.305 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.44 131.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 123.002 1.382 . . . . 0.0 112.16 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.4 m -72.71 170.51 14.4 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.184 -2.28 . . . . 0.0 110.985 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' GLY . 45.7 t -159.39 143.02 14.71 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . 1.4 pt? -73.12 167.72 20.56 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.8 176.05 5.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -74.54 -11.36 60.19 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.56 -1.338 . . . . 0.0 112.163 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 t -92.53 -5.62 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -89.74 96.62 10.77 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 124.342 1.026 . . . . 0.0 108.992 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.81 74.33 0.21 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 106.55 -2.62 . . . . 0.0 106.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.12 176.42 7.07 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.939 1.759 . . . . 0.0 113.683 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -89.67 171.3 9.76 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 18.8 m -73.27 82.87 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 21.8 ttt180 109.9 145.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.64 6.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -59.29 140.23 56.23 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.267 -0.466 . . . . 0.0 110.949 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -111.65 147.75 34.85 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 18' ' ' LEU . 1.2 pt? -150.39 70.87 1.03 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.476 1.131 . . . . 0.0 111.215 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.6 m -70.31 -26.9 64.0 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -80.51 -159.65 21.02 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 63.1 m -151.42 153.86 35.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 23' ' ' TRP . 3.1 tp -101.52 149.82 23.7 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.016 -1.902 . . . . 0.0 106.683 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.407 ' N ' ' HG ' ' A' ' 22' ' ' LEU . 68.8 m95 -127.51 128.39 45.59 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.082 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 3.7 mt -88.99 -10.71 46.63 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.006 -2.815 . . . . 0.0 108.721 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -63.25 150.43 89.17 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 112.524 -2.125 . . . . 0.0 106.21 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.18 -14.39 43.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.663 1.576 . . . . 0.0 113.817 -163.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 p -125.51 13.75 8.16 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 69.03 -115.73 6.71 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.156 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.3 t -42.67 107.69 0.57 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 110.557 -2.822 . . . . 0.0 113.315 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 37.1 Cg_endo -75.47 124.76 8.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 174.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 p -41.34 108.43 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.21 -4.11 3.76 Favored Glycine 0 C--N 1.293 -1.829 0 N-CA-C 105.08 -3.208 . . . . 0.0 105.08 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.733 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.5 m95 -116.97 167.48 11.09 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 100.906 -3.738 . . . . 0.0 100.906 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -93.91 -83.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 119.69 3.219 . . . . 0.0 119.69 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.775 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 7.6 p30 154.07 153.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 128.93 2.892 . . . . 0.0 105.057 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -150.66 -31.72 0.18 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 123.468 0.48 . . . . 0.0 111.642 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 29.1 mmmt -125.96 88.35 2.84 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.45 34.5 0.05 Allowed 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.78 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -137.49 -21.39 1.16 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.64 -130.23 2.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -61.89 -179.79 5.86 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 CA-C-N 119.167 1.483 . . . . 0.0 113.738 -5.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 p -78.12 -10.04 59.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.177 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tt -97.1 -26.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 121.917 0.865 . . . . 0.0 109.86 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 155.61 27.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 105.577 -3.009 . . . . 0.0 105.577 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 6.2 m95 -92.59 140.11 29.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 1.6 m -101.3 117.23 34.56 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 119.269 0.94 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 14.5 t -129.5 -165.05 1.47 Allowed 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.536 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 14.9 pttp -151.4 152.23 32.81 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.299 -1.603 0 O-C-N 124.545 1.153 . . . . 0.0 108.367 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.672 0 N-CA-C 105.435 -3.066 . . . . 0.0 105.435 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.4 t -89.68 157.09 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.6 m -70.61 167.73 17.92 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -160.1 121.22 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.645 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' A' ' 9' ' ' ASP . 9.5 mt -59.57 164.66 3.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.504 0.668 . . . . 0.0 110.775 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.47 ' C ' ' H ' ' A' ' 8' ' ' SER . 26.8 m -101.0 158.51 15.95 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.998 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 6.6 m-20 -73.77 30.13 0.07 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 6' ' ' CYS . 2.4 t -129.74 -12.4 4.3 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 111.855 -2.43 . . . . 0.0 107.562 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.545 ' CB ' HD22 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -98.51 -178.54 4.04 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 -175.96 34.33 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.62 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.82 166.97 24.56 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 123.4 2.733 . . . . 0.0 112.106 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.61 93.79 9.42 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 123.48 1.61 . . . . 0.0 110.703 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.29 21.74 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 111.903 -2.408 . . . . 0.0 107.259 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 16' ' ' ASN . 30.1 ttm180 76.28 163.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.744 -2.025 . . . . 0.0 107.24 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.16 -47.78 3.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 103.517 -3.833 . . . . 0.0 103.517 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 14' ' ' ARG . 3.2 p-10 -61.0 167.28 3.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.234 1.196 . . . . 0.0 107.866 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 18' ' ' LEU . 11.7 t -134.96 -166.4 1.82 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' C ' ' A' ' 17' ' ' THR . 6.2 mp -110.87 99.91 8.74 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 126.5 1.92 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -95.69 -6.32 40.21 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.642 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.42 -174.24 14.23 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-O 122.372 0.985 . . . . 0.0 112.608 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 99.6 m -151.17 155.41 38.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -104.81 141.12 37.07 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 112.304 -2.225 . . . . 0.0 108.325 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 78.2 m95 -111.85 133.43 54.07 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.292 -2.231 . . . . 0.0 110.83 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.25 -16.51 31.03 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.293 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -60.65 143.38 90.64 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.381 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -66.93 -9.95 26.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.882 1.721 . . . . 0.0 113.62 -165.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 p -117.47 12.14 14.08 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.328 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.55 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 67.59 -117.21 8.59 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-N 113.984 -1.462 . . . . 0.0 116.231 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 2.7 t -51.3 113.05 3.51 Favored Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 110.839 -2.68 . . . . 0.0 112.562 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 83.2 Cg_endo -80.92 138.21 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.161 2.574 . . . . 0.0 110.851 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -46.33 99.45 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -1.52 2.46 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 105.424 -3.07 . . . . 0.0 105.424 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TRP . . . . . 0.741 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 21.7 m95 -109.65 -153.85 0.52 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.619 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 0.7 OUTLIER -150.52 -101.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.489 0.661 . . . . 0.0 110.215 -179.565 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.582 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 25.1 p30 -169.78 157.76 7.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.54 -39.03 0.13 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.186 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 22.2 mmmt -101.31 114.48 28.5 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' ND1' ' A' ' 39' ' ' HIS . . . -76.89 10.33 2.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.893 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 38' ' ' ALA . 17.0 m-70 -133.26 -127.35 0.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.38 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.53 -145.65 10.21 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.1 -177.27 17.38 Favored 'Cis proline' 0 N--CA 1.499 1.842 0 CA-C-N 117.968 0.884 . . . . 0.0 111.764 7.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -91.14 -6.53 53.45 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.362 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -116.89 96.75 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.01 157.41 27.71 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TRP . . . . . 0.55 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -109.68 157.59 18.95 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 7.5 m -117.06 119.3 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.079 1.418 . . . . 0.0 109.137 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' C ' ' A' ' 34' ' ' HIS . 9.0 t -134.63 -163.76 1.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.408 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.04 149.71 29.87 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' C ' ' CE ' ' A' ' 48' ' ' LYS . 46.3 tt0 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.361 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 121.931 0.872 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.5 m -92.36 169.07 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.3 p -162.71 157.79 22.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.11 127.62 32.1 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 125.14 1.525 . . . . 0.0 112.594 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 60.7 m -93.39 173.05 7.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 125.338 1.649 . . . . 0.0 106.596 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 N--CA 1.496 1.868 0 CA-C-O 121.87 0.843 . . . . 0.0 109.817 179.838 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.532 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -84.37 -159.5 29.92 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.779 -1.677 . . . . 0.0 109.846 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 8.1 m -150.06 134.19 17.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -93.49 142.55 27.21 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.649 -2.523 . . . . 0.0 108.875 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 80.1 m95 -119.41 134.03 55.42 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 111.938 -2.392 . . . . 0.0 105.712 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.61 -11.89 44.19 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.943 1.354 . . . . 0.0 108.372 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -55.46 144.16 54.25 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 111.25 -2.704 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -64.95 -7.94 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.098 1.865 . . . . 0.0 113.55 -165.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 34.5 p -132.52 17.46 4.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 64.83 -112.02 4.66 Favored Glycine 0 N--CA 1.477 1.384 0 CA-C-N 113.601 -1.636 . . . . 0.0 116.633 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.615 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -47.06 116.87 4.32 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 111.003 -2.599 . . . . 0.0 115.238 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.9 Cg_endo -81.44 152.56 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.774 2.316 . . . . 0.0 109.794 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.1 t -64.57 109.11 1.87 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.956 -1.929 . . . . 0.0 106.18 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.79 -2.1 4.4 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 105.876 -2.89 . . . . 0.0 105.876 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 15.3 m95 -109.51 -154.04 0.53 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.441 ' CD2' ' ND2' ' A' ' 35' ' ' ASN . 20.3 t-160 -137.55 -65.57 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.795 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.5 p30 137.42 147.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 128.299 2.64 . . . . 0.0 108.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.74 -1.33 0.38 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.167 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 11.5 mmmm -140.5 106.36 5.16 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.818 0.699 . . . . 0.0 109.177 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.25 -13.76 62.58 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.748 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -140.12 -112.79 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -31.86 129.98 0.22 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.562 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 41.7 Cg_endo -71.46 -173.26 9.55 Favored 'Cis proline' 0 N--CA 1.508 2.367 0 N-CA-C 118.379 2.415 . . . . 0.0 118.379 6.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 t -122.23 18.53 10.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.2 mt -132.25 -75.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' PRO . . . -90.58 -155.18 31.07 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 27' ' ' SER . 6.5 m95 -141.17 167.5 22.03 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.57 1.685 . . . . 0.0 109.55 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.562 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 5.5 m -124.38 128.4 49.0 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.442 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.795 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.8 t -144.82 -169.25 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 35' ' ' ASN . 6.4 ptpp? -150.36 156.64 41.9 Favored 'General case' 0 C--N 1.298 -1.67 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.528 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' THR . 28.4 t . . . . . 0 N--CA 1.497 1.901 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.4 m -79.54 165.94 22.45 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 119.339 0.972 . . . . 0.0 111.808 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.8 t -162.79 144.48 10.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.56 115.19 27.5 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 m -88.04 156.62 19.21 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.019 -2.586 . . . . 0.0 104.019 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.542 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 40.9 m-20 . . . . . 0 N--CA 1.496 1.854 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.074 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.88 160.5 52.84 Favored Glycine 0 CA--C 1.496 -1.144 0 CA-C-O 124.226 2.015 . . . . 0.0 109.287 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 17.9 m -142.66 138.02 30.36 Favored 'General case' 0 C--N 1.28 -2.443 1 N-CA-C 100.108 -4.034 . . . . 0.0 100.108 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -99.82 140.86 33.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.444 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.437 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.1 m95 -114.61 131.91 56.54 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 111.688 -2.506 . . . . 0.0 108.481 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.79 -12.63 41.5 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.339 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -58.38 139.5 84.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 111.89 -2.414 . . . . 0.0 105.393 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -64.98 -7.07 14.15 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.432 1.422 . . . . 0.0 113.86 -163.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.4 p -122.68 13.11 9.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.591 1.182 . . . . 0.0 110.789 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.507 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 67.42 -118.62 10.24 Favored Glycine 0 C--N 1.298 -1.569 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.78 106.54 0.57 Allowed Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 110.87 -2.665 . . . . 0.0 113.503 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -76.52 130.32 11.68 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.877 2.385 . . . . 0.0 108.774 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -42.58 111.2 0.23 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.362 -1.745 . . . . 0.0 106.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.53 -8.55 4.97 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 104.33 -3.508 . . . . 0.0 104.33 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.2 m95 -105.69 -167.97 1.39 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.448 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.9 m-70 -135.5 -114.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.588 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -174.92 134.99 0.36 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 31.8 p -141.47 -52.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.168 -1.413 . . . . 0.0 109.86 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.542 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.8 mmmt -88.13 65.56 8.19 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.591 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.9 -3.24 1.5 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.389 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.437 ' H ' ' C ' ' A' ' 37' ' ' LYS . 12.9 m170 -98.58 -15.21 19.58 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 136.32 -166.29 24.76 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.168 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 23.8 Cg_endo -74.39 -179.17 25.16 Favored 'Cis proline' 0 N--CA 1.494 1.501 0 N-CA-C 115.513 1.313 . . . . 0.0 115.513 25.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 p -89.42 11.91 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.969 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.0 101.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.89 -171.38 46.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 103.572 -3.811 . . . . 0.0 103.572 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.507 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -127.04 149.41 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 118.95 1.375 . . . . 0.0 108.241 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -110.48 129.21 55.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.9 t -150.65 -168.05 2.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.799 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -150.38 162.22 40.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 115.789 -2.053 . . . . 0.0 106.982 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 t . . . . . 0 N--CA 1.498 1.957 0 CA-C-O 122.223 1.011 . . . . 0.0 108.841 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.66 160.02 23.83 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.935 -179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.12 144.09 9.49 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 123.547 0.53 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.2 176.8 6.29 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.34 138.7 54.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.748 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.549 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 20.0 m-20 . . . . . 0 N--CA 1.5 2.07 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 -179.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.499 1.992 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.85 -164.76 10.24 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -150.41 159.21 44.63 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.39 146.18 40.89 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.41 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 86.7 m95 -119.64 133.64 55.56 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 111.786 -2.461 . . . . 0.0 109.608 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -88.87 -14.9 35.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.83 144.2 81.61 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 111.43 -2.623 . . . . 0.0 105.913 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -66.9 -19.73 52.12 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.182 1.255 . . . . 0.0 112.486 -162.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.2 p -107.02 5.47 28.11 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.288 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 69.37 -113.82 5.35 Favored Glycine 0 C--N 1.298 -1.53 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.999 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -43.82 108.97 0.75 Allowed Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 110.451 -2.874 . . . . 0.0 111.316 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 38.1 Cg_endo -74.91 130.81 13.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 N-CA-C 106.06 -2.323 . . . . 0.0 106.06 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -45.92 101.87 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.018 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.6 -4.83 1.99 Allowed Glycine 0 C--N 1.296 -1.673 0 N-CA-C 104.375 -3.49 . . . . 0.0 104.375 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.692 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 20.2 m95 -105.53 -168.54 1.47 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -140.16 -70.61 0.39 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.832 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 7.8 p30 155.91 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 126.131 1.773 . . . . 0.0 114.258 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -140.82 -7.65 1.08 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.541 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 18.9 mmmt -134.22 108.31 8.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.359 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.79 31.31 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m-70 -132.58 -145.99 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.5 -98.3 1.87 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -79.13 -165.59 4.73 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 N-CA-C 114.195 0.806 . . . . 0.0 114.195 1.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -84.76 14.65 4.53 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.996 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 pt -147.24 81.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.7 171.55 44.95 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 107.561 -2.215 . . . . 0.0 107.561 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.48 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.4 m95 -116.68 142.44 46.9 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.058 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 13.1 m -103.9 120.74 41.65 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.832 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 1.7 t -142.64 -167.38 2.5 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 27.9 pttt -151.17 164.06 37.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 125.026 1.454 . . . . 0.0 112.714 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.498 1.938 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -79.71 163.19 24.71 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.6 t -157.06 155.85 31.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.924 0.765 . . . . 0.0 109.917 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 0.7 OUTLIER -89.67 121.01 31.44 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 20.0 m -94.41 152.78 18.35 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.823 0.82 . . . . 0.0 111.039 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.715 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 2.7 m-20 . . . . . 0 N--CA 1.507 2.402 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 120.711 0.291 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.84 -172.51 48.86 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -150.15 144.63 25.8 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.94 138.17 37.38 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 111.585 -2.552 . . . . 0.0 108.256 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -112.2 129.42 56.26 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 110.712 -2.949 . . . . 0.0 107.577 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.23 -14.11 36.68 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -57.33 148.77 51.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 CA-C-N 112.44 -2.164 . . . . 0.0 106.085 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -19.78 68.3 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 120.991 1.128 . . . . 0.0 113.283 -162.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -113.02 7.28 18.05 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.742 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 72.77 -115.59 5.32 Favored Glycine 0 CA--C 1.49 -1.526 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.576 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.0 OUTLIER -48.46 115.03 3.94 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 111.591 -2.304 . . . . 0.0 112.766 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 63.4 Cg_endo -77.89 165.94 25.79 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.556 2.171 . . . . 0.0 112.469 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 91.66 3.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 111.761 -2.472 . . . . 0.0 108.562 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 151.42 -1.04 0.34 Allowed Glycine 0 C--N 1.29 -1.992 0 CA-C-N 109.806 -3.361 . . . . 0.0 105.656 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.672 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.9 m95 -116.65 -167.35 1.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 4.6 m-70 -127.34 -73.38 0.61 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 117.795 2.517 . . . . 0.0 117.795 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.781 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.4 p30 143.06 150.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.025 2.53 . . . . 0.0 109.314 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 20.8 p -151.46 -53.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 123.341 1.543 . . . . 0.0 109.407 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HZ1' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -88.39 78.33 7.96 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.129 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.62 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.775 -1.557 . . . . 0.0 108.62 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.33 -55.36 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.86 -162.75 9.24 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.439 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.762 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 25.6 Cg_endo -78.71 -173.59 13.16 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 CA-C-N 117.718 0.759 . . . . 0.0 111.384 4.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 p -90.07 5.96 44.46 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.167 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 pt -145.39 102.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 123.91 0.756 . . . . 0.0 109.071 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 169.93 46.12 Favored Glycine 0 N--CA 1.506 3.31 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.542 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 12.3 m95 -109.06 149.78 28.78 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 118.176 0.988 . . . . 0.0 110.522 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.762 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.7 m -111.06 130.75 55.51 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 11.7 t -150.19 -167.9 2.95 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.514 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.39 160.57 43.65 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.7 tt0 . . . . . 0 C--N 1.298 -1.657 0 O-C-N 125.182 1.551 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -80.79 163.43 23.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 35.4 t -144.38 168.44 20.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.576 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 5.3 tp -119.09 129.85 55.29 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD ' ' A' ' 48' ' ' LYS . 80.7 m -97.56 151.08 20.41 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.304 0.573 . . . . 0.0 110.653 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.563 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 62.5 m-20 . . . . . 0 N--CA 1.508 2.432 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 t . . . . . 0 N--CA 1.503 2.211 0 CA-C-O 121.163 0.506 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -166.29 37.64 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.3 m -150.01 157.3 43.0 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -111.97 141.62 45.4 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 111.946 -2.388 . . . . 0.0 107.274 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.419 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 80.0 m95 -112.85 130.86 55.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.8 -2.909 . . . . 0.0 106.138 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.22 -13.1 41.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.523 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 8.5 m-30 -56.67 142.71 70.63 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 111.576 -2.556 . . . . 0.0 107.067 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -63.33 -17.01 58.1 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.015 1.143 . . . . 0.0 113.652 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.7 p -113.62 6.41 16.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.791 -1.549 . . . . 0.0 112.82 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.515 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 73.98 -116.71 5.4 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.478 -1.344 . . . . 0.0 115.043 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -45.75 116.36 3.25 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 111.785 -2.207 . . . . 0.0 112.668 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 93.0 Cg_endo -81.48 160.88 19.66 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.117 1.878 . . . . 0.0 108.206 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -69.56 110.2 4.67 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.071 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.28 -4.63 4.52 Favored Glycine 0 C--N 1.289 -2.042 0 N-CA-C 105.208 -3.157 . . . . 0.0 105.208 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 19.0 m95 -116.49 -164.85 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -126.39 -87.93 0.58 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.694 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.1 p30 149.9 149.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 127.047 2.139 . . . . 0.0 108.627 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 23.1 p -150.78 -46.78 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.555 1.169 . . . . 0.0 108.3 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 25.3 mmmt -88.61 80.19 7.37 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.118 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.6 49.82 1.23 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.338 1.066 . . . . 0.0 108.266 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -146.81 -52.26 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.177 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -143.27 4.93 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 59.2 Cg_endo -70.55 161.24 88.9 Favored 'Cis proline' 0 C--N 1.311 -1.424 0 CA-C-O 123.135 1.223 . . . . 0.0 115.214 8.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 p -72.53 33.38 0.06 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.368 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.4 pt -140.98 -41.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 121.506 0.67 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.12 165.27 28.59 Favored Glycine 0 N--CA 1.493 2.466 1 N-CA-C 101.367 -4.693 . . . . 0.0 101.367 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.515 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 11.5 m95 -100.95 154.6 18.54 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.443 2.121 . . . . 0.0 111.741 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.3 m -107.19 123.86 48.89 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.694 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.8 t -150.5 -179.83 7.55 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.844 0.831 . . . . 0.0 110.087 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CD ' ' SG ' ' A' ' 6' ' ' CYS . 34.5 mtmt -142.2 156.15 45.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.7 tt0 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 125.555 1.784 . . . . 0.0 114.607 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 m -75.59 165.05 25.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 52.0 t -159.79 165.8 31.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -100.79 150.03 23.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 48' ' ' LYS . 32.6 m -99.94 161.78 13.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.743 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 7.3 m-20 . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 122.313 1.054 . . . . 0.0 111.054 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 N--CA 1.504 2.265 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.58 -169.62 27.76 Favored Glycine 0 C--N 1.3 -1.469 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -150.56 146.79 26.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -102.28 141.83 34.48 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 111.522 -2.581 . . . . 0.0 107.94 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.3 m95 -114.23 132.64 56.05 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.461 -3.063 . . . . 0.0 107.215 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.66 -12.26 42.98 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.364 -1.743 . . . . 0.0 108.282 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -59.43 139.05 89.01 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.254 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.13 -13.13 33.57 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 120.66 0.907 . . . . 0.0 114.26 -160.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 p -114.57 4.6 15.21 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.167 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 78.95 -122.09 5.74 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 113.771 -1.558 . . . . 0.0 116.178 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -44.64 116.24 2.63 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 111.04 -2.58 . . . . 0.0 114.341 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 87.7 Cg_endo -77.5 167.1 24.89 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.779 2.319 . . . . 0.0 112.853 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -70.7 103.16 2.48 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.182 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.31 1.44 4.36 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 105.056 -3.218 . . . . 0.0 105.056 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.781 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -117.26 -162.56 0.87 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.5 m-70 -133.5 -114.82 0.21 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.732 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER 177.93 136.5 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 23.9 p -145.62 -46.63 0.21 Allowed 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.579 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.3 mmmt -88.54 69.66 8.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.704 1.24 . . . . 0.0 109.785 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 5.76 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.163 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 95.1 m-70 -107.57 -16.12 14.43 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.09 -148.79 17.13 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.706 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 92.3 Cg_endo -68.15 -171.3 5.44 Favored 'Cis proline' 0 N--CA 1.493 1.474 0 CA-C-N 118.67 1.235 . . . . 0.0 114.681 4.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 t -93.36 20.81 6.7 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.837 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 mm -123.84 -57.52 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 CA-C-O 121.552 0.691 . . . . 0.0 110.114 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.71 13.61 Favored Glycine 0 N--CA 1.501 3.015 1 N-CA-C 102.913 -4.075 . . . . 0.0 102.913 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 11.3 m95 -108.49 146.22 33.51 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 120.293 2.046 . . . . 0.0 109.684 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.706 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 6.7 m -104.2 130.46 51.96 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.9 t -150.48 -163.98 1.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.625 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -150.19 164.25 36.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 116.484 -1.722 . . . . 0.0 109.692 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.496 1.869 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 51.2 m -134.73 177.36 7.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.588 1.18 . . . . 0.0 109.305 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -160.49 160.79 32.44 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 125.924 2.015 . . . . 0.0 110.993 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 tt -61.92 117.12 5.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 126.143 2.152 . . . . 0.0 110.394 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.5 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 76.5 m -93.61 159.58 15.16 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.705 -0.798 . . . . 0.0 113.099 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 . . . . . 0 N--CA 1.504 2.24 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.3 t . . . . . 0 N--CA 1.48 1.051 0 N-CA-C 110.156 -0.312 . . . . 0.0 110.156 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -86.51 -156.88 29.27 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.5 m -150.36 148.71 29.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 102.327 -3.212 . . . . 0.0 102.327 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.3 tt -109.56 138.86 45.3 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.864 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 82.4 m95 -108.55 130.8 55.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.934 -2.394 . . . . 0.0 109.368 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.78 -16.18 32.79 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.075 -2.329 . . . . 0.0 108.847 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -57.37 147.24 59.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 112.138 -2.301 . . . . 0.0 108.12 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -65.49 -12.13 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.047 1.831 . . . . 0.0 113.41 -162.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 p -120.81 6.08 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.499 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.32 -119.6 6.28 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-O 122.984 1.325 . . . . 0.0 113.775 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.57 109.37 0.93 Allowed Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 110.63 -2.785 . . . . 0.0 114.047 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 75.1 Cg_endo -79.25 136.1 12.51 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.966 3.111 . . . . 0.0 110.128 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 m -47.32 104.27 0.05 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.748 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.5 -3.62 2.68 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.79 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.8 m95 -117.6 -171.43 2.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 55.9 m80 -140.45 -99.64 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.16 0.912 . . . . 0.0 112.977 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.665 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -163.47 153.25 15.14 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.67 -30.78 0.23 Allowed 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.51 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 14.6 mmmt -117.68 93.53 4.19 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.87 42.9 0.4 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 71.2 m-70 -140.21 -29.43 0.7 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.355 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.65 -114.8 0.93 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.669 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 14.5 Cg_endo -86.49 -152.95 0.7 Allowed 'Cis proline' 0 C--N 1.314 -1.265 0 CA-C-N 118.537 1.169 . . . . 0.0 110.59 8.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -82.57 9.3 9.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.97 113.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.23 -174.02 27.52 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 106.041 -2.824 . . . . 0.0 106.041 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.521 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 m95 -127.17 135.07 50.18 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.441 1.121 . . . . 0.0 108.187 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.669 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 51.9 m -96.12 122.24 38.74 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.31 1.053 . . . . 0.0 108.987 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 5.5 t -144.26 -168.92 3.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.61 168.75 23.35 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 3.4 tt0 . . . . . 0 C--N 1.297 -1.681 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 24.4 m -90.41 -178.33 5.32 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 49.2 t -162.63 169.01 20.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 125.611 1.819 . . . . 0.0 108.356 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.2 mt -104.77 137.76 42.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.585 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -89.93 161.73 15.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.692 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.951 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 m . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.94 -166.22 10.98 Favored Glycine 0 CA--C 1.555 2.547 0 O-C-N 125.27 1.607 . . . . 0.0 111.872 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 90.0 m -150.76 160.27 43.97 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 103.066 -2.938 . . . . 0.0 103.066 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -113.13 136.88 52.24 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -110.01 134.12 52.47 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.956 1.36 . . . . 0.0 110.574 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.96 -17.01 30.37 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.409 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -57.9 147.46 63.48 Favored Pre-proline 0 N--CA 1.492 1.641 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.424 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -63.69 -11.11 24.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.034 1.823 . . . . 0.0 114.58 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 67.9 p -126.17 10.07 7.44 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.61 1.194 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.547 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.18 -114.17 4.85 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 119.381 -1.39 . . . . 0.0 113.823 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.22 112.09 1.48 Allowed Pre-proline 0 C--N 1.295 -1.772 0 CA-C-N 111.639 -2.281 . . . . 0.0 111.892 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 85.1 Cg_endo -83.57 151.91 13.34 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 123.191 2.594 . . . . 0.0 109.207 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -52.96 116.35 2.31 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.287 -2.233 . . . . 0.0 108.138 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 2.23 11.7 Favored Glycine 0 C--N 1.29 -2.024 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.333 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.572 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.3 m95 -114.33 -177.91 3.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 4.7 m-70 -130.4 -101.52 0.3 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.594 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -169.45 133.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 m -133.46 -20.09 2.1 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.952 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 31.4 mmmt -140.77 95.89 2.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.454 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.961 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -120.13 -64.73 1.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -167.56 -160.9 15.85 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 39.2 Cg_endo -76.45 162.68 91.42 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 CA-C-N 118.707 1.253 . . . . 0.0 113.473 25.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 33.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 tt -150.48 117.9 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.59 45.76 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 103.759 -3.736 . . . . 0.0 103.759 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 42.7 m95 -136.49 156.9 47.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 119.781 1.791 . . . . 0.0 107.564 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.9 m -120.16 117.28 27.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.5 t -150.66 -173.8 4.58 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 2.6 tmmm? -150.44 155.44 39.55 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.307 -1.259 0 O-C-N 125.878 1.986 . . . . 0.0 108.561 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.498 1.933 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 71.9 m -98.75 177.25 5.35 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.265 0.353 . . . . 0.0 110.479 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 t -175.92 172.69 2.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 124.954 1.409 . . . . 0.0 110.557 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -113.33 166.47 11.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 60.1 m -99.88 171.5 7.82 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.342 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.509 2.48 0 CA-C-O 123.408 1.575 . . . . 0.0 111.9 179.852 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.505 2.302 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.17 -162.07 10.8 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.4 m -150.84 160.96 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 101.358 -3.571 . . . . 0.0 101.358 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.1 tt -116.97 141.66 47.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.271 -1.786 . . . . 0.0 108.5 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -119.5 129.62 54.8 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 110.634 -2.984 . . . . 0.0 106.715 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.62 -18.98 26.86 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -45.54 146.09 1.88 Allowed Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 110.843 -2.89 . . . . 0.0 109.187 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -65.72 -12.11 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.792 1.661 . . . . 0.0 112.61 -162.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 63.4 p -129.12 21.43 5.76 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.573 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 59.43 -115.66 7.76 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.487 -1.233 . . . . 0.0 116.042 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.23 108.16 0.78 Allowed Pre-proline 0 C--N 1.298 -1.649 0 CA-C-N 110.928 -2.636 . . . . 0.0 113.423 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -76.65 139.17 19.91 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.607 2.205 . . . . 0.0 108.12 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 p -52.24 101.45 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 112.253 -2.248 . . . . 0.0 108.296 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.5 -3.81 1.66 Allowed Glycine 0 CA--C 1.543 1.804 0 N-CA-C 104.942 -3.263 . . . . 0.0 104.942 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.4 m95 -112.92 -174.68 2.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.56 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.3 m-70 -131.68 -101.84 0.28 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.67 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -167.37 146.58 5.07 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.31 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -145.44 -51.98 0.26 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.5 mmmt -98.65 106.69 18.99 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.478 -1.289 . . . . 0.0 107.84 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.15 2.94 55.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -129.69 -83.58 0.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.42 -169.05 45.53 Favored Glycine 0 N--CA 1.504 3.213 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 5.1 Cg_endo -85.02 28.95 7.87 Favored 'Cis proline' 0 N--CA 1.499 1.798 0 CA-C-N 119.424 1.612 . . . . 0.0 115.522 -6.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.4 m 67.05 -23.09 0.11 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -108.13 137.33 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.23 -151.98 9.01 Favored Glycine 0 N--CA 1.508 3.471 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.573 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 5.7 m95 -135.96 127.92 29.51 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.372 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 m -99.44 113.89 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.585 1.184 . . . . 0.0 108.094 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.4 t -134.09 -163.75 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.73 154.17 36.88 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.303 -1.453 1 N-CA-C 98.803 -4.517 . . . . 0.0 98.803 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 t . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 15.5 m -85.29 -178.53 6.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 109.333 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.0 t -162.67 149.33 12.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.945 1.403 . . . . 0.0 112.384 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 4.8 mt -94.72 139.09 31.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 61.2 m -88.36 146.96 24.98 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 . . . . . 0 N--CA 1.501 2.09 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.752 -179.897 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 19.0 t . . . . . 0 N--CA 1.512 2.651 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.49 -175.31 14.17 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-O 123.213 1.452 . . . . 0.0 111.921 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 89.5 m -150.58 153.59 36.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 135.57 44.7 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 110.856 -2.884 . . . . 0.0 109.09 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.48 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 85.3 m95 -109.91 129.34 55.67 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 109.816 -3.356 . . . . 0.0 107.263 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -88.66 -12.74 41.58 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.117 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -57.17 148.46 51.76 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 111.852 -2.431 . . . . 0.0 108.918 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -63.53 -16.54 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.355 1.37 . . . . 0.0 113.247 -163.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.414 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 57.6 p -121.3 10.16 10.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.218 1.574 . . . . 0.0 111.637 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.46 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.0 -116.78 6.1 Favored Glycine 0 C--N 1.298 -1.574 0 CA-C-N 114.559 -1.2 . . . . 0.0 115.012 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -42.9 109.49 0.76 Allowed Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 111.807 -2.196 . . . . 0.0 113.104 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -77.42 126.03 8.09 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.973 2.448 . . . . 0.0 108.688 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -43.26 100.35 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 112.578 -2.101 . . . . 0.0 109.837 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.54 -8.11 1.81 Allowed Glycine 0 C--N 1.296 -1.688 0 N-CA-C 104.087 -3.605 . . . . 0.0 104.087 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.691 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.8 m95 -97.97 -151.5 0.37 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.556 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.6 t-160 -150.07 -105.73 0.07 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.007 0.192 . . . . 0.0 111.064 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.679 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -168.4 141.12 2.96 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 119.587 -0.245 . . . . 0.0 111.655 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.591 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -147.66 -15.83 0.37 Allowed 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HG3' ' CB ' ' A' ' 46' ' ' CYS . 1.6 mmpt? -129.3 105.6 8.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 1.88 53.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.97 1.419 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -132.25 -60.02 0.91 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.24 -160.61 17.97 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.753 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.67 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 50.1 Cg_endo -73.45 -175.58 15.12 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 O-C-N 122.829 0.91 . . . . 0.0 111.093 -7.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -86.92 5.24 38.06 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.3 pt -143.88 123.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.66 -169.47 54.31 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.46 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 20.9 m95 -130.16 155.2 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.67 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -122.21 129.67 52.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.55 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.1 t -150.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.591 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.58 165.67 33.56 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.238 -1.839 . . . . 0.0 108.497 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.3 m -69.57 166.78 18.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 37' ' ' LYS . 7.2 t -156.08 135.48 12.32 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.407 ' O ' ' HE2' ' A' ' 37' ' ' LYS . 4.5 mt -92.09 118.06 30.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 8.8 m -88.23 153.96 20.81 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.512 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 . . . . . 0 C--N 1.297 -1.682 0 CA-C-N 113.375 -1.738 . . . . 0.0 113.454 -179.711 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 N--CA 1.495 1.777 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -90.8 164.96 30.44 Favored Glycine 0 C--N 1.309 -0.954 0 CA-C-O 125.207 2.559 . . . . 0.0 114.991 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 m -151.1 136.58 17.81 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.17 -2.515 . . . . 0.0 106.184 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 19.5 tp -93.11 138.03 31.91 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 109.703 -3.408 . . . . 0.0 107.649 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 86.5 m95 -118.51 130.41 55.91 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.429 -3.078 . . . . 0.0 106.263 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.92 -7.05 56.79 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.086 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -58.6 154.64 33.79 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.181 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.18 -24.75 72.63 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.295 1.33 . . . . 0.0 112.358 -166.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 29' ' ' CYS . 25.3 p -116.74 9.16 13.91 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.541 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 49.77 -84.75 0.01 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 125.919 2.012 . . . . 0.0 110.435 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -38.53 93.63 0.07 OUTLIER Pre-proline 0 C--N 1.283 -2.308 1 CA-C-N 107.764 -4.218 . . . . 0.0 109.942 -179.93 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 42.7 Cg_endo -86.61 126.18 2.55 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.037 1.824 . . . . 0.0 110.376 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -44.62 112.78 0.46 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.068 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.57 -5.16 6.23 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 104.457 -3.457 . . . . 0.0 104.457 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.613 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 15.0 m95 -108.17 -171.06 1.79 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 3.7 m-70 -128.56 -124.43 0.22 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.867 -3.012 . . . . 0.0 102.867 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 6.3 p30 -162.39 159.0 24.72 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.61 -49.71 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.423 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 9.7 mmtt -89.01 75.14 8.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -4.81 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.024 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 37' ' ' LYS . 83.7 m-70 -103.73 -21.84 13.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 143.55 -165.61 27.11 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.812 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 43.8 Cg_endo -71.86 -171.15 7.61 Favored 'Cis proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.348 1.574 . . . . 0.0 114.347 16.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 t -95.71 -6.6 39.47 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.671 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.8 pt -106.68 99.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.08 -159.25 28.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 105.129 -3.188 . . . . 0.0 105.129 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 4.6 m95 -141.58 142.45 33.48 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.3 m -106.37 116.84 32.63 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 90.7 m -133.31 -171.83 2.79 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -137.75 161.63 36.03 Favored 'General case' 0 C--N 1.295 -1.767 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.5 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 115.357 -2.259 . . . . 0.0 111.087 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.502 2.144 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 4.8 m -79.49 160.08 26.69 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t -158.68 151.17 21.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.5 164.55 18.72 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 m -103.7 163.12 12.53 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 N--CA 1.504 2.268 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.414 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m . . . . . 0 N--CA 1.498 1.932 0 CA-C-O 120.754 0.311 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -171.25 23.7 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 106.742 -2.543 . . . . 0.0 106.742 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.9 m -150.41 149.76 30.47 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 1.4 tt -110.15 143.14 40.69 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.065 -1.88 . . . . 0.0 107.538 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 87.1 m95 -114.09 131.75 56.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 111.499 -2.591 . . . . 0.0 108.453 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.38 -10.75 48.26 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.882 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 7.3 m-30 -56.87 145.78 61.76 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 112.172 -2.285 . . . . 0.0 106.99 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -66.18 -16.59 52.46 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.488 1.459 . . . . 0.0 113.265 -164.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 p -111.81 6.11 19.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.112 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.575 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.66 -117.78 5.56 Favored Glycine 0 C--N 1.297 -1.589 0 CA-C-N 114.5 -1.227 . . . . 0.0 114.363 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -53.8 119.97 21.26 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 111.616 -2.292 . . . . 0.0 113.115 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.5 Cg_endo -74.85 165.04 32.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-O 125.528 2.22 . . . . 0.0 112.897 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -78.39 79.31 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.363 -2.653 . . . . 0.0 113.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 159.79 9.64 0.04 OUTLIER Glycine 0 C--N 1.29 -2.017 1 CA-C-N 107.738 -4.301 . . . . 0.0 106.168 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.7 m95 -125.09 -169.84 2.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.442 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.6 m-70 -133.52 -106.31 0.24 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.65 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.0 OUTLIER 179.93 131.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 122.703 0.401 . . . . 0.0 111.879 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.9 p -150.57 11.61 0.69 Allowed 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 39' ' ' HIS . 0.9 OUTLIER -150.5 67.46 0.95 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.08 29.94 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 37' ' ' LYS . 37.4 m170 -110.74 -10.12 14.47 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.56 0.344 . . . . 0.0 111.073 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -123.98 4.35 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 43' ' ' ILE . 52.2 Cg_endo -71.6 148.9 91.4 Favored 'Cis proline' 0 N--CA 1.494 1.54 0 N-CA-C 116.42 1.661 . . . . 0.0 116.42 -8.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.16 -9.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 41' ' ' PRO . 47.6 pt -122.7 0.01 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.66 144.34 7.37 Favored Glycine 0 N--CA 1.503 3.139 1 N-CA-C 102.733 -4.147 . . . . 0.0 102.733 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.575 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -95.15 138.65 32.58 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 119.719 1.759 . . . . 0.0 111.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.67 127.12 43.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.7 t -148.2 -164.8 2.1 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.001 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 6' ' ' CYS . 65.3 pttt -151.12 165.16 34.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.154 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m -114.0 176.42 5.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.33 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 p -174.34 161.95 3.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.21 153.36 23.67 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 4.4 m -99.37 162.15 13.2 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 . . . . . 0 N--CA 1.497 1.905 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.498 -179.953 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.23 -166.33 38.16 Favored Glycine 0 N--CA 1.483 1.779 0 CA-C-O 122.825 1.236 . . . . 0.0 113.031 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -141.1 137.49 32.85 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -101.68 133.05 46.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.484 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 72.5 m95 -107.63 127.42 53.64 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.467 -2.151 . . . . 0.0 109.881 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.28 -9.8 51.7 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.283 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -63.37 149.34 91.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 CA-C-N 112.413 -2.176 . . . . 0.0 105.465 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -62.22 -14.77 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.495 1.463 . . . . 0.0 114.052 -161.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 5.7 p -123.17 5.49 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.385 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 79.87 -120.46 5.23 Favored Glycine 0 C--N 1.299 -1.513 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.874 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -40.78 107.48 0.48 Allowed Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 110.583 -2.808 . . . . 0.0 113.172 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 59.4 Cg_endo -79.49 129.96 8.71 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.381 2.721 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -42.06 106.04 0.06 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.629 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.92 -4.64 3.27 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 104.181 -3.567 . . . . 0.0 104.181 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.782 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.0 m95 -110.04 -162.93 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.46 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.3 m80 -137.55 -117.28 0.15 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.696 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p-10 -176.34 132.78 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.611 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 32.0 p -140.01 -53.37 0.52 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.836 -1.146 . . . . 0.0 109.74 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 28.9 mmmt -87.19 66.96 9.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.335 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 2.94 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m170 -113.48 -9.46 13.3 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 133.78 -171.52 22.0 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.621 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 22.6 Cg_endo -76.74 174.89 12.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 N-CA-C 116.728 1.78 . . . . 0.0 116.728 33.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -79.92 26.12 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.577 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.5 mt -148.57 99.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.99 -173.31 52.21 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 104.935 -3.266 . . . . 0.0 104.935 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 25.1 m95 -125.31 147.77 48.99 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 120.154 1.977 . . . . 0.0 108.966 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 m -110.51 129.7 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.5 t -150.64 -166.94 2.68 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.406 -1.724 . . . . 0.0 109.172 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -150.96 159.88 44.28 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.8 tt0 . . . . . 0 C--N 1.305 -1.361 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.531 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.497 1.908 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 74.4 m -135.27 179.78 6.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.164 0.915 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -162.91 166.24 24.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 125.736 1.898 . . . . 0.0 109.496 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.13 130.25 42.17 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 124.456 1.098 . . . . 0.0 110.307 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.05 156.27 16.73 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.762 0.792 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.507 2.406 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.19 -153.26 7.39 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 118.748 -1.692 . . . . 0.0 112.608 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 33.1 m -150.2 147.21 27.43 Favored 'General case' 0 C--N 1.298 -1.658 1 N-CA-C 100.0 -4.074 . . . . 0.0 100.0 179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -103.51 137.66 41.29 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.449 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 69.7 m95 -111.59 129.73 55.98 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.021 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mt -88.25 -13.55 40.67 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 111.973 -2.376 . . . . 0.0 108.706 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -59.19 147.61 74.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 112.355 -2.202 . . . . 0.0 106.84 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.95 -12.0 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.936 1.757 . . . . 0.0 114.342 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 p -124.17 12.56 8.92 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 71.75 -120.64 8.22 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-O 122.448 1.027 . . . . 0.0 113.521 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.75 120.7 6.34 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 111.431 -2.385 . . . . 0.0 113.816 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 23' ' ' TRP . 96.6 Cg_endo -79.4 -177.48 3.91 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.545 2.163 . . . . 0.0 108.663 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -87.26 137.59 32.22 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.82 13.04 41.62 Favored Glycine 0 C--N 1.285 -2.251 0 CA-C-N 111.578 -2.556 . . . . 0.0 107.692 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 9.4 m95 -119.5 -160.24 0.81 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 35' ' ' ASN . 16.0 t-160 -132.86 -127.23 0.18 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -172.36 132.77 0.63 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 18.9 p -142.07 -59.57 0.46 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.401 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.636 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 30.4 mmmt -87.55 60.7 6.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 123.49 1.614 . . . . 0.0 110.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.78 24.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 37' ' ' LYS . 92.5 m-70 -126.47 -66.31 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 41' ' ' PRO . . . -170.56 -177.77 40.85 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.749 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 36.5 Cg_endo -74.53 176.99 40.48 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 O-C-N 123.738 1.388 . . . . 0.0 112.256 29.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -97.43 -8.7 28.8 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -96.33 78.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.81 -178.01 33.31 Favored Glycine 0 N--CA 1.497 2.718 1 N-CA-C 102.659 -4.177 . . . . 0.0 102.659 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.466 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.5 m95 -121.03 160.49 23.48 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.749 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 20.2 m -119.99 131.84 55.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.3 t -151.15 -168.55 3.13 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -151.45 166.43 31.12 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 101.489 -3.522 . . . . 0.0 101.489 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.9 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t . . . . . 0 N--CA 1.492 1.67 1 N-CA-C 100.126 -4.027 . . . . 0.0 100.126 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.1 m -79.42 155.84 28.17 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -159.57 133.86 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.94 178.47 0.81 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.375 1.083 . . . . 0.0 113.291 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.532 ' C ' ' HD3' ' A' ' 37' ' ' LYS . 32.9 m -101.19 -177.96 3.6 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.548 -1.66 . . . . 0.0 113.224 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 . . . . . 0 N--CA 1.501 2.082 0 O-C-N 120.608 -1.307 . . . . 0.0 111.297 -179.769 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 117.327 2.344 . . . . 0.0 117.327 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.89 -164.34 37.76 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.4 m -151.2 147.39 26.95 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -99.98 137.19 38.77 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.415 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.8 m95 -112.65 128.6 56.43 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 110.985 -2.825 . . . . 0.0 105.984 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.46 -10.19 49.95 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.278 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -57.21 145.47 66.21 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 111.999 -2.364 . . . . 0.0 107.846 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -64.94 -9.72 22.53 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.71 1.607 . . . . 0.0 113.67 -164.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 35.6 p -125.75 15.78 8.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.173 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 63.56 -117.86 12.12 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.451 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.73 110.91 1.36 Allowed Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.759 -2.721 . . . . 0.0 114.989 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -77.09 136.45 16.33 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 124.3 3.334 . . . . 0.0 109.718 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -48.15 108.38 0.17 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.029 1.395 . . . . 0.0 108.182 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.55 2.18 3.66 Favored Glycine 0 N--CA 1.481 1.689 0 CA-C-N 110.532 -3.031 . . . . 0.0 106.45 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.0 m95 -116.44 -157.4 0.65 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.453 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.5 t-160 -150.25 -110.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.107 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.592 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 2.3 p30 -169.45 147.9 3.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.609 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.31 -63.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 124.233 0.958 . . . . 0.0 109.247 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.532 ' HD3' ' C ' ' A' ' 6' ' ' CYS . 32.1 mmmt -88.71 59.31 5.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.37 17.15 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.9 p80 -129.32 -36.6 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.02 171.72 32.66 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.667 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 65.1 Cg_endo -73.04 175.34 45.61 Favored 'Cis proline' 0 N--CA 1.5 1.881 0 O-C-N 122.903 0.949 . . . . 0.0 114.559 4.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -93.43 19.56 8.22 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.152 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.04 -39.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.711 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.01 165.97 20.81 Favored Glycine 0 N--CA 1.505 3.276 1 N-CA-C 102.276 -4.33 . . . . 0.0 102.276 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.7 m95 -101.58 132.01 47.47 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 119.651 1.725 . . . . 0.0 110.532 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.6 m -99.62 111.9 24.19 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.7 t -127.53 -168.09 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.728 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.66 164.81 36.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 33' ' ' TRP . 3.5 tt0 . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t . . . . . 0 N--CA 1.502 2.149 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.9 m -84.02 172.08 12.34 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 t -155.93 165.11 37.45 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.411 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 4.6 tp -105.33 129.23 53.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' SG ' ' HE3' ' A' ' 48' ' ' LYS . 79.8 m -87.49 158.39 18.96 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.211 -2.195 . . . . 0.0 107.118 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 71.4 m-20 . . . . . 0 N--CA 1.507 2.386 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 p . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.47 -177.13 49.62 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 41.7 m -149.1 145.01 27.02 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -99.85 133.97 43.42 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.514 -3.039 . . . . 0.0 109.271 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 81.3 m95 -109.61 129.45 55.59 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 111.548 -2.569 . . . . 0.0 107.546 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.89 -7.55 57.02 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 11.3 m-30 -57.99 149.7 54.13 Favored Pre-proline 0 C--N 1.301 -1.518 0 CA-C-N 111.913 -2.403 . . . . 0.0 106.569 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.32 -15.06 45.89 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.287 1.324 . . . . 0.0 113.946 -163.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 p -122.1 7.84 9.77 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.157 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 78.36 -119.42 5.15 Favored Glycine 0 CA--C 1.489 -1.548 0 CA-C-N 114.175 -1.375 . . . . 0.0 114.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.82 115.79 3.53 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 111.851 -2.175 . . . . 0.0 113.318 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 79.1 Cg_endo -76.4 174.94 12.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 CA-C-O 125.604 2.252 . . . . 0.0 114.169 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m -81.69 107.22 14.26 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 110.311 -3.132 . . . . 0.0 105.271 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.67 3.87 5.41 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 11.9 m95 -119.7 -159.63 0.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.469 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 8.1 t-80 -134.49 -118.0 0.18 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.748 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.707 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p30 -175.62 129.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.524 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.436 ' C ' ' HG2' ' A' ' 37' ' ' LYS . 18.0 p -150.82 10.37 0.63 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 2.2 mmpt? -135.87 92.02 2.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.58 38.0 0.09 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -140.89 -26.09 0.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.43 -107.65 0.52 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.66 -173.86 10.59 Favored 'Cis proline' 0 N--CA 1.494 1.527 0 N-CA-C 117.782 2.186 . . . . 0.0 117.782 -4.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -85.51 19.25 2.43 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.325 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.38 23.85 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 122.21 1.005 . . . . 0.0 109.689 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.64 167.09 11.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 103.178 -3.969 . . . . 0.0 103.178 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.519 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.7 m95 -106.69 158.95 16.57 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.66 1.73 . . . . 0.0 110.97 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 1.8 m -116.28 126.98 54.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.013 0.821 . . . . 0.0 109.205 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 16.0 t -151.6 -163.74 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.749 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' SG ' ' A' ' 6' ' ' CYS . 32.5 ttmt -150.93 163.31 39.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.8 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.895 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.494 1.774 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.6 m -90.07 172.13 9.05 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 30.8 t -146.18 160.77 41.5 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.497 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 6.8 mp -83.59 126.13 32.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.32 -178.77 5.98 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 123.63 1.681 . . . . 0.0 108.346 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.504 2.275 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 48' ' ' LYS . . . -77.24 -169.59 32.21 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.398 0.999 . . . . 0.0 111.43 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 30.2 m -150.55 147.35 27.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 101.676 -3.453 . . . . 0.0 101.676 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 45' ' ' TRP . 5.0 tt -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.225 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -119.1 137.42 53.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.893 -1.958 . . . . 0.0 107.133 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.84 -15.23 35.05 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.486 1.612 . . . . 0.0 108.873 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -56.98 138.49 79.3 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 110.541 -3.027 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.09 -6.54 14.78 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.627 1.552 . . . . 0.0 112.662 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 p -126.74 22.25 6.89 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.944 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.565 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 57.8 -111.75 3.26 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 114.126 -1.397 . . . . 0.0 116.274 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.16 115.48 5.42 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 112.038 -2.081 . . . . 0.0 113.308 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 71.2 Cg_endo -80.28 150.84 20.14 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.678 2.252 . . . . 0.0 108.72 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.7 t -60.91 108.62 0.89 Allowed 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.43 -4.17 3.36 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 110.706 -2.952 . . . . 0.0 106.637 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.72 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 24.4 m95 -115.48 -160.55 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 78.8 m-70 -135.89 -89.56 0.31 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.658 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER 177.19 156.42 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.6 -43.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 124.357 1.035 . . . . 0.0 109.997 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 39' ' ' HIS . 4.3 mmtt -99.52 104.2 16.0 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.97 21.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 37' ' ' LYS . 35.9 m80 -135.96 -15.48 1.76 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.15 -86.44 0.23 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.699 -1.239 . . . . 0.0 112.111 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.47 -164.02 2.32 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 CA-C-N 118.394 1.097 . . . . 0.0 111.091 -6.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 p -74.31 23.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.4 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 5.2 mp -148.38 100.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.13 -149.8 21.24 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 104.794 -3.322 . . . . 0.0 104.794 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 14.2 m95 -142.89 152.88 42.57 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.986 1.393 . . . . 0.0 107.724 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 6.2 m -114.07 116.11 28.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.066 0.936 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.658 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 12.0 t -139.34 -168.62 2.49 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.879 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 28.8 tptp -151.25 151.82 32.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 103.0 -2.963 . . . . 0.0 103.0 179.68 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.499 1.998 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -119.3 174.67 6.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.25 168.51 22.34 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.527 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 2.1 tt -80.49 106.46 12.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.525 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 58.3 m -89.68 162.02 15.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 123.5 1.619 . . . . 0.0 112.165 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.501 2.113 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -91.37 -163.99 38.9 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.282 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.422 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 15.5 m -150.84 142.3 23.44 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 98.971 -4.455 . . . . 0.0 98.971 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 24' ' ' LEU . 4.2 tt -105.02 143.97 32.47 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.425 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.6 m95 -117.21 135.46 53.77 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 111.822 -2.445 . . . . 0.0 107.954 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 22' ' ' LEU . 11.7 mt -88.72 -17.4 30.0 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.874 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -52.07 138.65 35.52 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 110.907 -2.861 . . . . 0.0 109.097 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -66.18 -10.81 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.551 1.501 . . . . 0.0 113.254 -166.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -118.72 16.76 13.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.827 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 60.75 -118.64 15.64 Favored Glycine 0 C--N 1.297 -1.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 117.089 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.08 114.45 4.35 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 110.713 -2.744 . . . . 0.0 114.295 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 76.1 Cg_endo -80.66 127.63 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.57 2.18 . . . . 0.0 109.762 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 p -44.45 106.58 0.07 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.554 -2.112 . . . . 0.0 105.952 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.4 -7.33 3.1 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.785 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.4 m95 -111.3 -164.24 0.9 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 48.2 m80 -139.44 -109.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 123.94 0.775 . . . . 0.0 110.254 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.622 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.7 p-10 -164.36 153.02 13.02 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -150.33 -33.82 0.17 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.457 1.599 . . . . 0.0 111.118 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HA ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -115.48 105.01 12.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.64 4.11 17.04 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.996 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -117.22 -112.98 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.282 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.82 -154.87 20.29 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 116.739 1.456 . . . . 0.0 116.739 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 91.7 Cg_endo -67.02 167.68 56.85 Favored 'Cis proline' 0 N--CA 1.501 1.953 0 O-C-N 122.77 0.879 . . . . 0.0 111.373 11.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -25.12 61.66 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.883 0.849 . . . . 0.0 109.585 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 tp -103.37 106.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.33 -177.16 39.21 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.513 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.4 m95 -135.88 135.57 39.83 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.72 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 21.5 m -97.47 130.81 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 17.6 t -148.58 -166.54 2.57 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.496 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 36' ' ' CYS . 12.3 ptmm? -152.18 164.0 38.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.2 tt0 . . . . . 0 C--N 1.305 -1.342 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 123.002 1.382 . . . . 0.0 112.16 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.4 m -72.71 170.51 14.4 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.184 -2.28 . . . . 0.0 110.985 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' GLY . 45.7 t -159.39 143.02 14.71 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -73.12 167.72 20.56 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.8 176.05 5.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.507 2.421 0 O-C-N 120.56 -1.338 . . . . 0.0 112.163 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.6 m . . . . . 0 N--CA 1.502 2.16 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -80.51 -159.65 21.02 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 63.1 m -151.42 153.86 35.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 23' ' ' TRP . 3.1 tp -101.52 149.82 23.7 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.016 -1.902 . . . . 0.0 106.683 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.407 ' N ' ' HG ' ' A' ' 22' ' ' LEU . 68.8 m95 -127.51 128.39 45.59 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.082 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 3.7 mt -88.99 -10.71 46.63 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.006 -2.815 . . . . 0.0 108.721 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -63.25 150.43 89.17 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 112.524 -2.125 . . . . 0.0 106.21 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.18 -14.39 43.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.663 1.576 . . . . 0.0 113.817 -163.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 p -125.51 13.75 8.16 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 69.03 -115.73 6.71 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.156 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.3 t -42.67 107.69 0.57 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 110.557 -2.822 . . . . 0.0 113.315 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 37.1 Cg_endo -75.47 124.76 8.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 174.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 p -41.34 108.43 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.21 -4.11 3.76 Favored Glycine 0 C--N 1.293 -1.829 0 N-CA-C 105.08 -3.208 . . . . 0.0 105.08 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.733 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.5 m95 -116.97 167.48 11.09 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 100.906 -3.738 . . . . 0.0 100.906 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -93.91 -83.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 119.69 3.219 . . . . 0.0 119.69 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.775 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 7.6 p30 154.07 153.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 128.93 2.892 . . . . 0.0 105.057 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -150.66 -31.72 0.18 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 123.468 0.48 . . . . 0.0 111.642 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 29.1 mmmt -125.96 88.35 2.84 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.45 34.5 0.05 Allowed 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.78 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -137.49 -21.39 1.16 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.64 -130.23 2.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -61.89 -179.79 5.86 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 CA-C-N 119.167 1.483 . . . . 0.0 113.738 -5.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 p -78.12 -10.04 59.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.177 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tt -97.1 -26.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 121.917 0.865 . . . . 0.0 109.86 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 155.61 27.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 105.577 -3.009 . . . . 0.0 105.577 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 6.2 m95 -92.59 140.11 29.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 1.6 m -101.3 117.23 34.56 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 119.269 0.94 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 14.5 t -129.5 -165.05 1.47 Allowed 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.536 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 14.9 pttp -151.4 152.23 32.81 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.299 -1.603 0 O-C-N 124.545 1.153 . . . . 0.0 108.367 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.4 t . . . . . 0 N--CA 1.494 1.735 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.6 m -70.61 167.73 17.92 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -160.1 121.22 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.645 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 5' ' ' LEU . 9.5 mt -59.57 164.66 3.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.504 0.668 . . . . 0.0 110.775 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 26.8 m -101.0 158.51 15.95 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.998 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 6.6 m-20 . . . . . 0 N--CA 1.506 2.335 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.501 2.121 0 N-CA-C 111.642 0.238 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.42 -174.24 14.23 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-O 122.372 0.985 . . . . 0.0 112.608 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 99.6 m -151.17 155.41 38.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -104.81 141.12 37.07 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 112.304 -2.225 . . . . 0.0 108.325 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 78.2 m95 -111.85 133.43 54.07 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.292 -2.231 . . . . 0.0 110.83 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.25 -16.51 31.03 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.293 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -60.65 143.38 90.64 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.381 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -66.93 -9.95 26.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.882 1.721 . . . . 0.0 113.62 -165.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 p -117.47 12.14 14.08 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.328 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.55 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 67.59 -117.21 8.59 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-N 113.984 -1.462 . . . . 0.0 116.231 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 2.7 t -51.3 113.05 3.51 Favored Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 110.839 -2.68 . . . . 0.0 112.562 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 83.2 Cg_endo -80.92 138.21 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.161 2.574 . . . . 0.0 110.851 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -46.33 99.45 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -1.52 2.46 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 105.424 -3.07 . . . . 0.0 105.424 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TRP . . . . . 0.741 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 21.7 m95 -109.65 -153.85 0.52 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.619 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 17.7 t-160 -150.52 -101.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.489 0.661 . . . . 0.0 110.215 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.582 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -169.78 157.76 7.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.54 -39.03 0.13 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.186 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 22.2 mmmt -101.31 114.48 28.5 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' ND1' ' A' ' 39' ' ' HIS . . . -76.89 10.33 2.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.893 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 38' ' ' ALA . 17.0 m-70 -133.26 -127.35 0.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.38 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.53 -145.65 10.21 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.1 -177.27 17.38 Favored 'Cis proline' 0 N--CA 1.499 1.842 0 CA-C-N 117.968 0.884 . . . . 0.0 111.764 7.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -91.14 -6.53 53.45 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.362 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -116.89 96.75 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.01 157.41 27.71 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TRP . . . . . 0.55 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -109.68 157.59 18.95 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 7.5 m -117.06 119.3 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.079 1.418 . . . . 0.0 109.137 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' C ' ' A' ' 34' ' ' HIS . 9.0 t -134.63 -163.76 1.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.408 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.04 149.71 29.87 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' C ' ' CE ' ' A' ' 48' ' ' LYS . 46.3 tt0 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.361 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.591 0 N-CA-C 105.731 -2.948 . . . . 0.0 105.731 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -114.99 115.12 48.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 CA-C-O 121.931 0.872 . . . . 0.0 110.268 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.5 m -92.36 169.07 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 113.544 -1.662 . . . . 0.0 110.812 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 15.3 p -162.71 157.79 22.17 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.11 127.62 32.1 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 125.14 1.525 . . . . 0.0 112.594 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 60.7 m -93.39 173.05 7.9 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 125.338 1.649 . . . . 0.0 106.596 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -60.59 -14.05 17.9 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-O 121.87 0.843 . . . . 0.0 109.817 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.7 t -97.5 1.15 48.72 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 114.168 -1.378 . . . . 0.0 110.434 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -106.3 160.02 15.68 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.82 -72.55 0.43 Allowed Glycine 0 N--CA 1.482 1.76 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -72.19 166.77 28.72 Favored 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.93 1.753 . . . . 0.0 111.582 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.7 p -89.2 91.14 8.66 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.35 1.071 . . . . 0.0 109.13 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.0 p -132.34 158.54 43.31 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 109.823 -3.353 . . . . 0.0 109.461 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.14 134.37 56.42 Favored 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.398 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.58 1.78 58.87 Favored Glycine 0 N--CA 1.499 2.854 0 CA-C-N 114.713 -1.131 . . . . 0.0 111.534 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -51.22 161.24 0.44 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 126.006 1.651 . . . . 0.0 113.246 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 33.3 m 105.16 175.37 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 101.773 -3.417 . . . . 0.0 101.773 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.586 ' H ' ' CD2' ' A' ' 18' ' ' LEU . 1.2 pt? -87.61 89.19 7.9 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-O 125.188 2.423 . . . . 0.0 107.294 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.0 t -87.72 -3.61 58.95 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 111.729 -2.487 . . . . 0.0 117.158 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.532 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -84.37 -159.5 29.92 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.779 -1.677 . . . . 0.0 109.846 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 8.1 m -150.06 134.19 17.1 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.6 OUTLIER -93.49 142.55 27.21 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 111.649 -2.523 . . . . 0.0 108.875 179.89 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.406 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 80.1 m95 -119.41 134.03 55.42 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 111.938 -2.392 . . . . 0.0 105.712 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.8 mt -88.61 -11.89 44.19 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-O 122.943 1.354 . . . . 0.0 108.372 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.3 m-30 -55.46 144.16 54.25 Favored Pre-proline 0 C--N 1.298 -1.639 0 CA-C-N 111.25 -2.704 . . . . 0.0 110.293 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -64.95 -7.94 16.65 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.098 1.865 . . . . 0.0 113.55 -165.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.442 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 34.5 p -132.52 17.46 4.37 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.319 -1.309 . . . . 0.0 111.16 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.427 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 64.83 -112.02 4.66 Favored Glycine 0 N--CA 1.477 1.384 0 CA-C-N 113.601 -1.636 . . . . 0.0 116.633 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.615 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.9 OUTLIER -47.06 116.87 4.32 Favored Pre-proline 0 C--N 1.292 -1.919 0 CA-C-N 111.003 -2.599 . . . . 0.0 115.238 -179.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.9 Cg_endo -81.44 152.56 17.87 Favored 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 122.774 2.316 . . . . 0.0 109.794 174.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.1 t -64.57 109.11 1.87 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 112.956 -1.929 . . . . 0.0 106.18 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.79 -2.1 4.4 Favored Glycine 0 C--N 1.294 -1.758 0 N-CA-C 105.876 -2.89 . . . . 0.0 105.876 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 15.3 m95 -109.51 -154.04 0.53 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 105.979 -1.859 . . . . 0.0 105.979 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.441 ' CD2' ' ND2' ' A' ' 35' ' ' ASN . 20.3 t-160 -137.55 -65.57 0.53 Allowed 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.795 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.5 p30 137.42 147.45 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 C-N-CA 128.299 2.64 . . . . 0.0 108.774 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.74 -1.33 0.38 Allowed 'General case' 0 N--CA 1.499 1.993 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.167 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 11.5 mmmm -140.5 106.36 5.16 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 123.818 0.699 . . . . 0.0 109.177 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -69.25 -13.76 62.58 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 118.881 -1.128 . . . . 0.0 111.748 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -140.12 -112.79 0.14 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -31.86 129.98 0.22 Allowed Glycine 0 N--CA 1.505 3.249 0 N-CA-C 116.113 1.205 . . . . 0.0 116.113 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.562 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 41.7 Cg_endo -71.46 -173.26 9.55 Favored 'Cis proline' 0 N--CA 1.508 2.367 0 N-CA-C 118.379 2.415 . . . . 0.0 118.379 6.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.2 t -122.23 18.53 10.7 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.307 -0.861 . . . . 0.0 108.735 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 90.2 mt -132.25 -75.61 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' O ' ' HG2' ' A' ' 41' ' ' PRO . . . -90.58 -155.18 31.07 Favored Glycine 0 N--CA 1.499 2.898 0 N-CA-C 103.74 -3.744 . . . . 0.0 103.74 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.442 ' CZ2' ' HA ' ' A' ' 27' ' ' SER . 6.5 m95 -141.17 167.5 22.03 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 119.57 1.685 . . . . 0.0 109.55 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.562 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 5.5 m -124.38 128.4 49.0 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.442 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.795 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.8 t -144.82 -169.25 3.13 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.432 ' NZ ' ' O ' ' A' ' 35' ' ' ASN . 6.4 ptpp? -150.36 156.64 41.9 Favored 'General case' 0 C--N 1.298 -1.67 1 N-CA-C 100.047 -4.057 . . . . 0.0 100.047 179.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.303 -1.449 0 C-N-CA 118.685 -1.206 . . . . 0.0 111.528 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.588 0 N-CA-C 105.694 -2.962 . . . . 0.0 105.694 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' THR . 28.4 t -90.09 152.39 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 103.219 -2.882 . . . . 0.0 103.219 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 18' ' ' LEU . 5.4 m -79.54 165.94 22.45 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 119.339 0.972 . . . . 0.0 111.808 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.8 t -162.79 144.48 10.22 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 9' ' ' ASP . 1.0 OUTLIER -90.56 115.19 27.5 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 179.465 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.9 m -88.04 156.62 19.21 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.019 -2.586 . . . . 0.0 104.019 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.542 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 40.9 m-20 -61.73 -16.44 49.34 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 118.369 -1.332 . . . . 0.0 111.074 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 15.3 m -89.9 -1.74 58.04 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.349 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.411 ' HB2' HD23 ' A' ' 5' ' ' LEU . 38.5 m-20 -89.44 91.72 8.83 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.24 124.01 26.96 Favored Glycine 0 N--CA 1.499 2.892 0 CA-C-N 114.349 -1.296 . . . . 0.0 111.467 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -66.65 166.75 21.1 Favored 'Trans proline' 0 N--CA 1.491 1.352 0 C-N-CA 122.58 2.187 . . . . 0.0 114.742 -170.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -150.3 -176.58 5.53 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.4 m -87.69 -156.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 mmt180 -61.82 131.17 48.96 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.267 -0.973 . . . . 0.0 109.585 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 108.38 29.75 4.1 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 108.319 -1.912 . . . . 0.0 108.319 -179.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -68.6 173.98 4.61 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.012 0.911 . . . . 0.0 111.831 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.7 p -123.75 -177.96 3.89 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 112.574 -2.103 . . . . 0.0 107.362 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.536 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 3.2 mp -147.39 115.29 6.47 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 4.4 m -84.8 -33.43 22.96 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -74.88 160.5 52.84 Favored Glycine 0 CA--C 1.496 -1.144 0 CA-C-O 124.226 2.015 . . . . 0.0 109.287 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 2' ' ' VAL . 17.9 m -142.66 138.02 30.36 Favored 'General case' 0 C--N 1.28 -2.443 1 N-CA-C 100.108 -4.034 . . . . 0.0 100.108 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.463 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -99.82 140.86 33.41 Favored 'General case' 0 C--N 1.278 -2.52 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.444 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.437 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.1 m95 -114.61 131.91 56.54 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 111.688 -2.506 . . . . 0.0 108.481 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.79 -12.63 41.5 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 112.959 -1.928 . . . . 0.0 108.339 -179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.1 m-30 -58.38 139.5 84.65 Favored Pre-proline 0 C--N 1.301 -1.514 0 CA-C-N 111.89 -2.414 . . . . 0.0 105.393 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -64.98 -7.07 14.15 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.432 1.422 . . . . 0.0 113.86 -163.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 57.4 p -122.68 13.11 9.99 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.591 1.182 . . . . 0.0 110.789 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.507 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 67.42 -118.62 10.24 Favored Glycine 0 C--N 1.298 -1.569 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.78 106.54 0.57 Allowed Pre-proline 0 C--N 1.297 -1.688 0 CA-C-N 110.87 -2.665 . . . . 0.0 113.503 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -76.52 130.32 11.68 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 122.877 2.385 . . . . 0.0 108.774 -179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.1 t -42.58 111.2 0.23 Allowed 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 113.362 -1.745 . . . . 0.0 106.491 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.53 -8.55 4.97 Favored Glycine 0 C--N 1.292 -1.869 0 N-CA-C 104.33 -3.508 . . . . 0.0 104.33 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.2 m95 -105.69 -167.97 1.39 Allowed 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 104.759 -2.311 . . . . 0.0 104.759 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.448 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.9 m-70 -135.5 -114.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.588 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -174.92 134.99 0.36 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 31.8 p -141.47 -52.35 0.44 Allowed 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.168 -1.413 . . . . 0.0 109.86 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.542 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.8 mmmt -88.13 65.56 8.19 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 114.058 -1.428 . . . . 0.0 112.591 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -62.9 -3.24 1.5 Allowed 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.516 -1.274 . . . . 0.0 110.389 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.437 ' H ' ' C ' ' A' ' 37' ' ' LYS . 12.9 m170 -98.58 -15.21 19.58 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 136.32 -166.29 24.76 Favored Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.471 -1.347 . . . . 0.0 113.168 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.614 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 23.8 Cg_endo -74.39 -179.17 25.16 Favored 'Cis proline' 0 N--CA 1.494 1.501 0 N-CA-C 115.513 1.313 . . . . 0.0 115.513 25.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.3 p -89.42 11.91 17.87 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.559 -1.655 . . . . 0.0 111.969 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.4 pt -138.0 101.66 2.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.346 -2.094 . . . . 0.0 105.346 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.89 -171.38 46.72 Favored Glycine 0 N--CA 1.496 2.677 0 N-CA-C 103.572 -3.811 . . . . 0.0 103.572 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.507 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 10.7 m95 -127.04 149.41 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 118.95 1.375 . . . . 0.0 108.241 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.614 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -110.48 129.21 55.83 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 104.589 -2.374 . . . . 0.0 104.589 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.588 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.9 t -150.65 -168.05 2.99 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 117.845 -1.542 . . . . 0.0 109.799 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -150.38 162.22 40.96 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.564 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.304 -1.373 0 CA-C-O 115.789 -2.053 . . . . 0.0 106.982 179.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.865 0 N-CA-C 105.916 -2.873 . . . . 0.0 105.916 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.9 t -140.12 144.68 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 125.016 1.068 . . . . 0.0 108.841 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.608 ' CB ' HD22 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -81.66 160.02 23.83 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.707 -2.042 . . . . 0.0 111.935 -179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.7 t -163.12 144.09 9.49 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 123.547 0.53 . . . . 0.0 109.673 179.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.43 ' HA ' ' H ' ' A' ' 19' ' ' SER . 0.6 OUTLIER -74.2 176.8 6.29 Favored 'General case' 0 N--CA 1.505 2.282 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 179.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.3 m -122.34 138.7 54.43 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.33 -1.305 . . . . 0.0 108.748 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.549 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 20.0 m-20 -54.05 -2.98 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 119.139 3.014 . . . . 0.0 119.139 -179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.0 t -110.32 -6.13 15.08 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.86 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -110.48 115.18 29.18 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -121.25 60.64 0.54 Allowed Glycine 0 N--CA 1.49 2.251 0 C-N-CA 120.465 -0.874 . . . . 0.0 111.226 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -67.7 150.45 79.32 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.983 1.789 . . . . 0.0 109.805 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.8 p -89.02 102.34 14.99 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.431 -0.907 . . . . 0.0 111.567 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.44 HG22 ' N ' ' A' ' 14' ' ' ARG . 5.4 p 179.06 171.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 CA-C-N 111.952 -2.386 . . . . 0.0 106.994 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' N ' HG22 ' A' ' 13' ' ' VAL . 0.6 OUTLIER -156.82 167.55 30.13 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.41 -32.18 1.38 Allowed Glycine 0 N--CA 1.5 2.941 0 C-N-CA 120.263 -0.97 . . . . 0.0 112.666 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 14' ' ' ARG . 51.8 t30 -140.94 167.15 22.87 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.3 m 90.91 128.23 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.614 0 O-C-N 125.746 1.904 . . . . 0.0 112.239 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.608 HD22 ' CB ' ' A' ' 3' ' ' SER . 1.4 pp -150.89 159.11 44.77 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 105.864 -1.902 . . . . 0.0 105.864 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.43 ' H ' ' HA ' ' A' ' 5' ' ' LEU . 49.4 m -141.56 2.45 1.62 Allowed 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.232 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -136.85 -164.76 10.24 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 99.2 m -150.41 159.21 44.63 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.7 tt -114.39 146.18 40.89 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 113.14 -1.845 . . . . 0.0 110.731 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.41 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 86.7 m95 -119.64 133.64 55.56 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 111.786 -2.461 . . . . 0.0 109.608 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.1 mt -88.87 -14.9 35.78 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 113.835 -1.53 . . . . 0.0 109.478 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.9 m-30 -58.83 144.2 81.61 Favored Pre-proline 0 C--N 1.298 -1.656 0 CA-C-N 111.43 -2.623 . . . . 0.0 105.913 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -66.9 -19.73 52.12 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 121.182 1.255 . . . . 0.0 112.486 -162.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 13.2 p -107.02 5.47 28.11 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 112.33 -2.213 . . . . 0.0 110.288 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.48 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 69.37 -113.82 5.35 Favored Glycine 0 C--N 1.298 -1.53 0 CA-C-N 114.202 -1.363 . . . . 0.0 113.999 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -43.82 108.97 0.75 Allowed Pre-proline 0 C--N 1.295 -1.803 0 CA-C-N 110.451 -2.874 . . . . 0.0 111.316 -179.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 38.1 Cg_endo -74.91 130.81 13.73 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 N-CA-C 106.06 -2.323 . . . . 0.0 106.06 176.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -45.92 101.87 0.03 OUTLIER 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 112.84 -1.982 . . . . 0.0 109.018 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 142.6 -4.83 1.99 Allowed Glycine 0 C--N 1.296 -1.673 0 N-CA-C 104.375 -3.49 . . . . 0.0 104.375 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.692 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 20.2 m95 -105.53 -168.54 1.47 Allowed 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 104.723 -2.325 . . . . 0.0 104.723 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -140.16 -70.61 0.39 Allowed 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 120.117 3.377 . . . . 0.0 120.117 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.832 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 7.8 p30 155.91 140.78 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.649 0 C-N-CA 126.131 1.773 . . . . 0.0 114.258 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.427 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -140.82 -7.65 1.08 Allowed 'General case' 0 N--CA 1.505 2.316 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.541 179.624 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 18.9 mmmt -134.22 108.31 8.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.359 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.79 31.31 0.16 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.489 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.449 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m-70 -132.58 -145.99 0.27 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -96.5 -98.3 1.87 Allowed Glycine 0 N--CA 1.499 2.849 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -79.13 -165.59 4.73 Favored 'Cis proline' 0 C--N 1.309 -1.533 0 N-CA-C 114.195 0.806 . . . . 0.0 114.195 1.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -84.76 14.65 4.53 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.848 -1.069 . . . . 0.0 108.996 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.2 pt -147.24 81.36 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.7 171.55 44.95 Favored Glycine 0 N--CA 1.502 3.047 0 N-CA-C 107.561 -2.215 . . . . 0.0 107.561 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.48 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.4 m95 -116.68 142.44 46.9 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.058 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 13.1 m -103.9 120.74 41.65 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.832 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 1.7 t -142.64 -167.38 2.5 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 106.658 -1.608 . . . . 0.0 106.658 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.427 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 27.9 pttt -151.17 164.06 37.41 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 101.72 -3.437 . . . . 0.0 101.72 179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.692 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.4 tt0 . . . . . 0 C--N 1.297 -1.703 0 O-C-N 125.026 1.454 . . . . 0.0 112.714 -179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.736 0 N-CA-C 105.529 -3.028 . . . . 0.0 105.529 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.55 142.58 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.6 m -79.71 163.19 24.71 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 18' ' ' LEU . 52.6 t -157.06 155.85 31.85 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 123.924 0.765 . . . . 0.0 109.917 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' A' ' 18' ' ' LEU . 0.7 OUTLIER -89.67 121.01 31.44 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' C ' ' H ' ' A' ' 8' ' ' SER . 20.0 m -94.41 152.78 18.35 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.823 0.82 . . . . 0.0 111.039 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.715 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 2.7 m-20 -65.79 15.32 0.03 OUTLIER 'General case' 0 N--CA 1.507 2.402 0 N-CA-C 114.479 1.288 . . . . 0.0 114.479 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.482 ' H ' ' C ' ' A' ' 6' ' ' CYS . 22.7 t -131.72 1.16 4.0 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.438 ' HB2' ' CD2' ' A' ' 5' ' ' LEU . 39.9 m-20 -88.73 61.2 5.9 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 69.04 -121.39 11.66 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-N 113.577 -1.647 . . . . 0.0 109.051 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -68.33 173.63 9.36 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 121.566 1.511 . . . . 0.0 112.268 -172.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.9 p -88.95 -176.75 5.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.718 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.432 HG22 ' H ' ' A' ' 14' ' ' ARG . 11.9 p 45.46 -132.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 O-C-N 123.651 0.595 . . . . 0.0 109.582 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.432 ' H ' HG22 ' A' ' 13' ' ' VAL . 39.3 mtt85 -118.97 160.81 21.29 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 145.12 -33.5 1.6 Allowed Glycine 0 N--CA 1.502 3.051 0 N-CA-C 107.74 -2.144 . . . . 0.0 107.74 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.437 ' CG ' ' N ' ' A' ' 17' ' ' THR . 20.8 t30 -109.91 164.03 12.98 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 113.158 -1.521 . . . . 0.0 110.444 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.437 ' N ' ' CG ' ' A' ' 16' ' ' ASN . 69.0 m -66.49 150.3 49.16 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.555 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.2 OUTLIER -102.36 136.62 41.88 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.075 -1.42 . . . . 0.0 108.848 179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.1 p -126.2 0.61 7.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 124.922 1.389 . . . . 0.0 110.243 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -85.84 -172.51 48.86 Favored Glycine 0 C--N 1.306 -1.084 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -150.15 144.63 25.8 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.025 -2.213 . . . . 0.0 105.025 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.94 138.17 37.38 Favored 'General case' 0 C--N 1.279 -2.493 0 CA-C-N 111.585 -2.552 . . . . 0.0 108.256 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 74.8 m95 -112.2 129.42 56.26 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 110.712 -2.949 . . . . 0.0 107.577 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.6 mt -89.23 -14.11 36.68 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 112.557 -2.11 . . . . 0.0 109.057 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.2 m-30 -57.33 148.77 51.82 Favored Pre-proline 0 N--CA 1.492 1.67 0 CA-C-N 112.44 -2.164 . . . . 0.0 106.085 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -63.55 -19.78 68.3 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 120.991 1.128 . . . . 0.0 113.283 -162.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 33.6 p -113.02 7.28 18.05 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 113.432 -1.713 . . . . 0.0 111.742 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.542 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 72.77 -115.59 5.32 Favored Glycine 0 CA--C 1.49 -1.526 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.576 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.672 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.0 OUTLIER -48.46 115.03 3.94 Favored Pre-proline 0 C--N 1.296 -1.74 0 CA-C-N 111.591 -2.304 . . . . 0.0 112.766 -179.673 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 63.4 Cg_endo -77.89 165.94 25.79 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.556 2.171 . . . . 0.0 112.469 174.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.8 m -76.52 91.66 3.38 Favored 'General case' 0 C--N 1.286 -2.163 0 CA-C-N 111.761 -2.472 . . . . 0.0 108.562 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 151.42 -1.04 0.34 Allowed Glycine 0 C--N 1.29 -1.992 0 CA-C-N 109.806 -3.361 . . . . 0.0 105.656 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.672 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 17.9 m95 -116.65 -167.35 1.27 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 102.023 -3.325 . . . . 0.0 102.023 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.421 ' O ' ' HB3' ' A' ' 35' ' ' ASN . 4.6 m-70 -127.34 -73.38 0.61 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 117.795 2.517 . . . . 0.0 117.795 -179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.781 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 10.4 p30 143.06 150.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 128.025 2.53 . . . . 0.0 109.314 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.44 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 20.8 p -151.46 -53.16 0.13 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 123.341 1.543 . . . . 0.0 109.407 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.715 ' HZ1' ' CG ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -88.39 78.33 7.96 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.88 -1.509 . . . . 0.0 111.129 -179.626 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -75.84 6.62 4.81 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.775 -1.557 . . . . 0.0 108.62 179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -109.33 -55.36 2.43 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -140.86 -162.75 9.24 Favored Glycine 0 N--CA 1.489 2.213 0 C-N-CA 119.787 -1.196 . . . . 0.0 110.439 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.762 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 25.6 Cg_endo -78.71 -173.59 13.16 Favored 'Cis proline' 0 C--N 1.314 -1.271 0 CA-C-N 117.718 0.759 . . . . 0.0 111.384 4.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 8.7 p -90.07 5.96 44.46 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.965 -1.47 . . . . 0.0 110.167 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.4 pt -145.39 102.71 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.006 0 O-C-N 123.91 0.756 . . . . 0.0 109.071 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 84.25 169.93 46.12 Favored Glycine 0 N--CA 1.506 3.31 0 N-CA-C 105.502 -3.039 . . . . 0.0 105.502 -179.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.542 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 12.3 m95 -109.06 149.78 28.78 Favored 'General case' 0 N--CA 1.502 2.138 0 CA-C-N 118.176 0.988 . . . . 0.0 110.522 -179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.762 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.7 m -111.06 130.75 55.51 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.781 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 11.7 t -150.19 -167.9 2.95 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.514 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -150.39 160.57 43.65 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 101.533 -3.506 . . . . 0.0 101.533 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.645 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.7 tt0 . . . . . 0 C--N 1.298 -1.657 0 O-C-N 125.182 1.551 . . . . 0.0 111.791 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.618 0 N-CA-C 105.794 -2.922 . . . . 0.0 105.794 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.0 t -99.18 143.82 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 m -80.79 163.43 23.48 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.576 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 35.4 t -144.38 168.44 20.09 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.576 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 5.3 tp -119.09 129.85 55.29 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' SG ' ' CD ' ' A' ' 48' ' ' LYS . 80.7 m -97.56 151.08 20.41 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.304 0.573 . . . . 0.0 110.653 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.563 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 62.5 m-20 -60.68 -16.27 37.49 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.4 m -88.48 1.4 54.89 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.199 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.454 ' HB2' ' CD1' ' A' ' 5' ' ' LEU . 20.1 m-20 -105.55 133.94 49.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 124.016 0.822 . . . . 0.0 110.363 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -161.28 59.3 0.3 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -80.45 136.12 10.95 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 C-N-CA 123.133 2.555 . . . . 0.0 111.229 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.0 p -89.29 93.56 9.59 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.574 1.178 . . . . 0.0 109.732 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.404 HG22 ' N ' ' A' ' 14' ' ' ARG . 8.9 p -154.21 174.49 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 110.743 -2.935 . . . . 0.0 107.798 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.404 ' N ' HG22 ' A' ' 13' ' ' VAL . 20.9 mtp180 -134.75 149.61 50.45 Favored 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.96 -29.65 10.0 Favored Glycine 0 N--CA 1.507 3.388 0 N-CA-C 111.239 -0.745 . . . . 0.0 111.239 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -160.51 153.2 21.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.563 ' H ' HD23 ' A' ' 18' ' ' LEU . 25.1 m -156.53 36.48 0.32 Allowed 'General case' 0 C--N 1.297 -1.698 0 O-C-N 125.425 1.703 . . . . 0.0 109.027 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 17' ' ' THR . 2.0 pt? -151.13 125.62 9.51 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.275 -1.329 . . . . 0.0 109.643 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.4 t -131.42 5.47 4.39 Favored 'General case' 0 N--CA 1.503 2.211 0 O-C-N 124.777 1.298 . . . . 0.0 110.201 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.6 -166.29 37.64 Favored Glycine 0 C--N 1.303 -1.287 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 98.3 m -150.01 157.3 43.0 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -111.97 141.62 45.4 Favored 'General case' 0 C--N 1.276 -2.622 0 CA-C-N 111.946 -2.388 . . . . 0.0 107.274 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.419 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 80.0 m95 -112.85 130.86 55.95 Favored 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 110.8 -2.909 . . . . 0.0 106.138 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -88.22 -13.1 41.9 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.242 -1.345 . . . . 0.0 108.523 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.419 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 8.5 m-30 -56.67 142.71 70.63 Favored Pre-proline 0 N--CA 1.491 1.622 0 CA-C-N 111.576 -2.556 . . . . 0.0 107.067 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -63.33 -17.01 58.1 Favored 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.015 1.143 . . . . 0.0 113.652 -162.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 25.7 p -113.62 6.41 16.93 Favored 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 113.791 -1.549 . . . . 0.0 112.82 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.515 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 73.98 -116.71 5.4 Favored Glycine 0 C--N 1.298 -1.54 0 C-N-CA 119.478 -1.344 . . . . 0.0 115.043 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.565 ' SG ' ' CB ' ' A' ' 33' ' ' TRP . 0.7 OUTLIER -45.75 116.36 3.25 Favored Pre-proline 0 C--N 1.294 -1.842 0 CA-C-N 111.785 -2.207 . . . . 0.0 112.668 -179.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 93.0 Cg_endo -81.48 160.88 19.66 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.117 1.878 . . . . 0.0 108.206 173.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.2 p -69.56 110.2 4.67 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.071 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.28 -4.63 4.52 Favored Glycine 0 C--N 1.289 -2.042 0 N-CA-C 105.208 -3.157 . . . . 0.0 105.208 -179.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 19.0 m95 -116.49 -164.85 1.0 Allowed 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 104.064 -2.569 . . . . 0.0 104.064 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 57.9 m-70 -126.39 -87.93 0.58 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.184 1.549 . . . . 0.0 115.184 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.694 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 9.1 p30 149.9 149.76 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 127.047 2.139 . . . . 0.0 108.627 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.414 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 23.1 p -150.78 -46.78 0.12 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.555 1.169 . . . . 0.0 108.3 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 25.3 mmmt -88.61 80.19 7.37 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.118 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.6 49.82 1.23 Allowed 'General case' 0 N--CA 1.503 2.214 0 CA-C-O 122.338 1.066 . . . . 0.0 108.266 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 69.7 m-70 -146.81 -52.26 0.22 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.207 -1.815 . . . . 0.0 111.177 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -177.67 -143.27 4.93 Favored Glycine 0 N--CA 1.481 1.662 0 N-CA-C 108.365 -1.894 . . . . 0.0 108.365 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 59.2 Cg_endo -70.55 161.24 88.9 Favored 'Cis proline' 0 C--N 1.311 -1.424 0 CA-C-O 123.135 1.223 . . . . 0.0 115.214 8.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.3 p -72.53 33.38 0.06 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 114.325 -1.307 . . . . 0.0 113.368 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 22.4 pt -140.98 -41.94 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.442 0 CA-C-O 121.506 0.67 . . . . 0.0 111.248 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.12 165.27 28.59 Favored Glycine 0 N--CA 1.493 2.466 1 N-CA-C 101.367 -4.693 . . . . 0.0 101.367 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.515 ' HB2' ' CA ' ' A' ' 28' ' ' GLY . 11.5 m95 -100.95 154.6 18.54 Favored 'General case' 0 N--CA 1.501 2.102 0 CA-C-N 120.443 2.121 . . . . 0.0 111.741 -179.527 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.3 m -107.19 123.86 48.89 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 114.303 -1.317 . . . . 0.0 110.456 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.694 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.8 t -150.5 -179.83 7.55 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-O 121.844 0.831 . . . . 0.0 110.087 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CD ' ' SG ' ' A' ' 6' ' ' CYS . 34.5 mtmt -142.2 156.15 45.31 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 103.961 -2.607 . . . . 0.0 103.961 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.611 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.7 tt0 . . . . . 0 C--N 1.301 -1.534 0 O-C-N 125.555 1.784 . . . . 0.0 114.607 -179.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.759 0 N-CA-C 104.989 -3.244 . . . . 0.0 104.989 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.3 t -89.45 133.08 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 m -75.59 165.05 25.66 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.4 ' C ' ' HB2' ' A' ' 18' ' ' LEU . 52.0 t -159.79 165.8 31.67 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.4 pp -100.79 150.03 23.22 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.486 ' SG ' ' NZ ' ' A' ' 48' ' ' LYS . 32.6 m -99.94 161.78 13.4 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.965 -1.47 . . . . 0.0 108.743 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.493 ' CG ' ' HZ2' ' A' ' 37' ' ' LYS . 7.3 m-20 -61.86 -23.82 66.52 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-O 122.313 1.054 . . . . 0.0 111.054 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 m -67.3 -29.01 68.48 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.95 68.35 8.36 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 105.329 -2.1 . . . . 0.0 105.329 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -38.77 118.12 0.73 Allowed Glycine 0 N--CA 1.502 3.071 0 CA-C-N 113.222 -1.808 . . . . 0.0 109.432 179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -69.51 176.74 6.18 Favored 'Trans proline' 0 C--N 1.314 -1.272 0 C-N-CA 121.965 1.777 . . . . 0.0 113.55 -162.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 76.0 p -144.93 156.22 43.86 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.416 ' O ' ' HB3' ' A' ' 14' ' ' ARG . 14.8 m -81.34 79.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.416 ' HB3' ' O ' ' A' ' 13' ' ' VAL . 58.8 ttt85 85.47 165.06 0.09 Allowed 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 111.452 -2.613 . . . . 0.0 106.564 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.68 7.52 74.65 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -68.28 149.65 49.2 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 113.496 -1.352 . . . . 0.0 109.681 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.0 m -94.19 156.92 16.31 Favored 'General case' 0 N--CA 1.491 1.602 0 CA-C-N 114.009 -1.45 . . . . 0.0 107.343 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.49 HD23 ' N ' ' A' ' 18' ' ' LEU . 1.1 pt? -149.47 78.73 1.38 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 123.273 1.511 . . . . 0.0 112.063 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.1 m -82.47 2.92 30.44 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 112.8 -2.0 . . . . 0.0 114.005 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -101.58 -169.62 27.76 Favored Glycine 0 C--N 1.3 -1.469 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 49.5 m -150.56 146.79 26.79 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 104.404 -2.443 . . . . 0.0 104.404 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.432 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.8 OUTLIER -102.28 141.83 34.48 Favored 'General case' 0 C--N 1.278 -2.508 0 CA-C-N 111.522 -2.581 . . . . 0.0 107.94 179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.49 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.3 m95 -114.23 132.64 56.05 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.461 -3.063 . . . . 0.0 107.215 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mt -88.66 -12.26 42.98 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 113.364 -1.743 . . . . 0.0 108.282 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.4 m-30 -59.43 139.05 89.01 Favored Pre-proline 0 C--N 1.301 -1.526 0 CA-C-N 112.105 -2.316 . . . . 0.0 105.254 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -63.13 -13.13 33.57 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 120.66 0.907 . . . . 0.0 114.26 -160.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.6 p -114.57 4.6 15.21 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 114.512 -1.222 . . . . 0.0 113.167 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 45' ' ' TRP . . . 78.95 -122.09 5.74 Favored Glycine 0 C--N 1.297 -1.622 0 CA-C-N 113.771 -1.558 . . . . 0.0 116.178 179.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.781 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -44.64 116.24 2.63 Favored Pre-proline 0 C--N 1.294 -1.816 0 CA-C-N 111.04 -2.58 . . . . 0.0 114.341 -179.371 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 87.7 Cg_endo -77.5 167.1 24.89 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.779 2.319 . . . . 0.0 112.853 177.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -70.7 103.16 2.48 Favored 'General case' 0 C--N 1.281 -2.405 0 CA-C-N 111.495 -2.593 . . . . 0.0 109.182 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 132.31 1.44 4.36 Favored Glycine 0 C--N 1.293 -1.848 0 N-CA-C 105.056 -3.218 . . . . 0.0 105.056 -179.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.781 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 15.3 m95 -117.26 -162.56 0.87 Allowed 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 104.227 -2.508 . . . . 0.0 104.227 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.437 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 5.5 m-70 -133.5 -114.82 0.21 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.732 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER 177.93 136.5 0.08 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.602 179.663 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 23.9 p -145.62 -46.63 0.21 Allowed 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.579 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.493 ' HZ2' ' CG ' ' A' ' 7' ' ' ASP . 27.3 mmmt -88.54 69.66 8.89 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 122.704 1.24 . . . . 0.0 109.785 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.12 5.76 0.48 Allowed 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 113.846 -1.524 . . . . 0.0 112.163 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 95.1 m-70 -107.57 -16.12 14.43 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.319 1.6 . . . . 0.0 115.319 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 161.09 -148.79 17.13 Favored Glycine 0 N--CA 1.487 2.059 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.841 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.706 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 92.3 Cg_endo -68.15 -171.3 5.44 Favored 'Cis proline' 0 N--CA 1.493 1.474 0 CA-C-N 118.67 1.235 . . . . 0.0 114.681 4.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 14.2 t -93.36 20.81 6.7 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.629 -1.168 . . . . 0.0 109.837 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.7 mm -123.84 -57.52 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.663 0 CA-C-O 121.552 0.691 . . . . 0.0 110.114 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -133.94 -174.71 13.61 Favored Glycine 0 N--CA 1.501 3.015 1 N-CA-C 102.913 -4.075 . . . . 0.0 102.913 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 22' ' ' LEU . 11.3 m95 -108.49 146.22 33.51 Favored 'General case' 0 N--CA 1.509 2.493 0 CA-C-N 120.293 2.046 . . . . 0.0 109.684 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.706 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 6.7 m -104.2 130.46 51.96 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.732 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.9 t -150.48 -163.98 1.91 Allowed 'General case' 0 N--CA 1.49 1.555 0 CA-C-N 114.843 -1.071 . . . . 0.0 112.625 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.486 ' NZ ' ' SG ' ' A' ' 6' ' ' CYS . 0.0 OUTLIER -150.19 164.25 36.16 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 -179.923 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 116.484 -1.722 . . . . 0.0 109.692 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.847 0 N-CA-C 105.674 -2.97 . . . . 0.0 105.674 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.6 t -122.15 139.88 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 51.2 m -134.73 177.36 7.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 124.588 1.18 . . . . 0.0 109.305 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.685 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -160.49 160.79 32.44 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 125.924 2.015 . . . . 0.0 110.993 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.536 HD21 ' O ' ' A' ' 9' ' ' ASP . 4.2 tt -61.92 117.12 5.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 126.143 2.152 . . . . 0.0 110.394 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.5 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 76.5 m -93.61 159.58 15.16 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 119.705 -0.798 . . . . 0.0 113.099 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -49.29 -14.19 0.09 Allowed 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 13.8 m -97.26 -20.23 18.03 Favored 'General case' 0 N--CA 1.501 2.11 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.938 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.536 ' O ' HD21 ' A' ' 5' ' ' LEU . 2.1 m-20 -89.66 112.36 23.59 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -116.96 64.58 0.35 Allowed Glycine 0 N--CA 1.497 2.712 0 CA-C-O 118.883 -0.954 . . . . 0.0 111.372 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -73.99 -174.97 1.92 Allowed 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.59 2.193 . . . . 0.0 113.859 179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.9 p -90.04 -179.87 5.79 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 113.379 -1.737 . . . . 0.0 109.427 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -73.9 124.66 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 1 N-CA-C 96.364 -5.421 . . . . 0.0 96.364 179.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.9 ttt-85 83.14 135.81 0.06 Allowed 'General case' 0 N--CA 1.504 2.273 0 N-CA-C 103.414 -2.81 . . . . 0.0 103.414 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.78 13.92 18.86 Favored Glycine 0 N--CA 1.505 3.262 0 C-N-CA 120.188 -1.006 . . . . 0.0 110.615 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -54.46 129.18 34.99 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 121.922 0.868 . . . . 0.0 109.48 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.2 m -103.1 128.13 50.12 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 113.172 -1.831 . . . . 0.0 109.786 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 ' N ' HD12 ' A' ' 18' ' ' LEU . 10.8 mp -89.32 61.85 5.85 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 124.109 1.909 . . . . 0.0 106.675 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.3 t -65.52 -50.52 64.92 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 108.939 -3.755 . . . . 0.0 110.156 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -86.51 -156.88 29.27 Favored Glycine 0 N--CA 1.485 1.914 0 C-N-CA 120.018 -1.087 . . . . 0.0 111.76 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.5 m -150.36 148.71 29.14 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 102.327 -3.212 . . . . 0.0 102.327 179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.685 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 3.3 tt -109.56 138.86 45.3 Favored 'General case' 0 C--N 1.282 -2.341 0 CA-C-N 113.464 -1.698 . . . . 0.0 107.864 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.426 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 82.4 m95 -108.55 130.8 55.28 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 111.934 -2.394 . . . . 0.0 109.368 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.6 mt -88.78 -16.18 32.79 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.075 -2.329 . . . . 0.0 108.847 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.4 m-30 -57.37 147.24 59.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 CA-C-N 112.138 -2.301 . . . . 0.0 108.12 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -65.49 -12.13 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.047 1.831 . . . . 0.0 113.41 -162.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 29.1 p -120.81 6.08 10.45 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.893 -1.503 . . . . 0.0 110.499 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.521 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.32 -119.6 6.28 Favored Glycine 0 C--N 1.298 -1.566 0 CA-C-O 122.984 1.325 . . . . 0.0 113.775 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.57 109.37 0.93 Allowed Pre-proline 0 C--N 1.299 -1.6 0 CA-C-N 110.63 -2.785 . . . . 0.0 114.047 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.514 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 75.1 Cg_endo -79.25 136.1 12.51 Favored 'Trans proline' 0 C--N 1.313 -1.303 0 C-N-CA 123.966 3.111 . . . . 0.0 110.128 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.7 m -47.32 104.27 0.05 Allowed 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.748 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.5 -3.62 2.68 Favored Glycine 0 C--N 1.294 -1.791 0 N-CA-C 104.936 -3.266 . . . . 0.0 104.936 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.79 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.8 m95 -117.6 -171.43 2.05 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 102.873 -3.01 . . . . 0.0 102.873 179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 55.9 m80 -140.45 -99.64 0.15 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 124.16 0.912 . . . . 0.0 112.977 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.665 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -163.47 153.25 15.14 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 179.325 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -149.67 -30.78 0.23 Allowed 'General case' 0 N--CA 1.515 2.798 0 C-N-CA 119.356 -0.938 . . . . 0.0 111.51 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.496 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 14.6 mmmt -117.68 93.53 4.19 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.914 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.87 42.9 0.4 Allowed 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 37' ' ' LYS . 71.2 m-70 -140.21 -29.43 0.7 Allowed 'General case' 0 N--CA 1.493 1.695 0 CA-C-N 115.409 -0.814 . . . . 0.0 112.355 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.65 -114.8 0.93 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.37 -1.395 . . . . 0.0 111.186 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.669 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 14.5 Cg_endo -86.49 -152.95 0.7 Allowed 'Cis proline' 0 C--N 1.314 -1.265 0 CA-C-N 118.537 1.169 . . . . 0.0 110.59 8.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.1 p -82.57 9.3 9.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.213 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.469 ' N ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -144.97 113.98 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.23 -174.02 27.52 Favored Glycine 0 N--CA 1.504 3.211 0 N-CA-C 106.041 -2.824 . . . . 0.0 106.041 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.521 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 4.9 m95 -127.17 135.07 50.18 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 118.441 1.121 . . . . 0.0 108.187 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.669 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 51.9 m -96.12 122.24 38.74 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.31 1.053 . . . . 0.0 108.987 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.665 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 5.5 t -144.26 -168.92 3.01 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.621 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.547 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.61 168.75 23.35 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.434 ' O ' ' NZ ' ' A' ' 48' ' ' LYS . 3.4 tt0 . . . . . 0 C--N 1.297 -1.681 1 N-CA-C 97.867 -4.864 . . . . 0.0 97.867 179.152 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.687 0 N-CA-C 105.974 -2.85 . . . . 0.0 105.974 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.6 t -139.45 132.68 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.532 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 24.4 m -90.41 -178.33 5.32 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.986 -1.006 . . . . 0.0 110.363 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.503 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 49.2 t -162.63 169.01 20.83 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 125.611 1.819 . . . . 0.0 108.356 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.503 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 8.2 mt -104.77 137.76 42.09 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 113.807 -1.542 . . . . 0.0 109.585 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.3 m -89.93 161.73 15.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.025 -1.443 . . . . 0.0 107.692 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -62.41 -34.66 77.18 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.7 m -77.1 -2.09 32.48 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 125.123 1.514 . . . . 0.0 113.452 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -89.97 176.69 6.71 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.95 173.05 48.65 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 119.026 -1.559 . . . . 0.0 109.239 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -61.61 -170.32 0.07 OUTLIER 'Trans proline' 0 N--CA 1.492 1.424 0 C-N-CA 120.936 1.091 . . . . 0.0 110.097 166.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.45 103.58 15.99 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 123.285 1.517 . . . . 0.0 110.176 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -163.97 163.65 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 112.333 -2.212 . . . . 0.0 107.965 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 58.0 mtp180 -67.59 167.65 12.6 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 86.35 -43.49 3.24 Favored Glycine 0 N--CA 1.496 2.68 0 N-CA-C 106.128 -2.789 . . . . 0.0 106.128 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -74.55 164.77 26.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 18' ' ' LEU . 63.6 m -144.08 164.15 31.49 Favored 'General case' 0 N--CA 1.493 1.721 0 CA-C-O 121.586 0.707 . . . . 0.0 112.16 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.41 HD23 ' CB ' ' A' ' 3' ' ' SER . 9.9 mp -88.68 86.69 7.04 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.749 -1.945 . . . . 0.0 105.749 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 42.6 m -81.92 25.94 0.54 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.59 -1.244 . . . . 0.0 112.481 -179.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -142.94 -166.22 10.98 Favored Glycine 0 CA--C 1.555 2.547 0 O-C-N 125.27 1.607 . . . . 0.0 111.872 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 90.0 m -150.76 160.27 43.97 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 103.066 -2.938 . . . . 0.0 103.066 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.6 OUTLIER -113.13 136.88 52.24 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 179.301 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 71.7 m95 -110.01 134.12 52.47 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 122.956 1.36 . . . . 0.0 110.574 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 8.1 mt -88.96 -17.01 30.37 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 112.728 -2.033 . . . . 0.0 109.409 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -57.9 147.46 63.48 Favored Pre-proline 0 N--CA 1.492 1.641 0 CA-C-N 112.009 -2.359 . . . . 0.0 109.424 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -63.69 -11.11 24.86 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.034 1.823 . . . . 0.0 114.58 -164.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.404 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 67.9 p -126.17 10.07 7.44 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 124.61 1.194 . . . . 0.0 110.744 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.547 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.18 -114.17 4.85 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 119.381 -1.39 . . . . 0.0 113.823 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -45.22 112.09 1.48 Allowed Pre-proline 0 C--N 1.295 -1.772 0 CA-C-N 111.639 -2.281 . . . . 0.0 111.892 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 85.1 Cg_endo -83.57 151.91 13.34 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 123.191 2.594 . . . . 0.0 109.207 173.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.1 m -52.96 116.35 2.31 Favored 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 112.287 -2.233 . . . . 0.0 108.138 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 120.67 2.23 11.7 Favored Glycine 0 C--N 1.29 -2.024 0 CA-C-N 110.953 -2.839 . . . . 0.0 107.333 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.572 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 28.3 m95 -114.33 -177.91 3.24 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.455 ' O ' ' SG ' ' A' ' 47' ' ' CYS . 4.7 m-70 -130.4 -101.52 0.3 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 117.983 2.586 . . . . 0.0 117.983 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.594 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.5 OUTLIER -169.45 133.52 1.35 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.028 1.122 . . . . 0.0 114.028 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.521 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 1.2 m -133.46 -20.09 2.1 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.427 -1.26 . . . . 0.0 110.952 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 31.4 mmmt -140.77 95.89 2.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.454 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -80.32 7.38 9.7 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.961 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -120.13 -64.73 1.22 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.407 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . -167.56 -160.9 15.85 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 106.946 -2.462 . . . . 0.0 106.946 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 39.2 Cg_endo -76.45 162.68 91.42 Favored 'Cis proline' 0 C--N 1.308 -1.596 0 CA-C-N 118.707 1.253 . . . . 0.0 113.473 25.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.47 33.43 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 114.611 -1.177 . . . . 0.0 112.98 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 16.1 tt -150.48 117.9 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 65.77 -159.59 45.76 Favored Glycine 0 N--CA 1.505 3.281 0 N-CA-C 103.759 -3.736 . . . . 0.0 103.759 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.547 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 42.7 m95 -136.49 156.9 47.95 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 119.781 1.791 . . . . 0.0 107.564 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.9 m -120.16 117.28 27.5 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.594 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 4.5 t -150.66 -173.8 4.58 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 107.456 -1.313 . . . . 0.0 107.456 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.521 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 2.6 tmmm? -150.44 155.44 39.55 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.3 tt0 . . . . . 0 C--N 1.307 -1.259 0 O-C-N 125.878 1.986 . . . . 0.0 108.561 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.731 0 N-CA-C 106.233 -2.747 . . . . 0.0 106.233 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.57 148.08 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.476 ' CB ' HD22 ' A' ' 18' ' ' LEU . 71.9 m -98.75 177.25 5.35 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.265 0.353 . . . . 0.0 110.479 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.0 t -175.92 172.69 2.41 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 124.954 1.409 . . . . 0.0 110.557 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.5 mt -113.33 166.47 11.44 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 104.959 -2.237 . . . . 0.0 104.959 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.436 ' C ' ' H ' ' A' ' 8' ' ' SER . 60.1 m -99.88 171.5 7.82 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 120.053 -0.659 . . . . 0.0 111.342 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -81.56 16.5 1.7 Allowed 'General case' 0 N--CA 1.509 2.48 0 CA-C-O 123.408 1.575 . . . . 0.0 111.9 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.436 ' H ' ' C ' ' A' ' 6' ' ' CYS . 23.8 p -108.53 -49.78 3.12 Favored 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 111.956 -2.383 . . . . 0.0 107.657 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -89.19 175.76 7.23 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.77 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 156.72 59.22 0.01 OUTLIER Glycine 0 N--CA 1.481 1.669 0 CA-C-N 113.01 -1.904 . . . . 0.0 109.381 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -74.57 131.97 15.47 Favored 'Trans proline' 0 N--CA 1.488 1.18 0 C-N-CA 121.6 1.533 . . . . 0.0 111.413 -168.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.7 p -90.02 169.52 11.13 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.782 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG12 ' N ' ' A' ' 14' ' ' ARG . 38.9 t 69.35 167.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.201 0 CA-C-O 122.858 1.313 . . . . 0.0 112.882 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.444 ' N ' HG12 ' A' ' 13' ' ' VAL . 9.8 ptm85 -60.29 143.47 52.75 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 113.837 -1.529 . . . . 0.0 107.928 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.89 -4.12 24.22 Favored Glycine 0 N--CA 1.499 2.847 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 20.5 t30 -47.75 154.65 0.47 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 125.112 1.125 . . . . 0.0 111.409 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.1 p -147.33 175.44 10.78 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.545 -1.207 . . . . 0.0 113.181 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.476 HD22 ' CB ' ' A' ' 3' ' ' SER . 1.1 mt -114.44 103.04 10.65 Favored 'General case' 0 N--CA 1.509 2.518 0 N-CA-C 107.199 -1.408 . . . . 0.0 107.199 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.4 p -81.27 -7.1 59.51 Favored 'General case' 0 N--CA 1.505 2.302 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.17 -162.07 10.8 Favored Glycine 0 C--N 1.304 -1.221 0 N-CA-C 106.408 -2.677 . . . . 0.0 106.408 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 62.4 m -150.84 160.96 43.54 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 101.358 -3.571 . . . . 0.0 101.358 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 22' ' ' LEU . 7.1 tt -116.97 141.66 47.96 Favored 'General case' 0 C--N 1.281 -2.375 0 CA-C-N 113.271 -1.786 . . . . 0.0 108.5 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -119.5 129.62 54.8 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 110.634 -2.984 . . . . 0.0 106.715 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 21.0 mt -88.62 -18.98 26.86 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -45.54 146.09 1.88 Allowed Pre-proline 0 N--CA 1.49 1.544 0 CA-C-N 110.843 -2.89 . . . . 0.0 109.187 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -65.72 -12.11 33.71 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 121.792 1.661 . . . . 0.0 112.61 -162.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.463 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 63.4 p -129.12 21.43 5.76 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 113.726 -1.579 . . . . 0.0 109.846 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.573 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 59.43 -115.66 7.76 Favored Glycine 0 C--N 1.3 -1.439 0 CA-C-N 114.487 -1.233 . . . . 0.0 116.042 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.23 108.16 0.78 Allowed Pre-proline 0 C--N 1.298 -1.649 0 CA-C-N 110.928 -2.636 . . . . 0.0 113.423 -179.604 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.492 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -76.65 139.17 19.91 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.607 2.205 . . . . 0.0 108.12 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.6 p -52.24 101.45 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 112.253 -2.248 . . . . 0.0 108.296 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.5 -3.81 1.66 Allowed Glycine 0 CA--C 1.543 1.804 0 N-CA-C 104.942 -3.263 . . . . 0.0 104.942 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.777 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.4 m95 -112.92 -174.68 2.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 105.756 -1.942 . . . . 0.0 105.756 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.56 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.3 m-70 -131.68 -101.84 0.28 Allowed 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.67 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -167.37 146.58 5.07 Favored 'General case' 0 N--CA 1.506 2.366 0 CA-C-O 118.33 -0.843 . . . . 0.0 111.31 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -145.44 -51.98 0.26 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 179.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.477 ' CG ' ' HB3' ' A' ' 46' ' ' CYS . 29.5 mmmt -98.65 106.69 18.99 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 118.478 -1.289 . . . . 0.0 107.84 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -95.15 2.94 55.17 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -129.69 -83.58 0.55 Allowed 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -86.42 -169.05 45.53 Favored Glycine 0 N--CA 1.504 3.213 0 N-CA-C 108.647 -1.781 . . . . 0.0 108.647 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 5.1 Cg_endo -85.02 28.95 7.87 Favored 'Cis proline' 0 N--CA 1.499 1.798 0 CA-C-N 119.424 1.612 . . . . 0.0 115.522 -6.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 90.4 m 67.05 -23.09 0.11 Allowed 'General case' 0 N--CA 1.504 2.25 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.4 mt -108.13 137.33 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.318 0 CA-C-O 120.821 0.343 . . . . 0.0 110.515 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 53.23 -151.98 9.01 Favored Glycine 0 N--CA 1.508 3.471 0 N-CA-C 108.432 -1.867 . . . . 0.0 108.432 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.573 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 5.7 m95 -135.96 127.92 29.51 Favored 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.372 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.486 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 3.4 m -99.44 113.89 26.52 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.585 1.184 . . . . 0.0 108.094 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.67 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.4 t -134.09 -163.75 1.41 Allowed 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.56 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.49 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -150.73 154.17 36.88 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 179.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 C--N 1.303 -1.453 1 N-CA-C 98.803 -4.517 . . . . 0.0 98.803 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.701 0 N-CA-C 105.945 -2.862 . . . . 0.0 105.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.6 t -147.17 142.09 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 15.5 m -85.29 -178.53 6.77 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 109.333 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.439 ' O ' ' HB3' ' A' ' 18' ' ' LEU . 9.0 t -162.67 149.33 12.95 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.945 1.403 . . . . 0.0 112.384 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.425 ' O ' ' HE3' ' A' ' 37' ' ' LYS . 4.8 mt -94.72 139.09 31.71 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.464 ' SG ' ' HB3' ' A' ' 19' ' ' SER . 61.2 m -88.36 146.96 24.98 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 106.62 -1.622 . . . . 0.0 106.62 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -55.06 -32.33 61.82 Favored 'General case' 0 N--CA 1.501 2.09 0 C-N-CA 118.348 -1.341 . . . . 0.0 111.752 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 67.7 m -78.03 -0.2 27.0 Favored 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 113.231 -1.804 . . . . 0.0 113.612 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -89.76 35.39 0.83 Allowed 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 119.491 1.042 . . . . 0.0 110.373 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.52 -155.67 51.43 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.433 -1.365 . . . . 0.0 111.477 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.89 164.15 32.19 Favored 'Trans proline' 0 N--CA 1.488 1.204 0 C-N-CA 122.913 2.408 . . . . 0.0 113.656 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.1 p -91.6 -175.43 4.19 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.943 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.9 t 57.31 24.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.22 0 CA-C-O 122.152 0.977 . . . . 0.0 112.194 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -173.82 -159.05 0.1 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.548 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 79.78 -48.28 3.46 Favored Glycine 0 N--CA 1.488 2.12 0 CA-C-N 113.694 -1.594 . . . . 0.0 111.031 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 31.6 t30 74.02 160.04 0.23 Allowed 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 -179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.1 m 71.04 168.96 0.32 Allowed 'General case' 0 N--CA 1.51 2.53 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.467 ' CB ' ' HB3' ' A' ' 3' ' ' SER . 4.5 mp -140.35 130.18 24.54 Favored 'General case' 0 N--CA 1.504 2.269 0 CA-C-O 118.014 -0.993 . . . . 0.0 111.827 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . 19.0 t -89.44 -4.64 57.9 Favored 'General case' 0 N--CA 1.512 2.651 0 CA-C-N 119.918 1.236 . . . . 0.0 108.165 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -125.49 -175.31 14.17 Favored Glycine 0 N--CA 1.476 1.347 0 CA-C-O 123.213 1.452 . . . . 0.0 111.921 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.501 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 89.5 m -150.58 153.59 36.01 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 103.416 -2.809 . . . . 0.0 103.416 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -103.33 135.57 44.7 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 110.856 -2.884 . . . . 0.0 109.09 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.48 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 85.3 m95 -109.91 129.34 55.67 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 109.816 -3.356 . . . . 0.0 107.263 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.4 mt -88.66 -12.74 41.58 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 113.202 -1.817 . . . . 0.0 109.117 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.3 m-30 -57.17 148.46 51.76 Favored Pre-proline 0 C--N 1.3 -1.581 0 CA-C-N 111.852 -2.431 . . . . 0.0 108.918 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -63.53 -16.54 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 121.355 1.37 . . . . 0.0 113.247 -163.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.414 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 57.6 p -121.3 10.16 10.54 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 125.218 1.574 . . . . 0.0 111.637 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.46 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 72.0 -116.78 6.1 Favored Glycine 0 C--N 1.298 -1.574 0 CA-C-N 114.559 -1.2 . . . . 0.0 115.012 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.691 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.6 OUTLIER -42.9 109.49 0.76 Allowed Pre-proline 0 C--N 1.294 -1.825 0 CA-C-N 111.807 -2.196 . . . . 0.0 113.104 -179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.573 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 56.9 Cg_endo -77.42 126.03 8.09 Favored 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 122.973 2.448 . . . . 0.0 108.688 176.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m -43.26 100.35 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.216 0 CA-C-N 112.578 -2.101 . . . . 0.0 109.837 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 144.54 -8.11 1.81 Allowed Glycine 0 C--N 1.296 -1.688 0 N-CA-C 104.087 -3.605 . . . . 0.0 104.087 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.691 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.8 m95 -97.97 -151.5 0.37 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 106.356 -1.72 . . . . 0.0 106.356 179.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.556 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.6 t-160 -150.07 -105.73 0.07 Allowed 'General case' 0 C--N 1.298 -1.639 0 O-C-N 123.007 0.192 . . . . 0.0 111.064 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.679 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -168.4 141.12 2.96 Favored 'General case' 0 N--CA 1.502 2.13 0 CA-C-O 119.587 -0.245 . . . . 0.0 111.655 179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.591 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.8 OUTLIER -147.66 -15.83 0.37 Allowed 'General case' 0 N--CA 1.511 2.616 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 179.755 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.637 ' HG3' ' CB ' ' A' ' 46' ' ' CYS . 1.6 mmpt? -129.3 105.6 8.24 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 102.988 -2.967 . . . . 0.0 102.988 179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -87.99 1.88 53.09 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 124.97 1.419 . . . . 0.0 109.596 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m-70 -132.25 -60.02 0.91 Allowed 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -110.24 -160.61 17.97 Favored Glycine 0 N--CA 1.499 2.897 0 C-N-CA 120.146 -1.026 . . . . 0.0 113.753 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.67 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 50.1 Cg_endo -73.45 -175.58 15.12 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 O-C-N 122.829 0.91 . . . . 0.0 111.093 -7.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.5 t -86.92 5.24 38.06 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.031 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.3 pt -143.88 123.65 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.66 -169.47 54.31 Favored Glycine 0 N--CA 1.499 2.864 0 N-CA-C 106.685 -2.566 . . . . 0.0 106.685 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.46 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 20.9 m95 -130.16 155.2 46.62 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.67 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.2 m -122.21 129.67 52.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.535 -1.211 . . . . 0.0 110.55 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.679 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.1 t -150.92 -164.33 1.99 Allowed 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.591 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.58 165.67 33.56 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 102.722 -3.066 . . . . 0.0 102.722 178.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.552 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.238 -1.839 . . . . 0.0 108.497 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 3.029 0 N-CA-C 105.419 -3.072 . . . . 0.0 105.419 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -89.48 140.66 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.548 ' CB ' HD13 ' A' ' 18' ' ' LEU . 6.3 m -69.57 166.78 18.24 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' HG3' ' A' ' 37' ' ' LYS . 7.2 t -156.08 135.48 12.32 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 5' ' ' LEU . 4.5 mt -92.09 118.06 30.44 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 105.584 -2.006 . . . . 0.0 105.584 179.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.526 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 8.8 m -88.23 153.96 20.81 Favored 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 113.709 -1.587 . . . . 0.0 108.512 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -60.44 -8.76 2.93 Favored 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.375 -1.738 . . . . 0.0 113.454 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 7.5 p -97.52 -6.76 32.92 Favored 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.145 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.52 156.08 18.87 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 125.152 1.533 . . . . 0.0 110.623 -179.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -117.63 115.86 3.32 Favored Glycine 0 N--CA 1.492 2.422 0 CA-C-O 118.727 -1.041 . . . . 0.0 111.311 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -70.44 163.35 39.14 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 C-N-CA 122.039 1.826 . . . . 0.0 112.903 178.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 30.4 p -133.03 170.93 14.67 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.006 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.9 m -78.27 84.03 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 76.21 -167.83 0.07 Allowed 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 112.005 -2.361 . . . . 0.0 109.081 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 88.34 -41.98 3.07 Favored Glycine 0 N--CA 1.498 2.823 0 CA-C-O 118.933 -0.926 . . . . 0.0 112.431 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.458 HD21 ' CD1' ' A' ' 18' ' ' LEU . 15.0 t30 65.72 148.84 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.632 0 O-C-N 124.593 0.819 . . . . 0.0 112.518 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 16' ' ' ASN . 10.1 p -169.91 138.63 1.79 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 102.975 -2.972 . . . . 0.0 102.975 -179.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.548 HD13 ' CB ' ' A' ' 3' ' ' SER . 3.7 mp -140.9 121.88 14.58 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.5 m -83.43 -27.08 29.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.526 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -90.8 164.96 30.44 Favored Glycine 0 C--N 1.309 -0.954 0 CA-C-O 125.207 2.559 . . . . 0.0 114.991 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 31.1 m -151.1 136.58 17.81 Favored 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 111.17 -2.515 . . . . 0.0 106.184 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.476 ' HB2' ' SG ' ' A' ' 46' ' ' CYS . 19.5 tp -93.11 138.03 31.91 Favored 'General case' 0 C--N 1.28 -2.416 0 CA-C-N 109.703 -3.408 . . . . 0.0 107.649 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.605 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 86.5 m95 -118.51 130.41 55.91 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 110.429 -3.078 . . . . 0.0 106.263 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.3 mt -88.92 -7.05 56.79 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 113.655 -1.611 . . . . 0.0 109.086 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 6.7 m-30 -58.6 154.64 33.79 Favored Pre-proline 0 N--CA 1.489 1.477 0 CA-C-N 112.118 -2.31 . . . . 0.0 105.181 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -63.18 -24.75 72.63 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 121.295 1.33 . . . . 0.0 112.358 -166.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.472 ' O ' ' N ' ' A' ' 29' ' ' CYS . 25.3 p -116.74 9.16 13.91 Favored 'General case' 0 C--N 1.292 -1.934 0 CA-C-N 111.649 -2.523 . . . . 0.0 107.541 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 49.77 -84.75 0.01 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 125.919 2.012 . . . . 0.0 110.435 -179.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.501 ' SG ' ' O ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -38.53 93.63 0.07 OUTLIER Pre-proline 0 C--N 1.283 -2.308 1 CA-C-N 107.764 -4.218 . . . . 0.0 109.942 -179.93 . . . . . . . . 4 4 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.613 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 42.7 Cg_endo -86.61 126.18 2.55 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.037 1.824 . . . . 0.0 110.376 -172.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.1 m -44.62 112.78 0.46 Allowed 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 112.303 -2.226 . . . . 0.0 107.068 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.57 -5.16 6.23 Favored Glycine 0 C--N 1.288 -2.116 0 N-CA-C 104.457 -3.457 . . . . 0.0 104.457 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.613 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 15.0 m95 -108.17 -171.06 1.79 Allowed 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 104.39 -2.448 . . . . 0.0 104.39 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.501 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 3.7 m-70 -128.56 -124.43 0.22 Allowed 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 102.867 -3.012 . . . . 0.0 102.867 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.452 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 6.3 p30 -162.39 159.0 24.72 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 105.221 -2.14 . . . . 0.0 105.221 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -150.61 -49.71 0.13 Allowed 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 119.14 -1.024 . . . . 0.0 109.423 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HG3' ' SG ' ' A' ' 4' ' ' CYS . 9.7 mmtt -89.01 75.14 8.02 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.246 1.943 . . . . 0.0 116.246 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.6 -4.81 0.46 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 113.582 -1.645 . . . . 0.0 112.024 179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' H ' ' C ' ' A' ' 37' ' ' LYS . 83.7 m-70 -103.73 -21.84 13.64 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 143.55 -165.61 27.11 Favored Glycine 0 N--CA 1.496 2.657 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.812 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 43.8 Cg_endo -71.86 -171.15 7.61 Favored 'Cis proline' 0 N--CA 1.499 1.806 0 CA-C-N 119.348 1.574 . . . . 0.0 114.347 16.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 3.4 t -95.71 -6.6 39.47 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.671 179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 9.8 pt -106.68 99.24 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 89.08 -159.25 28.71 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 105.129 -3.188 . . . . 0.0 105.129 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.496 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 4.6 m95 -141.58 142.45 33.48 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.476 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.3 m -106.37 116.84 32.63 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.452 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 90.7 m -133.31 -171.83 2.79 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.758 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -137.75 161.63 36.03 Favored 'General case' 0 C--N 1.295 -1.767 1 N-CA-C 98.539 -4.615 . . . . 0.0 98.539 -179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.5 tt0 . . . . . 0 C--N 1.299 -1.591 0 CA-C-O 115.357 -2.259 . . . . 0.0 111.087 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.776 0 N-CA-C 105.094 -3.202 . . . . 0.0 105.094 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.1 t -89.82 143.45 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 N-CA-C 105.701 -1.962 . . . . 0.0 105.701 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 4.8 m -79.49 160.08 26.69 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 50.2 t -158.68 151.17 21.8 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.2 pp -84.5 164.55 18.72 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.695 -0.802 . . . . 0.0 108.987 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.421 ' SG ' ' HD3' ' A' ' 48' ' ' LYS . 24.3 m -103.7 163.12 12.53 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 104.98 -2.23 . . . . 0.0 104.98 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -50.97 -28.48 9.96 Favored 'General case' 0 N--CA 1.504 2.268 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.2 m -66.64 -13.86 61.72 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 112.991 -1.913 . . . . 0.0 113.201 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -88.15 58.58 4.85 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 123.943 1.83 . . . . 0.0 108.753 -179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.28 -52.47 6.71 Favored Glycine 0 N--CA 1.496 2.67 0 CA-C-N 111.707 -2.497 . . . . 0.0 112.232 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -78.14 175.67 10.87 Favored 'Trans proline' 0 N--CA 1.493 1.448 0 C-N-CA 122.369 2.046 . . . . 0.0 111.764 167.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.467 ' HA ' ' OG1' ' A' ' 17' ' ' THR . 89.1 p -150.35 142.54 24.13 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 117.836 -1.078 . . . . 0.0 109.811 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.6 m -132.01 168.34 24.27 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 124.554 1.159 . . . . 0.0 108.971 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 71.6 mtm180 -42.7 125.85 3.49 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 123.738 0.649 . . . . 0.0 110.869 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.71 -33.03 6.3 Favored Glycine 0 N--CA 1.499 2.86 0 N-CA-C 104.955 -3.258 . . . . 0.0 104.955 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 50.2 t30 88.95 158.5 0.06 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 128.285 2.634 . . . . 0.0 110.904 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.467 ' OG1' ' HA ' ' A' ' 12' ' ' SER . 0.2 OUTLIER -92.46 92.57 8.15 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.046 0.927 . . . . 0.0 113.43 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -150.88 119.31 6.42 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 69.5 m -143.0 14.09 1.88 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.425 -0.797 . . . . 0.0 110.799 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.6 -171.25 23.7 Favored Glycine 0 C--N 1.304 -1.195 0 N-CA-C 106.742 -2.543 . . . . 0.0 106.742 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 32.9 m -150.41 149.76 30.47 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 103.334 -2.839 . . . . 0.0 103.334 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 1.4 tt -110.15 143.14 40.69 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 113.065 -1.88 . . . . 0.0 107.538 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' HZ3' ' CZ ' ' A' ' 25' ' ' TYR . 87.1 m95 -114.09 131.75 56.29 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 111.499 -2.591 . . . . 0.0 108.453 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 9.0 mt -88.38 -10.75 48.26 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 113.23 -1.805 . . . . 0.0 107.882 -179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.44 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 7.3 m-30 -56.87 145.78 61.76 Favored Pre-proline 0 C--N 1.3 -1.573 0 CA-C-N 112.172 -2.285 . . . . 0.0 106.99 179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -66.18 -16.59 52.46 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.488 1.459 . . . . 0.0 113.265 -164.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 31.2 p -111.81 6.11 19.45 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 113.483 -1.69 . . . . 0.0 110.112 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.575 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 74.66 -117.78 5.56 Favored Glycine 0 C--N 1.297 -1.589 0 CA-C-N 114.5 -1.227 . . . . 0.0 114.363 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -53.8 119.97 21.26 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 111.616 -2.292 . . . . 0.0 113.115 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 73.5 Cg_endo -74.85 165.04 32.29 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-O 125.528 2.22 . . . . 0.0 112.897 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 p -78.39 79.31 4.83 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 111.363 -2.653 . . . . 0.0 113.567 -179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' TRP . . . 159.79 9.64 0.04 OUTLIER Glycine 0 C--N 1.29 -2.017 1 CA-C-N 107.738 -4.301 . . . . 0.0 106.168 179.97 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.702 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 16.7 m95 -125.09 -169.84 2.06 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.442 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 5.6 m-70 -133.52 -106.31 0.24 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 116.438 2.014 . . . . 0.0 116.438 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.65 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.0 OUTLIER 179.93 131.01 0.09 Allowed 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 122.703 0.401 . . . . 0.0 111.879 179.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.9 p -150.57 11.61 0.69 Allowed 'General case' 0 N--CA 1.514 2.727 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.418 ' C ' ' H ' ' A' ' 39' ' ' HIS . 0.9 OUTLIER -150.5 67.46 0.95 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 179.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.08 29.94 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' H ' ' C ' ' A' ' 37' ' ' LYS . 37.4 m170 -110.74 -10.12 14.47 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 122.56 0.344 . . . . 0.0 111.073 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.33 -123.98 4.35 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.084 -2.006 . . . . 0.0 108.084 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 43' ' ' ILE . 52.2 Cg_endo -71.6 148.9 91.4 Favored 'Cis proline' 0 N--CA 1.494 1.54 0 N-CA-C 116.42 1.661 . . . . 0.0 116.42 -8.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -42.16 -9.36 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.15 0 N-CA-C 117.406 2.372 . . . . 0.0 117.406 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' N ' ' O ' ' A' ' 41' ' ' PRO . 47.6 pt -122.7 0.01 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.249 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -174.66 144.34 7.37 Favored Glycine 0 N--CA 1.503 3.139 1 N-CA-C 102.733 -4.147 . . . . 0.0 102.733 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.575 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -95.15 138.65 32.58 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 119.719 1.759 . . . . 0.0 111.851 -179.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.67 127.12 43.4 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.65 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.7 t -148.2 -164.8 2.1 Favored 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 119.478 -0.889 . . . . 0.0 112.001 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.421 ' HD3' ' SG ' ' A' ' 6' ' ' CYS . 65.3 pttt -151.12 165.16 34.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 103.716 -2.698 . . . . 0.0 103.716 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.2 tt0 . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 116.68 -1.628 . . . . 0.0 112.154 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.76 0 N-CA-C 105.803 -2.919 . . . . 0.0 105.803 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.0 t -131.3 135.91 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 CA-C-N 118.764 1.282 . . . . 0.0 108.048 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 61.0 m -114.0 176.42 5.04 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 112.739 -2.028 . . . . 0.0 107.33 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 1.1 p -174.34 161.95 3.51 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 102.805 -3.035 . . . . 0.0 102.805 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.21 153.36 23.67 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 37' ' ' LYS . 4.4 m -99.37 162.15 13.2 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 102.837 -3.023 . . . . 0.0 102.837 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -57.11 -23.4 46.74 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.463 -1.295 . . . . 0.0 109.498 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 2.2 p -59.79 -20.51 57.23 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-N 114.492 -1.231 . . . . 0.0 110.24 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -89.54 2.8 54.14 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.862 -1.517 . . . . 0.0 111.828 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 48.69 -135.08 20.45 Favored Glycine 0 N--CA 1.501 3.029 0 CA-C-N 113.704 -1.589 . . . . 0.0 116.675 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -77.39 142.72 21.36 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 123.114 2.543 . . . . 0.0 115.431 -160.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.6 p -89.17 78.48 7.34 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 124.027 1.87 . . . . 0.0 111.094 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.8 t -97.68 28.09 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.126 0 CA-C-N 110.066 -3.243 . . . . 0.0 107.732 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 4.0 tmt_? 66.51 157.21 0.11 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-N 113.969 -1.469 . . . . 0.0 109.77 -179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.1 30.78 76.25 Favored Glycine 0 N--CA 1.503 3.134 0 N-CA-C 108.759 -1.737 . . . . 0.0 108.759 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.21 169.23 16.58 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 122.557 1.17 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.9 p -94.28 122.19 36.57 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 112.308 -2.224 . . . . 0.0 116.348 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 10.0 mp -89.25 62.65 6.21 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 21.5 t -78.2 -24.66 47.0 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -93.23 -166.33 38.16 Favored Glycine 0 N--CA 1.483 1.779 0 CA-C-O 122.825 1.236 . . . . 0.0 113.031 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.8 m -141.1 137.49 32.85 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 102.761 -3.052 . . . . 0.0 102.761 179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.481 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.4 OUTLIER -101.68 133.05 46.99 Favored 'General case' 0 C--N 1.282 -2.329 0 N-CA-C 106.116 -1.809 . . . . 0.0 106.116 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.484 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 72.5 m95 -107.63 127.42 53.64 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 112.467 -2.151 . . . . 0.0 109.881 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.9 mt -88.28 -9.8 51.7 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 112.711 -2.04 . . . . 0.0 109.283 -179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -63.37 149.34 91.86 Favored Pre-proline 0 N--CA 1.489 1.489 0 CA-C-N 112.413 -2.176 . . . . 0.0 105.465 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -62.22 -14.77 40.24 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.495 1.463 . . . . 0.0 114.052 -161.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.425 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 5.7 p -123.17 5.49 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-N 113.985 -1.461 . . . . 0.0 112.385 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 79.87 -120.46 5.23 Favored Glycine 0 C--N 1.299 -1.513 0 CA-C-N 113.66 -1.609 . . . . 0.0 113.874 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -40.78 107.48 0.48 Allowed Pre-proline 0 C--N 1.296 -1.743 0 CA-C-N 110.583 -2.808 . . . . 0.0 113.172 -179.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.508 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 59.4 Cg_endo -79.49 129.96 8.71 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 123.381 2.721 . . . . 0.0 109.084 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 m -42.06 106.04 0.06 Allowed 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 113.429 -1.714 . . . . 0.0 107.629 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.92 -4.64 3.27 Favored Glycine 0 C--N 1.294 -1.765 0 N-CA-C 104.181 -3.567 . . . . 0.0 104.181 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.782 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 22.0 m95 -110.04 -162.93 0.83 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 103.89 -2.633 . . . . 0.0 103.89 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.46 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 43.3 m80 -137.55 -117.28 0.15 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.696 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p-10 -176.34 132.78 0.23 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 120.17 -0.612 . . . . 0.0 112.611 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.411 ' SG ' ' N ' ' A' ' 37' ' ' LYS . 32.0 p -140.01 -53.37 0.52 Allowed 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.836 -1.146 . . . . 0.0 109.74 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.498 ' HG2' ' HA ' ' A' ' 6' ' ' CYS . 28.9 mmmt -87.19 66.96 9.49 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.335 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.41 2.94 1.06 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.345 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.458 ' H ' ' C ' ' A' ' 37' ' ' LYS . 11.5 m170 -113.48 -9.46 13.3 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 116.365 1.987 . . . . 0.0 116.365 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 37' ' ' LYS . . . 133.78 -171.52 22.0 Favored Glycine 0 N--CA 1.497 2.764 0 C-N-CA 119.609 -1.281 . . . . 0.0 112.621 -179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.546 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 22.6 Cg_endo -76.74 174.89 12.1 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 N-CA-C 116.728 1.78 . . . . 0.0 116.728 33.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 2.0 m -79.92 26.12 0.34 Allowed 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.577 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.5 mt -148.57 99.48 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.276 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.99 -173.31 52.21 Favored Glycine 0 N--CA 1.506 3.326 0 N-CA-C 104.935 -3.266 . . . . 0.0 104.935 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.483 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 25.1 m95 -125.31 147.77 48.99 Favored 'General case' 0 N--CA 1.51 2.561 0 CA-C-N 120.154 1.977 . . . . 0.0 108.966 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.546 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 4.4 m -110.51 129.7 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 8.5 t -150.64 -166.94 2.68 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 113.406 -1.724 . . . . 0.0 109.172 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -150.96 159.88 44.28 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 104.25 -2.5 . . . . 0.0 104.25 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.627 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 2.8 tt0 . . . . . 0 C--N 1.305 -1.361 0 C-N-CA 118.463 -1.295 . . . . 0.0 111.531 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.703 0 N-CA-C 106.021 -2.832 . . . . 0.0 106.021 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.0 t -143.9 141.75 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.402 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 74.4 m -135.27 179.78 6.11 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 124.164 0.915 . . . . 0.0 110.922 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.582 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.8 OUTLIER -162.91 166.24 24.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 125.736 1.898 . . . . 0.0 109.496 -179.918 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.13 130.25 42.17 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 124.456 1.098 . . . . 0.0 110.307 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 1.6 m -98.05 156.27 16.73 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-O 121.762 0.792 . . . . 0.0 111.096 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.42 -5.65 3.91 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.2 p -107.82 12.34 27.35 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-O 120.72 0.295 . . . . 0.0 111.237 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -106.75 4.66 27.9 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 -179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 122.09 -141.82 14.57 Favored Glycine 0 N--CA 1.49 2.273 0 CA-C-N 113.688 -1.596 . . . . 0.0 112.037 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -80.38 171.95 14.21 Favored 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.809 2.339 . . . . 0.0 112.148 -176.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.3 115.92 27.14 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 119.229 -0.988 . . . . 0.0 108.697 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.471 HG22 ' N ' ' A' ' 14' ' ' ARG . 4.3 p -170.57 -179.03 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.471 ' N ' HG22 ' A' ' 13' ' ' VAL . 9.1 ptt180 -131.52 135.73 47.3 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 104.021 -2.585 . . . . 0.0 104.021 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 129.23 -27.23 4.28 Favored Glycine 0 N--CA 1.5 2.948 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -61.76 -75.28 0.07 Allowed 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.0 t 179.98 -173.33 0.22 Allowed 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 106.76 -1.571 . . . . 0.0 106.76 179.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.578 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.5 OUTLIER -145.96 58.41 1.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 123.167 1.46 . . . . 0.0 111.026 -179.714 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -44.78 -33.61 1.97 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 112.193 -2.276 . . . . 0.0 114.912 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.19 -153.26 7.39 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 118.748 -1.692 . . . . 0.0 112.608 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 33.1 m -150.2 147.21 27.43 Favored 'General case' 0 C--N 1.298 -1.658 1 N-CA-C 100.0 -4.074 . . . . 0.0 100.0 179.322 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.582 ' HB2' ' SG ' ' A' ' 4' ' ' CYS . 0.3 OUTLIER -103.51 137.66 41.29 Favored 'General case' 0 C--N 1.282 -2.348 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.449 ' CZ2' ' HG3' ' A' ' 30' ' ' PRO . 69.7 m95 -111.59 129.73 55.98 Favored 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 113.401 -1.727 . . . . 0.0 109.021 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 10.4 mt -88.25 -13.55 40.67 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 111.973 -2.376 . . . . 0.0 108.706 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -59.19 147.61 74.52 Favored Pre-proline 0 N--CA 1.491 1.615 0 CA-C-N 112.355 -2.202 . . . . 0.0 106.84 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -62.95 -12.0 27.32 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 121.936 1.757 . . . . 0.0 114.342 -165.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 41.8 p -124.17 12.56 8.92 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.381 -1.281 . . . . 0.0 111.461 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.466 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 71.75 -120.64 8.22 Favored Glycine 0 C--N 1.299 -1.492 0 CA-C-O 122.448 1.027 . . . . 0.0 113.521 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.604 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.75 120.7 6.34 Favored Pre-proline 0 C--N 1.296 -1.73 0 CA-C-N 111.431 -2.385 . . . . 0.0 113.816 -179.553 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG3' ' CZ2' ' A' ' 23' ' ' TRP . 96.6 Cg_endo -79.4 -177.48 3.91 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.545 2.163 . . . . 0.0 108.663 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.9 t -87.26 137.59 32.22 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 102.574 -3.121 . . . . 0.0 102.574 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.82 13.04 41.62 Favored Glycine 0 C--N 1.285 -2.251 0 CA-C-N 111.578 -2.556 . . . . 0.0 107.692 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 9.4 m95 -119.5 -160.24 0.81 Allowed 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 103.458 -2.793 . . . . 0.0 103.458 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.479 ' CG ' ' H ' ' A' ' 35' ' ' ASN . 16.0 t-160 -132.86 -127.23 0.18 Allowed 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.617 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.6 OUTLIER -172.36 132.77 0.63 Allowed 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.67 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.636 ' SG ' ' HG2' ' A' ' 37' ' ' LYS . 18.9 p -142.07 -59.57 0.46 Allowed 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 118.776 -1.169 . . . . 0.0 110.401 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.636 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 30.4 mmmt -87.55 60.7 6.15 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-O 123.49 1.614 . . . . 0.0 110.425 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.78 24.99 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.028 -2.351 . . . . 0.0 109.516 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.576 ' H ' ' C ' ' A' ' 37' ' ' LYS . 92.5 m-70 -126.47 -66.31 0.92 Allowed 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 41' ' ' PRO . . . -170.56 -177.77 40.85 Favored Glycine 0 N--CA 1.479 1.535 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.749 ' HD2' ' SG ' ' A' ' 46' ' ' CYS . 36.5 Cg_endo -74.53 176.99 40.48 Favored 'Cis proline' 0 N--CA 1.501 1.912 0 O-C-N 123.738 1.388 . . . . 0.0 112.256 29.606 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.9 t -97.43 -8.7 28.8 Favored 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.902 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 70.8 mt -96.33 78.56 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 103.615 -2.735 . . . . 0.0 103.615 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.81 -178.01 33.31 Favored Glycine 0 N--CA 1.497 2.718 1 N-CA-C 102.659 -4.177 . . . . 0.0 102.659 -179.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.466 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.5 m95 -121.03 160.49 23.48 Favored 'General case' 0 N--CA 1.499 2.018 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.749 ' SG ' ' HD2' ' A' ' 41' ' ' PRO . 20.2 m -119.99 131.84 55.29 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.617 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 15.3 t -151.15 -168.55 3.13 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -151.45 166.43 31.12 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 101.489 -3.522 . . . . 0.0 101.489 179.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.9 tt0 . . . . . 0 C--N 1.297 -1.702 0 CA-C-O 117.439 -1.267 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.873 0 N-CA-C 104.837 -3.305 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 24.9 t -89.26 135.03 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 N-CA-C 100.126 -4.027 . . . . 0.0 100.126 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 18' ' ' LEU . 1.1 m -79.42 155.84 28.17 Favored 'General case' 0 C--N 1.287 -2.13 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.1 t -159.57 133.86 7.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 17' ' ' THR . 3.9 pp -64.94 178.47 0.81 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-O 122.375 1.083 . . . . 0.0 113.291 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.532 ' C ' ' HD3' ' A' ' 37' ' ' LYS . 32.9 m -101.19 -177.96 3.6 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-N 113.548 -1.66 . . . . 0.0 113.224 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.494 ' CG ' ' N ' ' A' ' 8' ' ' SER . 9.4 p-10 -66.1 -47.19 75.01 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.608 -1.307 . . . . 0.0 111.297 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.494 ' N ' ' CG ' ' A' ' 7' ' ' ASP . 20.2 m -69.24 0.53 4.75 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 111.652 -2.522 . . . . 0.0 112.606 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 5' ' ' LEU . 14.7 m-20 -89.57 -167.73 1.95 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 124.16 0.913 . . . . 0.0 110.719 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.02 -175.6 49.93 Favored Glycine 0 N--CA 1.487 2.096 0 CA-C-N 114.467 -1.242 . . . . 0.0 111.561 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -62.41 153.98 67.12 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.951 1.767 . . . . 0.0 111.238 -171.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.9 p -88.51 94.26 9.81 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 123.693 1.711 . . . . 0.0 114.388 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.3 p -156.33 159.14 2.9 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 102.238 -3.245 . . . . 0.0 102.238 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 15' ' ' GLY . 14.7 ttt-85 -72.15 -174.24 1.23 Allowed 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 116.899 -1.921 . . . . 0.0 107.503 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.426 ' H ' ' HG2' ' A' ' 14' ' ' ARG . . . 80.85 -40.04 2.45 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.544 ' ND2' ' H ' ' A' ' 17' ' ' THR . 0.7 OUTLIER -80.81 -152.96 0.09 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.544 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 24.7 p -82.11 156.79 24.34 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.528 HD23 ' N ' ' A' ' 18' ' ' LEU . 1.3 pt? -152.32 44.54 0.71 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.668 179.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 50.6 m -63.29 -27.87 69.63 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 117.327 2.344 . . . . 0.0 117.327 -179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -92.89 -164.34 37.76 Favored Glycine 0 C--N 1.298 -1.532 0 N-CA-C 107.442 -2.263 . . . . 0.0 107.442 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.4 m -151.2 147.39 26.95 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 102.703 -3.073 . . . . 0.0 102.703 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.453 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.5 OUTLIER -99.98 137.19 38.77 Favored 'General case' 0 C--N 1.279 -2.477 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 179.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.415 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 84.8 m95 -112.65 128.6 56.43 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-N 110.985 -2.825 . . . . 0.0 105.984 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mt -88.46 -10.19 49.95 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 113.432 -1.713 . . . . 0.0 108.278 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.4 m-30 -57.21 145.47 66.21 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 111.999 -2.364 . . . . 0.0 107.846 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -64.94 -9.72 22.53 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 121.71 1.607 . . . . 0.0 113.67 -164.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.408 ' HA ' ' CZ2' ' A' ' 45' ' ' TRP . 35.6 p -125.75 15.78 8.08 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.2 -1.364 . . . . 0.0 110.173 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.53 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 63.56 -117.86 12.12 Favored Glycine 0 C--N 1.297 -1.611 0 CA-C-N 114.245 -1.343 . . . . 0.0 115.451 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.806 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.73 110.91 1.36 Allowed Pre-proline 0 C--N 1.297 -1.698 0 CA-C-N 110.759 -2.721 . . . . 0.0 114.989 -179.389 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 74.3 Cg_endo -77.09 136.45 16.33 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 124.3 3.334 . . . . 0.0 109.718 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -48.15 108.38 0.17 Allowed 'General case' 0 C--N 1.293 -1.882 0 CA-C-O 123.029 1.395 . . . . 0.0 108.182 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.55 2.18 3.66 Favored Glycine 0 N--CA 1.481 1.689 0 CA-C-N 110.532 -3.031 . . . . 0.0 106.45 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.806 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 27.0 m95 -116.44 -157.4 0.65 Allowed 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.453 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 9.5 t-160 -150.25 -110.67 0.06 Allowed 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 120.521 -0.472 . . . . 0.0 112.107 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.592 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 2.3 p30 -169.45 147.9 3.7 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.609 ' SG ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -150.31 -63.23 0.2 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 124.233 0.958 . . . . 0.0 109.247 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.532 ' HD3' ' C ' ' A' ' 6' ' ' CYS . 32.1 mmmt -88.71 59.31 5.04 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -61.37 17.15 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 N-CA-C 115.721 1.749 . . . . 0.0 115.721 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.472 ' H ' ' C ' ' A' ' 37' ' ' LYS . 18.9 p80 -129.32 -36.6 1.69 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.136 0.791 . . . . 0.0 113.136 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.02 171.72 32.66 Favored Glycine 0 N--CA 1.495 2.592 0 C-N-CA 119.478 -1.344 . . . . 0.0 112.667 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.551 ' HD3' ' SG ' ' A' ' 46' ' ' CYS . 65.1 Cg_endo -73.04 175.34 45.61 Favored 'Cis proline' 0 N--CA 1.5 1.881 0 O-C-N 122.903 0.949 . . . . 0.0 114.559 4.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 9.0 t -93.43 19.56 8.22 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 115.841 -0.618 . . . . 0.0 112.152 -179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 20.6 pt -130.04 -39.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 C-N-CA 119.34 -0.944 . . . . 0.0 112.711 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -128.01 165.97 20.81 Favored Glycine 0 N--CA 1.505 3.276 1 N-CA-C 102.276 -4.33 . . . . 0.0 102.276 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.53 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.7 m95 -101.58 132.01 47.47 Favored 'General case' 0 N--CA 1.501 2.105 0 CA-C-N 119.651 1.725 . . . . 0.0 110.532 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.551 ' SG ' ' HD3' ' A' ' 41' ' ' PRO . 1.6 m -99.62 111.9 24.19 Favored 'General case' 0 N--CA 1.508 2.466 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.592 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 6.7 t -127.53 -168.09 1.84 Allowed 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.064 -0.971 . . . . 0.0 112.728 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.609 ' HG2' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.66 164.81 36.12 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 -179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.479 ' HG3' ' CD2' ' A' ' 33' ' ' TRP . 3.5 tt0 . . . . . 0 C--N 1.303 -1.433 0 N-CA-C 104.721 -2.326 . . . . 0.0 104.721 179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.798 0 N-CA-C 106.403 -2.679 . . . . 0.0 106.403 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.0 t -149.26 143.78 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.9 m -84.02 172.08 12.34 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.6 t -155.93 165.11 37.45 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 106.495 -1.668 . . . . 0.0 106.495 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 9' ' ' ASP . 4.6 tp -105.33 129.23 53.72 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' SG ' ' HE3' ' A' ' 48' ' ' LYS . 79.8 m -87.49 158.39 18.96 Favored 'General case' 0 N--CA 1.502 2.133 0 C-N-CA 116.211 -2.195 . . . . 0.0 107.118 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.509 ' CG ' ' HZ1' ' A' ' 37' ' ' LYS . 71.4 m-20 -64.88 -7.03 9.68 Favored 'General case' 0 N--CA 1.507 2.386 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 -179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 3.7 t -113.71 5.56 16.48 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 112.713 -2.039 . . . . 0.0 108.173 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.523 ' HB2' HD12 ' A' ' 5' ' ' LEU . 34.0 m-20 -99.95 27.13 5.72 Favored 'General case' 0 N--CA 1.505 2.323 0 CA-C-O 121.8 0.81 . . . . 0.0 110.566 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.48 171.3 14.98 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-O 119.464 -0.631 . . . . 0.0 112.48 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -76.39 -174.89 2.29 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 123.069 2.513 . . . . 0.0 110.315 162.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 p -89.49 158.23 17.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.861 -0.735 . . . . 0.0 110.042 179.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 92.1 t 94.08 146.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 C-N-CA 127.232 2.213 . . . . 0.0 107.127 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.73 155.24 2.37 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.194 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 133.5 -28.53 3.26 Favored Glycine 0 N--CA 1.501 3.011 0 N-CA-C 105.333 -3.107 . . . . 0.0 105.333 -179.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.431 ' ND2' HD22 ' A' ' 5' ' ' LEU . 7.2 p-10 -73.08 178.95 4.04 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 112.064 -2.068 . . . . 0.0 108.628 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 p -118.36 -175.08 2.8 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.8 OUTLIER -148.91 83.75 1.46 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.729 1.252 . . . . 0.0 109.149 -179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 3.8 p -86.66 2.18 49.33 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.263 -1.335 . . . . 0.0 113.506 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.47 -177.13 49.62 Favored Glycine 0 C--N 1.303 -1.252 0 N-CA-C 107.618 -2.193 . . . . 0.0 107.618 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 41.7 m -149.1 145.01 27.02 Favored 'General case' 0 C--N 1.293 -1.86 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 45' ' ' TRP . 0.3 OUTLIER -99.85 133.97 43.42 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 110.514 -3.039 . . . . 0.0 109.271 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.543 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 81.3 m95 -109.61 129.45 55.59 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 111.548 -2.569 . . . . 0.0 107.546 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.7 mt -87.89 -7.55 57.02 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 113.985 -1.461 . . . . 0.0 108.908 -179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.439 ' CZ ' ' HZ3' ' A' ' 23' ' ' TRP . 11.3 m-30 -57.99 149.7 54.13 Favored Pre-proline 0 C--N 1.301 -1.518 0 CA-C-N 111.913 -2.403 . . . . 0.0 106.569 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -63.32 -15.06 45.89 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.287 1.324 . . . . 0.0 113.946 -163.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 4.8 p -122.1 7.84 9.77 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.157 -179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.519 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 78.36 -119.42 5.15 Favored Glycine 0 CA--C 1.489 -1.548 0 CA-C-N 114.175 -1.375 . . . . 0.0 114.101 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.654 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -46.82 115.79 3.53 Favored Pre-proline 0 C--N 1.294 -1.814 0 CA-C-N 111.851 -2.175 . . . . 0.0 113.318 -179.626 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HD3' ' CG ' ' A' ' 23' ' ' TRP . 79.1 Cg_endo -76.4 174.94 12.01 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 CA-C-O 125.604 2.252 . . . . 0.0 114.169 177.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.4 m -81.69 107.22 14.26 Favored 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 110.311 -3.132 . . . . 0.0 105.271 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.67 3.87 5.41 Favored Glycine 0 C--N 1.294 -1.751 0 N-CA-C 104.971 -3.252 . . . . 0.0 104.971 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.656 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 11.9 m95 -119.7 -159.63 0.78 Allowed 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 104.309 -2.478 . . . . 0.0 104.309 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.469 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 8.1 t-80 -134.49 -118.0 0.18 Allowed 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.748 -179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.707 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 1.3 p30 -175.62 129.26 0.26 Allowed 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 120.759 -0.377 . . . . 0.0 111.524 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.436 ' C ' ' HG2' ' A' ' 37' ' ' LYS . 18.0 p -150.82 10.37 0.63 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 116.148 1.907 . . . . 0.0 116.148 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.519 ' HG3' ' HB3' ' A' ' 46' ' ' CYS . 2.2 mmpt? -135.87 92.02 2.76 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 -179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -73.58 38.0 0.09 Allowed 'General case' 0 N--CA 1.504 2.258 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -140.89 -26.09 0.73 Allowed 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 141.43 -107.65 0.52 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.006 -1.237 . . . . 0.0 110.006 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -71.66 -173.86 10.59 Favored 'Cis proline' 0 N--CA 1.494 1.527 0 N-CA-C 117.782 2.186 . . . . 0.0 117.782 -4.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 7.2 t -85.51 19.25 2.43 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 114.491 -1.232 . . . . 0.0 111.325 -179.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 15.3 pt -139.38 23.85 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-O 122.21 1.005 . . . . 0.0 109.689 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 133.64 167.09 11.52 Favored Glycine 0 N--CA 1.495 2.618 0 N-CA-C 103.178 -3.969 . . . . 0.0 103.178 -179.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.519 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 10.7 m95 -106.69 158.95 16.57 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 119.66 1.73 . . . . 0.0 110.97 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.519 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 1.8 m -116.28 126.98 54.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 124.013 0.821 . . . . 0.0 109.205 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.707 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 16.0 t -151.6 -163.74 1.82 Allowed 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.749 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.599 ' HE3' ' SG ' ' A' ' 6' ' ' CYS . 32.5 ttmt -150.93 163.31 39.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 101.721 -3.437 . . . . 0.0 101.721 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.656 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 4.8 tt0 . . . . . 0 C--N 1.301 -1.533 0 CA-C-O 117.116 -1.421 . . . . 0.0 113.895 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.609 0 N-CA-C 105.748 -2.941 . . . . 0.0 105.748 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.3 t -126.67 133.23 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 N-CA-C 105.212 -2.144 . . . . 0.0 105.212 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.556 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 14.6 m -90.07 172.13 9.05 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' SG ' ' N ' ' A' ' 5' ' ' LEU . 30.8 t -146.18 160.77 41.5 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.497 ' N ' ' SG ' ' A' ' 4' ' ' CYS . 6.8 mp -83.59 126.13 32.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 67.7 m -88.32 -178.77 5.98 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -33.72 67.6 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 123.63 1.681 . . . . 0.0 108.346 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.4 m -64.64 -32.89 74.75 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-N 112.468 -2.151 . . . . 0.0 108.253 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -89.46 73.4 7.86 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 104.824 -2.288 . . . . 0.0 104.824 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' H ' ' HD2' ' A' ' 11' ' ' PRO . . . -108.95 -70.24 0.67 Allowed Glycine 0 N--CA 1.487 2.092 0 CA-C-N 111.671 -2.513 . . . . 0.0 109.013 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 10' ' ' GLY . 38.2 Cg_endo -76.2 150.75 33.51 Favored 'Trans proline' 0 N--CA 1.49 1.297 0 C-N-CA 122.035 1.823 . . . . 0.0 113.446 177.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 p -89.59 110.27 21.15 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.9 t -126.65 141.91 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 125.968 2.043 . . . . 0.0 108.824 -179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -63.31 121.88 14.82 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.41 -23.4 12.38 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 107.296 -2.321 . . . . 0.0 107.296 -179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.573 ' ND2' ' H ' ' A' ' 17' ' ' THR . 9.2 t-20 -68.18 167.2 14.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.573 ' H ' ' ND2' ' A' ' 16' ' ' ASN . 6.8 t -172.45 -154.92 0.08 Allowed 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 103.095 -2.928 . . . . 0.0 103.095 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.544 HD23 ' N ' ' A' ' 18' ' ' LEU . 0.3 OUTLIER -121.36 93.06 3.89 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 103.272 -2.862 . . . . 0.0 103.272 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -76.96 -16.95 59.19 Favored 'General case' 0 N--CA 1.504 2.275 0 CA-C-N 114.55 -1.205 . . . . 0.0 113.784 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.529 ' HA2' ' HD3' ' A' ' 48' ' ' LYS . . . -77.24 -169.59 32.21 Favored Glycine 0 N--CA 1.481 1.685 0 CA-C-O 122.398 0.999 . . . . 0.0 111.43 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.556 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 30.2 m -150.55 147.35 27.35 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 101.676 -3.453 . . . . 0.0 101.676 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 45' ' ' TRP . 5.0 tt -105.65 144.56 32.23 Favored 'General case' 0 C--N 1.28 -2.433 0 CA-C-N 113.079 -1.873 . . . . 0.0 109.225 179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 81.2 m95 -119.1 137.42 53.59 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.893 -1.958 . . . . 0.0 107.133 -179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 mt -88.84 -15.23 35.05 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-O 123.486 1.612 . . . . 0.0 108.873 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 7.0 m-30 -56.98 138.49 79.3 Favored Pre-proline 0 C--N 1.296 -1.733 0 CA-C-N 110.541 -3.027 . . . . 0.0 109.539 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -66.09 -6.54 14.78 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 121.627 1.552 . . . . 0.0 112.662 -164.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 50.0 p -126.74 22.25 6.89 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 114.501 -1.227 . . . . 0.0 110.944 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.565 ' CA ' ' CG ' ' A' ' 45' ' ' TRP . . . 57.8 -111.75 3.26 Favored Glycine 0 CA--C 1.487 -1.7 0 CA-C-N 114.126 -1.397 . . . . 0.0 116.274 179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.72 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.16 115.48 5.42 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 112.038 -2.081 . . . . 0.0 113.308 -179.735 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.515 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 71.2 Cg_endo -80.28 150.84 20.14 Favored 'Trans proline' 0 C--N 1.314 -1.268 0 C-N-CA 122.678 2.252 . . . . 0.0 108.72 175.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.7 t -60.91 108.62 0.89 Allowed 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 105.602 -1.999 . . . . 0.0 105.602 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.43 -4.17 3.36 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 110.706 -2.952 . . . . 0.0 106.637 -179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.72 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 24.4 m95 -115.48 -160.55 0.75 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 105.838 -1.912 . . . . 0.0 105.838 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' SG ' ' A' ' 29' ' ' CYS . 78.8 m-70 -135.89 -89.56 0.31 Allowed 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -179.56 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.658 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 0.3 OUTLIER 177.19 156.42 0.31 Allowed 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 105.06 -2.2 . . . . 0.0 105.06 179.519 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.598 ' SG ' ' HB2' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.6 -43.79 0.12 Allowed 'General case' 0 N--CA 1.503 2.225 0 O-C-N 124.357 1.035 . . . . 0.0 109.997 179.679 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 39' ' ' HIS . 4.3 mmtt -99.52 104.2 16.0 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 179.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -63.97 21.82 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 114.36 1.245 . . . . 0.0 114.36 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' H ' ' C ' ' A' ' 37' ' ' LYS . 35.9 m80 -135.96 -15.48 1.76 Allowed 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 115.535 1.68 . . . . 0.0 115.535 -179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 137.15 -86.44 0.23 Allowed Glycine 0 N--CA 1.493 2.49 0 C-N-CA 119.699 -1.239 . . . . 0.0 112.111 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' ILE . 0.6 OUTLIER -89.47 -164.02 2.32 Favored 'Cis proline' 0 C--N 1.313 -1.293 0 CA-C-N 118.394 1.097 . . . . 0.0 111.091 -6.091 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.5 p -74.31 23.96 0.08 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.4 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 5.2 mp -148.38 100.86 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 102.551 -3.129 . . . . 0.0 102.551 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 55.13 -149.8 21.24 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 104.794 -3.322 . . . . 0.0 104.794 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.565 ' CG ' ' CA ' ' A' ' 28' ' ' GLY . 14.2 m95 -142.89 152.88 42.57 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-N 118.986 1.393 . . . . 0.0 107.724 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.413 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 6.2 m -114.07 116.11 28.63 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 122.066 0.936 . . . . 0.0 109.636 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.658 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 12.0 t -139.34 -168.62 2.49 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.879 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.598 ' HB2' ' SG ' ' A' ' 36' ' ' CYS . 28.8 tptp -151.25 151.82 32.39 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 179.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.0 tt0 . . . . . 0 C--N 1.304 -1.39 0 N-CA-C 103.0 -2.963 . . . . 0.0 103.0 179.68 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.695 0 N-CA-C 105.922 -2.871 . . . . 0.0 105.922 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t -124.41 164.95 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.3 m -119.3 174.67 6.22 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.606 1.335 . . . . 0.0 114.606 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 22' ' ' LEU . 0.0 OUTLIER -148.25 168.51 22.34 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 113.923 -1.489 . . . . 0.0 112.527 -179.33 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' O ' ' HD2' ' A' ' 37' ' ' LYS . 2.1 tt -80.49 106.46 12.53 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.525 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.566 ' SG ' ' HA3' ' A' ' 20' ' ' GLY . 58.3 m -89.68 162.02 15.8 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 123.5 1.619 . . . . 0.0 112.165 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.17 21.04 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 6' ' ' CYS . 69.3 m -147.91 19.51 1.13 Allowed 'General case' 0 C--N 1.29 -2.014 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.168 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.42 ' OD1' ' HB2' ' A' ' 6' ' ' CYS . 6.2 m-20 -89.53 -145.79 0.16 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.18 153.65 22.95 Favored Glycine 0 CA--C 1.538 1.487 0 N-CA-C 104.484 -3.446 . . . . 0.0 104.484 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.45 ' HA ' HG23 ' A' ' 17' ' ' THR . 21.7 Cg_endo -78.74 140.77 16.72 Favored 'Trans proline' 0 N--CA 1.492 1.441 0 C-N-CA 123.28 2.653 . . . . 0.0 115.078 -176.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 60.3 p -149.46 -166.35 2.53 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 105.475 -2.046 . . . . 0.0 105.475 179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.3 m -67.8 175.75 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 119.099 -1.04 . . . . 0.0 112.478 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.472 ' HA ' ' HE ' ' A' ' 14' ' ' ARG . 1.0 OUTLIER -74.59 168.38 19.9 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 106.927 -1.509 . . . . 0.0 106.927 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.97 18.42 64.49 Favored Glycine 0 N--CA 1.504 3.218 0 N-CA-C 107.454 -2.258 . . . . 0.0 107.454 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -163.39 -178.59 5.99 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 102.915 -2.995 . . . . 0.0 102.915 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.45 HG23 ' HA ' ' A' ' 11' ' ' PRO . 10.4 m 81.61 42.96 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.467 0 CA-C-O 122.895 1.331 . . . . 0.0 113.104 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.499 ' H ' HD23 ' A' ' 18' ' ' LEU . 0.8 OUTLIER -150.38 109.85 4.0 Favored 'General case' 0 N--CA 1.505 2.306 0 CA-C-N 113.59 -1.641 . . . . 0.0 107.852 179.637 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 t -104.6 -6.32 20.62 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -179.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.566 ' HA3' ' SG ' ' A' ' 6' ' ' CYS . . . -91.37 -163.99 38.9 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.623 -1.275 . . . . 0.0 110.282 179.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.422 ' HB ' ' CZ3' ' A' ' 33' ' ' TRP . 15.5 m -150.84 142.3 23.44 Favored 'General case' 0 C--N 1.292 -1.9 1 N-CA-C 98.971 -4.455 . . . . 0.0 98.971 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.444 HD21 HD23 ' A' ' 24' ' ' LEU . 4.2 tt -105.02 143.97 32.47 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.425 ' CG ' ' HD3' ' A' ' 30' ' ' PRO . 83.6 m95 -117.21 135.46 53.77 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-N 111.822 -2.445 . . . . 0.0 107.954 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.444 HD23 HD21 ' A' ' 22' ' ' LEU . 11.7 mt -88.72 -17.4 30.0 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 114.107 -1.406 . . . . 0.0 108.874 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -52.07 138.65 35.52 Favored Pre-proline 0 C--N 1.299 -1.625 0 CA-C-N 110.907 -2.861 . . . . 0.0 109.097 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -66.18 -10.81 28.66 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 C-N-CA 121.551 1.501 . . . . 0.0 113.254 -166.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 56.9 p -118.72 16.76 13.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 114.091 -1.413 . . . . 0.0 108.827 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.513 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 60.75 -118.64 15.64 Favored Glycine 0 C--N 1.297 -1.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 117.089 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.785 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 0.5 OUTLIER -50.08 114.45 4.35 Favored Pre-proline 0 C--N 1.297 -1.676 0 CA-C-N 110.713 -2.744 . . . . 0.0 114.295 -179.301 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 76.1 Cg_endo -80.66 127.63 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.57 2.18 . . . . 0.0 109.762 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.2 p -44.45 106.58 0.07 Allowed 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 112.554 -2.112 . . . . 0.0 105.952 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.4 -7.33 3.1 Favored Glycine 0 N--CA 1.484 1.851 0 N-CA-C 103.918 -3.673 . . . . 0.0 103.918 -179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.785 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 25.4 m95 -111.3 -164.24 0.9 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 103.138 -2.912 . . . . 0.0 103.138 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 48.2 m80 -139.44 -109.83 0.16 Allowed 'General case' 0 C--N 1.298 -1.663 0 O-C-N 123.94 0.775 . . . . 0.0 110.254 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.622 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 11.7 p-10 -164.36 153.02 13.02 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 104.273 -2.491 . . . . 0.0 104.273 179.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.449 ' HB3' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -150.33 -33.82 0.17 Allowed 'General case' 0 N--CA 1.511 2.583 0 CA-C-O 123.457 1.599 . . . . 0.0 111.118 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.602 ' HA ' ' CE ' ' A' ' 37' ' ' LYS . 0.0 OUTLIER -115.48 105.01 12.32 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 104.16 -2.533 . . . . 0.0 104.16 179.64 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -79.64 4.11 17.04 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.996 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 84.0 m-70 -117.22 -112.98 0.34 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.166 -0.925 . . . . 0.0 112.282 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.82 -154.87 20.29 Favored Glycine 0 N--CA 1.495 2.581 0 N-CA-C 116.739 1.456 . . . . 0.0 116.739 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 46' ' ' CYS . 91.7 Cg_endo -67.02 167.68 56.85 Favored 'Cis proline' 0 N--CA 1.501 1.953 0 O-C-N 122.77 0.879 . . . . 0.0 111.373 11.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -25.12 61.66 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 121.883 0.849 . . . . 0.0 109.585 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.2 tp -103.37 106.62 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.33 -177.16 39.21 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 105.915 -2.874 . . . . 0.0 105.915 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.513 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 3.4 m95 -135.88 135.57 39.83 Favored 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 118.873 1.337 . . . . 0.0 109.72 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 41' ' ' PRO . 21.5 m -97.47 130.81 44.53 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.622 ' SG ' ' HA ' ' A' ' 35' ' ' ASN . 17.6 t -148.58 -166.54 2.57 Favored 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 114.894 -1.048 . . . . 0.0 108.496 -179.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.449 ' HG2' ' HB3' ' A' ' 36' ' ' CYS . 12.3 ptmm? -152.18 164.0 38.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 102.609 -3.108 . . . . 0.0 102.609 179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' TRP . 3.2 tt0 . . . . . 0 C--N 1.305 -1.342 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.615 0 N-CA-C 104.837 -3.305 . . . . 0.0 104.837 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.44 131.52 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 123.002 1.382 . . . . 0.0 112.16 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 3.4 m -72.71 170.51 14.4 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 112.184 -2.28 . . . . 0.0 110.985 -179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.424 ' O ' ' N ' ' A' ' 20' ' ' GLY . 45.7 t -159.39 143.02 14.71 Favored 'General case' 0 N--CA 1.504 2.227 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 18' ' ' LEU . 1.4 pt? -73.12 167.72 20.56 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 73.8 m -104.8 176.05 5.29 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.034 -1.098 . . . . 0.0 108.034 179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' HA ' ' NZ ' ' A' ' 37' ' ' LYS . 0.6 OUTLIER -74.54 -11.36 60.19 Favored 'General case' 0 N--CA 1.507 2.421 0 O-C-N 120.56 -1.338 . . . . 0.0 112.163 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 41.3 t -92.53 -5.62 51.38 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 106.577 -1.638 . . . . 0.0 106.577 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -89.74 96.62 10.77 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 124.342 1.026 . . . . 0.0 108.992 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.81 74.33 0.21 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 106.55 -2.62 . . . . 0.0 106.55 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -70.12 176.42 7.07 Favored 'Trans proline' 0 N--CA 1.488 1.174 0 C-N-CA 121.939 1.759 . . . . 0.0 113.683 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.7 p -89.67 171.3 9.76 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 113.456 -1.702 . . . . 0.0 111.435 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.463 ' O ' ' CB ' ' A' ' 14' ' ' ARG . 18.8 m -73.27 82.87 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.463 ' CB ' ' O ' ' A' ' 13' ' ' VAL . 21.8 ttt180 109.9 145.27 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 103.199 -2.889 . . . . 0.0 103.199 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.2 35.64 6.23 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 106.92 -2.472 . . . . 0.0 106.92 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -59.29 140.23 56.23 Favored 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.267 -0.466 . . . . 0.0 110.949 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.0 t -111.65 147.75 34.85 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 18' ' ' LEU . 1.2 pt? -150.39 70.87 1.03 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 122.476 1.131 . . . . 0.0 111.215 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.6 m -70.31 -26.9 64.0 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 115.417 1.636 . . . . 0.0 115.417 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . -80.51 -159.65 21.02 Favored Glycine 0 N--CA 1.482 1.763 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 63.1 m -151.42 153.86 35.51 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 103.703 -2.703 . . . . 0.0 103.703 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 23' ' ' TRP . 3.1 tp -101.52 149.82 23.7 Favored 'General case' 0 C--N 1.281 -2.398 0 CA-C-N 113.016 -1.902 . . . . 0.0 106.683 179.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.407 ' N ' ' HG ' ' A' ' 22' ' ' LEU . 68.8 m95 -127.51 128.39 45.59 Favored 'General case' 0 C--N 1.292 -1.927 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.082 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.402 ' H ' ' HG ' ' A' ' 24' ' ' LEU . 3.7 mt -88.99 -10.71 46.63 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 111.006 -2.815 . . . . 0.0 108.721 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 9.7 m-30 -63.25 150.43 89.17 Favored Pre-proline 0 N--CA 1.489 1.498 0 CA-C-N 112.524 -2.125 . . . . 0.0 106.21 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -64.18 -14.39 43.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 121.663 1.576 . . . . 0.0 113.817 -163.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 46.8 p -125.51 13.75 8.16 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.737 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 45' ' ' TRP . . . 69.03 -115.73 6.71 Favored Glycine 0 C--N 1.301 -1.379 0 CA-C-N 113.508 -1.678 . . . . 0.0 113.156 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.733 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 1.3 t -42.67 107.69 0.57 Allowed Pre-proline 0 C--N 1.296 -1.726 0 CA-C-N 110.557 -2.822 . . . . 0.0 113.315 -179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.571 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 37.1 Cg_endo -75.47 124.76 8.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 N-CA-C 107.826 -1.644 . . . . 0.0 107.826 174.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 25.9 p -41.34 108.43 0.09 Allowed 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 105.017 -2.216 . . . . 0.0 105.017 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 136.21 -4.11 3.76 Favored Glycine 0 C--N 1.293 -1.829 0 N-CA-C 105.08 -3.208 . . . . 0.0 105.08 -178.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.733 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 30.5 m95 -116.97 167.48 11.09 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 100.906 -3.738 . . . . 0.0 100.906 179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -93.91 -83.49 0.33 Allowed 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 119.69 3.219 . . . . 0.0 119.69 -179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.775 ' N ' ' SG ' ' A' ' 47' ' ' CYS . 7.6 p30 154.07 153.58 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 128.93 2.892 . . . . 0.0 105.057 179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.519 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -150.66 -31.72 0.18 Allowed 'General case' 0 N--CA 1.509 2.513 0 O-C-N 123.468 0.48 . . . . 0.0 111.642 179.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 46' ' ' CYS . 29.1 mmmt -125.96 88.35 2.84 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 105.849 -1.908 . . . . 0.0 105.849 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -71.45 34.5 0.05 Allowed 'General case' 0 N--CA 1.506 2.345 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.78 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -137.49 -21.39 1.16 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -179.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 155.64 -130.23 2.72 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 107.896 -2.082 . . . . 0.0 107.896 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -61.89 -179.79 5.86 Favored 'Cis proline' 0 C--N 1.311 -1.421 0 CA-C-N 119.167 1.483 . . . . 0.0 113.738 -5.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 6.0 p -78.12 -10.04 59.44 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.358 -1.292 . . . . 0.0 113.177 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 10.9 tt -97.1 -26.17 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-O 121.917 0.865 . . . . 0.0 109.86 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 155.61 27.08 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 105.577 -3.009 . . . . 0.0 105.577 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.504 ' HB2' ' HA3' ' A' ' 28' ' ' GLY . 6.2 m95 -92.59 140.11 29.88 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.497 ' HB2' ' HB2' ' A' ' 37' ' ' LYS . 1.6 m -101.3 117.23 34.56 Favored 'General case' 0 N--CA 1.499 1.996 0 CA-C-N 119.269 0.94 . . . . 0.0 109.359 179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.775 ' SG ' ' N ' ' A' ' 35' ' ' ASN . 14.5 t -129.5 -165.05 1.47 Allowed 'General case' 0 N--CA 1.507 2.416 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.536 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.519 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 14.9 pttp -151.4 152.23 32.81 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 103.558 -2.756 . . . . 0.0 103.558 179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.449 ' HG3' ' CE2' ' A' ' 33' ' ' TRP . 5.6 tt0 . . . . . 0 C--N 1.299 -1.603 0 O-C-N 124.545 1.153 . . . . 0.0 108.367 179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.672 0 N-CA-C 105.435 -3.066 . . . . 0.0 105.435 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 83.4 t -89.68 157.09 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 101.757 -3.423 . . . . 0.0 101.757 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 21' ' ' THR . 16.6 m -70.61 167.73 17.92 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.141 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 42.6 t -160.1 121.22 3.09 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.645 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.545 HD22 ' CB ' ' A' ' 9' ' ' ASP . 9.5 mt -59.57 164.66 3.37 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-O 121.504 0.668 . . . . 0.0 110.775 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.47 ' C ' ' H ' ' A' ' 8' ' ' SER . 26.8 m -101.0 158.51 15.95 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 113.736 -1.575 . . . . 0.0 114.998 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.481 ' OD1' ' NZ ' ' A' ' 37' ' ' LYS . 6.6 m-20 -73.77 30.13 0.07 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.47 ' H ' ' C ' ' A' ' 6' ' ' CYS . 2.4 t -129.74 -12.4 4.3 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 111.855 -2.43 . . . . 0.0 107.562 179.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.545 ' CB ' HD22 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -98.51 -178.54 4.04 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 115.006 1.484 . . . . 0.0 115.006 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.39 -175.96 34.33 Favored Glycine 0 N--CA 1.497 2.746 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.62 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -77.82 166.97 24.56 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 123.4 2.733 . . . . 0.0 112.106 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -90.61 93.79 9.42 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-O 123.48 1.61 . . . . 0.0 110.703 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.0 t -129.29 21.74 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.975 0 CA-C-N 111.903 -2.408 . . . . 0.0 107.259 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.443 ' C ' ' H ' ' A' ' 16' ' ' ASN . 30.1 ttm180 76.28 163.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 112.744 -2.025 . . . . 0.0 107.24 -179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.16 -47.78 3.37 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 103.517 -3.833 . . . . 0.0 103.517 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.443 ' H ' ' C ' ' A' ' 14' ' ' ARG . 3.2 p-10 -61.0 167.28 3.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 125.234 1.196 . . . . 0.0 107.866 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 18' ' ' LEU . 11.7 t -134.96 -166.4 1.82 Allowed 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.408 -0.917 . . . . 0.0 109.252 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.508 HD12 ' C ' ' A' ' 17' ' ' THR . 6.2 mp -110.87 99.91 8.74 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 126.5 1.92 . . . . 0.0 109.315 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.1 p -95.69 -6.32 40.21 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 120.221 -0.591 . . . . 0.0 111.642 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -141.42 -174.24 14.23 Favored Glycine 0 N--CA 1.483 1.767 0 CA-C-O 122.372 0.985 . . . . 0.0 112.608 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.647 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 99.6 m -151.17 155.41 38.82 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -104.81 141.12 37.07 Favored 'General case' 0 C--N 1.28 -2.451 0 CA-C-N 112.304 -2.225 . . . . 0.0 108.325 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.429 ' CE2' ' HG3' ' A' ' 30' ' ' PRO . 78.2 m95 -111.85 133.43 54.07 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 112.292 -2.231 . . . . 0.0 110.83 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 7.7 mt -89.25 -16.51 31.03 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 110.977 -2.829 . . . . 0.0 109.293 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -60.65 143.38 90.64 Favored Pre-proline 0 C--N 1.3 -1.584 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.381 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -66.93 -9.95 26.72 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 121.882 1.721 . . . . 0.0 113.62 -165.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 p -117.47 12.14 14.08 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.113 -1.403 . . . . 0.0 109.328 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.55 ' HA3' ' CG ' ' A' ' 45' ' ' TRP . . . 67.59 -117.21 8.59 Favored Glycine 0 C--N 1.299 -1.508 0 CA-C-N 113.984 -1.462 . . . . 0.0 116.231 179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.741 ' SG ' ' HB3' ' A' ' 33' ' ' TRP . 2.7 t -51.3 113.05 3.51 Favored Pre-proline 0 C--N 1.296 -1.729 0 CA-C-N 110.839 -2.68 . . . . 0.0 112.562 -179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 33' ' ' TRP . 83.2 Cg_endo -80.92 138.21 11.45 Favored 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 123.161 2.574 . . . . 0.0 110.851 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.2 m -46.33 99.45 0.02 OUTLIER 'General case' 0 C--N 1.281 -2.396 0 CA-C-N 111.777 -2.465 . . . . 0.0 111.702 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 139.23 -1.52 2.46 Favored Glycine 0 C--N 1.297 -1.592 0 N-CA-C 105.424 -3.07 . . . . 0.0 105.424 -179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TRP . . . . . 0.741 ' HB3' ' SG ' ' A' ' 29' ' ' CYS . 21.7 m95 -109.65 -153.85 0.52 Allowed 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.619 ' C ' ' SG ' ' A' ' 47' ' ' CYS . 17.7 t-160 -150.52 -101.34 0.07 Allowed 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.489 0.661 . . . . 0.0 110.215 -179.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.582 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 0.4 OUTLIER -169.78 157.76 7.06 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 179.168 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.663 ' SG ' ' HB3' ' A' ' 48' ' ' LYS . 0.1 OUTLIER -150.54 -39.03 0.13 Allowed 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 118.893 -1.123 . . . . 0.0 108.186 179.511 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.481 ' NZ ' ' OD1' ' A' ' 7' ' ' ASP . 22.2 mmmt -101.31 114.48 28.5 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 104.05 -2.574 . . . . 0.0 104.05 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.43 ' O ' ' ND1' ' A' ' 39' ' ' HIS . . . -76.89 10.33 2.34 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.893 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.43 ' ND1' ' O ' ' A' ' 38' ' ' ALA . 17.0 m-70 -133.26 -127.35 0.17 Allowed 'General case' 0 N--CA 1.495 1.794 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.38 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.53 -145.65 10.21 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.1 -177.27 17.38 Favored 'Cis proline' 0 N--CA 1.499 1.842 0 CA-C-N 117.968 0.884 . . . . 0.0 111.764 7.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 4.4 t -91.14 -6.53 53.45 Favored 'General case' 0 N--CA 1.501 2.11 0 C-N-CA 118.755 -1.178 . . . . 0.0 108.362 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 45.6 mm -116.89 96.75 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 102.734 -3.061 . . . . 0.0 102.734 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 85.01 157.41 27.71 Favored Glycine 0 N--CA 1.499 2.885 0 N-CA-C 107.368 -2.293 . . . . 0.0 107.368 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TRP . . . . . 0.55 ' CG ' ' HA3' ' A' ' 28' ' ' GLY . 1.3 m95 -109.68 157.59 18.95 Favored 'General case' 0 N--CA 1.503 2.216 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.423 ' HB3' ' HG3' ' A' ' 37' ' ' LYS . 7.5 m -117.06 119.3 34.85 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 123.079 1.418 . . . . 0.0 109.137 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.619 ' SG ' ' C ' ' A' ' 34' ' ' HIS . 9.0 t -134.63 -163.76 1.42 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-N 113.627 -1.624 . . . . 0.0 112.408 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.663 ' HB3' ' SG ' ' A' ' 36' ' ' CYS . 0.0 OUTLIER -151.04 149.71 29.87 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 104.183 -2.525 . . . . 0.0 104.183 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' C ' ' CE ' ' A' ' 48' ' ' LYS . 46.3 tt0 . . . . . 0 C--N 1.304 -1.387 0 CA-C-O 117.492 -1.242 . . . . 0.0 111.361 -179.9 . . . . . . . . 1 1 . 1 stop_ save_